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Chinese! Hamster! Ovary! (CHO)! cells! are! the! industrial! standard! and! production!
vehicle!of!choice!for!recombinant!therapeutic!protein!manufacture.!This!is!largely!
due!to!their!capacity!to!be!suspension!adapted!to!warrant!a!high!cell!density!and!
scalePup! in! large! bioreactors! and! also! their! ability! to! execute! postPtranslational!
modifications! such! as! glycosylation! (Tescione! et# al.! 2015).! Their! prevalence! has!
lead! to! constant! commercial! competition! to! improve! and! develop! new! CHO! cell!
lines!that!are!better!able!to!produce!therapeutic!products,!either!in!terms!of!their!
cell!specific!productivity,!their!growth!rate!or!of!the!quality!and!efficacy!of!the!final!
drug!product.!A!popular!method!of! improving!cell!specific!productivity! is! to!shift!
dense! cell! cultures,! proliferating! at! their! optimum! temperature! (~37°C)! to!
hypothermic!conditions!(~32°C),!arresting!cell!cycle!progression.!This!strategy!has!
been!correlated!positively!on!numerous!occasions!with!multiPfold!increases!in!cell!
specific! production! rates! (Kumar! et# al.! 2008;! Tan! et# al.! 2008;! Masterton! et# al.!
2010).! However,! it! is! realised! that! if! this! effect! could! be! simulated! without! the!
hindrance!of!cell!cycle!arrest,!then!overall!titre!could!be!improved!even!further.!A!
common!attempt!at!resolving!this!as!been!to!adapt!stably!producing!CHO!cells!to!




The! work! described! in! first! research! chapter! of! this! thesis! demonstrates! an!
alternative!approach! in!which!a!host!(not!stably!producing)!CHOK1SV!cell! line! is!
adapted!to!hypothermia!prior!to!stable!transfection.!Once!adapted,!it!was!observed!
that! cell! size! is! increased! substantially! compared! to! the!parental!phenotype.!Not!
only! this,! but! protein! content! and! RNA! content! were! shown! to! also! increase!
proportionately! whilst! the! number! of! sets! of! chromosomes! (ploidy)! remained!
normal,! implying! inherently! improved! transcription! rates! in! the! hypothermiaP
adapted!cells.!!
Following!this,!in!second!research!chapter,!production!functionality!was!assessed!
in! the! hypothermiaPadapted! cultures! which! showed! an! impressive! ~100%!
increase!in!reporter!protein!(SEAP)!production!compared!to!the!parental!cultures.!
This! high! productivity! was! also! mirrored! using! industrially! relevant! proteins,!
cB72.3! and!Enbrel,!where! in! both! transient! and! stable! production! platforms! the!
hypothermiaPadapted! cell! line! consistently! outperforms! the! parental! cell! line.!
Supportive! evidence! is! also! presented! that! the! evolution! process,! that! was!






the! biology! that! may! underpin! the! observed! differences.! There! is! strong!
supporting!evidence,! including! low!reactive!oxygen!species!(ROS)!and!disparities!
in!mitochondrial!function,!that!the!evolved!cell!line!could!be!undergoing!adaptive#
non-shivering# thermogenesis! to! overcome! the! stress! of! hypothermia.! Using!
Affymetrix®! differential! gene! expression! analysis,! 974! significantly! upPregulated!
transcripts! were! observed! in! the! evolved! cell! line.! Such! transcripts! concerned:!
adaptive!thermogenesis,!increase!in!cell!membrane!fluidity!(a!common!response!to!





most! interestingly! in! the! increased! uptake! of! proline! in! the! evolved! cell! line.!
Uptake! of! proline! has! been! shown! in! other! model! organisms! to:! act! as! a!
cryoprotectant! and!molecular! chaperone! to! stabilise! the! structure! of! proteins! in!
hypothermic! conditions;! play! a! key! role! in! antioxidant! systems!by! reducing!ROS!
concentrations;! influence! membrane! fluidity! and! also! maintain! osmotic! balance!
(Kumar!&!Yadav!2009;!Ishmayana!et#al.#2011;!Hayat!et#al.#2012;!Koštál!et#al.!2012;!
Liu!et#al.!2013).!!
Many! potential! genePengineering! targets! have! been! identified! as! a! result! of! the!
mechanistic!analysis!that!could!permit!the!development!of!new!cell! lines!without!
the! need! for! a! long,! directed! evolution! process.! That! said,! however,! the! shear!































































































































































































































3.1! A! staggered! passaging! regime! schematic! to! show! how! different!
combinations!of!dilution!ratio!and!number!of!cell!divisions!can!be!achieved.!










3.7! The! viable! cell! density! over! time! for! control! cultures! seeded! at! 0.2! ×106!
cells/!mL!and!passaged!every!3!or!4!days.!
3.8!The!growth!rate,!µ! (daysP1),!over! time! for!cultures!seeded!at!1!×106!cells/!
mL,!3!×106!cells/!mL!and!5!×106!cells/!mL!and!passaged!every!day.!


































3.24! The! flow! cytometry! cell! cycle! profile! of! a! culture! from! the! primary! cell!
bank!(figure!3.2,!step!2)!that!was!cultured!shortPterm!(several!passages)!at!
37°C.!
3.25! The! growth! rate! and! cell! size! of! A)! culture! 30A,! B)! culture! 30B! and! C)!
culture!30C!at!32°C,!preP!and!postP!cryopreservation.!
4.1! Example! histograms! to! show! the! determination! of! transfection! efficiency!
using!GFP!and!flow!cytometry.!






4.3! Example! histograms! to! show! the! typical! transfection! efficiency! profile!
achieved!by!electroporation!transfection.!!
4.4! The! median! fluorescence! (24! hours! postPtransfection)! of! all! cell! cultures!
(32A,! 32B,! 32C,! 37A,! 37B!and!37C)! transfected! (via! electroporation)!with!
GFP!and!incubated!postPtransfection!at!both!32°C!and!37°C.!
4.5!The!transfection!efficiencies!(24!hours!postPtransfection)!of!all!cell!cultures!
(32A,! 32B,! 32C,! 37A,! 37B!and!37C)! transfected! (via! electroporation)!with!
GFP!and!incubated!postPtransfection!at!both!32°C!and!37°C.!
4.6! Example! histograms! to! show! the! typical! transfection! efficiency! profile!
achieved!by!lipofection!transfection.!
4.7! Transfection! efficiencies! (24! hours! postPtransfection)! of! evolved! and!
parental!cell!lines,!at!their!native!temperatures,!transfected!(via!lipofection)!
with!GFP!according!to!different!DNA:!Lipofectamine!ratios.!
4.8! Median! fluorescence! values! (24! hours! postPtransfection)! of! evolved! and!
parental!cell!lines,!at!their!native!temperatures,!transfected!(via!lipofection)!
with!GFP!according!to!different!DNA:!Lipofectamine!ratios.!
4.9! Culture! viability! (24!hours! postPtransfection)! of! evolved! and!parental! cell!








4.13!Day! 4! (3! days! postPtransfection)! transfection! efficiencies! of! evolved! and!
parental! cell! lines! under! a! longPterm! transient! fedPbatch!platform!at! both!
32°C!and!37°C.!!!
4.14! Day! 4! (3! days! postPtransfection)! median! fluorescence! of! evolved! and!
parental! cell! lines! under! a! longPterm! transient! fedPbatch!platform!at! both!
32°C!and!37°C.!









either! stably! transfected! pools! of! evolved! or! parental! CHOK1SV! cells,! or!






5.2! Fluorescence! of! parental! and! evolved! cell! lines! stained! with! CellROX®!
Oxidative!Stress!Deep!Red!Reagent.!
5.3! Insights! into! cellular! mitochondrial! respiration,! including! oxygen!




5.4! Optimisation! titrations! of! A)! Oligomycin,! B)! FCCP! and! C)! Antimycin! A! &!
Rotenone!for!use!in!the!XF24!Mitochondrial!respiration!assay!system.!
5.5! The! OCR! of! parental! and! evolved! cell! lines! over! the! time! course! of! a!
complete!XF24!mitochondrial!assay.!
5.6!Individual!parameters!(basal!respiration!(A),!maximal!respiration!(B),!ATP!
production! (C),! proton! leak! (D),! nonPmitochondrial! respiration! (F)! and!
sparePrespiratory!capacity!(E))!that!can!be!inferred!from!measurements!of!
oxygen! consumption! rates! (OCR)! from! the! Seahorse! XF24! mitochondrial!
assay.!
5.7!Example!of!an!electropherogram!produced!by!the!Agilent!2100!Bioanalyzer.!





5.10! Transcript! expression! (Avg.! fluorescence)! ranges! for! both! parental! and!
evolved!cell!lines.!
5.11! Functional! grouping! of! significantly! differentially! expressed! transcripts!
with!a!fold!change!of!≥!2.!










5.15! Expression! of! endoplasmic! reticulum! (ER)−associated! transcripts! in! the!
evolved!cell!line!versus!the!parental!cell!line.!
5.16! Expression! of! oxidative! stress−associated! transcripts! in! the! evolved! cell!
line!versus!the!parental!cell!line.!
5.17! Expression! of! mitochondria/! mitochondrial! energy!
metabolism−associated! transcripts! in! the! evolved! cell! line! versus! the!
parental!cell!line.!
5.18! Expression! of! cell! cycle−associated! transcripts! in! the! evolved! cell! line!
versus!the!parental!cell!line.!
5.19! Expression! of! transcripts! associated!with! cellular! responses! to! stress! in!
the!evolved!cell!line!versus!the!parental!cell!line.!










5.27!Absolute!amino!acid!concentrations! in!supernatant! throughout! fed!batch!
culture!of!the!parental!(A)!and!evolved!(B)!cell!lines.!
5.28!Specific!amino!acid! transport! rates!of! the!parental!and!evolved!cell! lines!
through! earlyPexponential,! midPexponential! and! stationary! phases! of! fed!
batch!culture.!
5.29! Summed! specific! amino! acid! import! and! export! transport! rates! of! the!
parental!and!evolved!cell! lines!through!early!exponential,!mid!exponential!







and! evolved! cell! lines! through! early! exponential,! mid! exponential! and!



















3.1! The! relationship! between! increasing! generation! number,! number! of! cells!
and!number!of!cell!divisions.!
3.2! A! summary! of! data! from! the! optimisation! of! cell! culture! passaging!
parameters!for!rapid!evolution!of!growth!rate.!











5.4! Summary! of! Agilent! 2100! Bioanalyzer! data! including! RNA! Integrity!
Numbers! (RIN)! and! rRNA! ratios! [28S/18S],! for! the! samples! used! in!
Affymetrix®!GeneChip®!array.!







































































































































This% chapter% introduces% and% discusses% the% literature% that% underpins% the% work%
described% later% in% this% thesis.% Specifically,% this% section%will% review% the%history% of% the%
biopharmaceutical% industry% with% a% spotlight% on% recombinant% therapeutic% protein%
production,% focusing% on% crucial% milestones% and% highlighting% examples% of% the%
advantages,% disadvantages,% obstacles% and% achievements% that% the% industry% has%
experienced% to% date.% A% more% detailed% examination% on% the% use% of% mammalian% cell%
culture,%particularly%Chinese%Hamster%Ovary%(CHO)%cells,% for%the%production%of% large%
and% complex% products% such% as% monoclonal% antibodies% (mAbs)% will% follow% this.% The%
future% and% predicted% directions% for% the% industry% will% also% be% considered% alongside%
emerging%technologies.%To%conclude%this%section,% the%biology%and%relevant% literature%











synthesis,( where( the( initial( substance( is( derived( from( a( natural( host( but( is(
subsequently( modified( by( organic( chemistry( to( become( a( biologically( active(
pharmaceutical,(for(example(semiEsynthetic(antibiotics.(Thirdly,(there(is(the(group(
of(drugs(that(are(acquired(by(direct(extraction(from(a(natural(biological(source,(for(
example,( alkaloids.( Finally( and( most( recently( there( is( the( category( of(
biopharmaceuticals(that(has(shown(dramatic(growth(since(its(establishment,(with(
an(average(annual(sales(increase(of(about(20%((Walsh(&(Murphy(1999;(Matasci(et%
al.( 2008).( Biopharmaceuticals( can( be( most( simply( defined( as( medical( drugs(
produced( using( biotechnology.( Specifically,( biopharmaceuticals( are( nonEnative(
products( manufactured( by( an( engineered( host( organism( or( cell,( as( opposed( to(
direct(extraction(or(derivatives(of(inherent,(natural(compounds((Walsh(2010).((The(
biopharmaceutical( industry( encompasses( a( range( of( product( types,( such( as(
proteins( and( nucleic( acids,( constructed( via( a( variety( of( methods( in( a( vast(
assortment(of(different(hosts(or(industrial(workhorses.(
The( production( of( the( first( recombinant( protein( approved( for( therapeutic( use(
occurred( in( 1982( and( was( developed( by( a( company( called( Genentech.( The(




create( a( genetic( sequence( of( nucleic( acids( that(would( not( otherwise( be( found( in(




choice( for( this( therapeutic.( However,( many( drugs( demand( more( complex(
processing( capacities( from( the( host( and( in( such( cases( mammalian( cells( are(
considered(appropriate(workhorses(due(to(their(ability(to(perform(such(tasks((Hu(
2012).(In(1986,(the(emergence(of(mammalian(cell(culture(as(the(biopharmaceutical(
industry’s( main( host( of( choice( was( triggered.( This( was( due( to( the( approval( of(
recombinant( tissue( plasminogen( activator( (TPA),( a( therapeutic( protein( used( to(
Chapter(1:(Introduction(–(Literature(review(and(project(outline(
( 27(
treat( acute( myocardial( infraction( and( embolic( or( thrombotic( stroke,( which( was(
produced( in( Chinese( Hamster( Ovary( cells,( again( by( Genentech( (Goldhaber( et% al.(
1986;(Walsh( 2010).(Mammalian( cells( have( inherent( capacity( for( correct( folding,(
assembly( and( postEtranslational( modifications( of( proteins( that( are( to( be( fit( for(
therapeutic(purposes(in(humans((Hu(2012).((
Although(the(first(therapeutic(recombinant(protein(was(approved(in(1982,(the(first(
monoclonal( antibody( (mAb)( (now( the( most( predominant( type( of(
biopharmaceuticals)(was(produced(years(before(in(1975(by(hybridoma(technology(
(Köhler( &( Milstein( 1975).( In( short,( this( technology( comprises( of( exposing(
(immunising)( a( mammal,( e.g.( a( mouse,( to( the( antigen( that( an( antibody( is( to( be(
generated(against,(B( cells( are( then( isolated( from( the(mammal’s( spleen(and( these(
are( then( fused( with( immortalised( myeloma( (cancer)( cells( and( after( a( period( of(
selection,( culture( and( screening,( the( antibodies( produced( by( the( fused( cells( are(
harvested( (Nelson( et%al.( 2000).(However,( the( first( therapeutic(mAb(produced( by(
hybridoma(technology(was(not(ready(to(be(released(on(the(market(until(1986(and(
still( then( such( products( harnessed( immunogenic( side( effects,( such( as( the(HAMA(
(human(antiEmouse(antibody)(response(in(which(the(human(body(would(create(a(
new( set( of( antibodies( against( the( hybridoma,( with( patients( suffering( symptoms(
from(mild( rashes( to( lifeEthreatening( renal( failure( (Tjandra( et%al.( 1990).(Not( only(
this,( but( the( efficacy( of( the( mAbs( was( poor( which( is( commonly( attributed( to(




1984).( Chimeric( antibodies( are( around( twoEthirds( human,( however,( despite(
eliciting(the(desired( immune(responses(equivalent( to(those(of(a(human(antibody,(
they( also( stimulated( undesired( immunogenic( reactions( (Waldmann( 2003).( A(
couple(of( years( later( in(1986,(humanised( anitbodies(were(developed(which(were(
90%( human.( These( are( distinct( from( chimerised( antibodies( as( the( protein(






singleEchain( Fv( (scFv)( or( Fab’( molecules( are( displayed( on( the( surface( of( a(
filamentous( bacteriophage.( ( This( is( achieved( by( fusing( sequences( encoding( the(
protein( to( be( displayed( with( genes( encoding( the( pIII( or( pVIII( coat( proteins.((
Screening( a( large( combinatorial( phage( library( of( heavy( and( light( chain( variable(
regions( for( binding( to( a( particular( antigen( (in( Fab’( or( scFv( format)( allows(
identification(of(phage(displaying(scFv(or(Fab’Especific(for(the(antigen((McCafferty(
et% al.( 1990;( Carmen( &( Jermutus( 2002).( These( phage( can( be( purified( and( the(
variable( region( sequenced( cloned.( ( At( this( stage( the( variable( regions( can( be(
engineered(into(a(full(mAb(if(desired.(
By(2002,(phage(display(had(provided(approximately(30%(of(all(human(antibodies(
in( clinical( development( (Kretzschmar(&(Rüdent( 2002).( By( 2005( there(were( also(
over( 30( different( drugs( in( clinical( testing( which( contained( variable( regions(
encoded(by(human(sequences(from(transgenic%animals.(Animals(that(are(transgenic(
contain(a(gene(or(set(of(genes(that(have(been(transferred(from(a(different(organism(
or( species.( Antibodies( produced( in( this( way,( in( addition( to( phage( display(
technologies,( are( considered( fully( human,( with( none( of( the( immune( responses(
associated(with,(for(example,(chimeric(antibodies,(and(therefore(such(products(had(
better(success(in(the(clinic((Lonberg(2005).(
Over( time,(a(variety(of(host(cell( systems(have(emerged( that(can(be(employed( for(
the(production(of(different(recombinant(proteins;(these(include(mammalian(cells,(






Today,( mammalian( cell( culture( is( the( preferred( choice( for( production( of(
monoclonal(antibodies((and(other(recombinant(therapeutic(proteins)(due(to(their(
inherent( cellular( machinery( that( allows( for( better( protein( production,( including(
crucial( postEtranslational( modifications( such( as( glycosylation( (addition( of(
carbohydrate( molecules)( which( promotes( proper( protein( folding( and( stability.(
Glycosylation( also( has( dramatic( impact( on( the( function( and( solubility( of(
recombinant(proteins((Bork(et%al.(2009;(Hu(2012).((




Figure$ 1.1( The$ percentage$ usage$ of$ different$ host$ cell$ systems$ for$
production$ of$ recombinant$ proteins$ approved$ by$ 2009$ for$




















An( array( of( cell( lines( are( available( for( therapeutic( protein( expression,( including(







activator( in( the( 1980’s( E( CHO( cells( have( become( the( dominant( choice( for(
commercial( mAb( production( (Kelley( 2009).( Since( then,( much( knowledge( and(
expertise( has( accumulated( surrounding(CHO( cells,( ensuring( they(have( remained,(
and( are( predicted( to( persist( as,( the( industry’s( premier( workhorse( with( around(
70%(of(all(therapeutic(recombinant(proteins(being(a(product(manufactured(in(CHO(
cells((Jayapal(et%al.(2007).(In(recent(years,(of(the(top(10(selling(biologic(drugs,(CHO(
cells( accounted( for( US$39( billion( in( worldwide( annual( sales,( while( the( other(
production(cell(lines(accounted(for(only(US$14(billion((Jayapal(et%al.(2007;(Noh(et%
al.( 2013).( A( short( account( of( the( history( of( the( Chinese( hamster( and( its(
contribution(to(scientific(research(is(given(in(box(1(below.(
Box$1.(The$Chinese$Hamster$and$its$contribution$to$scientific$research.(
Chinese( hamsters,( Cricetulus% griseus,( belong( to( a( family( of( rodents( native( to(
Mongolian( and(northern(Chinese(deserts.( They(were( first( used( as( a( laboratory(
specimen( for( typing( pneumococci( in( 1919.( By( the( early( 1920’s( they( became(
valuable( tools( for( research( into( epidemiology( due( to( often( being( carriers( of( a(
parasite(known(as(Leishmania(that(causes(black(fever.(As(a(consequence(of(this,(
when( they( were( smuggled( into( the( United( States,( those( responsible( (Dr.( R.(
Watson( and( Dr.( C.( H.( Hu)( were( later( accused( of( war( crimes( resulting( in( the(
imprisonment(of(Dr.(C.(H.(Hu((Yerganian(1985).(In(the(midE20th(century,(efforts(at(












and( karyotype( heterogeneity( between( cell( populations( became( a( key( area( of(
interest( and( a( model( system( for( chromosome( abnormality( studies.( CHO( cells(
later( became( an( in( important( contribution( to( biomedical( and( cell( biology(
research((Jayapal(et%al.(2007).(The(transition(from(laboratory(model(to(industrial(
bioreactors( was( brought( about( by( early( work( involving( mutagenesis( of( these(
cells( and( isolation( of( certain( auxotrophs( (a( mutant( individual( that( has( a(
nutritional( requirement( not( shared( by( the( parent,( e.g.( losing( the( ability( to(
synthesise( particular( compounds( required( for( growth)( (Puck( &( Kao( 1967).(





mutation( in( the( second( allele.( This( cell( line( has( now( become( a( standard(
expression(system(in(many(upstream(processes(requiring(vectorEmediated(gene(
transfer( into( the( cell( (Urlaub( &( Chasin( 1980;( Jayapal( et% al.( 2007)( (see( section(
1.2.2(for(more(details).(Being(able(to(transfect,(select,(amplify(and(subsequently(
stably( express( biologically( active( proteins( quickly( become( of( great( interest( to(
many( biopharmaceutical( companies.( There( is( a( sense( of( irony( that( these(
hamsters,(originally(thought(to(be(planned(for(use(as(agents(of(biological(warfare(






DNA,( via( a( plasmid( expression( vector( or( virally,( into( the( host( cell( nucleus( for(
chromosomal( integration( (although( integration( is( not( always( necessary( –( see(
below).( This( process( is( called( transfection( and( there( are( several( protocols(
commonly(used(including(lipofection,(electroporation(and(polyethylenimine((PEI)(
mediated( transfection.( The( term( ‘transduction’( is( preferred( for( virusEmediated(
DNA( transfer( (Hu( 2012).( Recombinant( therapeutic( proteins( can( be( produced( by(











into( the( host( chromosome( is( very( low( and( even( lower( for( integrating( into( loci(
where(it(will(be(sufficiently(well(expressed.( (Hence,(after(the(host(cells(have(been(
transfected,(a(selection(and(screening(strategy( is( required( to(determine( in(which(
cells( this( has( successfully( occurred.( ( Further( rounds( of( screening( along( with( a(
cloning( step( are( usually( required( to( identify( the( most( suitable( cell( lines( for( a(
manufacturing( process.( ( Depending( on( the( expression( system( being( used,( there(





The( two( most( commonly( used( selection( systems( used( in( industry( are( the(
dihydrofolate( reductase( (DHFR)/(methotrexate( (MTX)( system(and( the( glutamine(
synthetase( (GS)/( methionine( sulphoximine( (MSX)( system,( both( of( which( are(
outlined(below((Butler(2007).(((
1.2.2.1$Dihydrofolate$reductase$(DHFR)/$methotrexate$(MTX)$
DHFR( is( a( small(monomeric( enzyme( that( catalyses( the( conversion( of( a( common(
vitamin,( folic(acid,( into( tetrahydrofolate( (THF).(THF( is(a( cofactor(carrier( for(oneE
carbon( moieties( required( for( multiple( biosynthetic( reactions( including( purine,(
thymidine(and(glycine(synthesis.( (There(are(two(DHFR(deficient((DHFRE)(CHO(cell(






medium( lacking( purine( derivative( (hypoxanthine),( thymidine( and( glycine,( as(
DHFRE(cells(are(auxotrophic(for(these(nutrients.( (Amplification(of(the(cloned(DNA(
can(be(achieved(by(subsequent(culture( in(media(containing(a( folic(acid(analogue,(
methotrexate( (MTX)( that( blocks( DHFR( activity.( Successive( increases( in( the(
concentration(of(MTX(are(applied(during(each(round(of(selection.(This(sequentially(
raises(the(selection(pressure,(requiring(the(transfected(cell(to(increase(expression(
of(DHFR( in(order( to( stay(viable,( in(which(cells(must( survive( further( reduction( in(
DHFR(activity(by(increased(MTX.(Surviving(cells,(in(theory,(will(have(amplified(the(
copy(number(of(the(DHFR(loci(and(due(to(the(genetic(linkage(between(this(and(the(
transfected( gene( of( interest,( this( process( ensures( that( the( transgene( is( too( coE
amplified,(increasing(the(chances(of(isolating(a(high(producing(strain((Butler(2007;(
Jayapal( et% al.( 2007;( Lai( et% al.( 2013).( Due( to( the( successive( rounds( of( increasing(
inhibitor(treatment,(it(is(not(unusual(for(the(above(process(to(take(over(six(months(





Comparable( to( the( DHFR( system,( this( system( works( on( the( principle( of( a( key(
metabolic( pathway( and( a( relevant( inhibitor( for( amplification( and( again,( like( the(
DHFR(system,(the(gene(for(glutamine(synthetase(and(the(gene(for(the(recombinant(
protein( product( are( coEtransfected( for( integration( into( the( host( cell( genome.((
Glutamine(synthetase(is(the(enzyme(responsible(for(the(biosynthesis(of(glutamine(
from( glutamate( and( ammonia.( In( a( mammalian( cell,( this( reaction( is( the( only(




of( this(and(with(such(cell( lines(a( transfected(GS(gene(can( function(as(a(selectable(
marker(by(permitting(growth(in(glutamine(free(media.(CHO(cell(lines(are(different(
in( the( way( that( they( inherently( can( express( sufficient( glutamine( synthetase(
without( glutamine( supplementation( in( the( growth( media.( Because( of( this,( a(
glutamine( synthetase( inhibitor,(methionine( sulphoximine( (MSX),( is( often(used( to(
inhibit(endogenous(glutamine(synthetase(activity(so(that(only(cells(with(additional(




This( system( can( be( further( enhanced( by( using( a( GSEknockout( parental( cell( line(
which( has( had( the( endogenous( GS( gene( specifically( targeted,( meaning( the(














only( in( the( last( two( decades( has( it( been( scaled( up( for( use( in( biopharmaceutical(
work.(Transient(gene(expression(is(typically(reputed(for(producing(lower(yields(of(
recombinant(product(compared(to(stable(gene(expression(as(the(genetic(material(is(
only( transiently( expressed.( In( this( type( of( gene( expression,( all( of( the( cells( are(





is( because( those( cells( that( have( not( been( transfected( will( still( be( viable( and(
consequently(use(up(nutrients(and(space(in(the(culture(media(that(would(be(more(
valuable( if( utilised( by( the( productive( cells.(However,( some( transfection(methods(
can(be(toxic(to(cells(so(the(optimisation(process(often(has(to(determine(a(balance(
between(these(factors((Geisse(&(Fux(2009;(Hu(2012).(
Transient( transfection( is( often( employed( at( the( early( stages( of( development,(
commonly(to(test(the(effect(of(the(production(process(on(the(end(characteristics(of(
the( recombinant( product( (Condreay( et% al.( 1999;( Butler( 2007).( This( is( because,(
compared( to( stable( gene( expression,( the( transient(process( is(multipleEfold( faster(
and( conducted( in( a( matter( of( weeks( as( opposed( to( many( months.( Performing(
product( tests( from(stable(cell( lines(would(be(costly( in( terms(of(consumables(and(
labour,(particularly(if(the(product(possessed(undesirable(characteristics(at(the(end(






as( the( product( and( the( choice( of( cell( line( is( paramount( to( process( performance(
(Jenkins( et% al.( 1996;( Croset( et% al.( 2012).( Transient( production( also( offers( the(
opportunity( for( small( amounts( of( new(drugs( to( be(manufactured( for( early( stage(
clinical(trials(and(also(production(on(a(small(scale(for(prospective(personal(drugs(
or(drugs(for(rare(illnesses.(However,(the(yields(from(transient(gene(expression(are(
increasing( as( technology( advances( and( protocols( are( optimised( and( there( is(





After( cell( line( development,( scaleEup( procedures( and( production( of( the(
recombinant(protein(in(the(bioreactor,(the(product(is(then(harvested(and(must(be(















The(obvious(contaminants( that(need( to(be(removed(are( the(biomass( (cell(debris,(
host(cell(proteins(which(can(damage(the(product,(DNA(etc.)(and(water.(In(addition(
to( these,( product( variants( (for( example( if( the( protein( product( has( become(
truncated,(aggregated(or(hydrophobic)(must(also(be(removed(during(downstream(
purification.(Since(mAbs(are(secreted(into(the(cell(culture(medium,(the(removal(of(
cells( is( usually( achieved( by( centrifugation,( however,( this( process( does( not(
completely(remove(all(cell(components(and(subsequently(depth%filtration(steps(are(
implemented.( Depth( filtration( refers( to( the( use( of( porous( materials( that( are(
capable( of( capturing( particulates( throughout( its( matrix( rather( than( just( on( its(
surface((Fiore(et%al.(1980;(Shukla(et%al.(2007).(In(bioprocessing,(such(tools(usually(
comprise(of(polypropylene(or(cellulose(fibres(with(a(filter(aid(and(binder(and(are(
single(use.(The(pore( size(usually( ranges( from(0.2(µm(to(0.45(µm(and( removal(of(
certain(contaminants(in(this(step(has(shown(to(prevent(potential(issues(in(the(next(





affinity( for( Protein( A( will( be( retained( in( the( column( and( all( other( nonbinding(
proteins(will(flow(through.(The(mAb(product(can(then(be(eluted(from(the(column(
using(a(low(pH(solution(that(disrupts(the(protein(A–mAb(complexes.(This(process(
is( highly( selective( and( can( yield( a( product( of( over( 99%( purity( (Gagnon( 1995;(
Shukla( et%al.( 2007).( The( FDA( stipulates( two( orthogonal( dedicated( steps( for( viral(
reduction( and( the( next( purification( stage( is( a( low( pH( viral( inactivation.( Low( pH(
treatment(has(been(shown(to(fully(inactivate(retroviruses(for(a(variety(of(products(
in( the( biopharmaceutical( industry( (FDA( Q5A( Guidance( Document( 1998).( The(
addition( of( an( acid( solution,( such( as( 0.5( M( phosphoric( acid,( to( the( elution( pool(
lowers(the(pH(to(below(3.8.(Strong(acids(such(as(HCl(are(not(usually(used(due(to(





exist( more( stably.( Subsequent( steps( are( known( as( ‘polishing( chromatographic(




pressurised( tanks.( Following( the( above( downstream( purification( processes,( the(
product( is( then( buffer( exchanged( in( an( ultrafiltration/( diafiltration( system.( The(
retentate(from(this(step(is(then(filtered(to(generate(the(bulk(drug(substance(–(this(
step( is( called( absolute( filtration.( The( product( is( then( ready( for( ‘fill( and( finish(
operations’( which( incorporate( a( range( of( processes( depending( on( the( product,(
including(freezeEthawing,( freeze(drying/( lyophilisation(and(filling((dispensing(the(
product(into(vials,(syringes,(etc.)((Patro(et%al.(2002;(Shukla(et%al.(2007).((
Downstream( process,( although( not( central( to( the( work( described( later( in( this(
document,(is(an(extremely(important(part(of(biopharmaceutical(bioprocessing(and(
in(the(case(of(monoclonal(antibodies(accounts(for(80E90%(of(the(total(production(
costs.( It( is( relevant( to( upstream( processes( in( the( way( that( modifications( of(
upstream( processes( can( have( considerable( knockEon( effects( downstream.( For(
example,( if(viable(cell(density(during(expression(can(be( increased,(or(cell(specific(
productivity( can( be( significantly( improved,( there( will( be( a( higher( proportion( of(
product( in( the( culture( supernatant( and( consequently( less( supernatant( running(
through( expensive( downstream( equipment,( for( example,( chromatography(
columns,(which(would(cut(down(materials(costs.(The(purification(process(can(also(







1.4$ The$ current$ state$ and$ outlook$ of$ cell$ culture$ technology$ for$
biopharmaceutical$production(
The( impact( of( advances( in( biopharmaceutical( manufacturing,( particularly( using(
CHO( cell( lines,( on( the( pharmaceutical( industry( as( a( whole( is( vast.( Monoclonal(
antibodies( in( particular( constitute( the( largest( product( category( by( far.( For(
example,(in(2003(there(were(75(candidate(mAbs(in(production(and(just(three(years(
later( this(number(rose( to(400(by(which( time( the(global(annual(sale(of(mAbs(was(
US$20.6( billion( (CocoEMartin( &( Harmsen( 2008).( By( 2009,( another( three( years(
later,( mAb( sales( grew( to( US$38( billion( out( of( the( total( US$99( billion(
biopharmaceutical( market( (Evers( 2010;( Walsh( 2010).( Most( of( this( growth( has(
been(attributed( to(better(production(of( cell( lines(and(optimisation(of( cell( culture(
strategies( as( opposed( to( simple( but( costly( expansion( of( culture( volumes( and(
reactor(sizes((Walsh(2010).(
There( are( two( key( approaches( of( cell( and(metabolic( engineering( strategies( that(
have(greatly(increased(titre(of(product;(1)(increasing(cell(specific(productivity((qP)(
and(2)(increasing(the(integral(viable(cell(concentration/(density((IVCC/(IVCD)(–(the(
total( amount( of( cellular( biomass( that( can( be( maintained( in( a( viable( state( in( a(
bioreactor(over(the(culture(time(period.(These(two(approaches(are(exemplified(by(
two( significant( pieces( of( research( conducted( by( different( groups.( Firstly,( the(
identification(and(subsequent(delay(or(even(elimination(of(programmed(cell(death(
has( been( important( for( increasing( IVCD.( Initial(work( on( this( focussed( on( BclE2/(
BclEX(L),( which( are( effectors( of( apoptosis( well( characterised( by( cancer( studies.(
These(genes(were(overexpressed( in(CHO(cells(and( it(was( found( that(overall( titre(
could( be( greatly( increased( without( loss( of( product( quality( (Majid( et% al.( 2007;(
Carlage( et% al.( 2012).( It( was( also( demonstrated( that( BclE2( transfected( cell( lines(
became(more( robust( in( the( sense( that( they(became(more( resistant( to( changes( in(
pH,(hyperosmotic(media(and(high(concentrations(of(ammonia(and(lactate((Dorai(et%
al.( 2009).(Although(not( historically( as( successful( as( attempts( at( increasing( IVCD,(




and( assembly( of( the( protein( product.( These( rates( can( vary( greatly,( introducing(




the(endoplasmic(reticulum.( In(2005,(Borth(et%al.(hypothesised(that(an( increase( in(
folding( and( assembly( machinery( would( make( the( cellular( production( of( a( mAb(
quicker( and( consequently( increase( qP.( They( found( that( overexpression( of( PDI(
alone( caused( an( increase( in( specific( product( secretion( rate( by( 37%( (Borth( et%al.(
2005;(Butler(&(MenesesEAscosta(2012).((
The(expression(level(of(the(transgene(can(also(be(attributed(to(the(vector(design(as(
well( as( the( loci( of( integration( of( that( vector( and( vast( improvements( have( been(
made(in(this(area((Le(et%al.(2015).(For(example,(there(has(been(much(focus(on(the(
optimisation(of(the(promoter(region((the(region(that(drives(the(expression(of(the(
transgene).( Typically,( promoters( have( been( chosen( because( of( their( availability(
and(most( frequently( this( has( included( promoters( derived( from( viruses,( humans(
and( mice.( However,( more( recently,( promoters( from( CHO( cells( have( also( gained(
attention( including( timeEdynamic( promoters( that( can,( for( example,( drive(
expression( of( the( transgene( in( concert(with( cell( growth.( Endogenous( promoters(
such( as( these( offer( more( predictable( expression( levels( (Le( et% al.( 2013).( The(
construction(of(synthetic(promoters(has(also(been(of(interest(as(way(of(modulating(
gene( expression( levels( (Brown( et% al.% 2014).( Synthetic( promoters( allow( the(
regulatory( motifs( to( be( customised( into( different( combinations( offering( precise(
control( of( recombinant( transcriptional( activity,( whilst( also( being( less( speciesE










expression( stability( and( high( expression( levels,( as( well( as( engineering( the( host(
cells(characteristics((Le(et%al.(2015).(As(more(and(more(genome(sequences(of(host(
and( producer( cell( lines( become( readily( available( (Xu( et%al.( 2011;( Brinkrolf( et%al.(




Box$ 2.$ “‘Omics”$ and$ its$ contribution$ to$ advances$ in$ biopharmaceutical$
production$
Since( the( publication( of( the( full( human( genome( sequence( in( 2003,( a( key(
milestone( in(genetic( research,( it(has(become(ever(easier,( faster(and(cheaper( to(
sequence(macromolecules((DNA,(RNA(etc.).(This(has(meant(the(information(that(
can(be(derived(from(such(data(is(no(longer(an(unattainable(notion(to(researchers(
in(many( fields( (Kandpal( et% al.%2009).( Subsequently,( research( focus( has(moved(
beyond( the( genome( to( the( role( of( genes,( including( transcriptional( regulation,(
biochemical(functions(of(the(gene(products(and(how(they(influence(metabolism.(
This( has( resulted( in( a( collection( of( fields( of( research( (such( as( transcriptomics,(
proteomics( and( metabolomics)( that( have( collectively( been( coined( ‘omics,(
inspired(by(the(original(term,(genomics.(Through(further(bioinformatics(analysis,(
useful(information(can(be(derived,(for(example,(identifying(potential(gene(targets(
and( key( pathways( for( engineering( purposes( (Yan( et% al.( 2015).( To( put( this( in(
perspective,(in(the(last(halfEdecade,(over(1000(peerEreviewed(articles(have(been(
published( involving( ‘omics( technologies( in( combination(with(CHO(cells( alone(–(
not(accounting( for(other( types(of(production(hosts.(Prior( to( this,( less( than(200(
studies(of(this(vein(had(been(published(in(total,(demonstrating(the(rapid(growth(
of( interest( in( this( area( (Lewis( et% al.( 2016).( The( use( of( ‘omics( in( the(





modified( to( achieve( more( desirable,( fitEforEpurpose( phenotypes.( However,(
unwanted( genetic( modifications( can( also( arise,( including( genetic( duplications(
and(chromosomal(rearrangements,(often(due(to(environmental(stresses(such(as(
media( adaptation( and( other( culture( conditions.( As( a( consequence( of( this,(
industrial(cell( lines(show(distinctive(genomes(and(epigenetic(profiles.(However,(
comparison( between( recombinant( cell( lines( has( been( found( to( be( rather(
complex,(and(such(cell(lines(tend(to(be(preferentially(compared(to(their(parental,(
unmodified( versions( that( serve( as( a( reference.( This( information,( coupled(with(
reliable(gene(annotation,(has(been(used(to(understand(cellEline(specific(cellular(
responses( to( system( perturbations( as( well( as( enabling( high( throughput(
methodologies( such( as( microarray( profiling( (Becker( et% al.( 2011;( Rupp( et% al.(
2014).( Other( work( has( examined( transcripts( that( are( differentially( expressed(
through( the( course( of( batch( culture,( including( lag,( exponential( and( stationary(
phases.( Over( 1400(mRNAs(were( found( to( be( differentially( regulated( over( this(
time( frame,( alongside( 100(micro( (mi)RNAs( whose( primary( role( is( to( regulate(
mRNAs.( This( work( gave( valuable( insights( into( understanding( growthEphase(




Proteomics,( too,( has( provided( valuable( information( for( biopharmaceutical(









sophisticated( proteomic( techniques( have( allowed( the( characterisation( of(
glycosylation( patterns( to( be( linked( to( corresponding( genomic( modifications(
(North(et%al.(2010).(
A( common( problem( in( research( and( development( in( the( biopharmaceutical(
industry( lies( in( the( scale( up( from( bench( to( manufacturing( volumes( E( there( is(
often(disparity(when(trying(to(predict(how(a(cell(line(will(perform(in(largeEscale(
bioreactors( from( laboratory( scale(experiments,( even( though(culture(media(and(
parameters( are( kept( the( same( (Lewis( et% al.( 2016).( Metabolite( profiling( is( a(
branch(of(‘omics(that(has(shed(some(light(on(this(issue.(For(example,(Aranibar(et%
al.( (2011)( compared( the( intra( and( extracellular( metabolite( profiles( of( a(




From( the( emergence( of( ‘omics( technologies( in( many( areas( of( bioprocess(
development,( alongside( continual( investment( from( large( biopharmaceutical(
companies(in(to(the(improvement(of(sequencing(platforms,(it(is(evident(that(the(
way( in( which( we( learn( about,( manipulate( and( choose( our( host( cell( lines( for(
protein( production( is( changing.( However,( there( is( still( much( room( for(
improvement( in( this( area:( although( obtaining( the( data( is( becoming( easier( and(
cheaper,(interpreting(such(information(is(the(principal(bottleneck,(alongside(the(
lack( of( sufficient( computational( tools.( There( is( demand( for( an( improved,(
standardised( workflow( for( ‘omics( technologies( and( a( framework( for( their(
integration((Lewis(et%al.(2016).(
(
In( upcoming( years( it( is( also( expected( that( disposable,( single( use( and( reusable(
technologies(will(be( increasingly(adopted(by(GMP((good(manufacturing(practice)(








which( time( there( is(a(constant( flow(of(culture(media(allowing(a(constant(harvest(
volume( to( be( obtained( (Langer( &( Rader( 2014).( Other( great( improvements( in(
mammalian( cell( based( biopharmaceutical( production( have( been( made,( and(
continue(to(advance,(in(areas(such(as:(media,(feed(and(nutrients,(process(control(to(
improve( product( quality,( dissolved( oxygen( control( and( ammonia( reduction( (Zhu(
2012;( Le( et% al.( 2015).( One( commonly( employed( yet( relatively( simple(method( of(
enhancing(production( is( to( introduce(a(phaseEshift( in( temperature,(which,(due( to(
its(extensive(relevance(to(the(work(in(this(thesis,(is(discussed(separately(in(section(
1.6.(
As( patents( expire( and( research( expands,( alternative( strategies( to( improve(
biopharmaceutical( processes( are( constantly( anticipated.( A( moderately( novel(
approach( to( improving( biopharmaceutical( yields( is( that( of( directed( evolution(







used( in(bioprocessing,(particularly( in(CHO(cells.(For(background(purposes(and( in(
order(to(understand(why(certain(methods(are(employed,(the(heterogenetic(nature(








studied( with( regards( to( their( chromosome( structure,( karyotyping( and( gene(
mapping.(As(is(common(for(many(transformed(cell(lines,(CHO(cell(populations(are(
functionally( heterogeneous,( meaning( they( are( diverse( in( their( functional(
phenotypes.( This( diversity( derives( from( an( inherent( genetic( instability( that( can(
modify(chromosomal(arrangement,(transcriptional(activity(and(gene(copy(number(
(Derouazi(et%al.(2006,(Xu(et%al.(2011,(Davies(et%al.(2013).(Since(their(isolation,(it(can(
be( estimated( that( CHO( cells( have( undergone( about( 25000( generations/( division(
events.( ( This,( along( with( their( inherent( heterogeneity( means( their( genome( has(
undergone( constant( rearrangement( that( has( allowed( the( evolution( of( new(




in( different( growth(medias( and( can( reach( high( cell( densities( and(maintain( high(
viabilities(over(a(long(culture(period((Prentice(et%al.(2007).((
Although( genetic( heterogeneity( is( often( used( to( an( advantage( in( terms( of(
generating(new(cell(lines(with(useful(metabolic(traits,(it(is(also(undesirable(because(





short( time( periods( and,( if( a( new( phenotype( confers( a( selection% advantage( (see(




Random,( spontaneous( mutations( in( genes( controlling( apoptosis( and( also( DNA(
repair(and(replication(are(key(drivers(of(genetic(instability.(Such(events(facilitate(a(
high(rate(of(genomic(acquisitions,(alterations(and(deletions((see(section(1.5.2.1(on(
DNA( mutation)( (Lengauer( et% al.( 1998).( Although( relatively( few( specific( genetic(






genes( that(maintain( a( stable( genome,( for( example( DNA(mismatch( repair( (MMR)(
genes,(have(been(made.(Without(a(fully(functional(mismatch(repair(system,(damage(
to( DNA( or( improper( synthesis( of( DNA( during( replication( cannot( always( be(
rectified.( This( is( likened( to( the( process( of( carcinogenesis,(where( a( normal( cell( is(
genetically(reprogrammed(to(undergo(uncontrolled(proliferation(due(to(an( initial(
mutation( in( a(DNA( repair( gene,(which( then( leads( to( a( subsequent(mutation( in( a(
protoEoncogene.(Mutations( in(protoEoncogenes(can(cause(that(gene(to(become(an(
oncogene,(which( in( turn(can( lead( to( the( inactivation(of(other( tumour(suppressor(
genes((O’Callaghan(&(James(2008).(
This( project( aims( to(manipulate( this( genetic( instability( by( directed( evolution( in(
order( to( generate( CHO( cells( with( enhanced( biomanufacturing( properties.(
Specifically,( culturing( regimes( for( rapid( in% vitro( evolution( are( to( be( deciphered,(
which(requires(an(understanding(of(key(evolutionary(processes(that(take(place(in(a(
subEculturing( environment,( namely;( mutation( events( with( respect( to( natural(










organism( genome.( They( are( a( result( of( DNA( damage( that( has( bypassed( relevant(
repair(processes.(Errors(such(as(these(most(often(occur(during(DNA(replication(as(
part( of( cell( division.( Depending( on( the( location( and( severity( of( a( mutation,(
conformational(changes(in(the(protein(encoded(by(that(gene(may(be(induced(that(
can(result( in( the(appearance(of(a(new(phenotype( in( that(organism.(Alternatively,(
some(mutations( are( silent,( meaning( no( observable( or( discernable( changes( have(






1) Spontaneous( mutation( by( molecular( decay( –( this( includes( molecular(
alterations( such( as( nucleotide( base( changes( from( the( repositioning( of( a(
hydrogen(atom(known(as(tautomerism((altering(the(hydrogen(bonding(in(
that( base( leading( to( incorrect( base( pairing( during( replication).( Base(
hydrolysis(is(also(included(in(this(category,(for(example(the(deamination(
of( cytosine( to( uracil( (which( can( usually( be( corrected( by( DNA( repair(
mechanisms)((Alberts(et%al.(2002;(Lodish(et%al.(2008).((
2) Mutagen(induced(mutations(–(these(can(be(a(consequence(of(exposure(to(
certain( chemical( agents( such( as( nitrous( acid( (which( converts( amine(
groups(on(adenine(and(cytosine( to(diazo(groups,(changing( the(hydrogen(
bonding(which(as(previously(mentioned(leads(to(incorrect(base(pairing).(







tolerance( in( which( the( cells( DNA( replication( machinery( is( ‘allowed’( to(
replicate(past(the(point(of(existing(DNA(damage((such(as(thymine(dimers).(
This( involves( switching( from( the( use( of( regular( DNA( polymerases( to(
specialised( translesion( polymerases( that( often( have( active( sites( that(
facilitate(the(insertion(of(bases(opposite(the(damaged(nucleotide(s).(This(
subset( of( polymerases( are( characterised( by( a( high( propensity( to( insert(
incorrect( bases( (have( low( fidelity)( on( intact( DNA( strands( compared( to(
regular( polymerases,( however,(many( are(more( efficient( at( inserting( the(





in( this( category(are(often(due( to(doubleEstrand(breaks( (DSBs).(Although(
DSBs( occur( naturally( at( a( relatively( low( frequency,( their( repair( often(
carries(a(high(chance(of(resulting(mutations.(The(main(repair(pathway(for(
DSBs( is(nonEhomologous(end( joining((NHEJ),(a(process(which(comprises(
of( the( realignment( and( reEjoining( (ligation)( of( the( two( ends( by( the(
addition( of( new( nucleotides( with( no( homologous( template.( When( the(
overhanging( ends( of( a( DSB( are( compatible,( NHEJ( typically( provides(
accurate( repair.( However,( when( overhangs( are( not( compatible,(
nucleotides( are( often( lost( to( allow( ligation( and( this( is( where( imprecise(







of( natural( spontaneous( mutations( arise( due( to( error( prone( replication( (DNA(
damage( tolerance)( and( errors( introduced( during( DNA( damage( repair.( In(
mammalian( cells,( it( has( been( estimated( that( naturally( occurring( DNA( damage(







(transition)( as( opposed( to( purine( replace( by( a( pyrimidine( or( vice( versa(
(transversion).(As( it( takes(three(nucleotide(bases( to(code( for(one(amino(acid,( the(
replacement(of(one(base(may(be(classed(as(silent((where(the(replaced(base(codes(
for(the(same(amino(acid(as(the(original(base(triplet),(neutral((where(the(replaced(
base( codes( for( a( different,( but( chemically( similar( amino( acid,( resulting( in( no(
significant( protein( change),( missense( (where( the( replaced( base( codes( for( a(
different( amino( acid)( or( nonsense( (where( the( replaced( base( codes( for( a( stop(




into( codons( has( changed( from( the( point( of( mutation( (See( figure( 1.2).( Reading(
frameEshifts( can( be( avoided( if( the( number( of( extra( nucleotides( inserted( is( a(
multiple(of(3.(Insertions(in(the(coding(region(of(a(gene(can(alter(mRNA(splicing,(if(a(









• Amplifications( (duplications)( –( resulting( in( multiple( copies( of( that(
chromosomal(region(and(the(genes(within.(
• Rearrangement( mutations( that( juxtapose( pieces( of( DNA( that( were(
previously( independent(–( this(can(occasionally(result( in( functionally(novel(
fusion%genes.(Such(mutations(include:(
o Chromosomal( translocations( –( the( exchange( of( chromosome( parts(
from(nonEhomologous(chromosomes.(
o Chromosomal( inversions( –( reversing( the( orientation( of( a( region( of(
the(chromosome(so(it(is(essentially(‘flipped’(back(on(itself.(
o Interstitial(deletions(–(intraEchromosome(deletion(removing(a(region(
of( the(chromosome( leading( to( the( joining(of( two(previously(distant(
genes.(
• Loss(of(heterozygosity(–(the(loss(of(one(allele((in(organisms(that(ordinarily(
have( two( different( alleles).( This( typically( occurs( by( deletion( or(
recombination(events((Lodish(et%al.(2008).(
5' AUG CGA UUA UAC GGG 3'
Met Arg Leu Tyr Gly
5' AUG CGA UUA UUA GGG G 3'
Met Arg Leu Leu Arg
5' AUG CGA UUA UAC GGG AAA 3'
Met Arg Leu Tyr Gly
5' AUG CGA UUA UAG GGG AA 3'
Met Arg Leu Stop
Insertion
Deletion
Figure$ 1.2$ An$ insertion$ and$ deletion$ mutation,$






homozygous,( meaning( that( the( mutation( is( present( in( only( one( allele( or( both(
alleles,( respectively.( Mutations( can( also( be( classed( according( to( their( effect( on(
phenotypic( function( and( ultimately( effect( on( evolutionary% fitness,( summarised(
below.(
Effect$on$phenotypic$function$
• Gain( of( function(mutations( –( these( are( the( consequence( of( the( new( gene(
product( (usually( a( protein( with( altered( primary,( secondary( or( tertiary(
structure)(now(having(a(new,(novel(phenotype(that(is(functionally(superior(
to( the( original( gene( product.( Resulting( phenotypes( from( these(mutations(
are(often(dominant.(
• Loss( of( function( (amorphic)( mutations( –( are( the( result( of( the( new( gene(
product( having( less( of( a( function( than( the(wild( type.( Sometimes,( the(new(




• Dominant( negative( (antimorphic)(mutations( –( these(mutations( result( in( a(
gene( product( that( is( antagonistic( to( the( wild( type( allele.( They( are( often(
dominant(and(have(been( implicated( in(cancer(and(autosomal(diseases,( for(













To( understand( these( effects,( it( is( important( to( clearly( define( what( is( meant( by(
‘evolutionary( fitness’.( Evolutionary( fitness( is( manifested( by( an( individual’s(
phenotype((observable(traits),(and(it(describes(the(ability(to(survive(and(reproduce(
due(to(such(phenotypes(in(a(given(environment.(Because(the(environment(as(well(
as( underlying( genetics( influences( the( phenotype( it( is( therefore( possible( for( two(
individuals( with( the( same( genotype( but( subjected( to( differ( environmental(
pressures( to( have( different( finesses.( If( two( different( alleles( of( a( gene( confer(
phenotypes( of( varying( fitness,( the( frequencies( of( each( allele( will( change( from(
generation( to( generation,( with( the( allele( of( higher( fitness( eventually( becoming(
more(common((Maynard(Smith(1998;(Michod(2000).(This( is( the(core(principle(of(
natural( selection,( one( of( the( main( processes( of( evolution( (discussed( in( section(
1.5.2.2).(The(different(effects( that(mutations(can(have(on( fitness(are(described(as(
the(following:(
• Neutral( –( these(mutations( have( no( overall( harmful( or( beneficial( effect( on(
the( organism,( meaning( no( decrease( or( increase( in( the( fitness( of( the(
organism.((
• Advantageous( –( these( mutations( result( in( beneficial( effects( on( the(
phenotype,(increasing(the(organism’s(fitness.(
• Deleterious( –( mutations( of( this( type( have( a( negative( effect( on( the(
phenotype,(decreasing(fitness.(






more( or( less( frequent( in( a( given( population.( Phenotypic( variation( exists( in( all(
Chapter(1:(Introduction(–(Literature(review(and(project(outline(
( 53(
populations( (and( as( described( earlier( there( is( much( heterogeneity( in( CHO( cell(
populations),( which( occurs( because( of( genomic( changes( from( mutation( events.(
Some(phenotypes(will(convey(greater( fitness(over(others,(and(although(the(word(
‘selection’( may( imply( the( involvement( of( cognisant( and( active( choice,( natural(
selection(is(simply(the(result(of(those(organisms(of(greater(fitness(having(greater(
ability( to( reproduce( and( pass( on( that( beneficial( phenotype( to( its( offspring,(
resulting( in( that( phenotype( being( present( in( a( larger( proportion( of( the( next(
generation( (Darwin( 1859;( Fisher( 1930).( As( this( process( is( repeated( from(
generation( to( generation,( the(population(evolves(until( that(phenotypic( trait( (and(
underlying( alleles)( is( present( in( every( individual( or,( until( it( no( longer( conveys( a(
selection(advantage((see(figure(1.3(for(schematic(of(the(natural(selection(process).(
The(former(scenario(is(likely(to(occur(if(the(population(is(undergoing(adaptation(to(
a( particular( environmental( condition( or( challenge.( Adaptation( is( another(
evolutionary(process(that(is(maintained(by(natural(selection.(When(a(population(is(
exposed( to( adverse( conditions,( adaptation( allows( survival( and( elevated( fitness(
where(a(nonEadapted(population(would(struggle(or(fail(to(survive((Mayr(1982).(
(
Figure$ 1.3$ Schematic$ of$ the$ natural$ selection$ process.( A( beneficial( mutation( (dots)(
appears( as( generation( 1( gives( rise( to( generation( 2.( This( mutation( conveys( a( selection(
advantage( that( better( enables( that( individual( to( survive( and( consequently( pass( on( its(
genes( (generation( 3).( Over( time,( a( beneficial( mutation( will( propagate( through( the(
population( (so( long( as( it( remains( selectively( advantageous)( until( it( becomes( fixed(
(generation(n).(
(
Mutation,( natural( selection( and( adaptation( are( very( important( processes( of(
evolution( but( are( not( the( only( processes.( For( the( sake( of( completeness,( all(
mechanisms(of(evolution(are(listed(below,(some(of(which(are(more(relevant(to(this(
Generation n Generation 1 Generation 2 Generation 3 
Mutation 










other( evolutionary( processes( (e.g.( mutation( and( adaptation),( the( evolved(
population( has( become( so( genetically( different( to( the( original( population(
that( individuals( from( each( would( no( longer( be( able( to( produce( fertile(
offspring.(As(this(project(concerns(the(subculture(of(an(immortal(cell(line(in%
vitro,(evolution(by(speciation(is(not(further(discussed.((
5) Geneflow( (gene( migration)( –( this( evolutionary( process( describes( the(
transfer( of( alleles( from(one( geographically( distinct( population( to( another,(
again(not(pertinent(considering(the(in%vitro(nature(of(this(project.(
6) Genetic(drift(–(In(short,(genetic(drift(is(the(change(in(frequency(of(an(allele(
in( a( population( due( to( random( sampling.( In( a( subEculturing( regime,( as( is(
routine( practice( in( mammalian( suspension( adapted( cell( culture,( random(
sampling( occurs( at( every( passage,(making( this( evolutionary( process( very(
relevant(to(this(project.(Genetic(drift(is(described(in(more(detail(below.(
Evolution(in(standard( in%vitro(conditions(essentially(occurs( in(a(pattern(as(can(be(






Figure$ 1.4$ The$ evolution$ process$ in,vitro.(As( cells( grow,( they(undergo(mitosis(where(








‘sample’( of( the( alleles( from( the(parent( (previous)( generation( (Masel(2011).(Over(
time,(genetic(drift(can(cause(certain(alleles(to(completely(be(abolished(or(be(fixed(
within(a(population.(When(an(allele(is(fixed(it(simply(means(that(every(individual(
in( that( population( possesses( that( allele.( Fixation( can( happen( due( to( natural(
selection(of(beneficial( alleles(or(due( to(genetic(drift( in( the( case(of(neutral( alleles(
(Futuyma(1998).((
Genetic( drift( is( not( concerned( with( the( fitness( conveyed( by( particular( alleles;(
rather,(it(is(the(role(of(pure(chance(that(some(alleles(just(happen(to(get(passed(on(
to( the( next( generation( while( other( alleles( do( not.( With( genetic( drift,( beneficial,(
neutral( or( disadvantageous( alleles( are( no(more( or( less( likely( to( be( subjected( to(
such(random(events(that(can(change(allele(frequency,(for(example,(a(certain(area(of(
a( population( gets( killed( off( due( to( a( natural( disaster( (Campbell( &( Reece( 2004).(
When(alleles(of(a(gene(do(not(differ(with(regard(to(fitness,(it(is(said(that(on%average(












populations( will( parent( the( next( generation( only( once.( Because( of( this,( the(













genetic(drift:(when( there( are(many( copies(of( an( allele( in( a( given(population( that(
allele(is(less(sensitive(to(the(effect(of(genetic(drift((as(during(sampling(events(there(
is(greater(chance(of(selecting(that(allele(meaning(it(is(more(likely(to(persist(in(the(
next( generation),( whereas( when( there( are( few( copies( of( an( allele( it( is( more(
sensitive(to(the(effect(of(genetic(drift((likely(resulting(in(a(change(in(frequency(of(
that( allele( in( the(next( generation)( (Ewens(2004).( Population( size( is( also( a( factor(
that( can( vary( the( effect( of( genetic( drift( and( the( time% to% fixation( of( an( allele( in( a(





















with( growth( rate( are( neutral( in( an( evolutionary( context;( the( alleles( of( such(will(
‘drift’(in(frequency(from(generation(to(generation.(If(other(selection(pressures(are(
applied,( which( they( will( have( been( during( the( course( of( this( project,( formerly(
evolutionary( neutral( genes( may( now( bear( evolutionary( advantages( under( such(
pressure(and(therefore(be(selected( for.( (There( is(another,( related(source(of(allele(
frequency(change(not(mentioned(thus(far(and(that(is(genetic(draft,(also(known(as(
genetic(hitchhiking.(Genetic(draft( is(a(process(by(which(an(allele(may( increase( in(
frequency( due( to( being( proximal( (linked( loci)( to( genes( that( are( under( positive(
evolutionary(selection(pressure((Gillespie(2001).((
As( discussed,( genetic( drift( can( vary( due( to( different( population( characteristics(
(population/( sample( size,( allele( frequency)( that( can( influence( the( rate( at( which(
alleles( become( fixed( or( abolished( from( a( population.( The( very( first( part( of( this(







effect’,( which( is( defined( as( a( loss( of( genetic( variation( that( occurs( when( a( new(
population( is( established( by( a( very( small( number( of( individuals( from( a( larger(
population.( This( effect( occurs( when( a( sample( of( ‘founder’( members( are( not(
genetically( representative( of( the( population( from( which( they( originated( (Mayr(







This( project( centralises( round( the( aim( that( CHO( cells( with( enhanced(
biomanufacturing(properties(can(be(attained(through(directed(evolution.(This(type(
of(engineering(approach(has(so(far(not(been(ordinarily(applied(as(a(mammalian(cell(
line( development( technique( in( industry,( and( whole( mammalian( cell( directed(
evolution( is(seldom(seen( in(bioprocessing( literature((Hu(2012).( Just(as(yeast(and(
bacteria(have(often(been(adapted(to(tolerate(production(process(byEproducts,(such(
as( ethanol( during( fermentation,( mammalian( cells( too( can( be( adapted( for( better(
performance(in(industrial(processes,(as(will(be(discussed(in(this(section.(
In( 1992,( a( population( of( leukaemia( cells( (HLE60)( were( purposely( exposed( to(
concentrations(of(lactate(and(ammonia(in(the(toxic(range.(Surviving(cells(resistant(
to( these( major( metabolic( wastes( were( isolated( and( characterised( for( improved(
viability( and( growth( in( such( conditions( where( it( was( found( that( the( metabolic(
profile( of( adapted( cells( had( changed( –( lactate( and( ammonia( formation( was(
inhibited( in( the( presence( of( high( lactate( and( ammonia( in( the( medium,( while(




some( of( the( key( industrial( stressors( found( in( the( high( density( cell( culture(




adapted( to( a( range( of( harsh( conditions( in( a( process( they( termed( ‘bioreactor(
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evolution’.( This( bioreactor( evolution( essentially( comprised( of( subjecting( a( DG44(
CHO( host( cell( line( along( with( a( recombinant( production( cell( line( to( bioreactor(
stressors,( such( as( shear( stress,( hypoxia( and( nutrient( deprivation,( in( an( iterative(






Another( adaptation( study( concerning( metabolic( byEproducts( was( performed( by(
Bort(and(colleagues(whose(aim(was( to(adapt(CHOEK1(cells( to(grow( in(glutamineE
free(media.(Although(glutamine( is( supplemented(as( an(alternative(energy( source(
for(rapidly(growing(cells(that(oxidise(glucose(inefficiently,(the(resulting(byEproduct(
is( highly( concentrated( ammonia( that( has( a( negative( impact( on( protein( product(
glycosylation.( This( group( adapted( CHOEK1( cells( to( progressively( reduced(
glutamine(concentrations((8(mM,(4(mM,(2(mM(then(0(mM),(each(time(resulting(in(
decreased(maximum(cell(density(and(viability.( Surviving( cells(were(harvested(by(




of( Schumpp( &( Schlaeger( (1992)( with( their( HLE60( cells,( it( was( shown( that( a(
metabolic(profileEshift(had(occurred,(with(evolved(cells(in(this(study(compensating(
for( the( lack( of( glutamine( by( increasing( consumption( of( aspartate( and( glutamate(
(Bort(et%al.(2010).(
The( above( studies( are( examples( of( whole( cell( adaptations( towards( inherent( or(
environmental( stresses( with( a( view( to( improving( and( maintaining( the( evolved(
population( with( a( phenotype( better( suited( to( industrial( bioprocess( conditions.(







based( applications( in( commercially( relevant( cell( lines,( as( a( tool( for( directed(
evolution,( has( not( been( as( extensive( as( environmental( adaptation( approaches(
(Majors(et%al.(2009).(This(could(be(for(a(number(of(reasons(including(the(fact(that(it(
is( often( the( case( that( chemical( mutagens( are( inherently( harsh,( frequently(
rendering( the( surviving( cells( sick,( displaying( short,( finite( growth( characteristics(
upon(expansion( (Nicolaides(et%al.(2005).(The(use(of( radiation(and(chemicals(as(a(
method( for(mutagenesis( in( cell( lines( intended( for( biopharmaceutical( production(
may(also(introduce(more(criteria(that(need(to(be(met(for(FDA(approval,(potentially(
making( the( process( lengthy,( costly( and( difficult( to( achieve.( An( example( of( one(
concern(would( be( the( removal( of( all(mutagenic( agents( in( the( final( product,( and(
these( contaminants( would( be( much( more( of( a( hazard( than( the( ordinary(
contaminants(found(at(present,(such(as(host(cell(proteins((Majors(et%al.(2009).((
There(are(also(specific(genetic(methods(of(mutagenesis(that(could(be(employed(in(
directed( evolution( strategies.( For( example,( genomic( instability,( an( inherent(
property(of(cancer(cells(and(CHO(cells(causes(such(cell(lines(to(be(natural(mutators.(
In( 1998,( a( research( group( lead(by(Bert(Vogelstein( found( that( in( some( colorectal(
cancer( cells,( defects( in( the( DNA( mismatch( repair( (MMR)( machinery( introduces(
microsatellite(instability(resulting(in(a(mutator(phenotype(in(such(cells((Nicolaides(
et%al.(1998).(The(cause(of(the(MMR(defects(and(consequent(mutator(phenotype(was(
found( to( be( due( to( a( truncation(mutation( in( the( human( postmeiotic( segregation(
(hPMS2)( gene.( The( study( proceeded( to( show( that( the( introduction( of( a( mutant(
hPMS2(gene( inhibited(MMR(mechanisms(and(caused( the(subsequent(mutation(of(
an( exogenous( βEgalactosidase( gene( in( HEK( 293( and( normal( hamster( cells.( The(
hPMS2( gene(was( termed( ‘morphogene’( and(when( expressed( in( any( cell( line( the(
MMR(mechanisms(can(be( reversibly( inhibited,( leading( to(mutations(and(changed(
cell(phenotypes.(This(technique(was(applied(to(CHO(cells(and(as(well(as(leading(to(




addition(to( this,(cells(exhibiting( these(new(phenotypes(could(be( ‘cured’( to( inhibit(
the( morphogene,( permitting( an( element( of( control( on( the( degree( of( mutation(
created((Nicolaides(et%al.%1998;%Grasso(et%al.(2004;(Nicolaides(et%al.(2005;(Majors(et%
al.(2009).(
Whether( implementing( environmental( stressors,( radiation(or( chemical(mutagens(
or( introducing(mutation( through(genetic(manipulation,( each(of( these(approaches(
to(directed(evolution(have(advantages(and(disadvantages.(For(example,(relying(on(
spontaneous( mutation( and( adaptation( to( environmental( stress( can( be( an(
inherently(slow(process,(while(mutagens(to(speed(the(process(up(could(introduce(
obstacles( by( way( of( approval( by( appropriate( authoritative( bodies( and( also(


















producing% a% protein% product.% Typically,% a% biLphasic% method% will% include% an% initial%
rapid%cell%proliferation%stage%achieved%by%optimal%cell%culture%conditions%(often%37°C)%
followed% by% a% phase% in% which% the% cell% culture% is% shifted% to% a% lower% temperature%
(usually% in% the% range% of% 28L33°C)% (Kumar% et% al.% 2008).% This% section% explains% the%
biology% behind% this% process% and% also% the% drawbacks% of% the% method,% followed% by% a%





actually( extends( the( culture( viability( period( as( a( result( of( delayed( onset( of(
apoptosis.( One( study( has( identified( the( specific( increase( in( expression( of( the(
preciously(discussed(antiEapoptotic(gene,(BclE2,( in( response( to(mild(hypothermia(
(Slikker(et%al.(2001).(Once(apoptosis(is(initiated(the(manner(of(cell(death(is(similar(
to(what(can(be(observed(at(optimum(temperatures((Moore(et%al.(1997).(Cell(cycle(
arrest( has( been( correlated( positively( with( increased( production( due( to(
approximately(a(1.7(fold(increase(in(cell(specific(production(rates((qP).(When(you(
consider(this(with(the(fact(that(cells(are(viable(for(longer(and(therefore(producing(
for( longer( at( lower( temperatures,( the( overall( product( titre( one( can( yield( often(
reaches(reach(several(fold(more(than(cultivation(at(standard(temperatures,(as(IVCD(
has( been( improved( as( well( as( qP( (Kaufmann( et% al.( 1999;( Becerra( et% al.( 2012).(
Notably,( yields( from( hypothermic( perfusion( culture( using( CHO( cells( producing(
follicleEstimulating( hormone( can( be( improved( 13Efold( compared( to( equivalent(
cultures(at(37°C((Yoon(et%al.(2007).((







Other( phenomena( that( occur( at( low( temperature( include( a( reduction( in( glucose(
and( oxygen( uptake,( reduction( in( waste( (lactate( and( ammonia)( accumulation,(
reduced(proteolytic(activity,( improved(shear(stress( resistance(and(also( increased(
levels( of( mRNA( coding( for( the( recombinant( protein( (Chuppa( et% al.( 1997).( This(
latter( observation( has( been( attributed( to( increased( mRNA( stability( at( lower(
temperatures(or(enhanced(levels(of(transcription((Yoon(et%al.(2004).(There(are(also(
more(than(20(proteins,( including(coldEinducible(RNA(binding(protein((CIRP),(that(
have( been( reported( to( become( unregulated( during( a( phase( shift( to( lower(
temperatures.(Out( of( these(many(proteins,( it( is( CIRP( that(has(been( studied(most(
extensively.(This(protein(functions(as(an(RNA(chaperone,(modulating(transcription(
and( translation( and( it( has(been( shown( that( overexpression(of( CIRP( can( increase(
recombinant( protein( production( (performed( in( CHO( cells)( and( also( arrests( cell(
growth( (Kumar( et% al.( 2008;( Tan( et% al.( 2008).( In( addition( to( productivity(
enhancements,( postEtranslational( events( have( been( shown( to( occur( with( higher(
accuracy( and( fidelity( at( 32°C( that( 37°C,( resulting( in( a( yield( that( is( a( higher(
proportion(active(protein((Masterton(et%al.(2010).(Glycosylation(is(one(such(postE
translational( event( that( is( modified( through( growth( arrest,( with( sialilation( in(
particular( being(modified(which( can( improve( the( in% vivo( efficacy( of( the( product(
(Nam(et%al.(2008).(
The(activities(of(certain(beneficial(enzymes(are(also(increased(under(hypothermic(
conditions.( For( example,( glutathione( peroxidase( (one( of( the( more( efficient(
antioxidants)( levels( were( found( to( be( significantly( higher( in( CHO( cells( at( lower(
temperatures,(meaning(CHO(cells(at(lower(temperatures(should(be(more(resistant(
to( oxidative( stress.( This( was( demonstrated( by( exposing( CHO( cells( at( different(
temperatures( (ranging( from( 37°C( to( 30°C)( to( 100( μM( hydrogen( peroxide( (an(
oxidant)(–(it(was(found(that(significantly(higher(cell(viability(could(be(observed(in(
the( cells( at( the( lowest( temperature( in( the( study( (Slikker(et%al.( 2001).( ( This( is( an(
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area( of( interest( to( biopharmaceutical( research( as( reactive( oxygen( species( (ROS)(
tend( to( increase( in( late( exponential/( early( stationary( phase( of( growth,( causing(
oxidative( stress( which( can( lead( to( premature( death( of( a( host( cell,( potentially(
causing(a(reduction(in(product(titre((Templeton(et%al.(2013;(Young(2013).(
Despite(the(large(number(of(studies(that(show(positive(effects(of(mild(hypothermia(
on( specific( productivity( of( recombinant( proteins,( no( experimental( approach( has(
addressed(the(detrimental(effect(of(lower(temperatures(on(specific(cell(growth(rate(
(Vergara( et% al.( 2014):( although( a( lot( of( the( benefits( of( production( under(
hypothermic(conditions(are(attributed(to(the(arrest( in(cell(cycle(progression,( this(
phenomenon(consequently(negatively(effects(growth( rate(which( in( terms(of( titre(
can(sometimes(negate(the(positive(effects(of(a(temperature(shift,(such(as(enhanced(
qP( (Sunley( et% al.( 2008).( In( addition( to( this( unwanted( effect( on( growth( rate,( the(
magnitude(of(the(desired(effects(of(mild(hypothermia(can(be(different(between(cell(
lines( and( expression( systems( as( well( as( being( dependent( on( the( recombinant(
protein( product( itself( (Kaufmann( et% al.( 1999,( Becerra( et% al.( 2012;( Mason( et% al.(
2014).(
As(an(attempt(at(solving(the(problem(of(reduced(growth(rates(under(hypothermic(
conditions,( some( researchers( have( attempted( to( adapt( CHO( cells( to( low(
temperatures.(The(shared(aim(in(these(studies(was(to(attain(a(cell(type(that(possess(
the( same( desirable( productivity( attributes( of( a( cell( under( hypothermic( “shock”(
(temperature( phase( shift),( yet( retain( growth( rates( as( if( they( were( growing( at(
optimal(temperatures((37°C).(In(2006,(Yoon(and(colleagues(adapted(recombinant(
CHO( cells( producing( erythropoietin( (EPO)( and( also( CHO( cells( producing( follicleE
stimulating( hormone( (FSH)( to( growth( at( 32°C.( They( did( this( by( repeated( batch(
culture( in( spinner( flasks,( inoculating( each( successive( flask( with( cells( from( the(
previous(batch(at( seeding(density(of(2x105( cell/mL.(They( found( that( cell( specific(
growth( rates( gradually( improved( during( this( adaptation( process,( with( the( EPO(
producing( cell( line( increasing( by( 73%( and( the( FSH( producing( cell( line( by( 20%.(
However,(specific(productivities(decreased(by(49%(and(22%(for(the(EPO(and(FSH(





A( separate( study( by( a( different( research( group( conducted( work( in( which( a(







adapted( cells( were( initially( grown( at( 37°C( to( boost( growth( early( on( in( culture.(
However,( the(merits( of( this( study( fell( short( when( the( lowEtemperature( adapted(
cells( were( too( fragile( and( died( when( scaled( up( to( agitated( cultures,( which( is( a(





contamination( risks( upon( traditional( production( platforms,( which( could( be(
difficult(for(the(industry(to(widely(accept((Sunley(et%al.(2008).((
Of( the( examples( in( the( literature( that( attempt( to( evolve/( adapt( CHO( cells( to(
hypothermic( conditions( for( the( aforementioned( reasons,( all( perform( their(
adaptation(process(on(recombinant(stably(producing(cell(lines,(rather(than(a(CHO(
host(cell( line(that(has(not(yet(been(stably(transfected(with(the(gene(of( interest.(A(







As( outlined( in( the( literature( review,( directed( evolution( strategies( have( the(
potential( to(deliver(multiple( and( largeEscale( improvements( to(biopharmaceutical(
production.( The( work( in( this( thesis( continues( investigating( this( concept,(
specifically(focussing(on(the(acceleration(of(evolution(in%vitro(and(the(generation(of(





• Use( directed( evolution( to( enable( a( CHOK1SV( host( cell( line( adapt( to(
hypothermic(conditions((32°C)(and(characterise(phenotypic(changes(
• Assess( the( industrial( ability( of( this( host( cell( in( terms( of( transfection(
(transient(and(stable)(and(productivity(
• Retrospectively( investigate( the( biology( that( underpins( similarities( and(




The( next( chapter,( chapter( two,( details( the( common(materials( and(methods( that(
were(used(throughout(this(thesis.((
Chapter( three( firstly( presents( an( optimised( cellEculturing( regime( that( can( be(
applied( for( rapid( evolution( rates( in% vitro.( Following( this,( the( evolution( of( a(
hypothermia( (32°C)( adapted( CHOK1SV( host( cell( line( is( described.( Cellular(
alterations( that( arose( through( this( process( are( characterised,( including:( cell(








considered( important( in( cell( line( development.( This( includes( transient(
electroporation( transfection( productivity( and( efficiency,( longEterm( transient(
lipofection(performance(in(a(fedEbatch(platform,(and(stable(pool(generation.(Titre(







way( of( adaptive% thermogenesis( –( an( increase( in( inner( mitochondrial( membrane(
permeability( that( allows( protons( to( return( to( the(matrix,( generating( heat( in( the(




examined( in( the( hypothermiaEadapted( cell( line( and( presented( here.( Other(
mechanistic(analysis(documented(in(this(chapter(includes(comparative(amino(acid(
flux( through( culture( between( the( parental( and( evolved( cell( lines,( in( addition( to(
differential( gene( expression( analysis( via( the( Affymetrix®( CHO( Gene( ST( Array(
system.(


























that* were* used* to* conduct* work* described* in* subsequent* chapters* of* this* thesis.*
Materials* and* methods* in* this* chapter* are* those* that* were* common* to* multiple*










cabinet(was(always( sprayed(with(70%(Ethanol( to(prevent( contamination(of(CHO(
cell( cultures.( Unless( stated( otherwise,( the( culture( media( used( was( CD( CHO(
(Invitrogen,(Paisley,(UK)(supplemented(with(either(4%(200(mM(L3Glutamine((8.0(
mM(final(concentration)((Fisher,(Loughborough,(UK),(or,(supplemented(with(25(μM(
Methionine( sulfoximine( (MSX)( (Sigma( Aldrich,( Dorset,( UK),( if( culturing( stably(
transfected(cells.  
When(not(being(used(for(experimentation(or(routine(culturing,(cells(were(stored(in(













of( growth(with( viability( above( 95%.( The( viability,( along(with( viable( cell( density(
(VCD),(is(attained(by(taking(a(0.6(mL(sample(from(the(culture(for(viability(analysis(
using(a(Vi3CELL(XR(cell(viability(analyser((Beckmann(Coulter,(High(Wycombe,(UK).(
The(Vi3CELL(XR(uses( the( trypan(blue(exclusion(method( to(distinguish( living(cells(
amongst(those(that(have(undergone(apoptosis((cell(membranes(no(longer(intact).(













is( then( stored( at( 4°C( until( time( of( use( (N.B.( L3Glutamine( is( omitted( if( stably(






the(culture(medium(that( is( then(removed.(The(pellet( is( then(re3suspended( in( the(
cryopreservation(media((Vc).(The(VCD(and(%(viability(is(then(checked(again(using(
the( Vi3CELL( XR.( Aliquots( of( 1.5(mL( of( this( suspension( are( dispensed( into( sterile(
cryovials,(which(are(then(transferred(into(the(rate3controlled(freezer((Mr.(FrostyTM(
Thermo(Scientific,(Loughborough,(UK),(which(ensures(a(slow(rate(of(freezing(when(
transferred( to( the( 380°C( freezer( overnight.( The( next( day( the( cryovials( are(
transferred(to(liquid(nitrogen(cryostats(for(long3term(storage.(
2.1.2$Revival$from$cryopreservation$
Unlike( the( slow,( progressive( cooling( of( cells( for( cryostorage,( the( thawing( and(
revival(of(cells(must(be(carried(out(quickly.(Once(removed( from(the(cryostat,( the(
cryovial(is(held(in(a(small(beaker(of(sterile(filtered(37°C(water(in(a(37°C(water(bath(
until( the( contents( have( defrosted.( The( liquid( contents( are( then( transferred( to( a(
sterile( falcon( (Fisher,( Loughborough,( UK)( and( re3suspended( in( 6( mL( of( 4°C( CD(
CHO.(This(volume( is( then(centrifuged(at(200(×g( for(5(minutes( to( form(a(pellet(of(
cells.(The(remaining(media(is(removed(and(the(pellet(is(re3suspended(in(30(mL(of(




ensure(any( traces(of(DMSO(are( removed(as( soon(as(possible(whilst( ensuring( the(











2.2.1$ Cell$ specific$ growth$ rate,$ μ,$ in$ hours@1$ or$ days@1$ (commonly(referred( to(
simply(as(growth(rate)$
Using( the( Vi3CELL( XR,( cell( density( measurements( from( different( time( points( in(
culture(can(be(used(in(the(following(equation(to(determine(a(value(for(cell(specific(
growth(rate,(μ,(over(the(time(course(of(one(passage:(
! = ! !"#$ − !"#0!" − !0 = !
!" !"!0








2.2.2$The$ cell$ doubling$ time,$DT,$ (defined(as( the(period(of( time(required( for(a(
given(population(of(cells( to(double( in(number)(can(consequently(be(calculated(as(
follows:$































which( is( simply( the( area( under( the( growth( curve( and( it( signifies( the( number( of(

















cell( divisions( that( have( occurred( over( a( given( period( of( time( in( a( given( cell(
population)(can(be(calculated(as(follows:(




×g*for(5(minutes,(medium(was( removed(and(cells( resuspended( in(1X(phosphate3
buffered( saline( (PBS)( (Sigma3Aldrich,( Dorset,( UK)( to( a( concentration( of( 1( ×106(
cells/(mL.(The(cells(were(then(centrifuged(again( for(5(minutes(at(200(×g(and(the(



















This% chapter% addresses% the% first% and% second% aims% outlined% at% the% end% of% chapter% 1:%
Firstly,%a%cell%culturing%regime%that%delivers%an%enhanced%rate%of%evolution%is%defined%
by%manipulating% and% optimising% basic% parameters% such% as% culture% seeding% density%
and% dilution% ratio% at% passage.% Secondly,% directed% evolution% is% used% to% adapt% a% host%
CHOK1SV% cell% line% to% growth% in% hypothermic% conditions.% Initial% characterisation% of%
key%phenotypic%differences%and%similarities%between%the%evolved%cell%line%and%control%
and%parental%cultures%is%presented%in%terms%of%growth%rate,%cell%size,%biomass%content%
and% RNA% content% in% relation% to% chromosome% number% (ploidy).% In% addition% to% this,%
heritability% of% the% new% traits% that% the% evolved% cell% line% exhibits% were% tested% for%






work( of( Prentice( and( colleagues( (2007)( for( their( “bioreactor( evolution”( which(






that( could( reach(a(72%( increase( in( IVCD(and(an(evolved(producing( cell( line( that(
gave(a(36%( increase( in( recombinant(protein(product( titre( (Prentice(et%al.( 2007).(
Another( method( that( intended( to( reduce( the( levels( of( glycosylation9impacting(
ammonia(accumulating( in( culture(was( to(adapt( cells( to(growth( in(glutamine( free(
media:( ultimately( this( study( resulted( in( cells( of( higher( viability( that( had( shifted(
their(metabolic( profile( by( increasing( consumption( of( aspartate( and( glutamate( to(
compensate(for(the(lack(of(glutamine((Bort(et%al.(2010).((





ordinarily( be( achieved( under( standard( culturing( conditions.( This( is( achieved( by(
manipulating( the(basic(parameters(at(passage:( seeding(density(and(dilution(ratio(
(i.e.( the( proportion( of( the( previous( culture( that( is( discarded).( As( described( in(
chapter( 1,( opportunities( for( evolutionarily( beneficial( mutations( occur( at( cell(
division(when(DNA(is(replicated:(errors(made(during(DNA(replication(can(lead(to(
advantageous( phenotypes( arising( in( a( population( which( will( consequently( be(
selected( for( via( natural( selection.( In( terms( of( a( cell( culture( population,( we( can(
increase(the(chance(of(beneficial(mutation(arising(in(that(population(by(increasing(
the(population(size(i.e.( increase(the(cell(density(at(which(we(seed(the(subsequent(





to(the(effect( it(has(on(genetic(drift((described(as(the(change( in( frequency(of(gene(
variants( in( a( population( as( a( result( of( random( sampling( events).( The( optimum(







As(mentioned,( the(opportunity( for(mutation( (influenced(by( seeding(density)( and(
the( degree( of( genetic( drift( (applied( through( dilution( at( passage)( are(
interdependent( in( in% vitro( cell( culture,( as( seeding( density(will( alter( the( ultimate(
dilution(ratio.(The(initial(work(described(in(this(chapter(describes(an(optimisation(
study(to(determine(the(optimum(balance(of(these(parameters(in(order(to(achieve(a(
rapid(evolution( rate.( Seeding(density( is(varied(which(as( stated( results( in(varying(
dilution( ratios,( but( to( further( inform( the( optimisation(process,( passage( time( (i.e.(
days( of( culture)( is( also( altered( to( give( further( variations( of( seeding( density( and(
dilution( ratios.( The( indicator( for( evolution( rate( in( this( study( is( taken( as( rate( of(
change( in( growth( rate( (∆µ),( which( is( based( upon( in9house( work( by( Davies( and(









in( the( literature( review,( there( can( be(multiple( benefits( of( implementing( a( cold9
shock( culturing( strategy( for( enhanced( biopharmaceutical( production.( Typically(
this( strategy(will( include( a( period( of( culture( at( optimum( temperatures( for( rapid(
proliferation( (~37°C),( followed( by( a( shift( to( a( significantly( lower( temperature(
(usually( in( the( range(of(28933°C)( (Kumar(et%al.(2008).(The( latter(phase(has(been(
associated( with( extended( culture( viability( and( delayed( onset( of( apoptosis,(







that( can( sometimes( negate( the( positive( effects( of( a( temperature( shift:( the( ideal(
scenario( would( be( a( cell( line( that( shares( the( production( advantages( of( “cold9
shocking”(but(also(continues(to(proliferate(at(a(normal(rate((Sunley(et%al.(2008).(In(




and( a( erythropoietin( (EPO)( producing( cell( line( and( repeatedly( passaged( cells( in(
batch,( shake9flask( culture( at( 32°C.(Over( time,( vast( improvements( in( growth( rate(
were( noticed,( however,( productivities( of( both( producing( cell( lines( decreased(
significantly( over( the( adaptation( process( (Yoon( et% al.( 2006).( Another( similar(
example( (that(was(also( fully(described( in( chapter(1)( included( the(work(of( group(
who( used( a( similar( approach( but( iteratively( sub9cultured( their( interferon9β(





largely( impractical( solutions( (such( as( microcarriers)( would( have( to( be(
incorporated((Sunley(et%al.(2008).((




this( nature( existing( in( the( literature,( providing( an( opportunity( to( conduct( novel(
work( that( could(serve(at( least(as(a(proof(of( concept( that( could(be( taken( forward(
and(applied(to(industrial(manufacture.(Additionally,(the(concept(of(a(hypothermia9
adapted(host(cell(line(could(possibly(be(more(appealing(to(industry(as(it(provides(a(







to( optimise( culture( parameters( for( rapid( in% vitro( evolution.( It( also( details( the(
materials(and(methods(used(in(the(generation(and(primary(characterisation(of(an(
evolved,( hypothermia9adapted( CHOK1SV( cell( line.( The( reader( is( referred( to(
chapter( 2( for( details( on( any( other( experimental( techniques( mentioned( in( this(
chapter.((
3.2.1$ Designing$ a$ set$ of$ culturing$ regimes$ to$ determine$ the$ optimum$
parameters$for$rapid$evolution$
As(previously(described,(introducing(a(high(seeding(density(increases(the(number(
of( cell( divisions( per( unit( time( per( mL( of( culture( medium( (which( increases( the(
chance(of(mutation(in(that(population).(In(addition(to(this,(the(degree(of(dilution(at(
passage(is(also(known(to(effect(evolution(by(altering(the(probability(that(beneficial(
mutations( are( lost( or( kept( in( that( population.( This( study( aims( to( find( out(more(
about(the(effect(these(variables(can(have(with(respect(to(∆µ(over(time,(ultimately(
defining( an( ideal( seeding( density/( dilution( combination( that( provides( rapid(
evolution.(To(do( this,( cultures(with(various( seeding(densities(were(harvested( for(
passage(in(a(staggered(manner(along(their(exponential(growth(phase:(cells(that(are(
harvested(later(along(the(exponential(phase(require(a(larger(degree(of(dilution(to(
return( to( the( original( seeding( density.( Keeping( the( seeding( densities( fixed( but(
varying(the(passage(time(will(result(in(a(range(of(combinations(of( ‘number(of(cell(











































later!along! the!exponential!phase!requires!a! larger!degree!of!dilution! (smaller!dilution!ratio)! (denoted!by! the!red!vertical! lines)! to! return!to! the!
original!seeding!density!at!the!following!passage!(horizontal!green!lines).!Seeding!at!a!high!density!provides!a!larger!no.!of!cell!divisions!per!unit!
time! (shown! in!graph!A!here)!compared!to!seeding!at!a! lower!density! (graph!B),!however,!dilution!ratios!are! larger!with!a!high!seeding!density!
passage!plan!and!exponential!is!sustained!for!less!time.!Culturing!cells!at!range!of!seeding!densities!with!different!lengths!of!passage!time!provides!a!
range!of!combinations!of!no.!of!cell!divisions!and!dilution!ratios.!These!passaging!regimes!are!continued!over!longJterm!culture!and!∆µ!is!monitored!








replicated( introducing( the( chance( of( errors( to( be( made( and( mutations( to( be(
incorporated( into( the( genome.( In( order( to( determine( the( relationship( between(
generation(number((GN),(number(of(cells(in(a(population(at(GN,(and(number(of(cell(







0( 1( 2( 3( 4( 5(
No.(of(cells(at(time(
(2!")(
1( 2( 4( 8( 16( 32(
No.(of(cell(divisions(by(time(
(2!" − 1)(
0( 1( 3( 7( 15( 31(
As(can(be(seen(from(table(3.1(above,(the(relationship(between(number(of(divisions(
(D)( and( generation( number( (GN)( in( a( population( starting( with( one( cell( can( be(
defined(by:(




!!"!#$!!"##$ = ! 2!" − 1 !×! 0(







!! − 1)!×! 0(
= !"!0 − 1 !×! 0(
= !0 !"!0 − !0(





As( has( been( mentioned,( the( dilution( ratio( at( passage( can( affect( the( degree( of(






125(mL(Erlenmeyer( flasks( (with(vent( cap,(Fisher,( Loughborough,(UK)( containing(

















Each( regime( was( performed( in( triplicate,( giving( a( total( of( 27( cultures.( In(
addition(to(this,(3(control(cultures(were(set(up(that(were(passaged(on(a(394(day(
passage(routine,(seeding(at(0.2(×106(cells/(mL(each(time((these(parameters(are(
standard( in9house( laboratory( protocol).( The( regime( was( continued( for(
approximately(6(weeks.(Cultures(seeded(at(5(×106(cells/(mL(are(only(passaged(
every(1(or(2(days(as(exponential(phase(is(not(sustained(beyond(day(2;(cultures(
seeded( at( 3( ×106( cells/( mL( are( only( passaged( every( 1,( 2( or( 3( days( as(
exponential(phase(is(not(sustained(beyond(day(3;(and(cultures(seeded(at(1(×106(
cells/( mL( are( passaged( every( 1,( 2,( 3( or( 4( days( exponential( phase( is( not(
sustained(beyond(day(4.(1(×106(cells/(mL(was(chosen(as(the(lowest(seeding(to(
density( to( be( used( in( this( study( as( it( was( shown( to( be( the( highest( seeding(
density( that( could( sustain( growth( for( 4( days( (see( figure( 3.1).( Also,( it( is( not(



















cells( in( optimum( conditions( (37°C).( To( adapt( CHOK1SV( cells( to( hypothermic(
growth,(cultures(were(continuously(sub9cultured( in(an( incubator((Infors,(Reigate,(
UK)( set( to( 32°C,( with( all( other( parameters( set( to( standard( levels( (5%( CO2,( 140(
rpm)(for(approximately(160(generations.(For(control(purposes,(cultures(were(also(
continuously( sub9cultured( at( 37°C( (5%(CO2,( 140( rpm)( for( the( same( duration.( In(








standard( conditions( and( one( was( subsequently( incubated( at( 32°C.( This( created(













which!are!described!as! follows:!1)! a! single!vial!of! CHOK1SV! cells!was!received! from!Lonza!Biologics!cell!banking!department!
which!was!revived!and!seeded!into!125mL!Erlenmeyer!flask!(containing!standard!6!mM!glutamine!supplemented!CD!CHO!under!






















severe$ hypothermia$ (30°C)$ and$ returning$ evolved,$ 32°C7adapted$ CHOK1SV$
cells$to$standard$conditions$(37°C)$
Once(adapted( to(growth(at(32°C,( the(hypothermia(adapted( cells( from(A,(B(and(C(
lineages( (figure( 3.2)( were( used( to( also( seed( 3( new( 125( mL( Erlenmeyer( flasks(
(containing(6(mM(glutamine(supplemented(CD(CHO(under(standard(conditions(of(
5%,(CO2(and(140(rpm)( that(were( then( incubated(at(30°C.( In(addition( to( this,(un9














harvested( from( batch( Erlenmeyer( cultures( and( cell( density( and( viability( were(
measured( using( the( Vi9CELL( XR( cell( viability( analyser( (Beckmann( Coulter,( High(
Wycombe,(UK).(Using(the(viable(cell(density(just(measured,(triplicate(aliquots(of(5(








pH( 8)( was( added( to( each( aliquot( of( 5( ×106( cells( and( mixed( by( pipetting.( The(
aliquots(were( then( incubated( on( ice( for( 15(minutes.( Following( this,( the( aliquots(
were(centrifuged(at(2500(×g( for(5(minutes( to(pellet(cell(debris.(For(each(aliquot,(
triplicate(transfers(of(25(µL(of(supernatant(was(added(to(wells(of(a(flat9bottomed(
96( well( plate( (Sigma9Aldrich,( Dorset,( UK).( The( same( was( performed( for( the(




BCA( reagent( B( from( the( kit( to( the( ratio( of( 50:1)( is( added( to( each( well( (giving(




blank( standard( replicates( is( then( subtracted( from( the( 562( nm( absorbance(
measurement( of( all( the( other( sample( replicates( (unknown( samples( as( well( as(
standards).( A( standard( curve( is( then( generated( using( the( blank9corrected(
measurements( of( the( standards( versus( the( corresponding( concentrations( (in( µg(
mL91)( to(which( the( standards(were( prepared.( The( protein( concentration( of( each(
sample(can(now(be(determined(using(this(curve(and(protein(content(per(cell(can(be(
calculated( by( dividing( the( total( protein( per( sample( by( the( number( of( cells( that(
were(used(to(generate(the(sample((5(×106(cells).(
3.2.2.4$Quantification$of$total$cell$RNA$content$
On( day( 3( post( sub9culture,( samples( of( cell( cultures( were( harvested( from( batch(
Erlenmeyer( cultures( in( order( to(measure( cell( density( and( viability( using( the( Vi9
CELL( XR( cell( viability( analyser.( Using( the( Vi9CELL( viable( cell( density(
measurements,(triplicate(aliquots(of(5(×106(cells(were(taken(from(each(culture(for(






the( lysate( by( shearing( high9molecular( weight( genomic( DNA( and( other( high9
molecular( weight( components)( by( passing( the( lysate( through( a( QIAshredder(
QIAGEN,( Manchester,( UK).( The( lysate( then( was( centrifuged( at( maximum( speed(
(13000(rpm)(in(a(bench9top(centrifuge(and(the(supernatant(carefully(removed(by(
pipetting.( One( volume( of( 70%( ethanol( was( then( added( to( this( supernatant( and(
thoroughly( mixed( by( pipetting,( this( creates( conditions( that( promote( selective(
binding( of( RNA( to( the( RNeasy( spin( column.( This(mixture( is( then( applied( to( the(
RNeasy(spin(column((up(to(700(μL(at(a(time)(placed(in(a(2(mL(collection(tube.(This(
is( the( centrifuged( for( 15( seconds( at( 8000( ×g( and( the( flow9through( is( discarded.(
Following( this,( 500(μL( of(Buffer(RPE(was( added( to( the(RNeasy( spin( column(and(
centrifuged(for(15(seconds(at(8000(g,(again,(discarding(the(flow(through.(Another(
500(μL(of(Buffer(RPE(was(then(added(and(the(column(centrifuged(for(2(minutes(at(
8000(g.(At( this(point,( the(RNeasy(spin(column(is(placed( in(a(new(2(mL(collection(
tube,(50(μL(of(RNase9free(water( is( added(directly( to( the( spin( column(membrane(
and(the(column(plus(collection(tube(is(centrifuged(for(1(minute(at(8000(×g(to(elute(
the(RNA.((







line(possessed(was(determined(and(compared( to(a( culture( from( the(primary(cell(
bank( (figure( 3.2,( step( 2).( In( addition( to( this,( the( hypothermia( adapted( cells( that(
were(cultured(long9term(at(more(severe(hypothermic(conditions(of(30°C(were(also(
analysed.( This( was( done( using( FxCycleTM( PI/RNase( Staining( Solution( (Thermo(
Scientific,( Loughborough,( UK),( which( was( detected( using( a( BD( LSRII( Flow(
Cytometer( (BD( Biosciences,( Oxford,( UK).( FxCycleTM( PI/RNase( Staining( Solution(




bases( with( minimal( sequence( preference.( Propidium( iodide( also( binds( to( RNA,(
hence(the(requirement(of(RNase(so(that(only(DNA(is(stained.(The(measurement(of(
DNA(in(this(way(allows(the(study(of(cell(populations(in(various(phases(of(the(cell(
cycle( as( well( as( ploidy( detection.( DNA( content( can( be( measured( by( fluorescent(
stains( such( as( FxCycleTM( PI/RNase( Staining( Solution( as( the( emission( signal( is(
proportional(to(DNA(mass.(A(frequency(histogram(can(be(produced(which(reveals(
the(number(of(cells(undergoing(certain(cell(growth(phases:(G0/G1((one(paired(set(of(
chromosomes( per( cell),( S( (DNA( synthesis( –( variable( amounts( of( DNA( between(
G0/G1(and(G2/M)(and(G2/M((two(sets(of(paired(chromosomes(per( cell).(Anything(
larger(than(the(amount(of(DNA(in(G2/M(indicates(polyploidy.((
Staining(was( performed( as( follows:( On( day( 3( post( sub9culture,( cell( viability( and(
density(was(measured( using( the(Vi9CELL( XR.( Using( these(measurements,( 1(×106(
cells(were(harvested(from(day(three(of(culture((3(days(post(sub9culture)(and(fixed(
according(to(the(paraformaldehyde((PFA)(fixing(protocol((described(in(chapter(2).(
The( cells(were( then(washed(with(PBS( to( ensure( all( fixative(was( removed(before(
staining,( three( washes( were( performed( in( total,( centrifuging( at( 200( ×g( for( 5(
minutes( and( removing( the( supernatant( after( each( wash.( After( this,( 0.5( mL( of(
FxCycleTM(PI/RNase(Staining(Solution(stain(is(then(added(to(each(pellet(and(mixed(
well( by( pipetting.( The( samples( are( then( incubated( for( 30( minutes( at( room(
temperature,( protected( from( light.( The( samples( are( then( analysed( without(
washing,(using(532(nm(excitation(and(emission(collected(with(a(585/42(bandpass(








Using( only( the( parameters( that( can( be(manipulated( during( ordinary( cell( culture(
(routine( passaging),( parameters( such( as( seeding( density,( length( of( culture( and(
dilution(ratio,(differential(degrees(of(change(in(growth(rate(can(be(achieved(over(a(
culture(period(of(approximately(six(weeks.(Control(cultures((those(passaged(every(
394(days( and( seeded( at( 0.2(×106( cells/(mL)( showed(very( little( change( in( growth(
rate(over(this(time(period.(All(cultures(retained(high(viability(throughout(the(study(
(>95%).( The( viable( cell( densities( over( time( for( each( set( of( culturing( regimes(
(described( in( section(3.2.1.3),( plus( controls,( are( shown( in( figures( 3.3( to( 3.7.( The(
change( in( growth( rate( over( time( that( was( observed( for( each( of( the( culturing(
regimes,(plus(controls,(are(shown(in(figures(3.8(to(3.12.((
The(calculation(to(determine(the(change(in(growth(rate(over(time(for%each%culture(
was(as( follows:( [Mean(of( final( three(passage(growth(rates](–( [Mean(of( first( three(
passage(growth(rates].((



















































































































































































































Figure$ 3.4$ The$ viable$ cell$ density$ over$ time$ for$ cultures$ seeded$ at$ A)$ 1$ ×106$
cells/$mL,$B)$3$×106$cells/$mL$and$C)$5$×106$cells/$mL,$and$passaged$every$2$days.$
Markers(represent(the(actual(seeding(density(recorded((~1,(~3,(or(~5(×106(cells/(mL)(





Figure$ 3.5$ The$ viable$ cell$ density$ over$ time$ for$ cultures$ seeded$ at$ A)$ 1$×106$
cells/$mL$and$B)$3$×106$cells/$mL,$and$passaged$every$3$days.$Markers(represent(
the( actual( seeding( density( recorded( (~1( or( ~3( ×106( cells/(mL)( and( the( maximum(









































































































































Figure$3.7$The$viable$cell$ density$over$ time$ for$control$cultures$ seeded$at$0.2$
×106$ cells/$mL$ and$ passaged$ every$ 3$ or$ 4$ days.$These(parameters( are( used( for(
standard( cell( culture( and( have( been( implemented( for( control( purposes.( Markers(



































The(average(change( in(growth(rate(per(day( from(the(start(of( the(study( to( the(


































the( average( of( three( cultures( (error( bars( have( been( omitted( for( clarity(

































represent( the(growth(rate( of( cells(during(one(passage(and( are( the( average(of(
three(cultures((error(bars(have(been(omitted(for(clarity(purposes).(The(average(
change(in(growth(rate(per(day(from(the(start(of(the(study(to(the(end(was(3.56(





























×106$ cells/$mL$ and$ passaged$ every$ 4$ days.(Markers( represent( the( growth(
rate( of( cells( during( one(passage( and( are( the( average( of( three( cultures( (error(
bars( have( been( omitted( for( clarity( purposes).( The( average( change( in( growth(






























×106$ cells/$ mL$ and$ passaged$ every$ 3$ or$ 4$ days.( Markers( represent( the(
growth(rate(of( cells(during(one(passage(and(are( the(average(of( three(cultures(









Seeding&density&(cells/&mL): 1"x106 3"x106 5"x106 1"x106 3"x106 5"x106 1"x106 3"x106 1"x106 0.2"x106
Total"days"cultured 42 42 42 42 42 42 42 42 40 42
Average"change"in"growth"rate"(d(1) 152.0"x10(3 176.3"x10(3 157.7"x10(3 126.3"x10(3 46.0"x10(3 (50.3"x10(3 149.8"x10(3 180.0"x10(3 91.1"x10(3 23.9"x10(3
Average"change"in"growth"rate"per"day"(d(2) 3.61"x10(3 4.19"x10(3 3.75"x10(3 3.00"x10(3 1.09"x10(3 (1.19"x10(3 3.56"x10(3 4.29"x10(3 2.27"x10(3 0.57"x10(3
Average"no."cell"divisions/day/mL"(x106"d(1"mL(1) 0.761 2.356 4.020 0.990 2.729 4.221 1.330 4.463 2.016 0.486
Average"dilution"ratio"at"passage 0.562 0.562 0.556 0.334 0.355 0.374 0.200 0.183 0.110 0.117











1# 3# 5# 1# 3# 5# 1# 3# 1# 0.2#





































As(can(be(seen( from( figure(3.13(and( table(3.2,( there(are(clear(differentials( in( the(
evolution( of( growth( rate( according( to( cell( culture( regime( parameters:( when(
passaging(cultures(every(day,(little(difference(in(average(change(in(growth(rate(per(
day( is( observed( between( cultures( seeded( at( 1,( 3( and( 5( ×106( cells/(mL( (ranging(
between(3.61(×1093(days92( and(4.19(×1093(days92),( however( the( change( in(growth(
rate( is(positive( i.e.(cells( in(these(cultures(proliferate( faster(over(the(course(of( the(










days92),( meaning( the( rate( of( proliferation( of( the( cells( in( these( cultures( actually(
decreased(over( the( time(course(of( this(study.(The(dilution(ratio(of( these(cultures(
was(similar(again,(with(average(ratios(of(0.33(to(0.37,(meaning(that(approximately(
two(thirds(of(the(cell(population(is(removed(at(passage.(
When( passaging( every( 3( days,(we( see( large( average( changes( in( growth( rate( per(
day,(with( those( cultures( seeded( at( 1(×106( cells/(mL( showing( an( average( of( 3.56(
×1093(days92(and(those(seeded(at(3(×106(cells/(mL(showing(an(average(of(4.46(×1093(
days92,(which( is( the( largest(average(rate(of(change(observed( in( this(study.(As(has(
been(previously(mentioned,(there(were(no(cultures(seeded(at(5(×106(cells/(mL(and(
passaged(every(3(days,(as(exponential(phase(can(not(be(sustained( for( this( long(a(
time(period(at(this(seeding(density.(Average(dilution(ratios(following(these(regimes(











passaged( every( 3( or( 4( days( showed( very( little( change( in( growth( rate( over( the(













of( these(cultures(with( increasing(generation(number.(Generation(number( is(used(
here(as(it(provides(a(reference(to(how(many(times(the(cell(population(has(divided(
(doubling( time( of( the( cell( was( initially( extremely( slow( when( cells( were( first(
subjected( to( hypothermic( conditions).( Figure( 3.16( shows( the( growth( rate( of( the(
hypothermia9cultivated( CHOK1SV( cultures( (that( are( now( adapted( to( growth( at(
32°C)( when( they( are( returned( back( to( standard( conditions( (37°C).( Both( the(
hypothermia( adapted( cultures( (32A,( 32B( and( 32C)( and( their( standard9condition(


































Figure$ 3.16$ The$ growth$ rate$ of$ late$ generation$ (hypothermia$
adapted)$ 32A,$ 32B$ and$ 32C$ cultures$ at$ 32°C$ and$ when$
returned$to$standard$conditions$(37°C).$








32B( and( 32C( achieved( a( growth( rate( of( ~0.6( days91,( which( is( in( line( with( the(




cell( size(over( the(same(number(of(generations.(Figure(3.16(shows(that(when( late(
generation( cultures( of( 32A,( 32B( and( 32C( (that( have( adapted( to( growth( in(
hypothermic(conditions)(are(returned(to(standard(conditions((37°C),(growth(rate(
continues(at(a( lower(level(than(corresponding(cultures(that(remained(at(32°C.(All(
late( generation( cultures( (32A,( 32B,( 32C,( 37A,( 37B( and( 37C)( were( subsequently(
subject(to(culturing(under(more(extreme(hypothermic(conditions((30°C).(As(can(be(

















As$ a$ consequence$of$ observing$ the$dramatically$ improved$growth$ rate$ and$





The( cell( size( of( the( hypothermia( adapted( cultures( can( be( seen( in( figure( 3.14( to(
increase( from(~16(µm((at( the(start(of( the(study)( to(19.5(µm(in(diameter.(As( this(
increase( represents( such( a( marked( increase( in( cell( volume( (almost( a( doubling,(
assuming( a( spherical( cell),( the( biomass( (cell( protein)( content( was( measured( to(
determine(whether(the(cell(has(proportionately(increased(in(mass(or(whether(the(
increase( in( volume( has( compromised( biomass( density.( Figure( 3.19( shows( the(
protein(content(of(the(evolved,(hypothermia(adapted(cultures((32A,(32B(and(32C)(
and( also( shows( the( protein( content( of( corresponding( cell( cultures( from( the(
parental(banks(of(cultures(A,(B(and(C(for(reference(purposes((see(figure(3.2,(step(4(
for( further( details).( All( samples(were( taken( for( analysis( on( the( same(day( (day( 3(
post( sub9culture).( Figure( 3.19( shows( that( protein( content( is( indeed( also(
proportionately( increased( in( the( evolved,( hypothermia9adapted( cell( cultures(









In( line( with( the( previous( results,( RNA( content( was( measured( in( the( evolved,(
hypothermia9adapted( cell( cultures,( and( the( parental( (reference)( cultures( to(
determine(whether( cell(RNA(content(per( cell( has(proportionately( increased(with(
cell( volume( and( protein( content.( Figure( 3.20( shows( that( the( RNA( concentration(
extracted(from(5(×106(cells(is(substantially(and(proportianally(larger(for(cells(from(
evolved,(hypothermia9adapted(cultures(than(it(is(for(the(same(number(of(cells(from(
parental( cultures( (two9way( ANOVA(with( Tukey’s(multiple( comparisons( test,( see(
appendix(I).(
Figure$ 3.19$ The$ protein$ content$ of$ cells$ from$ evolved,$











































cytometry( detection( techniques.( The( protocol( described( in( section( 3.2.2.5( was(
performed( for:(a( culture( from(the(primary(cell(bank( (figure(3.2,( step(2)( that(was(
cultured( short9term( (several( passages)( at( 37°C,( the( hypothermia9adapted( cell(
cultures((32A,(32B(and(32C)(and(also(the(three(hypothermia9adapted(cultures(that(
were(subjected(to(long9term(culture(at(30°C((hereafter(termed(30A,(30B(and(30C).(
The( flow( cytometry( profile( produced( using( this( method( provides( quantitative(
information( about( the( proportion( of( cells( in( a( population( that( are( in( particular(






































culture( from( the( primary( cell( bank( exhibited( polyploidy( (normal( profiles( were(
observed( for( all( cultures( and(no( significant( peaks(were(detected( above( the(peak(
representing( 4N).( It( can( also( be( observed( that( all( histograms( represent( growing(
cells( (not( cells( arrested( in( G0/G1( phase( of( growth),( and( that( the( distribution( of(
cells(in(each(growth(phase(is(similar(between(cell(types.(
Figure$ 3.21$ A$ schematic$ showing$ the$ expected$ flow$ cytometry$ cell$ cycle$
profile$of$a$cell$population$with$normal$ploidy.$$The(left9most(peak((peak(1)(in(
the(diagram(represents(cells(in(G0/G1,(where(cells(are(defined(as(having(two(sets(
of( chromosomes.( To( the( right( of( this( peak,( cells( in( S9phase( are( represented,(
where(the(DNA(is(synthesised,(and(chromosome(number(is(increasing(from(2N(9>(






























32B$ and$ C)$ culture$ 32C.$The(x9axis( is( the( fluorescence( intensity( representing( the(
amount(of(DNA.(The(y9axis(shows(the(number(of(cells(exhibiting(a(given(fluorescence.(
The( profile( of( each( of( the( histograms( (A,( B( and( C)( shows( that( the( cells( in( these(













30B$ and$ C)$ culture$ 30C.$The(x9axis( is( the( fluorescence( intensity( representing( the(
amount(of(DNA.(The(y9axis(shows(the(number(of(cells(exhibiting(a(given(fluorescence.(
The( profile( of( each( of( the( histograms( (A,( B( and( C)( shows( that( the( cells( in( these(







3.3.2.5$ Primary$ characterisation:$ Heritability$ of$ phenotype$ through$
cryopreservation$
As( the( evolved,( hypothermia9adapted( cell( cultures( showed( divergence( in(
phenotype( from( the( parental( cultures( (e,g,( ability( to( rapidly( proliferate( at( 32°C,(
increase(in(cell(size)(the(heritability(of(these(phenotypes(through(the(freeze9thaw(
process(of(cryopreservation(was( investigated.(Figure(3.25(shows(that(all(evolved,(
hypothermia9adapted( cultures( (32A,( 32B( and( 32C)( retain( their( ability( to(






















C)$ culture$ 30C$ at$ 32°C,$ pre[$ and$ post[$ cryopreservation.$ All( evolved,(
hypothermia9adapted(cultures((32A,(32B(and(32C)(retain(their( large(cell(phenotype(








1,( the( advantages( of( directed( evolution( and( hypothermia( as( a( platform( for(
improved(cell( line(development(was(discussed.(The(research(aims(of(this(chapter(
were(to(develop(an(optimised(cell(culture(regime(for(rapid(evolution(of(growth(rate(
via( the(manipulation( of( basic( cell( culturing( parameters,( and( also( to( use( directed(
evolution( to( enable( the( adaptation( of( CHOK1SV( host( cells( to( growth( (exhibit(
normal(proliferation(rates)(under(hypothermic(conditions.(
The( first(section(of(work(presented( in(this(chapter(showed(that( it( is(possible,(via(
the(manipulation(of(seeding(density(and(passage(duration((and(consequently( the(
dilution(ratio(at(passage)(to(regulate(the(rate(of(change(in(growth(rate(over(long9










explored(here.(As(was(seen( in( figure(3.12(and( table(3.2,( the(control(cultures( that(
are( seeded( at( 0.2( ×106( cells/( mL( and( passaged( every( 3( or( 4( days( (common/(
standard(in9house(laboratory(protocol),(do(not(largely(vary(in(growth(rate(over(the(
~6( week( study:( these( cultures( had( an( average( dilution( ratio( of( ~0.11( and( an(
average( change( in(growth( rate(per(day(of(0.57(×1093(days92.(Contrary( to( this,( the(
largest( average( change( in( growth( rate( per( day( (an( average( of( 4.46(×1093( days92)(
was(observed( in( the(cultures(that(were(seeded(at(3(×106(cells/(mL(and(passaged(
every( 3( days,( and( the( average( dilution( ratio( for( these( cultures( was( ~0.18,(











that( could( positively( affect( growth( rate,( can( occur,( simply( due( to( the( population(
size( increasing.( Any( cells( that( had( acquired( a( faster( growth( rate( would( now(




of( average( change( in( growth( rate(per(day,( these(being( those( that(were(passaged(
every( day.( Cultures( passaged( every( day( and( seeded( at( 1(×106( cells/(mL,( 3(×106(
cells/(mL(and(5(×106( cells/(mL( showed( similar( average( changes( in( growth( rates(
per( day( (values( of( 3.61,( 4.19( and( 3.75( ×1093( days92,( respectively),( but(
understandably( were( largely( different( in( the( average( number( of( cell( divisions(




half( of( the( population(was( discarded( at( passage( and( it( is( also( a( largely( different(
ratio(to(that(suggested(by(Wahl(and(colleagues((2002).(
Interestingly,( in( those( cultures( passaged( every( 2( days,( it( was( only( the( cultures(
seeded( at( 1( ×106( cells/( mL( and( 3( ×106( cells/( mL( that( showed( and( increase( in(
average(change( in(growth(rates(per(day((albeit(a(small( increase( for(3(×106(cells/(
mL),(and(those(cultures(seeded(at(and(5(×106(cells/(mL(actually(showed(a(decrease(
in(growth(rate(over(the(~6(week(period,(with(an(average(change(in(growth(rate(per(





growth( for(2(days,( over( time(as( the( cells( become( continuously( subjected( to(high(
culture(densities((reaching(around(14(×106(cells/(mL(on(day(2)( the(conditions(of(
stationary(phase( could( be( simulated,( seeing( cells( reduce(proliferation( rates( as( is(








be( implemented( in( the( future(should( it(be(desired( to( fine9tune( the(results(of( this(
study.(However,(the(results(of(this(study(are(still(valuable(as(it(demonstrates(that(
great( improvements( in( growth( rate( can( be( achieved( by( simple( manipulation( of(
basic(commonplace(cell(culture(parameters.(
In( terms( of( practical( implementation,( although( it( has( been( observed( here( that(
passaging(every(day(results(in(large(average(changes(in(growth(rates(per(day,(it(is(
perhaps(too(labour(intensive(to(be(recommended(as(a(directed(evolution(culturing(
platform( (assuming( automated( culturing( is( unavailable,( as( was( the( case( in( this(
study).(However,(passaging(every(3(days(is(much(closer(to(conventional(protocol,(




Another(principal( result(of( this( chapter,( one( that( is( central( to(and(underpins( the(
subsequent(work(described( in( the( following(chapters(of( this( thesis,( is( that(of( the(







shock’( strategies( (described( in( the( introduction( section( to( this( chapter( and( in(
chapter(1),(without(the(disadvantage(of(cell(cycle(arrest.(As(was(shown(in(figures(
3.14( and( 3.15,( cultures( grown( under( hypothermic( conditions( (32°C)( for(
approximately( 150( generations( adapt( to( this( environment( by( way( of( improved(
growth( rate( (returning( to( normal( growth( rates( observed( under( optimal(
temperature( (37°C),( ~0.6( days91),( and( interestingly,( cultures( also( exhibited( a(
substantial(increase(in(cell(size,(from(a(diameter(of(approximately(~16(µm(to(~19+(
µm,( equating( to( an( almost( doubling( in( cell( volume( assuming( a( spherical( cell(
structure.(Possible(explanations(for(this(size(increase(include(it(being(a(cell(stress(
response,(a(phenomenon(that(has(been(demonstrated(in(mouse(cardiac(myocytes(
that( increase( in(cellular(volume(as(a(response( to(various(metabolic(and(chemical(
stressors( (Anastacio( et& al.( 2013).( Another( suggestion( is( that( the( increase( in( cell(
volume(is(a(thermodynamic(attempt(to(conserve(heat(in(the(colder(environment(by(




proportionately( in( the( evolved,( hypothermia9adapted( cultures( compared( to( their(
parental,( unevolved( counterparts.( This( suggests( that( the( density( of( the( cell(
constituents( has( not( been( compromised( as( a( result( of( the( increase( in( volume,(
meaning( that( the(evolved(cells(are(generating(more(biomass( than( the(unevolved,(
parental( cells,( whilst( growing( at( equivalent( rates( under( adverse,( hypothermic(
conditions.( This( could( suggest( that( these( cells( do( have( the( inherent,( improved(
protein( production( and(processing( capabilities( that(was( originally( sought( in( this(
study( –( a( concept( that( is( more( thoroughly( examined( in( the( succeeding( chapter(
(chapter(4).(Additionally,(a(feature(that(is(necessary(for(any(improved(cell(line(that(
is( to(be(used( for( industrial(purposes( is( the(heritability(and(preservation(of( those(





under( hypothermic( conditions( and( also( retain( their( large( cell( size( phenotype(
through(the(freeze9thaw(cycle(of(cryopreservation(and(revival.(
Out(of(interest,(and(to(determine(whether(growth(rate(could(be(improved(further,(
towards( the( end( of( the( long( term9culturing( period,( an( extra( set( of( the( evolved,(
hypothermia9adapted( cultures( were( created( and( then( returned( to( standard(
culturing(conditions((37°C).(As(was(shown(in(figure(3.16,(the(growth(rate(of(these(
cultures( actually( declined( in( their( growth( rate( compared( to( the( ones( that(
continued( to( be( cultured( at( 32°C.( This( shows( that( the( evolved( cultures( have(
adapted(to(hypothermic(conditions(to(the(degree(that( these(conditions(have(now(
become( their( optimal( growth( temperature( and( their( previous( native( (37°C)(
optimum( is( now( sub9optimal( in( terms( of( growth( rate.( In( addition( to( this,( the(
evolved,(hypothermia9adapted(cultures(were(also(subjected(to(long9term(culture(at(
more(extreme(hypothermia((30°C)(to(determine(whether(they(could(be(adapted(to(
grow( at( rapid( rates( at( even( lower( temperatures( (for( example,( could( they(
eventually(grow(at(the(same(temperatures(that(are(optimal(for(ectothermic(insect(
production( cell( lines(which(has(been( shown( to(be(~27°C( (Reuveny(et&al.( 1993)).((
Presented( in( figures( 3.17( and( 3.18,( results( showed( that( while( viability( was(
maintained(in(the(hypothermia9adapted(cultures(at(30°C,(the(growth(rate(did(not(
show( any( improvement( over( the( course( of( the( long9term( culturing( process.(
However,( the(control(cultures(were(also(subjected(to(culturing(at(30°C(and(these(
quickly( declined( in( growth( rate( and( ultimately( lost( all( viability( under( these(
conditions.((
















culture( (from( the( primary( cell( bank)( were( tested( for( polyploidy.( The( rationale(
behind( this( assessment( came( from( findings( in( the( literature( that( showed(
significant( relationships( between( organism( polyploidy( (multiple( sets( of(




aneuploidy( (an( abnormal( number( of( chromosomes),( or( large9scale( chromosomal(
rearrangements(may(also(aid(in(adaptation(to(stress((Pavelka(et&al.(2010;(Chen(et&
al.( 2012).( However,( information( regarding( aneuploidy( and( chromosomal(
rearrangements( cannot( be( interpreted( from( this( data( set( and( more( specialised(
analyses( would( need( to( be( performed( to( establish( whether( the( evolved,(
hypothermia9adapted( cultures( exhibit( aneuploidy( or( large9scale( chromosomal(
rearrangements.( Knowing( that( the( evolved( cell( lines( exhibit( normal( ploidy( (i.e.(
have( the( same( number( of( sets( of( chromosomes( as( the( parental( CHOK1SV),( but(
contain( substantially( more( RNA( than( the( parental( cultures,( implies( that(
transcription( in( the( hypothermia9adapted( cells(may( be( operating( at( significantly(
faster(rates(to(account(the(larger(disparity(between(DNA:(RNA(ratio,(which(could(
be(a(promising(feature(in(terms(of(recombinant(protein(productivity.(Alternatively,(











at(passage,( the(evolution(of( rapid(growth( rate( can(be( improved(compared( to( the(
average(rate(of(change(observed(in(cultures(following(standard(passaging(protocol.(
These( optimised( regimes( could( be( applied( in( directed( evolution( experiments(
where(rapid(increases(in(growth(rate(are(required.(
The( rest( of( the( work( presented( in( this( chapter( forms( the( foundations( for( the(
subsequent(chapters(in(this(thesis.(It(was(seen(that(three(cultures(of(CHOK1SV(host(
cells( were( successfully( evolved( over( long9term( culture( at( 32°C( to( become(
hypothermia9adapted,( proliferating( at( similar( rates( to( those( that( would( be(
expected(under(optimal(temperatures((37°C).(As(has(already(been(highlighted,(this(
result( is( particularly( notable( considering( the( literature( only( cites( partially(
successful( hypothermia9adaptation( experiments( using( only( stably( producing( cell(
lines( (Yoon( et& al.( 2006;( Sunley( et& al.( 2008),( and( there( is( no( evidence( that( any(
laboratory(has( successfully( adapted( a(host( CHO( cell( line( to(hypothermic( growth.(
The(dramatic( increase( in( cell( volume,( and(proportionate( increase( in(protein( and(
RNA(content(is(also(intriguing(and(potentially(fruitful(in(terms(of(cell(recombinant(
protein( production( capabilities.( The( obvious( future( work( that( would( be(
recommended(from(here,(and(is(explored(in(the(next(chapter,(would(be(to(asses(the(
evolved( cell( lines( in( terms( of( their( transient( transfection( and( production(
capabilities,( their( performance( in( fed9batch( culture( and( also( their( ability( to( be(
stably( transfected( into( stable( cell( lines( using( industrially( relevant( recombinant(
proteins.(
In( terms( of( other( future(work,( this( study(may( benefit( from( the( repetition( of( the(
adaptation( process( but( with( an( alternative( host( cell( line( (i.e.( not( CHOK1SV),( to(
determine(whether(other(host(cell( lines(are(able( to(adapt( to(growth(at(32°C.(The(
experiment( could( also( be( performed( in( different( laboratories( to( ensure(





iterative( temperature( reduction( approach,( to( determine(whether( the( adaptation(
process( time( could( be( reduced.( The( evolved,( hypothermia9adapted( cell( lines,(
although(found(not(to(be(polyploid,(could(be(tested(alongside(the(parental(control(
cultures(for(aneuploidy(by(karyotype(analysis,(which(would(reveal(information(on(
the( chromosome( count( and( also( chromosomal( aberrations,( highlighting( any(














hypothermia7adapted$CHOK1SV$cell$ cultures$described$ in$chapter$3.$The$ functional$
attributes$include$the$properties$of$a$cell$line$that$are$considered$directly$industrially$
relevant,$primarily$in$terms$of$recombinant$protein$productivity$and$quality.$Firstly,$
the$ three$ evolved,$ hypothermia7adapted$ cell$ cultures$ are$ assessed$ in$ terms$ of$
transient$ productivity$ using$ electroporation$ methods$ and$ the$ common$ reporter$
proteins,$ GFP$and$ SEAP,$ and$ compared$ to$ their$ corresponding$parental,$ unevolved$
cell$ lines.$From$here,$a$ single$ culture$ from$the$ three$evolved,$hypothermia7adapted$
cultures,$ “32A”,$and$ its$corresponding$parental,$unevolved$culture,$ “37A”,$are$taken$
forward$ for$ further$ comparative$ analysis.$ These$ cultures$ are$ hereafter$ referred$ to$
simply$ as$ the$ evolved$ cell$ line$ and$ the$ parental$ cell$ line,$ respectively.$ Such$ further$
analysis$includes$performance$in$a$fed7batch$culturing$platform,$long7term$transient$










culture( at( 32°C,( the( three( cultures( exhibited( growth( rates( similar( to( those( that(







this( project( have( also( exhibited( interesting( phenotypes,( with( an( increase( in( cell(
size(alongside(an( increase( in(protein(and(RNA(content,(whilst(retaining( the(same(
number(of(sets(of(chromosomes(as(the(parental(cells.((
There( is(potential(promise( that( these(evolved,(hypothermia7adapted(cell( cultures(
could( provide( an( industrial( cell( line( that( not( only( has( the( high( cell( specific(
productivity( (qP)(qualities( that(are(characteristic(of( cells(producing( recombinant(
protein( under( cold7shock( strategies,( but( the( hindrance( of( reduced( growth( rate(
(also( associated( with( a( cold7shock( strategy)( has( been( eradicated( here.( For(
industry,( this( could( mean( that( the( overall( titre( they( are( able( to( generate( may(
greatly( be( improved( by( using( these( cultures( at( 32°C( in( place( of( the( standard(
CHOK1SV(host(cell( line.(However,(the(hypothermia7adapted(cultures(need(first(to(
demonstrate( that( they( indeed(do(have(a(high(qP( compared( to( standard( cultures.(
This(chapter(first(examines(this(in(terms(of(transient(productivity,(assessing(both(
the( hypothermia( adapted( cultures( alongside( parental( cultures,( at( both( 37°C( and(
37°C.( Following( this,( the( ability( to( make( stable( cell( lines( from( one( of( the(

















the( parental( and( evolved( (hypothermia7adapted)( CHOK1SV( cultures( at( 37°C( or(
32°C,( respectively.( This( kit( was( chosen( based( on( the( compatibility( of( the(
supplements( (EfficientFeedTM(A( and(EfficientFeedTM(B)(with(CD(CHO(as( the(base(
media,( which( the( cultures( were( already( accustomed( to.( Feeds( were( added( in(
volumes(based(on(10%(of(the(volume(of(culture(in(the(flask(on(that(day((volume(of(
culture(was(calculated(by(subtracting(the(weight(of(an(empty(125(mL(Erlenmeyer(
flask( (Corning,( Surrey,( UK)( from( the( weight( of( a( 125( mL( Erlenmeyer( flask(
containing( culture,( taking( 1( g( as( equivalent( to( 1( mL).( The( different( feeds,(
EfficientFeedTM(A(and(EfficientFeedTM(B,(were(added(separately(or(in(combination,(
and(added(every(two(or(three(days,(to(a(maximum(of(4(feeds,(as(shown(in(table(4.1(
below.( The( previously( mentioned( optimisation( parameters( were( adapted( from(
those(suggested(in(manufacturer’s(guidelines.(Control(flasks(were(also(included(for(
both(cell(types((parental(and(evolved)(in(which(no(feed(supplements(were(added.(
All( flasks( were( initially( seeded( at( 0.2( ×106( cells/(mL$ and( daily( cell( density( and(
viability( measurements( were( made( daily( using( the( Vi7CELL( XR( cell( viability(
analyser((Beckmann(Coulter,(High(Wycombe,(UK).(Prior(to(use,(all(media(and(feeds(
were( warmed( to( 37°C( or( 32°C( for( use( with( the( parental( or( evolved( cultures,(










All( vectors( used( in( this( chapter( contain( the( gene( for( one( of( the( following:( GFP(
(Green( Fluorescent( Protein)( [phCMV( C7GFP( FSR( Vector( (Genlantis,( AMS7
Biotechnology,(Abingdon,(UK),(see(appendix(II(for(map];(SEAP((Secreted(Placental(
Alkaline( Phosphatase)( [gWIZTM( SEAP( (Genlantis,( AMS7Biotechnology,( Abingdon,(
UK),(see(appendix(II(for(map];(cB72.3((an(IgG4(mAb)((Lonza(Biologics,(Cambridge,(
UK);(or(Enbrel((A.K.A(Etanercept,(an(IgG1(Fc7fusion(protein,(typically(classed(as(a(
difficult( to( express( (DTE)( protein)( (Lonza( Biologics,( Cambridge,( UK).( Vectors(





(Life( Technologies,( Paisley,( UK)( according( to( the( manufacturer’s( recommended(
protocol.( 200( μL( of( cells( were( then( spread( onto( LB( agar( containing( antibiotic(
(ampicillin( or( kanamycin,( depending( on( plasmid( being( used)( which( was( then(
Day 0 1 2 3 4 5 6 7 8 9 10 11 12
Strategy EfficientFeedsTM
A A ✓ ✓ ✓ ✓
B A ✓ ✓ ✓ ✓
C B ✓ ✓ ✓ ✓
D B ✓ ✓ ✓ ✓
E A+B ✓ ✓ ✓ ✓
F A+B ✓ ✓ ✓ ✓
Table$4.1$The$feeding$strategies$used$ to$optimise$ fed8batch$culture$ in$ the$parental$
and$ evolved,$ hypothermia8adapted$ cultures.$ Strategies( followed( a(2(or(3( day( feeding(
pattern((to(a(total(of(4(feeds),(were(added(in(volumes(of(10%(of(total(culture(volume,(and(











and( inoculated( in( 5(mL( LB( broth( containing( antibiotic( (ampicillin( or( kanamycin,(
depending(on(plasmid(transformed).(This(was(then(incubated(for(~8(hours(at(37°C(
in( a( shaking( incubator( at( 250( rpm.( Following( this,( the( cells( were( then( used( to(
inoculate( larger( cultures( containing( 500( mL( LB( medium( containing( antibiotic(
(again,(ampicillin(or(kanamycin,(depending(on(plasmid(transformed)(which(were(
then( incubated( for( ~16( hours( at( 37°C( in( a( shaking( incubator( at( 200( rpm.( After(
incubation,(the(cells(were(pelleted(by(centrifugation(at(8000(rpm(for(10(minutes(at(
4°C.(At(this(stage(the(pellet(was(either(frozen(until(the(purification(step(or(purified(
immediately.( During( all( stages( of( the( amplification( process,( aseptic( techniques(
were(used.((
4.2.2.4$Purification$of$plasmid$DNA$
After( amplification,( plasmid( DNA( was( purified( using( either( of( the( following(
commercially( available( kits:( QIAGEN®( QIAprep( Spin( Miniprep( Kit,( QIAGEN®(
Plasmid( Plus( Mega( Kit( or( QIAGEN®( Plasmid( Plus( Giga( Kit( (all( QIAGEN,( West(
Sussex,(UK).(All(kits(were(used(according(to(the(manufacturer’s(protocols.(DNA(was(
eluted( in( a( laminar( flow( cabinet( to( ensure( DNA( is( sterile.( Eluted( DNA(was( then(
either( linearised( (for( stable( transfections)( or( stored( in( sterile( TE( buffer( (Sigma7
Aldrich,(Dorset,(UK)$at(a(concentration(of(400(±50(μg/(mL.(
4.2.2.5$ Linearisation$ and$ solubilisation$ of$ plasmid$ DNA$ for$ stable$
transfections$$
For(each(electroporation(performed,(40(μg(DNA(is(required,(however,(to(allow(for(







(Sigma7Aldrich,(Dorset,(UK),( and(make(up( to( a( final( volume(of( 100(μL(using(d.d.(
H2O.(Incubate(the(mix(for(476(hours(in(a(37°C(waterbath.(Following(incubation,(the(
DNA( is( precipitated( by( adding( 1/10th( volume( 3M( NaAc( and( 3( volumes( 100%(
ethanol,( which( is( mixed( by( pipetting( and( then( incubated( overnight( at( 720°C( to(
ensure(full(precipitation.(Next,(the(precipitated(DNA(is(pelleted(by(centrifugation(at(
13000( rpm( for( 10(minutes.( In( a( laminar( flow( cabinet,( the( pellet( is( then(washed(
with(200(μL(70%(ethanol(and(then(centrifuged(at(13000(rpm(for(10(minutes.(The(
supernatant( is( then( removed( and( the( pellet( left( to( air7dry( in( the( laminar( flow(
cabinet( for( max.( 15( minutes.( Once( all( ethanol( has( evaporated,( the( pellet( is(
resuspended(in(50(μL(1×TE(buffer((per(60(μg(DNA)(and(allowed(to(stand(for(1(hour(
at(room(temperature((remaining(in(the(laminar(flow(cabinet).(After(this(time,(the(
DNA(pellet/(TE(buffer(mix( is(pipetted(gently(several( times(to(ensure(the(pellet( is(




The( concentration( of( the( DNA( used( for( all( transfections( were( assessed( using( a(
NanoDropTM( 2000( Spectrophotometer( (Thermo( Scientific,( Loughborough,( UK).(




















pack( and( the( agarose( dissolved( in( TBE( buffer( was( gently( poured( onto( this( and(
mixed(gently(using( a( cell( spreader.(Once( set,( the( gel( pack(was( filled(with(1×TBE(
buffer(to(a(level(that(covered(the(agarose(gel.(An(equivalent(volume(of(the(1007200(
ng( digested( DNA( mixes( was( combined( with( 4( μL( loading( dye( (New( England(
Biolabs,(Hitchin,(UK)(and(added(to(individual(lane(wells.(Equivalent(amounts(of(27
log(ladder((New(England(Biolabs,(Hitchin,(UK)(were(also(loaded(into(end(wells(for(






N.B.$ All$ of$ the$ following$ work$ is$ performed$ in$ a$ laminar$ flow$ cabinet.( For( each(
transient(transfection,(10(×106(cells(are(required.(Cells(should(be(of(high(viability(
(>95%)( and( be( from( mid7exponential( phase( of( culture( growth( (usually( day( 3).(
Viability( and( cell( density( of( cultures( is( determined( using( the( Vi7CELL( XR( cell(
viability( analyser( (Beckmann( Coulter,( High(Wycombe,( UK).( Cell( concentration( is(
adjusted( by( centrifugation( at( 200( ×g( for( 5( minutes( and( the( pellet( of( cells( is(








mL( cells( in( fresh( CD( CHO(media( is( also( added( to( the( cuvette,( taking( care( not( to(
introduce( large(bubbles( to( this(DNA7cell(mix.(The(electroporation(pulse(chamber(
(Bio7Rad,( Hemel( Hempstead,( UK)( is( then( lightly( sprayed( with( 70%( ethanol( and(
placed(in(the(laminar(flow(cabinet(and(the(cuvette(is(installed.(The(main(unit(of(the(
Gene7Pulser(XcellTM( is( then(adjusted( to( the( following(settings:(300(V,(900(μF(and(
resistance(∞(Ω.( The( voltage( is( then( applied( through( the( cuvette,( electroporating(
the( cells.( The( time( constant( at( these( settings( was( ~18(ms,( within( the( expected(
range(of(12720(ms.(Control(transfections(should(also(be(performed(as(follows:(one(
control( in(which(cells(are(added(to(100(μL(TE(buffer(containing$no$DNA(and(then(
electroporated( (mock( transfected).( On( occasion,( an( additional( control( is( used( in(
which(cells(are(added(to(the(DNA(in(TE(buffer(but$not$electroporated.(Immediately(
following( electroporation,( cells( are( transferred( into( the( desired( volume( of( pre7
warmed,( 6( mM( glutamine( supplemented( CD( CHO( media.( With( transient(
electroporation( transfections,( productivity( of( the( recombinant( protein( is( usually(
measured(within(174(days(of(transfection.(
Stable$transfection$
N.B.$ All$ of$ the$ following$ work$ is$ performed$ in$ a$ laminar$ flow$ cabinet.( Stable(
electroporation( transfection( is( performed( as( it(would( be( for( transient,( however,(
linearised( DNA( is( used( ( (cB72.3( and( Enbrel)( and( the( treatment( of( cells( post7
electroporation( is( different,( as( follows:( Rather( than( the( return( of( the(
electroporated(cells(from(the(cuvette(to(CD(CHO(media(supplemented(with(6(mM(
gluatamine,( cells( are( added( to( 50(mL(of(warmed(CM55(media( in( a( sterile( T7175(
flask( (NuncTM,( Thermo( Scientific,( Loughborough,( UK).( CM55( media( is( made( by(
adding( 100×HT( supplement( (Invitrogen,( Paisley,( UK)( to( CD( CHO( media.( Once(
mixed,(25(mL(of(the(50(mL(T7flask(culture(is(then(either(transferred(to(a(separate(
T7175(flask((as(per(Lonza(Biologics(SOP),(or(discarded((as(it(was(in(this(study(due(
to( limited( incubator( capacity).( Each( T7175( flask( containing( 25( mL( of(
electroporated(cell( culture( is( then(placed( in(a(5%(CO2(static( incubator(at(37°C(or(





hypothermia7adapted(cells)( for(18724(hours.(Following( this(period(of( incubation,(
the( viability( and( cell( concentration( are( determined( using( the( Vi7CELL( XR( cell(
viability(analyser( (Beckmann(Coulter,(High(Wycombe,(UK).(Next,(75(mL(of(warm(





analyser.( Once( cells( reach( a( density( of( 0.1( ×106( cells/( mL,( Vi7CELL( XR(





[N.B.$ cross7temperature$ control$ cultures$ were$ also$ created$ in$ this$ study$ (i.e.$
transfected$ parental$ cultures$ that$ were$ incubated$ at$ 32°C$ and$ transfected$
hypothermia7adapted$ cultures$ incubated$ at$ 37°C),$ however,$ viability$ of$ these$




mediated( transfection( was( conducted( using( Lipofectamine®( LTX( with( PLUSTM(
reagent( (Life( Technologies,( Paisley,( UK).( Prior( to( experimentation,( ratio( of( DNA:(




would( contain( 12( μg( and( 24( μL( of( Lipofectamine®( LTX.( The( ideal( ratio( would(
provide( intense(GFP( fluorescence(whilst(maintaining(a( relatively(high(viability(of(





DNA( and( Lipofectamine®( LTX( are( dispensed( into( separate( sterile,( 1.5( mL(
microcentrifuge( tubes( (Eppendorf,( Stevenage,(UK).(PLUSTM(reagent(was(added( to(
the( DNA( in( equivalent( volume( to( that( of( DNA( and( mixed( by( pipetting.( The(
Lipofectamine®( LTX( was( diluted( in( Opti7MEM®( Reduced( Serum( medium( (Life(
Technologies,( Paisley,( UK)( to( a( total( volume( of( 0.5( mL,( and( the( DNA( +( PLUSTM(
reagent( mix( was( also( diluted( in( Opti7MEM®( Reduced( Serum(medium( to( a( total(
volume(of(0.5(mL.(These(two(0.5(mL(volumes(were(then(combined,(mixed(gently(by(
pipetting(and( then(allowed( to( stand(at( room(temperature( for(5(minutes( to(allow(
DNA7lipid( complexes( to( form.( The( DNA7Lipofectamine®( complex( is( then( used(
immediately.((




density( of( 1(×106( cells/(mL(had(been( established,( 10(mL( aliquots( of( this( culture(
were( then( added( to( each( 50( mL( CultiFlask( (Sartorius,( Thermo( Scientific,(




hypothermia7adapted( cells,( plus( cross7temperature( controls),( at( 170( rpm( under(
5%(CO2.(All(cultures(were(then(fed(10%(culture(volume((~1(mL)(of(EfficientFeedTM(
A( and( EfficientFeedTM( B( at( a( 1:1( ratio( on( days( 3,( 6( and( 9.( A( sample( of( cells(












Relative( secreted( alkaline( phosphatase( (SEAP)( reporter( protein( was( measured(
using(a( colorimetric(Anaspec(SensoLyte®( pNPP(Secreted(Alkaline(Reporter(Gene(
Assay( Kit( (Cambridge( Bioscience,( Cambridge,( UK).( The( hydrolysis( of(
paranitrophenyl( phosphate( (pNPP)( to( paranitrophenol( is( catalysed( by( alkaline(






405( nm( using( a( PowerWaveTM( spectrophotometer( plate( reader( (BioTek,( Potton,(
Bedfordshire,( UK).( Values( were( then( normalised( to( the( lowest( producing(
transfection(condition((parental(cells(cultured(at(37°C(post7transfection)( to(show(
the( %( increase( in( production( on( other( transfection( conditions( (parental( cells(
cultured( at( 32°C( post7transfection,( hypothermia7adapted( cells( cultured( at( 37°C(
post7transfection( and( hypothermia7adapted( cells( cultured( at( 32°C( post7
transfection).(
4.2.3.2$GFP$intensity$and$transfection$efficiency$using$flow$cytometry$$
Intracellular( green( fluorescent( protein( (GFP)( production( and( transfection(
efficiency( was( measured( using( flow( cytometry.( Fluorescence( intensity( was(
measured( using( an( Attune®( Acoustic( Focusing( Cytometer( (Life( Technologies,(
Paisley,( UK).( Samples( of( 10,000( cells( were( measured( and( negative( (‘mock7
transfected’)( control( cells( (without( GFP( plasmid( but( subject( to( the( transfection(
process,( e.g.( lipofection( or( electroporation)( were( used( to( determine( auto7
fluorescence( and( transfection( efficiency.( GFP( was( excited( using( a( 488( nm( laser(
passing( through( a( 530/30( centre/bandpass( filter( and( data( was( analysed( using(





size( (to( exclude( cell( debris)( and( a( daughter( plot( was( generated( to( assess( GFP(
expression.( Median( fluorescence( intensity( was( measured( and( transfection(
efficiency(was(calculated(in(terms(of(%(fluorescing(cells(out(of(the(total(cells(in(the(





Production( of( cB72.3( and( Enbrel(was(measured( using( a( FastELISA®( Human( IgG(
Quantification(kit((RD7Biotech,(Besançon,(France),(according(to(the(manufacturer’s(
protocol.( All( samples( were( diluted( 1( in( 500( in( the( sample( diluent( (supplied).(
Absorbance( of( each( sample( at( 450( nm( was( measured( using( a( PowerWaveTM(
spectrophotometer(plate(reader((BioTek,(Potton,(Bedfordshire,(UK).(Absorbances(
of(the(human(IgG(standards((supplied,(concentrations(ranging(from(0(to(1000(ng/(
Figure$ 4.1$ Example$ histograms$ to$ show$ the$ determination$ of$ transfection$
efficiency$ using$ GFP$ and$ flow$ cytometry.$ A)( Shows( the( histogram( for( control(
(mock(transfected)(cells.(B)(Shows(the(superimposed(histograms(of(the(control(cells(
and( a( transfected( cell( population.(A(gate( is( fitted( at( the( top(1%( fluorescing( control(










unknown(concentration(of( IgG( in( the(sample(supernatant( could( then(be(deduced(
via(this(standard(curve.(
4.2.3.4$Protein$A$purification$of$cB72.3$and$Enbrel$
Recombinant( IgG( protein( (cB72.3( and( Enbrel)( was( purified( from( cell( culture(
supernatants( using( HiTrap( Protein( A( HP( prepacked( columns( (GE( Healthcare,(
Buckinghamshire,(UK).(Prior(to(application(to(the(column,(supernatant(was(filtered(
through( 0.22( μm( syringe( filters( (Sigma7Aldrich,( Dorset,( UK).( The(manufacturer’s(
recommended( concentration( ranges/( pH( ranges( were( used( and( recommended(
protocol( for( operation( with( syringe( was( followed.( The( specific( volumes,(
concentrations( and( pH( as( were( used( as( follows,( according( to( recommendation(
from(Lonza(Biologics((Cambridge,(UK):(binding(buffer,(20(mM(sodium(phosphate,(
pH( 7;( elution( buffer,( 0.1(M( citric( acid,( pH( 3.5;( neutralisation( buffer( in( collection(
vial,( 150( μL( Tris7HCL.( Eluted,( purified( protein( was( stored( in( sterile( PBS( at( 4°C(
(short7term)(or(720°C((long7term).((
4.2.3.5$Quantification$of$purified$cB72.3$and$Enbrel$by$NanoDropTM$
The( concentrations( of( the( purified( protein( samples( of( cB72.3( and( Enbrel( were(
assessed( using( a( NanoDropTM( 2000( Spectrophotometer( (Thermo( Scientific,(
Loughborough,(UK).(This(was(performed(using(the(“Other(protein((E(1%)”(setting(
when( defining( protein( type.( Using( the( absorbance( at( 280( nm( and( using( the(
extinction( coefficients( of( 14.3( and( 11.6( for( cB72.3( and( Enbrel,( respectively,( the(
concentration( of( protein( in( each( sample( can( be( determined.( Prior( to(
measurements,(the(NanoDropTM(was(blanked(using(1(μL(PBS(from(the(same(batch(
that(was( used( for( protein( storage.( The( arm(was( then(wiped( clean(with( lint7free(
microscope(lens(tissue(and(samples(were(added(and(analysed(in(turn,(with(the(arm(









to( ensure( correct( banding( profile( of( each( protein.( Reduced( and( non7reduced(
proteins(were( run,( the( former(using(NuPAGE®( Sample(Reducing(Agent( (Thermo(
Scientific,(Loughborough,(UK).(First,(5(μg(of(protein(sample(was(diluted(in(d.d.(H2O(
to( a( volume( of( 10( μL.( To( this,( 2.5( μL( NuPAGE®( LDS( Sample( Buffer( (Thermo(
Scientific,( Loughborough,( UK)( was( added( to( all( samples.( To( create( a( reduced(
protein(sample,(1(μL(of(NuPAGE®(Sample(Reducing(Agent(was(added(and(this(was(
then(heated(at(70°C( for(10(minutes.(The(non7reduced(protein( sample(was( left( at(
ambient( temperature( for( the(same(duration.(Next,(10(μL(aliquots(of( reduced(and(
non7reduced(proteins(were(added(to(wells(of(NovexTM(4712%(Bis7Tris(Protein(Gels(
(pre7cast)((Thermo(Scientific,(Loughborough,(UK)(in(NuPAGE®(MOPS(SDS(Running(
Buffer( (Thermo( Scientific,( Loughborough,( UK).( Alongside( the( wells( containing(
protein( sample,( 10( μL( of(NuPAGE®( Sharp(Pre7Stained(Protein( Standard(Thermo(
Scientific,(Loughborough,(UK))(was(added(to(create(a(size(reference(ladder.(The(gel(
was(then(run(at(180(V(for(approximately(1(hour.(The(proteins(were(then(stained(
using( InstantBlueTM( Ultrafast( Protein( Stain( (Sigma7Aldrich,( Dorset,( UK)( and( the(
banding(profile(was(analysed.($
4.2.4$Glycan$profiling$of$cB72.3$and$Enbrel$
Protein( samples( of( cB72.3( and( Enbrel,( from( both( the( parental( cell( and( the(
hypothermia7adapted( cells,( produced( via( both( stable( production( (batch( culture)(
and( transient( fed7batch( Lipofection( methods( were( analysed( in( terms( of( their(










All( evolved( (hypothermia7adapted)( cultures( and( parental( (unevolved)( cultures(
(32A,( 32B,( 32C,( 37A,( 37B( and( 37C)( were( transfected( with( SEAP( via(
electroporation.(Six(electroporations(were(performed(for(each(culture,(3(replicates(
that( were( incubated( at( native( temperatures( (i.e.( at( 32°C( for( the( evolved,(
hypothermia( adapted( cultures( and( 37°C( for( the( parental( cultures)( post7
transfection,(and(3(that(were(incubated(at(non7native(temperatures((i.e.(at(37°C(for(
the( evolved,( hypothermia( adapted( cultures( and( 32°C( (a( “cold7shock”)( for( the(
parental( cultures).( A( one7way( ANOVA( with( Tukey’s( multiple( comparisons( test(
(comparison( test( between(mean(%( increase( to( all( other(mean(%( increase)( was(
performed(on( the(data,( see(appendix( II.(As(can(be(seen( in( figure(4.2,( the(evolved(
cultures( incubated( at( 32°C( post7transfection( showed( the( largest( SEAP(
productivities,( with( an( average( increase( of( ~100%( on( the( lowest( producing(















4.3.2$ GFP$ fluorescence$ of$ evolved,$ hypothermia8adapted$ cultures$ and$
parental$ cultures$ incubated$ at$ both$ 32°C$ and$ 37°C$ post8transfection$ to$
determine$relative$GFP$productivities$and$transfection$efficiencies$$
All(evolved((hypothermia7adapted)(cultures(and(parental(cultures((32A,(32B,(32C,(




non7native( temperatures( (i.e.( at( 37°C( for( the( evolved,( hypothermia( adapted(
cultures( and( 32°C( (a( “cold7shock”)( for( the( parental( cultures).( Results( were(
obtained( by( flow( cytometry:( median( fluorescence( values( represent( the( relative(
amount( of( intracellular(GFP(produced(by( the( cell( and( transfection( efficiency( (i.e.(
the( %( fluorescing( cells)( represents( the( %( of( the( population( that( has( been(
Figure$ 4.2$ Relative$ SEAP$ productivities$ (24$ hours$ post8transfection)$ of$ evolved$



















































successfully( transfected( with( GFP( (and( is( therefore( producing( the( recombinant(
GFP( protein).( An( example( histogram( showing( typical( transfection( efficiency(
achieved( from( electroporation( is( given( in( figure( 4.3( 7( this( is( chiefly( for( contrast(
purposes(to(the(typical(transfection(efficiencies(achieved(via(lipofection((which(is(




32C)( show( both( higher( median( fluorescence( values( and( higher( transfection(
efficiencies( than( that(of( their(equivalent(parental( cultures( (37A,(37B(and(37C).(A(




Figure$ 4.3$ Example$ histograms$ to$ show$ the$ typical$ transfection$ efficiency$










(32A,$32B,$32C,$ 37A,$37B$and$37C)$ transfected$ (via$ electroporation)$with$GFP$and$



































































Figure$ 4.5$ The$ transfection$ efficiencies$ (24$ hours$ post8transfection)$ of$ all$ cell$










limited+ resource+ availability,+ only+ one+ of+ the+ evolved+ cell+ cultures+ (and+ its+
parental,+ unevolved+ counterpart)+ is+ taken+ forward+ for+ further+ productivity+
analysis,+ stable+ cell+ line+ generation+ and+ subsequent+ product+ quality+ analysis+
by+ glycan+ profiling.+ The+ evolved+ cell+ culture+ taken+ forward+ was+ 32A+ for+ the+
following+ reasons:+ 1)+ 32A+ showed+ the+most+ interesting+ phenotype+ by+way+ of+
exhibiting+both+consistent+large+cell+size+and+the+highest+growth+rate+out+of+the+
three+cultures+ H+while+32B+was+marginally+ smaller+ in+ size+but+maintained+an+
adequate+growth+rate+and+32C+was+as+ large+as+32A+but+exhibited+marginally+
slower+ growth+ rates;+ 2)+When+assessing+preliminary+ productivity+ data+ (both+
with+SEAP+and+GFP),+32A+was+the+highest+producing+evolved+culture+out+of+the+











4.3.4.1$ Optimisation$ of$ DNA:Lipofectamine® $ LTX$ ratios$ and$ fed8batch$
feeding$strategy$
The( ratio( of( DNA:( Lipofectamine®( LTX( for( use( in( Lipofection( studies( was(
optimised( in( terms( of( transfection( efficiency,( cell( culture( viability( and( median(
fluorescence( of( intracellular( GFP.( An( example( histogram( showing( typical(
transfection(efficiency(achieved(from(lipofection(is(given(in(figure(4.6(below(7(this(
is( chiefly( for( contrast( purposes( to( the( typical( transfection( efficiency( histogram(
achieved(via(electroporation((which(was(shown(in(figure(4.3).((
(
As( can( be( seen( in( figures( 4.7( to( 4.9,( a( DNA:( Lipofectamine®( LTX( ratio( of( 1:2( is(



















































































strategy( for( fed7batch( culture( was( also( optimised( as( recommended( by( the(
manufacturer(of( the( feeds.(The(optimal(strategy(was(chosen(based(on(the( largest(
increase( in( IVCD( on( the( control( (un7fed,( batch( culture),( which( was( strategy( D( 7(
EfficientFeedTM(B(every(three(days((see(appendix(II).(
4.3.4.2$ Production$ of$ GFP,$ cB72.3$ and$Enbrel$ in$ a$ long8term$ transient,$ fed8
batch$platform$
Using(both(FastELISA®((for(cB72.3(and(Enbrel)(and(flow(cytometry((for(GFP),(the(



















Evolved# Parental# Evolved# Parental# Evolved# Parental# Evolved# Parental#






















32°C( and( 37°C.( As( can( be( seen( in( this( figure,( generally( speaking( Enbrel( titre( is(
higher(than(cB72.3(titre( in(each(condition.( It(can(also(be(seen(that,(when(at( their(
native(temperatures((i.e.(the(evolved(cell( line(at(32°C(and(the(parental(cell( line(at(
37°C),(the(evolved(cell(line(achieves(higher(titres(of(both(recombinant(IgG(proteins(
(cB72.3( and( Enbrel)( than( the( parental( cell( line( (one7way( ANOVA( with( Tukey’s(
multiple(comparisons(test,(see(appendix(II).((































































































































































































In( addition( to( lipofection( with( cB72.3( and( Enbrel,( cultures( lipofected( with( GFP(
were( also( assessed( in( this( platform( to( determine( transfection( efficiency( (as(
transfection(efficiency(cannot(be(determined(using(cB72.3(or(Enbrel).(Figure(4.13(
shows(the(transfection(efficiencies(and(figure(4.14(shows(the(median(fluorescence(
values( (from( intracellular(GFP(production)(achieved(by( the(evolved(and(parental(
cell(lines(in(a(long7term(transient(fed7batch(platform(at(both(32°C(and(37°C.(As(was(
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4.3.5.$Generation$of$ cB72.3$and$Enbrel$ stably$producing$ cell$ lines$ from$ the$
evolved$and$parental$cell$lines$
After( testing( negative( for( mycoplasma,( vials( of( evolved( and( parental( cells( were(
transported( to( Lonza( Biologics( (Cambridge,( UK)( where( work( to( generate( stably(
producing( cell( lines( from( these( cells( was( performed( (by( the( author( with(
supervision( from(Lonza(staff)( as(outlined( in( the(methods( section.(The(process(of(
stable(cell(line(generation(took(~4(weeks(from(transfection(to(transfer(from(static(
T7flask( culture( to( agitated( Erlenmeyer( culture.( As( already( stated,( cross7
temperature( control( cultures( were( also( created( at( the( onset( of( this( study( (i.e.(
transfected( parental( cultures( that( were( incubated( at( 32°C( and( transfected(











respectively,( the( concentration( of( purified( protein( was( assessed( using( the(
NanodropTM(and(back7calculated(to(determine(the(true(culture(titre((i.e.(taking(into(













Table$ 4.2$ The$ average$ protein$ concentration$ in$ protein$ A$ purified$ cB72.3$ and$
Enbrel$samples$from$stably$producing$evolved$and$parental$cultures$and$the$back8
calculated$protein$titres$for$those$stable$cell$cultures.$Samples(were(taken(at(the(end(
of( a( complete( fed7batch( culture( (once( cells( <50%( viability).( All( evolved( cultures(were(
cultured(at(32°C(and(all(parental(cultures(were(cultured(at(37°C.(
Protein(name:
Cell(line: Evolved Parental Evolved Parental
Average.protein.concentration.in.sample.after.
purification.(mg/.mL) 1.521 1.500 1.314 1.220
Average.culture.protein.titre.(backCcalcluated.to.
account.for.volume.of.supernatant.purified).(mg/.L) 310 272 348 303
cB72.3 Enbrel
Figure$4.15$Titre$from$evolved$and$parental$pools$stably$
transfected$with$ cB72.3$ or$ Enbrel.$ Samples(were( taken(at(
the( end( of( a( complete( fed7batch( culture( (once( cells( <50%(











































Titre from stable Evolved and Parental pools 







It( was( important( to( confirm( the( identity( of( the( stably( produced( recombinant(
proteins(before(they(were(analysed(for(glycan(profiling.(Reduced(and(non7reduced(
forms(of(both(the(cB72.3(and(Enbrel(purified(proteins((produced(from(both(stably(
transfected( cells( and( from( transient( lipofected( cultures( in( a( fed7batch( platform)(
were(analysed(using(SDS7PAGE.(The(banding(profiles(should(be(as(follows:(

















Figure$ 4.16$ SDS8PAGE$ images$ of$ A)$ reduced$ cB72.3$ and$ reduced$ Enbrel$ samples$ and$ B)(
reduced$cB72.3$and$non8reduced$Enbrel$samples.$For(the(reduced(samples,(it(can(be(seen(that(
cB72.3(has(prominent(bands(at(~50(kDa(and(~25(kDa,(as(expected,(and(Enbrel(has(a(prominent(
band( ~70( kDa,( as( expected.( For( the( non7reduced( samples( it( can( be( seen( that( cB72.3( has( a(
prominent( band( at( >150( kDa,( as( expected,( and( Enbrel( has( a( prominent( band( >180( kDa,( as(
expected.(N.B.(For(samples(of(cB72.3((for(both(reduced(and(non(reduced),(the(three(leftmost(lanes(
are( from( the( parental( cell( line( and( the( three( rightmost( lanes( are( from( the( evolved( cell( line.( For(











Research( and( Technology( department.( Results( were( returned( as( %( of( total( N7
glycan( and( are( shown( in( figure( 4.17.( For( cB72.3( (figure.( 4.17( part( A),( glycan(
profiling( largely( matched( the( profiling( observed( by( Lonza( Biologics( in( their(
analysis(of(cB72.3(produced(by(CHOK1SV(and(derived(host(clones((O’Callaghan(et$
al.$2015).(It(can(also(be(seen(that(the(largest(differences(in(%(of(total(N7glycan(are(
seen( when( making( comparisons( of( the( same( protein( from( the( same( cell( line(
between$ the$ two$ production$ platforms( (stable( versus( transient),( rather( than(
between$parental$and$evolved$ cell$ lines$within$ the$ same$production$platform.( This(
suggests(that(the(evolution(process(has(not( interfered(with(the(glycan(processing(
capabilities(of( the(cell,( and( it(may(suggest( that(glycan(processing(capabilities(are(
very(slightly(affected(by(the(production(platform(used.(That(said,(when(comparing(
the( variation( between( cell( lines,( there( is( more( variation( between( evolved( and(
parental( in( a( transient( platform( than( stable( pools( (in( which( there( is( almost( no(
variation).( Nevertheless,( the( variation( between( all( samples( analysed( here,(
regardless( of( cell( line/( production( platform,( is( less( than( that( is( observed( in( the(
CHOK1SV(clones(in(the(work(conducted(by(O’Callaghan(et$al.((2015).(However,(to(







Figure$ 4.17$ N8glycans$ of$ recombinant$ proteins:$ A)$ cB72.3$ and$ B)$ Enbrel,$ produced$ via$
either$ stably$ transfected$ pools$ of$ evolved$ or$ parental$ CHOK1SV$ cells,$ or$ evolved$ or$
parental$ CHOK1SV$ cells$ in$ a$ fed8batch$ transient$ lipofection$ platform.$ Schematics( above(
bars( represent( the( n7glycan( forms,( G0,( G0F,( Man5,( G1Fa,( G2Fb( or( G2F( (where( the( shapes(






























































The( work( presented( in( this( chapter( was( conducted( to( address( the( question( of(
whether( or( not( the( evolved,( hypothermia7adapted( cell( cultures( (that( were(
generated( as( described( in( chapter( 3)(make( a( suitable( industrial( host( cell( line( in(




investigations( were( performed( with( comparison( to( an( unevolved,( parental(
counterpart( at( all( times.( Initially,( this( included( three( evolved( cultures( being(
compared(to(three(parental(counterparts,(however,(as(the(analysis(deepened(and(
resources(became(limited,(only(one(evolved(culture(was(taken(forward(for(further(








However(when( the( evolved,( hypothermia7adapted( cells( (that(were( already(being(
cultured( at( 32°C)( are( then( subjected( to( the( same( hypothermic( conditions,( their(
productivity( is( further( increased( again.( This( shows( that( there( is( an( increased(
production(advantage(that(is(inherent(to(the(evolved(cell(cultures.(Although(it(has(
been(shown(in(the(literature(that(hypothermia7adapted(CHO(cells(show(significant(
increased( in( productivity( (Sunley( et( al.( 2008),( this( has( only( been( demonstrated(
with(stably(producing(cell( lines( that(were(subsequently(adapted( to(hypothermia,(







cultures(was(undertaken.( ( This( study(was(performed,( as( it(was(not( known(what(
effect,(if(any,(the(difference(in(cell(size(between(the(two(culture(types(may(have(on(
the(physical(processes(of( electroporation( (Bio7Rad( ‘Post7Transfection(Analysis(of(
Cells’(Bulletin(5969,(2010).(As(demonstrated(in(section(4.3.2,(the(evolved(cultures(
showed(higher(transfection(efficiencies(as(well(as(higher(median(GFP(fluorescence(
than( the(parental( cultures.(This(would(suggest( (assuming( the(cell( types(have( the(
same(bio7physical( composition)( that( the( increase( in( size( of( the( evolved( cells( has(
lead( to( improved( transfection( efficiencies,( which( may( also( account( for( the(
improved(median(fluorescence((a(proxy(of(GFP(production).(However,(as(has(been(
previously( discussed( there( are( numerous( reasons( why( you( might( expect( better(
productivity(at(lower(temperatures((for(example,(increased(mRNA(half7life(leading(
to( persistence( in( the( cell( (Yoon( et$ al.( 2004)).( That( said,( when( the( parental( cell(
cultures( are( incubated( at( 32°C( post( transfection,( there( is( no( general( increase( in(
median(fluorescence(or(transfection(efficiency.((
With( this( data( alone,( it( is( difficult( to( state( for( certain(whether( the(differences( in(
transfection( efficiency( are( cell( size7specific.( To( confirm( or( reject( this( potential(
relationship(one(could(FACS(sort( the(cells(of(each(culture(type(based(on(size(and(









The(evolved(and(parental( cell( lines(were( then(examined( in( terms(of(productivity(
with( larger,(more( industrially( relevant( recombinant(proteins,( these(being( cB72.3(





sponsors( of( this( project,( Lonza( Biologics,( use( both( proteins( in( early( cell( line(
development( assessment( phases( and( the( latter( (Enbrel)( is( typically( classed( as( a(
difficult( to( express( (DTE)( protein.( DTE( proteins( are( often( characterised( by( low(
yields(or(expensive(downstream(processing(costs,(both(of(which(increase(the(cost(
of(goods(and(time7to7market((Pybus(et$al.(2013).(Naturally,(to(be(equipped(with(a(
cell( line( that( is( inherently( more( able( to( express( such( DTE( proteins( would( be( a(
desirable(asset(in(industry.((
The(day(10(yields(achieved( in(a( transient( fed7batch(production(platform((section(
4.3.4.2)(were( comparable( to( the(yields(achieved(by(Pybus(and(colleagues( (2013)(
who( used( an( equivalent( transient( fed7batch( production( platform( to( produce( a(




IVCD.( An( unusual( and( unexpected( result( of( the( transient( fed7batch( production(
study( was( that( titres( for( Enbrel( were( consistently( higher( than( titres( for( cB72.3(
(when( produced( by( the( same( cell( line( at( the( same( temperature).( However,( this(
result( is( not( reflected( in( the( titres( observed( in( stably( producing( evolved( and(
parental( cell( lines,( in(which( case( the( evolved( cell( line( produces( a( higher( titre( of(
Enbrel( than( titre( of( cB72.3,( and( the( parental( cell( line( produces( a( higher( titre( of(
cB72.3(than(titre(of(Enbrel.(In(any(case,(the(evolved(cell(line(is(always(the(highest(
stable(producer(of(each(protein.(This(result(is(not(trivial(considering(that(all(other(
attempts( at( evolving( a( stable( cell( line( to( become( hypothermia7adapted( for( high(
productivity(have(either(ultimately( failed(at(scale(up((Sunley(et$al.(2008),(or(high(
productivity(has(been(lost(as(a(result(of(the(evolution(process((Yoon(et$al.(2006).(It(
would( appear( that( the( key( element( in( successfully( generating( a( high( producing(







It(was( seen(during( glycan(profiling( of( transient( and( stably( produced( cB72.3( and(
Enbrel(from(evolved(and(parental(cell(lines(that(there(was(little(variation(between(
samples( and( glycan( profiling( largely( matched( the( profiling( observed( by( Lonza(
Biologics(in(their(analysis(of(cB72.3(produced(by(CHOK1SV(and(derived(host(clones(
(O’Callaghan(et$al.$2015).( For( example( cB72.3(Man5(was( relatively( low( (>5%)( in(
both( the( work( presented( in( this( chapter( and( in( the( work( by( O’Callaghan( et$ al.(
(2015).( Low( Man5( glycans( (relative( to( other( glycoforms)( have( been( directly(
associated( with( reduced( clearance( of( IgG( antibodies( in( humans,( which( can(
ultimately(mean(that(time(between(intravenous(doses(of(therapeutic(drugs(can(be(
extended(as(the(drug(persists( in(the(body(for( longer.(This( is(more(convenient( for(




lines)( and( the( proportion( of( G0F( is( lower( (in( both( the( parental( and( evolved( cell(
lines).( In( line(with( this,( it( is( regularly( documented( that( afucosylated( therapeutic(
antibodies( exhibit( increased( antibody7dependent( cell7mediated( cytotoxicity(
(ADCC)((Satoh(et$al.(2006;(Jefferis(2007;(Raju(&(Jordan(2012).(Although(a(thorough(
conclusive(discussion(cannot(justly(be(given(regarding(glycan(profiling(due(to(an(N(
of(1(being(used( for(each(sample,( it( is( important( to(note( that,(even(with(a(sample(
size( of( 1,( there( were( no( major( differences( observed( between( the( evolved( and(
parental(cell(lines(for(each(glycan(species(measured.(This(is(important(as(it(shows(
that( the( hypothermia7adaptation( process( has( not( altered( or( compromised( the(
glycan(processing(capabilities.(In(addition(to(this,(the(fact(that(this(is(true(for(every(
glycan( species( profiled( adds( confidence( in( the( result( despite( N( being( 1.( The(
obvious( future( work( that( could( be( conducted( in( this( area,( funding( permitting,(
would(be(to(repeat(the(analysis(with(a(larger(sample(size.(Alternatively,(one(could(
perform( clonal( selection( on( the( stable( pools( to( try( and( identify( and( isolate( high(
producing(clones(whose(recombinant(proteins(demonstrated(the(preferred(glycan(
profile.(It(could(also(be(informative(to(investigate(sialilation(modifications(between(










industry,( it( has( also( shown( merits( in( transient( transfection( where( small( scale(
production( is( required( in( a( short( time7frame,( for( example( in( the( early( stages( of(
drug(development.(In(terms(of(future(work,(as(already(alluded(to,(the(degree(that(
cell( size( accounts( for( the( disparity( in( transfection( efficiency( and( viability( post7
transfection(could(be( investigated.(However,( in(some(respects,( from(an(industrial(
relevance(perspective,(this(is(likely(not(to(be(too(imperative.(Additionally,(to(fully(
confirm(whether( this(cell( line(could(be( taken( forward( from(an(academic(exercise(
into(an(industrial(setting,(a(full(technology(readiness(level((TRL)(assessment(would(
need(to(be(performed,(most(likely(in(collaboration(with(Lonza(Biologics.(This(may(









cell( lines( could( be( generated( from( the( evolved( cell( line( to( produce( other( DTE(
proteins(or,( for( example,(proteins( that(have(a(high(propensity( to( aggregate.(This(
would( determine( whether( the( evolved( cell( line( consistently( outperforms( the(
parental(cell( lime,(or(whether(the(results(presented(in(this(chapter(are(specific(to(
only( cB72.3( and( Enbrel.( To( complement( further( investigation( into( cell( line(
performance( and( functionality,( it( could( be( highly( beneficial( to( attain( a( more(





biological( changes( have( occurred( as( a( result( of( becoming( hypothermia7adapted.(
Being(quipped(with(this(information(could(enable(reverse(engineering(techniques(
to( be( developed,( or( it( could( lead( to( the( generation( of( hypothermia7adapted( cell(






























hypotheses%were% conducted,% as%well% as% experiments% that%would%be% informative% in% a%
hypothesis>free%manner,% such% as% comparative% transcriptomics% and% amino% acid% flux%






functional( feats( in( terms( of( industrial( performance( abilities:( Compared( to( the(
parental(cell(line,(the(evolved(cell(line(has(not(only(reached(equivalent(growth(rate,(
approximately( doubled( in( biomass,( become( twice( as( transcriptionally( active( and(
increased( in( transient( productivity,( it( has( also( exhibited( comparable( resilience(
during(stable(cell(line(production(delivering(improved(titres(and(has(also(displayed(




notable( when( considering( that( the( hypothermic( environment( initially( and(
ordinarily(halts(the(cell(cycle(and(prevents(cell(growth(and(proliferation.(
(This( cell( line( has( clearly( advanced( substantially( along( the( evolution( process,(
resulting( in( many( industrially( desirable( qualities.( However,( the( underlying(
modifications( that( underpin( these( observable( transformations( are( as( yet( largely(
undetermined.( As( stated,( the( purpose( of( this( chapter( is( to( explore( this( area( in(
depth,( with( intention( to( identify( and( characterise( the( cellular( mechanistic(
differences(between(the(hypothermia6adapted(and(parental(cell( lines.( Included(in(
this( chapter( is( work( that( investigates( both( specific( hypotheses( as( well( as( more(
global(examinations(of(the(evolved(cell(line,(in(the(areas(of:(mitochondrial(function,(
oxidative( stress,( amino( acid( flux( and( transcriptomics.( The( rationale( behind(
undertaking(this(analysis(is(that(it(could(lead(to(the(isolation(of(specific(targets(that(
may(be(used( to(engineer,( rather( than(evolve( (which(can(be(a( reasonably( lengthy(
process),( an( equivalent( cell( line.( Alternatively( the( analysis( could( lead( to(
information(that(could(assist(in(and(speed(up(the(hypothermia6adaptation(process.(
(
As( was( discussed( in( chapter( 1,( the( cellular( responses( of( CHO( cells( that( are(
subjected( to(a( temperature(phase(shift( to(enhance(production(have(been(studied(
extensively.( The( pervasive( findings( are( that( transcriptional( and( translational(
process( change(within( hours( of( temperature( reduction.( For( example,( commonly(
cited( in( the( literature,( cold6inducible( RNA( binding( protein( (CIRP)( is( found( to( be(
preferentially(transcribed(during(mild(hypothermia((Nishiyama(et%al.(1997;(Fuller(
2003).(In(addition(to(this,(evidence(of(targeted(post6translational(modifications(has(
also( been( identified( as( a( cellular( response,( such( as( tyrosine( phosphorylation( of(
proteins(in(CHO(cells((Kaufmann(et%al.(1999).(There(is(indication(that(the(ability(of(
cells(to(respond(to(hypothermia(can(be(enhanced(by(‘pre6conditioning’(them(to(up6
regulate( their( stress( response,( i.e.( in( the( case( for( biopharmaceutical( production(







so( far( regarding( cold6shock( strategies.( The( lengthy( evolution( process( may( have(
worked( as( iterative( pre6conditioning,( continuously( re6regulating( stress( response(
thresholds.((
It( is( also( considered( that( the(hypothermia6adapted( cell( line(may(have(developed(
orthogonal( solutions( to( sub6optimal( temperatures,( such( as( heat( conservation( or(
producing(heat(on(a(cellular(level(via(thermogenesis.(As(presented(in(chapter(3,(a(
characteristic( of( the( evolved( cell( line( is( its( significant( increase( in( cell( size.( In(
Zoology,( Bergmann’s( rule( states( that( there( is( an( intra6species( tendency( in(
homeothermic( organisms( to( have( increasing( body( size(with( decreasing( ambient(
temperature.( This( is( due( to( simple( thermodynamics:( a( small( surface( area( to(
volume(ratio(reduces(relative(heat(loss((Sand(et%al.(1995).(An(increased(cell(size(in(
the( hypothermia6adapted( cell( line( would( therefore( improve( its( homoeothermic(
efficiency(in(sub6optimal(temperatures.((
There( are( a( number( of( methods( by( which( the( cell( could( also( be( generating(
additional( heat( to( overcome( the( effects( of( the( surrounding( hypothermic(
environment.( Firstly,( adaptive( non6shivering( thermogenesis( is( a( process( that( is(
present( in( all( eutherian( mammals( (a( clade( to( which( Chinese( hamsters( belong)(
(Hayward( &( Lisson( 1992).( In( contrast( to( classical( non6shivering( thermogenesis,(
which( is( facultative( and( acts(within(minutes(when( an( organism( acutely( requires(
extra( heat,( adaptive( thermogenesis( takes( multiple( weeks( for( an( increase( in(
capacity(to(develop.(Non6shivering(thermogenesis(activity(usually(occurs(in(brown(
adipose( tissue(and(adaptive(non6shivering( thermogenesis(ordinarily( corresponds(
to( the( recruitment( of( such( tissue( (Cannon( &( Nedergaard( 2011).( As( the( name(
suggests,( non6shivering( thermogenesis(was(originally(defined(as( a( cold6inducible(
increase( in( heat( production( not( associated(with( the(muscle( activity( of( shivering(
(Himms6Hagen(1984).( It( is( in( fact(a(metabolic(process( involving(an(adaptation(of(
the( inner( membrane( of( the( mitochondrion( in( which( the( permeability(
(conductivity)( of( the( membrane( is( increased,( allowing( protons( pumped( by( the(




force,(dissipating(energy(as(heat( (Rial(&(Zardoya(2009).(A( family(of( transporters(
belonging( to( the(mitochondrial( carrier(protein(superfamily(known(as(uncoupling(
proteins((UCPs)(provide(the(pathway(for(this(proton(re6entry(and(ATP6synthase(is(
bypassed.( These(UCPs( have( been( found( to( be( activated( by( long6chain( fatty( acids(
(LCFAs)( (Fedorenko( et% al.( 2012).( This( adaptation( originally( evolved( as( a(
mechanism( to( allow( organisms( living( in( oxygen6rich( environments( to( overcome(
the(dangers(posed(by( ‘reactive(oxygen( species’( (ROS)( 6( these(are(highly( reactive,(
oxygen6derived(free(radicals(that(can(cause(damage(to(the(cell(known(as(oxidative(
stress.(It(is(widely(known(that(the(mitochondrial(respiratory(chain(is(a(major(site(
of(ROS(and(an( increase( in( respiration(due( to(UCP6mediated(uncoupling(has(been(
found( to( correlate(with( reduced(ROS( formation(and( increased(protection(against(
subsequent( oxidative( stress( (Rial( &( Zardoya( 2009).( Oxidative( costs( have( been(
found( to( greatly( differ( depending( on(whether(ATP6synthase( or(UCPs( are( driving(
respiration((Stier(et%al.(2014).(Once(this( latter(mechanism(to( increase(respiration(
evolved( to( become( operative,( it( was( subsequently( co6opted( to( fulfil( other(
physiological( roles,( such( as( the( generation( of( heat.( Now,( the( UCPs( are( so(
recognised( for( their( thermogenic( capacity( that( one( specific( uncoupling( protein,(
UCP1(has(been(alternatively(termed(thermogenin((Palou(et%al.(1998;(Rial(&(Zardoya(
2009)(
A( second( means( of( cellular( non6shivering( heat( generation( that( has( evolved(
primarily( to(maintain( physiological( temperatures( involves( the( cycling( of( Ca2+( by(
the(membrane(bound(sarco/endoplasmic(reticulum(Ca2+6ATPases((SERCA).(SERCA(
are(pumps(that(are(able(to(transport(Ca2+(ions(upon(hydrolysis(of(ATP(to(ADP(+(Pi(
which( also( generates( heat( energy( (Kozak( &( Young( 2012).( The( cytosolic( ADP(
generated( by( this( process( consequently( stimulates( mitochondrial( respiration,(
resulting( in( further( increased( heat( production( (de( Meis( 2001).( Furthermore,(
mutations( in( the( gene( encoding( for( the( ryanodine( receptor( have( been( found( to(
result( in(uncontrolled( leakage(of(Ca2+( into(the(cytoplasm,(generating(heat(as(Ca2+(
moves( along( its( concentration( gradient( (MacLennan(&(Phillips( 1992).(Related( to(
these( aforementioned( processes,( it( has( been( shown( that( thermogenesis( is(




known( as( substrate( cycles,( occur( when( two( metabolic( pathways( run(
simultaneously(in(opposing(directions(with(no(apparent(overall(purpose(or(effect(
other( than( to( dissipate( heat( energy( (Qian( &( Beard( 2006).( Concurrent( glycolysis(
and(gluconeogenesis(would(be(an(example(of(an(uneconomical(futile(cycle(in(which(
a(large(amount(of(chemical(energy(is(dissipated(as(heat((Nelson(et%al.(2008).(
This( chapter( describes( the( experimental( studies( that( were( undertaken( to(
investigate(the(theory(that(the(hypothermia6adapted(cell(line(could(be(undergoing(
thermogenesis( as( a( mechanism( to( thrive( in( sub6physiological( conditions.(
Differential(gene(expression(analysis(is(also(used(to(further(explore(this(hypothesis(
as(well(as(examining(global(transcriptome(changes(in(a(hypothesis6free(manner.(In(





This( section( describes( the( materials( and( methods( used( for( oxidative( stress(






(Molecular( Probes,( Life( Technologies,( Paisley,( UK).( CellROX®( Deep( Red( Reagent(
specifically(was(used(due(to(its(absorption/emission(maxima(being(~644/665(nm.(
Parental( CHOK1SV( (at( 37°C)( and( hypothermia6adapted( CHOK1SV( (at( 32°C)(
cultures(were(grown(in(66well(plates(in(humidified((%)(static(incubators(at(%(CO2).(






controls( of( each(were( also( incubated( for( the( same( time(period.(After( incubation,(
cell(cultures(were(centrifuged(at(200(×g(for(5(minutes,(supernatant(was(aspirated(
















lines( were( cultured( every( 4( days( in( 125( mL( vent6capped( Erlenmeyer( flasks(
(Corning,(Surrey,(UK)(using(30(mL(of(CD(CHO(medium((Life(Technologies,(Paisley,(
UK)( supplemented( with( 6( mM( glutamine.( On( day( 3( post( sub6culture( (mid6
exponential( growth( phase),( cells( were( sampled( to( assess( density( and( viability(
using( the( Vi6CELL( XR( cell( viability( analyser( (Beckmann( Coulter,( High(Wycombe,(
UK).( Following( this,( 2(×( 106( cells(were( centrifuged( at( 200( ×g( for( 5(minutes,( the(
supernatant( removed( and( the( cell( pellet( resuspended( in( fresh( CD( CHO(medium(
supplemented(with(6(mM(glutamine(at(a( final( cell(density(of(1.2(×(106(cells(mL61(
[N.B.(This% cell% density% is% specified% as% a% result% of% optimisation%work%performed%on%a%




determined% the% concentration%of% cells% in%100%μL% that%would%provide% cell% confluence!
across% the% surface% of% an% individual% XF24% Tissue% Culture% Plate% well% (Seahorse%




BCA% Protein% assays% (Thermo% Scientific,% Loughborough,% UK)% confirmed% that% a%
comparable% protein% biomass% content% between% cell% types% remained% adhered% to% each%
well,%meaning%potential%OCR%biomass%normalisation%steps%were%not%necessary].( 100(




37°C( and( 32°C,( to( serve( as( temperature( controls.( Plates(were( then( incubated( at(
37°C(or(32°C,(under(5%((v/v)(CO2(atmosphere(in(static(incubators(for(30(minutes(
to( allow( cell( attachment( to( the( well( bottom.( After( this( time,( an( inversed( light(
microscope(was(used(to(confirm(cell(attachment(and(visually(check(cell(confluence(
across( the(surface.(Next,( the(CD(CHO( in(which( the(cells(had(been(suspended(was(
carefully( removed,( leaving( the( cells( attached( to( the( well( bottom.( As( quickly( as(
possible,( 600(μL( of( un6buffered(XF(Media( (Seahorse(Biosciences,(North(Billerica,(
MA,(USA)(supplemented(with(2mM(glutamine(and(16.74(mM(glucose(at(pH(7.4(was(




pH(and( temperature(equilibration(before( transfer( to( the(XFe24(Extracellular(Flux(
Analyser((Seahorse(Biosciences,(North(Billerica,(MA,(USA).(The(XFe24(Extracellular(
Flux(Analyser(was(then(run(using(a(protocol(set(to(run(in(cycles(of(8(minutes,(each(
containing:( mix( for( 3( minutes,( wait( for( 2( minutes( then( measure( for( 3( minutes.(
Oxygen(consumption(rate((OCR)(and(extracellular(acidification(rate((ECAR)(are(the(
measurements(made(by(this(analyser.(After(measuring(basal(OCR(and(ECAR(rates,(




through( separate( injection( ports( located( on( sensor( cartridge( component( of( the(
FluxPak,(which(fits(complimentary(to(the(XF24(Tissue(Culture(Plate.(The(Seahorse(
injection(ports(were(loaded(as(follows,(in(this(order:((
• Port( A:( 75( μL( (10X( concentration)( of( Oligomycin( (synthase( inhibitor)( in(
Assay(media,(to(result(in(a(final(concentration(in(the(well(of(1.5(μM.(
• Port( B:( 82.5( μL( (10X( concentration)( of( FCCP( (electron( transport( chain(
accelerator)(in(Assay(media,(to(result(in(a(final(concentration(in(the(well(of(
0.75(μM.(




the( treatment( of( the( cells( up( to( the( point( of( analysis.( Once( complete,( the( XF24(
Tissue(Culture(Plate(was(removed(and(immediately(the(cells(were(viability(checked(
using(CyQUANT®(NF(Cell(Proliferation(Assay((see(section(5.2.2.3(below).(






mixed( together( in( a( laminar( flow( cabinet.( The( buffer( solution( and( NaOH( were(
sterile(filtered(prior(to(this.(Once(thoroughly(combined,(50(μL(of(this(solution(was(
added( to( each( well( of( the( XF24( Tissue( Culture( Plate( and( left( to( sit( at( room(
temperature( in( the( laminar( flow( cabinet( for( 20( minutes.( Next,( a( multichannel(
pipette(was(used(to(remove(all(of(the(solution,(with(extra(care(being(taken(not(to(












performed(as( soon(as(possible( after( analysis.( For(one(XF24(Tissue(Culture(Plate,(
8.4( μL( of( 500X( CyQUANT( NF( dye( reagent( (component( A)( and( 8.4( μL( 500X( Dye(





minutes.( The( fluorescence( intensity( of( each( sample( is( measured( using( a(
fluorescence(microplate(reader(with(excitation(at(~485(nm(and(emission(detection(
at( ~530( nm.( The( fluorescence( intensity( of( the( cells( that( have( undergone( XF24(
analysis(is(compared(to(the(fluorescence(intensity(of(control(cells(that(are(known(
to( be( of( high( viability( (>95%( viable),( confirmed( by( the( Vi6CELL( XR( cell( viability(
analyser.( The( CyQUANT®( NF( Cell( Proliferation( Assay( was( chosen( over( other(
proliferation(assay(kits(as(it(measures(independent(of(metabolic(status.(
5.2.3$Affymetrix® $GeneChip® $CHO$Gene$2.0$ST$Array$
The( methods( defined( in( this( section( include( preparatory( procedures,( technical(










5(minutes(and( the( supernatant(aspirated(once(again.(Cell(pellets(were( then(snap(
frozen(on(dry(ice(before(being(stored(at(680°C(until(required(for(RNA(extraction.(
5.2.3.2$RNA$extraction$for$Affymetrix® $Array$analysis$
An( RNeasy®( Mini( Kit( (QIAGEN,(Manchester,( UK)( was( used( to( extract( total( RNA(
from(cell(samples.(The(cells(were(first(disrupted((membranes( lysed)(using(Buffer(
RLT( and( homogenised( (reducing( the( viscosity( of( the( lysate( by( shearing( high6
molecular(weight(genomic(DNA(and(other(high6molecular(weight(components)(by(
passing( the( lysate( through( a( QIAshredder.( The( lysate( then( was( centrifuged( at(
maximum( speed( (13000( rpm)( in( a( benchtop( centrifuge( and( the( supernatant(
carefully(removed(by(pipetting.(1(volume(of(70%(ethanol(was( then(added(to( this(
supernatant( and( thoroughly( mixed( by( pipetting,( this( creates( conditions( that(
promote(selective(binding(of(RNA(to(the(RNeasy(spin(column.(This(mixture(is(then(
applied( to( the( RNeasy( spin( column( (up( to( 700( μL( at( a( time)( placed( in( a( 2( mL(
collection( tube.( This( is( the( centrifuged( for( 15( seconds( at( 8000( ×g( and( the( flow6
through(is(discarded.((
At( this(point,( an(optional(on6column(DNAse( I(digestion(was(performed(using( the(













Following( this,( 500(μL( of(Buffer(RPE(was( added( to( the(RNeasy( spin( column(and(
centrifuged(for(15(seconds(at(8000(g,(again,(discarding(the(flow(through.(Another(
500(μL(of(Buffer(RPE(was(then(added(and(the(column(centrifuged(for(2(minutes(at(
8000(g.(At( this(point,( the(RNeasy(spin(column(is(placed( in(a(new(2(mL(collection(





NanoDropTM( 2000( Spectrophotometer( (Thermo( Scientific,( Loughborough,( UK).(
Prior( to( sample(measurements,( the(NanoDropTM(was(blanked(using(1( μL(RNase6
free(water.(The(arm(was(then(wiped(clean(with(lint6free(microscope(lens(tissue(and(
samples(were(added(and(analysed(in(turn,(with(the(arm(being(cleaned(in(this(way(
between( each( sample.( All( measurements( were( performed( in( triplicate.( Purity( is(
assessed(using(the(ratio(of(absorbance(at(260(nm(and(280(nm((A260/280)(and(at(260(
nm( and( 230( nm( (A260/230),( which( can( indicate( carry( over( of( contaminants( from(









(RIN)( that( is(graded(on(a(scale(of(1( to(10,(1(being( totally(degraded(and(10(being(






Affymetrix®( GeneChip®( CHO( Gene( 2.0( ST( Arrays( were( run( at( the( Sheffield(
Institute(for(Translational(Neuroscience((SITraN)(core(facility(at(the(University(of(
Sheffield( following( the( standard( Affymetrix®( protocols.( Briefly( this( comprises(
preparing(cDNA(from(reverse(transcribing(the(total(extracted(mRNA.(This(cDNA(is(
then(used(in(an(in%vitro(transcription((IVT)(reaction(to(generate(biotinylated(cRNA.(
After( fragmentation( of( cRNA,( it( is( then( applied( to( the( array( and( incubated(with(
agitation( for( 16(hours( to( allow(hybridisation(of( the( fragments( to( complimentary(
DNA(probes(on(the(chip.(The(probes(on(the(chip(are(designed(to(cover(the(entire(
genome((in(this(case(the(CHO(genome).(The(chip(is(then(washed(to(remove(any(un6
hybridised( fragments( and( then( stained( with( PE6conjugated( streptavidin(
(fluorescent(stain(solution)(that(binds(to(the(biotin(with(high(affinity.(The(chip( is(
then( scanned( and( the( fluorescence( at( each( location( is( measured( to( produce( a(
reading( of( relative( expression( of( the( corresponding( gene( at( that( given( location.(
Following( this,( the( data( was( extracted( and( preliminary( analysis( was( performed(





extracted( using( significance( thresholds( of( both( p( ≤0.05( and( p≤0.01( (FDR( [False(
Discover(Rate](corrected(ANOVA),(fold(change(thresholds(could(also(be(applied(if(




with( a( fold( change( of( ≥2( were( classified( into( one( of( 14( categories,( each(





example,( certain(categories,( such(as(Reproduction,(would(not(be(of( relevance( for(
this( analysis).( The( number( of( differentially( expressed( transcripts( that( were(
assigned( to( each( category( was( recorded( according( to( whether( that( gene( was(







annotation( of( the( Cricetulus% griseus( genome( it( was( not( used( for( this( analysis.(
UniProt( IDs( were( then( linked( with( a( colour( that( represented( the( direction( of(
differential(gene(expression,( i.e.( increased( in( the(evolved(cell( line(or( increased( in(
the(parental(cell(line:(a(UniProt(ID(with(an(increased(expression(in(the(evolved(cell(
line(was(assigned(blue,(and(a(UniProt(ID(with(increased(expression(in(the(parental(
cell( line( was( assigned( red.( This( list( of( colour6associated( UniProt( IDs( was( then(
mapped(onto(pathways(using(the(KEGG(‘Search&Color’(function.(
Table$ 5.1$ Functional$ groups$ used$ in$




















5.2.4$ Amino$ acid$ analysis$ of$ parental$ and$ evolved$ cell$ lines$ in$ fedCbatch$
culture$
Samples(of(spent(culture(media(were(taken(from(3(replicates(cultures(of(both(the(
evolved(and(parental( cell( lines.( Samples(were( taken(on(day(0,( then(every(3(days(
pre6( and( post6( feeding( with( 10%( culture( volume( EfficientFeedBTM( (Life(
Technologies,( Paisley,( UK).( Samples( were( then( sent( to( Abingdon( Health(
(Birmingham,( UK)( for( concentration( quantification.( Briefly( the( analysis( at(
Abingdon(Health(comprised(of(vortexing(the(sample(thoroughly(and(100(μL(diluted(
to(a(total(volume(of(1(mL(with(TCA(and(centrifuged(to(precipitate(out(the(proteins,(
then( 25( μL( was( injected( into( the( ion( exchange( chromatography( analyser( (with(
ninhydrin( detection).( Amino( acid( concentrations( were( then( normalised( to( cell(
number( and( comparisons( between( cell( lines( through( culture( were( made.( N.B.(
Direct(correspondence(with(Abingdon(Health(has(given(the(following(comment(on(
method(accuracy:(“the(techniques(we(use(result(in(a(highly(reproducible(analysis,(
therefore( the(differences(observed(are( likely( to(be(due(to( the(sample( type(rather(
than(the(method(of(analysis(used”.(
5.3$Results$
5.3.1$ Oxidative$ stress$ in$ the$ hypothermia$ adapted$ cell$ line$ versus$ the$
parental$
Using( flow( cytometry( and( CellROX®( Oxidative( Stress( Deep( Red( Reagent,( the(
amount( of( reactive( oxygen( species( in( each( cell( could( be( inferred( using( the(
fluorescence( intensity.(The( autofluorescence( (unstained( sample)( of( each( cell( line(
was( first(measured( and(was( found( to( be( comparable( to( each( other,( as( expected(
(see(figures(5.1(A(and(B).(The(flow(cytometry(data(in(figures(5.1(C(and(D(also(again(
shows( a( clear( difference( in( cellular( sizes( between( the( parental( and( evolved( cell(
lines:(the(Forward(Scatter(parameter(along(the(x6axis((FSC6A)(is(a(measurement(of(
the( amount( of( the( laser( beam( that( passes( around( the( cell,( giving( a( relative(
indication(of(cell(size.(In(the(same(figures(the(Y6axis(is(the(Side(Scatter(parameter(




particulates( inside( the( cell.( This( measurement( can( be( used( to( infer( viability(
information(on( the(samples:( the(small( clusters( the(bottom( left(of( the(R1(gates( in(
figures(5.1(C(and(D(represent(the(dead(cells(in(the(population.(As(can(be(seen(from(






evolved$ cells,$ and$ Forward$ Scatter$ (FSCCA)$ and$ Side$ Scatter$ (SSCCA)$
information$ for$ C)$ CellROX® $ Oxidative$ Stress$ Deep$ Red$ Reagent$ treated$
parental$ cells$ and$D)$CellROX® $ Oxidative$ Stress$ Deep$ Red$Reagent$ treated$
evolved$cells.(As(can(be(seen(from(figures(5.1(A(and(5.1(B,(the(two(cell(lines(have(
similar( autofluorescence,( as(expected.(Figures( 5.1( C( and(5.1(D(show( that( there( is(
little( cell( death( in( both( cell( lines( from( treatment(with(CellROX®(Oxidative( Stress(
Deep( Red( Reagent( (small( sub6populations( with( low( SSC6A( to( the( LHS( of( the( R1(
gates).(Cells(from(the(parental(cell(line(are(smaller(than(those(from(the(evolved(cell(






between( the( two(cell( lines,(with( the(parental( cell( line( fluorescing(more( intensely(
than(the(evolved(cell(line.(There(was(a(larger(shift(in(median(fluorescence((median(

























































































Parental Evolved Parental Evolved Parental Evolved
Median.autofluorescence.(unstained) 151 295 120 250 170 321
Median.fluorescence.(stained) 11259 7808 10885 7009 11456 7463













the( parental( and( evolved( cell( lines.( The( Seahorse( XF24( system( quantifies(
respiration(by(measurements(of(oxygen(consumption(rate((OCR).(At(the(beginning(
of(analysis(cells(were(maintained(in(un6buffered(XF(Media,(allowing(basal(oxygen(
consumption( rates( to( be( measured.( As( described( in( methods( for( this( chapter(




of( oxygen( consumption( dedicated( to( ATP( synthesis( and( also( the( proportion( of(
oxygen( consumption( required( to( overcome( the( natural( proton( leak( across( the(
inner( mitochondrial( membrane( (IMM);( 2)( FCCP( (final( concentration( 0.75( μM)(
which( disrupts( ATP( synthesis( by( transporting( hydrogen( ions( across( the( IMM(
(instead(of(them(going(through(the(proton(channel(of(ATP(synthase((Complex(V)).(
This(collapse(of(mitochondrial(membrane(potential( leads(to(a(rapid(consumption(
of( energy(and(oxygen,(with(no(generation(of(ATP.(This( step( reveals( the(maximal(
respiratory(capacity(of(the(cell(and(also(the(spare(respiratory(capacity((defined(as(
the( quantitative( difference( between( the( initial( basal( OCR( and( the( maximal(
uncontrolled(OCR);(3)(Antimycin(A(and(Rotenone( (final( concentration(1(μM)(are(
Complex( III( and( Complex( I( inhibitors,( respectively.( Together( they( shut( down(









Figure% 5.3% Insights% into% cellular% mitochondrial% respiration,% including% oxygen%
consumption%rate%from:%basal%respiration;%ATP%Production;%overcoming%proton%leak;%
maximal% respiration;% spare% respiratory% capacity% and% also% nonGmitochondrial%
respiration,% can% be% revealed% using% a% sequential% combination% of% Oligomycin,% FCCP%
and%Antimycin%A%&%Rotenone.%%
%
To( most( accurately( gain( insights( into( mitochondrial( metabolism( using( this(
analysis,(the(concentrations(of(Oligomycin,(FCCP(and(Antimycin(A/Rotenone(stated(
above(were( first( optimised( to( ensure( complete( inhibition( of( the( target( and( also(










Figure! 5.4! Optimisation! titrations! of! A)! Oligomycin,! B)! FCCP! and! C)! Antimycin! A! &! Rotenone! for! use! in! the! XF24! Mitochondrial!
respiration! assay! system.!The!chemicals!used! in! this!assay!had! to! first!be! titrated! to!optimise! the!concentration!used! in! terms!of!keeping!
toxicity!to!a!minimum!and!ensuring!the!chemical!is!completely!inhibiting/!effecting!its!target.!The!lowest!concentration!of!each!inhibitor!that!














Once( the( concentrations( of( Oligomycin,( FCCP( and( Antimycin( A( &( Rotenone( had(
been(optimised,( the(XF24( system(was( run( in( triplicate,( each( time(using( an(XF24(
Tissue( Culture( Plate( containing( both( cells( from( the( parental( cell( line( and( the(
evolved(cell( line,(using(fresh(cells( for(each(run.(The(assay(was(performed(at(37°C(
and( then( 32°C( to( determine( any( differences( due( to( machine( operating(
temperature.( It(was(established( that(machine(operating( temperature(and(sample(
preparation( temperature( on( the(day(of( assay(did(not( affect( oxygen( consumption(
rates( (appendix( III),( therefore( data( from( all( runs(were( consolidated.( During( the(
analysis,(built6in(software(allows(plate(wells(to(be(grouped(according(to(statistical(
similarity( to( each( other.( Using( this( utility,( it(was( determined( that( cells( from( the(
parental(cell( line(and(the(evolved(cell( line(exhibit(distinct(mitochondrial(function,(
i.e.(each(of(the(parameters(that(can(be(inferred(from(this(assay((basal(respiration,(







Figure' 5.5' The' OCR' of' parental' and' evolved' cell' lines' over' the' time' course' of' a'
complete'XF24'mitochondrial'assay.(Time(indicators(A,(B(and(C(represent(the(point(at(
which( Oligomycin,( FCCP( and( Antimycin( A( &( Rotenone,( respectively,( were( added( to( the(
wells.(The(profiles(are(from(different(runs(of(the(assay(in(which(the(machine(was(operated(
at(either(37°C(and(then(32°C(for(control(purposes.(Using(the(built( in(analysis(software,( it(
was( determined( that( operating( temperature( did( not( effect( OCR.( Wells( containing( cells(
from(either(the(parental(or(evolved(cell(lines(were(automatically(grouped(together(by(the(
































Figure' 5.6' Individual' parameters' (basal' respiration' (A),'maximal' respiration' (B),'
ATP'production'(C),'proton'leak'(D),'nonKmitochondrial'respiration'(F)'and'spareK
respiratory' capacity' (E))' that' can' be' inferred' from' measurements' of' oxygen'
consumption'rates'(OCR)'from'the'Seahorse'XF24'mitochondrial'assay.'OCR(is(shown(






























































































































































Cells( from(the(evolved(cell( line(have( increased(their(average(basal(respiration(by(
76%,(maximal( respiration(by(53%,(ATP(production(by(83%,(proton( leak(by(53%(
and(non6mitochondrial( respiration( by( 45%,( compared( to( cells( from( the( parental(
cell(line.(There(was(only(a(5%(increase(in(spare(respiratory(capacity(in(the(evolved(
cells( compared( to( the( parental.( This( is( because( despite( the( elevated( maximal(
respiration( in( the( evolved( cells,( they( also( show( elevated( basal( respiratory( rates(
and( the( difference( between( these( two( (which( calculates( the( spare( respiratory(
capacity)(is(very(similar(between(both(cell(lines.(However,(this(also(means(that(the(
basal( respiration( in( evolved( cell( lines( works( proportionately( closer( to( their(







concentration( assessed( on( a( NanoDropTM( 2000( Spectrophotometer.(
Concentrations( and( purity( indicators( (A260/280( and( A260/230( ratios)( are( shown( in(
table(5.3.(All(samples(were(free(from(contaminants([indicated(by(values(of(~2.0(for(
A260/280(ratios(and(~2.062.2(for(A260/230(ratios,(which(historically(represent(“pure”(
RNA( (NanoDropTM( T0426Technical( Bulletin)],( so( could( then( be( assessed( for(
integrity.(
Sample'no: 1 2 3 1 2 3
Avg.(conc.((ng/µl)(from(5x106(cells 425.23 457.67 470.00 878.80 779.63 789.63
260/280(ratio 2.05 2.05 2.06 2.09 2.12 2.07











showing( peaks( representing( RNA( species( of( different( weights,( as( exemplified( in(
figure(5.7.(Good(quality(RNA(will(produce(an(electropherogram(with(two(distinct(
peaks(representing(18S(and(28S(ribosomal(RNA,(lots(of(other(small(peaks((smaller(
than( the( 18S( and( 28S)( would( indicated( RNA( of( poor( integrity.( RNA( Integrity(
Numbers((RIN)(are(produced(by( the(software(using(an(algorithm,(each(sample( is(
graded(on(a(scale(of(1((completely(degraded)(to(10((completely(intact).(The(rRNA(
ratio( [28S/18S]( can( be( used( to( check( quality( again( –( a( ratio( of( ~2.0( represents(


















This( section( covers( the( overall( outputs( generated( using( the( Affymetrix®(






identified.(For( the(majority(of( the(analysis(performed(on( the(Affymetrix®(data,(a(
strong(significance(threshold((p(≤(0.01,(FDR(corrected(ANOVA)(was(applied(when(
extracting( the( list( of( differentially( expressed( transcripts( that( resulted( in( 2069(
transcripts,(of(which(974(were(up6regulated(in(the(evolved(cell(line((which!can!also!
be!viewed!as!down!in!parental!cell!line)(and(1095(were(up6regulated(in(the(parental(
cell( line( (which! can! also! be! viewed! as! down! in! evolved! cell! line).( ( This( data( is(
graphically(represented(as(a(volcano(plot( in( figure(5.8(and(also( fully( tabulated( in(
appendix( III.( There( is( clear( disparity( in( the( pattern( of( differential( transcript(
expression( (i.e.( the( plot( is( not( symmetrical)(when( comparing( those( that( are( up6
regulated(in(the(evolved(cell(line((blue(markers,(spreading(more(and(further(across(
the( x6axis)( compared( to( the( parental( cell( line( (red( markers,( more( concentrated(
around(lower(values(on(the(x6axis).(((
(
Table' 5.4' Summary' of' Agilent' 2100' Bioanalyzer' data' including' RNA' Integrity'
Numbers'(RIN)'and'rRNA'ratios'[28S/18S],'for'the'samples'used'in'Affymetrix® '
GeneChip® 'array.'
Sample'no: 1 2 3 1 2 3
RIN 10.00 10.00 10.00 10.00 10.00 10.00






Figure' 5.8' Volcano' plot' representing' significantly' differentially' expressed'
transcripts' (p' ≤' 0.01,' FDR' corrected' ANOVA).( Differentially( expressed( transcripts(
below(this(significance(threshold(are(shown(in(grey.(Blue(markers(represent(differentially(
expressed( transcripts( up6regulated( in( the( evolved( cell( line( and( red( markers( represent(
differentially(expressed(transcripts(up6regulated(in(the(parental(cell( line.(Size(of(markers(
(as(well(as(position(along(the(y6axis)( indicates( level(of(significance((p(value),(with( larger(
markers( (higher( on( the( y6axis)( representing( smaller( p( values.( Distance( from( the( centre(








reduced(to(223(up6regulated( in( the(evolved(cell( line(and(204(up6regulated( in( the(
parental( cell( line,( giving( a( total( of( 427( differentially( expressed( transcripts(
compared( to(2069(when(no( fold( change( threshold( is( applied.(The(distribution(of(
these(fold(changes(according(to(whether(they(are(up(in(the(evolved(cell(line(or(the(
parental( cell( line( can( be( seen( in( figure( 5.9( in( which( all( differentially( expressed(
transcripts(with(a(fold(change(of((≥(2(are(ranked(consistent(with(size(of(fold(change.(


























Fold change of differentially expressed transcripts (p<0.01, FC>2)
Up in 32oC
Up in 37oC
Highest change - up in 32oC










For( comparative( purposes,( the( fluorescence( values( of( all( transcripts( were(
compared(between(the(evolved(and(parental(cell(lines.(This(data(is(shown(in(figure(











All( significantly( differentially( expressed( transcripts( (p( ≤( 0.01,( FDR( corrected(
ANOVA)(with(a(fold(change(of(≥(2(were(classified(into(14(functional(categories.(The(
‘other/( miscellaneous’( category( included( transcripts( with( unknown( function( or(
useful(no(chip(annotation.(As(can(be(seen(in(figure(5.11,(the(categories(with(highest(
representation( by( differentially( expressed( transcripts( are( signal(
































expressed( transcripts( over( a( fold( change( of( 2,( there( are( 223(up6regulated( in( the(
evolved( cell( line( and( 204( up6regulated( in( the( parental( cell( line( (approximately(
equally(distributed).(It(can(also(be(seen(in(figure(5.11(that(the(distribution(of(fold(
changes( in( each( category,( either( up6regulated( in( evolved( or( up6regulated( in(
parental,( is(approximately(equal,(meaning(that(there(are(not(particular(functional(
categories(that(are(being(overexpressed(in(either(cell(line,(more(just(an(exchange(in(





with' a' fold' change' of' ≥' 2.( Differentially( expressed( transcripts(were( classified( into( 14(





























































































































































biological( processes( of( interest( to( biopharmaceutical( production( (for( example,(
transcripts(associated(with(glycosylation),(or(according(to(hypothesis6lead(notions(
(for(example,(transcripts(related(to(oxidative(stress(and(mitochondria(due(to(their(
role( in( adaptive( thermogenesis).( The( transcript( expression( conservation( of( such(
processes( and( concepts( are( reviewed( further( in( the( discussion( section( of( this(
chapter.( ( Here,( the( correlations( of( these( sets( of( transcripts( are( presented,( from(
which(the(degree(of(transcript(conservation(can(be(inferred((figures(5.12(to(5.21).(
In( figures(5.12( to(5.21,( the( further( each(data(point( (representing(one( transcript)(
lies(from(the(line(y=x,(the(larger(the(fold(change(seen(in(that(transcripts(between(
the(two(cell(lines.(Data(points(below(the(line(y=x(represent(transcripts(that(are(up6
regulated( in( the( parental( cell( line,( and( data( points( above( the( line( y=x( represent(






































































































































































Figure' 5.15' Expression' of' endoplasmic' reticulum'
(ER)−associated'transcripts' in'the'evolved'cell' line'versus'the'
parental' cell' line.' Transcripts! with! a! fold! change! of! ≥! 2! are!
annotated!with!the!gene!alias.!
Figure' 5.14' Expression' of' unfolded' protein' response'
(UPR)−associated'transcripts'in'the'evolved'cell'line'versus'the'





































































































































































































































Figure' 5.18' Expression' of' cell' cycle−associated' transcripts' in'
the' evolved' cell' line' versus' the' parental' cell' line.' Transcripts!
with!a!fold!change!of!≥!2!are!annotated!with!the!gene!alias.!
Figure'5.19'Expression'of'transcripts'associated'with'cellular'
responses' to' stress' in' the' evolved' cell' line' versus' the'
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line(and( the(evolved(cell( line.(This( is(numerically( represented(by(subtracting( the(
log2( fluorescence(of(a( transcript( from(one(cell( line( from(the( log2( fluorescence(of(
that( same( transcript( from( the( other( cell( line,( giving( values( of( log2[linear( fold(
change].( Box( plots( that( show( the( distribution( of( these( values( (i.e.( the( relative(
degree(of(change)(for(each(set(of(transcripts(in(figures(5.12(to(5.21(can(be(seen(in(
figure( 5.22.( The( distribution( is( also( shown( for( all( transcripts( on( the( chip,( the(
median( of( which( lies( at( 0.01( (very( close( to( no( change).( Using( R,( notches( were(
applied( to(box(plots( to(determine(whether( any( change( in(median( is( significantly(




of( transcripts( for( cytoskeletal,( glycosylation,( amino( acid( metabolism( and(
housekeeping( genes( all( differed( significantly( from( the(median( of( all( transcripts.(
Housekeeping(and(glycosylation( transcript( sets(were(seen(as(up6regulated( in( the(
parental( cell( line( and( cytoskeletal( and( amino( acid( metabolism( transcripts( sets(
were(seen(as(up6regulated(in(the(evolved(cell(line.(It(is(worth(reiterating(here(that(




evolved( cell( line( are( also( seen( in( the( mitochondrial,( oxidative( stress( and( ER(






Figure' 5.22' Notched' box' plots' showing' the' relative' degree' of' change' of' sets' of'
transcripts'between'the'parental' and' the'evolved' cell' line.'Positive(changes((i.e.(box(
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KEGG( pathway( analysis( was( used( to( examine( whether( differentially( expressed(
transcripts((p(≤(0.01,(FDR(corrected(ANOVA,(no(fold(change(threshold(applied)(are(
working( in( concert( to( affect( particular( cellular( processes.( The( reader( is( also(
referred( to( the( appendix( to( note( the( degree( of( fold( change( associated( with(
identified/discussed( transcripts,( noting( that( certain( transcripts(may( be( found( at(
multiple( locations( on( the( chip( and( there( may( be( differences( in( the( fold( change(
values( between( these.( Pathways( analysed( included:( Metabolism;( Pathways( in(
cancer;(Cell(cycle(and(Protein(processing(in(the(endoplasmic(reticulum,(due(to(the(
potential( to( gain( insights( into( cell( line( performance( and( also( due( to( their( high(
representation( by( differentially( expressed( transcripts.( Differentially( regulated(
pathways(are(highlighted(in(figures(and(changes(described(in(preceding(text.(Other(







figure( 5.23( can( be( found( in( appendix( III( that( doesn’t( include( the( colour6coded(
representation(of(differentially(expressed(transcripts.(Fatty(acid(biosynthesis(and(
fatty( acid( degradation( are( up6regulated( in( the( evolved( cell( line( and( fatty( acid(
elongation( in( mitochondria( is( up6regulated( in( the( parental( cell( line.( There( is(
differential( regulation( occurring( in( the( transcripts( attributing( to( oxidative(




Figure' 5.23' KEGG'metabolism' pathway.' Significantly! differentially! expressed! transcripts!were!mapped! onto! this! pathway!using!KEGG!







pathway( map,( after( metabolism.( The( map( is( shown( in( figure( 5.24( with(
differentially(expressed(transcripts(highlighted(in(blue(or(red.(Casp8,(Fzd7,(Gnb5,(
Gng7,(Mitf,(Cxcl12,(Tgfbr1,(Tgfbr2,(Traf1,(Traf3,(Sufu(and(Hdac1(were(up6regulated(





Figure' 5.24' KEGG' pathways' in' cancer.' Significantly! differentially! expressed! transcripts! were! mapped! onto! this!
pathway!using!KEGG!Search&Color.!Transcripts! in!blue!represent! those! that!were!up?regulated! in!the!evolved!cell! line!







is( included( here( due( to( the( vast( changes( in( cell( cycle( that(were( observed( in( the(
evolved(cell(line(over(the(evolution(process((i.e.(very(slow(progression(of(cell(cycle(
when( first( exposed( to( hypothermic( conditions( to( normal( growth( rates( once(






Figure$ 5.25$ KEGG$ pathways$ in$ cell$ cycle.$ Significantly( differentially( expressed(
transcripts(were(mapped(onto(this(pathway(using(KEGG(Search&Color.(Transcripts(in(blue(
represent( those( that( were( up6regulated( in( the( evolved( cell( line( and( pathways( in( red(






Like( cell( cycle( pathways,( protein( processing( in( the( ER(was( not( one( of( the(most(
highly( represented( pathways( but( is( included( out( of( interested( due( to( the( large(
differences(between(the(evolved(and(parental(cell(line(in(their(recombinant(protein(
productivities.(Figure(5.26(shows(the(KEGG(pathway(map(for(protein(processing(in(
the( ER(with( differentially( expressed( transcripts( highlighted( in( blue( or( red.( Atf4,(





Figure$ 5.26$ KEGG$ protein$ processing$ in$ the$ endoplasmic$ reticulum.$ Significantly(
differentially( expressed( transcripts( were( mapped( onto( this( pathway( using( KEGG(
Search&Color.( Transcripts( in( blue( represent( those( that(were( up6regulated( in( the( evolved(







addition( of( feed( (which( occurred( on( days( 3,( 6( and( 9).( This( allowed( amino( acid(
concentrations( to( be( measured( during( early( exponential,( mid( exponential( and(




normalised( per( cell( per( unit( time,( calculated( as( follows:( [pmol(t2)( –( pmol(t1)](
/[IVCD(t26t1)])( were( then( analysed( and( compared( between( cell( lines( (see( figures(
5.28,(5.29(and(5.30).((
(A( two6way( ANOVA( with( Tukey’s( multiple( comparisons( test( (comparison( test(
between(mean( production/( consumption( of( each( amino( acid( by( each( cell( line( at(
each( stage( of( culture)( was( performed( on( the( un6summed( data( (i.e.( the( data(
presented(in(figure(5.28)((see(appendix(III).((
Notable( differences( were( observed( as( follows:( In( early( exponential( phase( of(
culture,(the(parental(cell(line(exports(Proline,(Threonine(and(Tryptophan,(whereas(
these(are(imported(in(the(evolved(cell(line;(Import(rates(of(Lysine,(Leucine,(Valine,(
Isoleucine,( Arginine,( Phenylalanine( and( Histidine( in( early( exponential( phase( are(
much( larger( in( the( evolved( cell( line( than( the( parental( cell( line;( Aspartic( acid( is(
exported(in(mid(exponential(phase(in(the(evolved(cell(line,(where(as(it(is(imported(
in( the( parental( cell( line;( transport( flux( of( Hydroxyproline( is( much( higher(
throughout(culture(in(the(parental(cell(line(than(the(evolved(cell(line.((It(can(be(seen(
in( figure( 5.29( that( when( amino( acid( transport( rates( are( summed( together(
according(to(import(or(export,(the(evolved(cell(line(has(higher(cell(specific(import(




















































































































































































Figure$ 5.28$ Specific$ amino$ acid$ transport$ rates$ of$ the$ parental$ and$ evolved$ cell$ lines$ through$
earlyCexponential,$ midCexponential$ and$ stationary$ phases$ of$ fed$ batch$ culture.$Negative( values(
represent(consumption(of(amino(acid(and(positive(values(represent(production/(export(from(the(cell.$A)(
and( B)( represent( amino( acids( with( large( scale( amino( acid( flux( in( the( parental( and( evolved( cell( line,(












































































































































































Figure$ 5.30$ Summed$ directionless$ specific$ amino$ acid$ transport$ rates$ of$ the$
parental$ and$ evolved$ cell$ lines$ through$ early$ exponential,$ mid$ exponential$ and$
stationary$phases$of$fed$batch$culture$and$also$total$transport$throughout$culture.$
All( transport( values( for( each( amino( acid(were(made(positive( and( summed( together( to(








cellular( dimensions,( growth( rate,( RNA( content,( and( transient( and( stable(
recombinant( protein( production( capabilities.( The(work( and( results( described( in(
this( chapter( aimed( to( provide( insight( into( the( underlying( mechanistic(
modifications( that(may(be(underpinning( the(phenotypic(changes(and( industrially(
relevant( improvements( that( have( been( observed( as( a( result( of( adaptation( to(
hypothermic(conditions(through(directed(evolution.((
This( work( presented( in( this( chapter( utilised( experimental( methods( that( would(
investigate(the(hypotheses(that(were(put(forward(in(the(introduction(in(a(“bottom6
up”(fashion,(but(also(used(methods(that(would(provide(information(that(could(be(
analysed( in(a(non6hypothesis( lead,( “top6down”(manner.(Taking(both(a(bottom6up(
and( top6down( approach( to( this( mechanistic( analysis( allows( the( pre6existing(
concepts( to( be( tested( as( well( as( gaining( a( more( complete( understanding( of( the(
entire(system.(







cell( line( now( employs( a( new( metabolic( process( involving( an( adaptation( of( its(
mitochondrial( proton( circuit( in( order( to( generate( heat( energy.( It( is( known( from(
pre6described(background(literature(the(uncoupling(proteins((UCPs),(activated(by(
long( chain( fatty( acids( (LCFAs),( provide( this( modification( of( the( mitochondrial(
proton(circuit(by(allowing(protons(to(re6enter(the(mitochondrial(matrix,(bypassing(






mechanism( to( allow( the( organism( to( live( in( oxygen( rich( environments( by(
increasing( respiration( by( UCP6mediated( uncoupling( which( is( associated( with(
reduced(ROS(formation((Rial(&(Zardoya(2009).((With(this(in(mind,(oxidative(stress(
(ROS)( levels( and( mitochondrial( bioenergetics( were( investigated( and( compared(
between(the(parental(cell(line(and(the(evolved(cell(line(to(determine(whether(there(
is(any(support(in(these(areas(for(adaptive(non6shivering(thermogenesis(occurring(




takes( into( account( that( the( fluorescence( is( measured( on( a( per( cell( basis:( if( the(
evolved( cells( and(parental( cells(had(an(equal(distribution(of(ROS( throughout( the(
cell,( it(would(be( expected( that,( given( that( the( evolved( cells( are( almost( double( in(
volume,(the(evolved(cells(would(fluoresce(more(intensely(anyway,(given(that(total(
ROS(per(cell(would(then(be(proportionately(greater(simply(due(to(the(increase(in(
volume.( However,( this( is( not( the( case( and( the( smaller,( parental( cells( in( fact(
fluoresce(more( intensely,( further( exaggerating( the( disparity( in( ROS( levels( when(
thought(of(in(a(per(unit(volume(basis.(Because(the(results(were(so(definitive(in(this(
way,(the(need(for(positive(flow(cytometry(controls(that(would(allow(quantification(
of( absolute( ROS( values( and( subsequent( normalisation( to( cell( volume( was( not(
deemed(necessary(to(address(the(intended(purposes(of(this(experiment.((
To(further(probe(these(findings,(an(investigation(into(mitochondrial(bioenergetics(
was( performed( using( the( Seahorse( XF24( system,( an( instrument( that( assays(
mitochondrial( respiration(by(using( chemical( inhibitors( and(effectors.(The( results(
showed(that(basal(respiration( levels(of(cells( from(the(evolved(cell( line(were(76%(
greater( than( basal( respiration( levels( of( cells( from( the( parental( cell( line.( These(
findings( support( the( adaptive( non6shivering( thermogenesis( hypothesis,( as( it( is(
known( that( increased( respiration( is( a( feature( of( adaptive( thermogenesis.(
Interestingly(too,(proton(leak(significantly(differed(between(the(two(cell(lines,(with(





indicates( cells( have( increased( permeability( across( the( inner( mitochondrial(
membrane( (Kokoszka( et( al.( 2001).( This( leakage( across( the( membrane( is( the(




in( the( spare( respiratory( capacity( between( the( two( cell( lines.( This( was( the( case(
because(although(basal(respiration(had(significantly( increased( in( the(evolved(cell(
line,( maximal( respiration( levels( had( also( significantly( increased:( The( spare(
respiratory( capacity( is( the( difference( between( these( two( levels,( a( value( that(
ultimately( remained( similar( between( cell( lines.( It( has( been( suggested( that( the(
maintenance(of(some(spare(respiratory(capacity,(even(under(conditions(of(intense(
physiological(stimulus(that(might(demand(increased(respiration,( is(a(major(factor(
contributing( to( the( vitality( and( survival( of( cells.( The( ability( to( satisfactorily(
respond(to(cellular(stressors( is(associated(with(a( large(spare(respiratory(reserve.(
This(capacity(is(determined(by(several(factors,(including(the(functional(capacity(of(
the( enzymes( involved( in( electron( transport( as( well( as( the( ability( of( the( cell( to(
deliver( substrate( to( the( mitochondria( (Desler( et( al.( 2012).( This( result( suggests(
these( abilities( have( been( maintained( through( the( evolution( process( suggesting(
these( important( survival(mechanisms(were( not( compromised.( Despite( seeing( an(
increase(in(heat(generating(proton(leak,(a(respiratory(measure(not(coupled(to(ATP(
production,( an( increase( in( ATP( production( is( also( seen( in( the( evolved( cell( line(
compared(to(the(parental(cell(line.(As(equivalent(biomass(of(each(cell(line(was(used,(




are(metabolic( pathways( that( run( simultaneously( in( opposing( directions(with( no(






produced( by( this( process( consequently( stimulates( mitochondrial( respiration,(
which(we(have(observed(as(elevated(in(the(evolved(cell( line((de(Meis(2001).(This(
discussion( assumes( these( differences( are( due( to( differential( mitochondrial(
bioenergetics(alone(and( that( the(density(of(mitochondria(within( the(cell( remains(
constant,( however,( it( could( also( be( possible( that( the( size( of(mitochondria( or( the(
density( of( their( distribution( in( the( cell( has( increased( in( the( evolved( cell( line( to(
facilitate(the(observed(bioenergetic(changes.(
Using(the(Affymetrix®(GeneChip®(CHO(Gene(2.0(Array(system,(the(expression(of(
29,890( transcripts( were( compared( between( the( two( cell( lines.( Applying( a(
significance( threshold( of( p( ≤( 0.01( (FDR( corrected( ANOVA)( to( the( analysis,( 2069(
transcripts( were( found( to( be( differentially( expressed( of( which( 974( were( up6
regulated( in( the( evolved( cell( line( (which( can( alternatively( be( viewed( as( down( in(
parental(cell(line)(and(1095(were(up6regulated(in(the(parental(cell(line((which(can(
alternatively(be(viewed(as(down(in(evolved(cell(line).((Interestingly(however,(despite(
this( roughly( equal( divide,( the( majority( of( significantly( differentially( expressed(
transcripts(with(particularly(high(fold(change(values((all(those(with(a(fold(change(>(
11.12,( to( a( maximum( fold( change( of( 87.89)( were( seen( as( up6regulated( in( the(
evolved(cell(line((see(figure(5.10),(suggesting(some(major(overexpression(of(certain(
transcripts(could(be(key(in(the(adaptation(to(hypothermic(conditions.((
It( is(widely(known(that( the(annotation(of( the(CHO(genome( is(still( relatively(poor(
(Wippermann( et( al.( 2015),( meaning( certain( transcripts( on( probes( on( the(
Affymetrix(chip(are(currently(without(meaningful(annotation,(such(as(a(gene(alias.(
Because(of( this,( coupled(with( the( lack(of(a( standardised(platform(that(allows( the(
analysis( of( such( data,( multiple( modes( of( exploring( the( data( were( performed( in(
order( to( derive( a( more( accurate( overview( of( the( major( mechanistic( differences(
between( the( two( cell( lines.( Such( methods( included:( manual( classification( of( all(
significantly( differentially( expressed( (with( a( fold( change( threshold( of( ≥( 2)(





of( transcripts( from( CHO( cells( that( represent( specific( biological( functions(
(transcript(sets(compiled(by(SA(Bioscience)(and(finally(KEGG(pathway(analysis(was(
performed( to( determine( whether( differentially( expressed( transcripts( were(
working( in( concert( to( affect( particular( cellular( processes( and( pathways.( An(
example( that( demonstrates( the( need( for( a( standardised( platform( is( found(when(
probing( the(data(set( for( information(on(cell( cycle:(using(SA(Bioscience( transcript(
sets( and( KEGG( pathway( analysis( results( in( largely( different( transcripts( lists( and(
total(transcript(numbers(in(terms(of(those(that(have(been(differentially(expressed.(
It( could( be( proposed( that( using( only( one( method( should( be( implemented( but(




From( the( functional( grouping( of( all( significantly( differentially( expressed(
transcripts( over( a( fold( change( of( 2,( we( saw( that( a( large( proportion( of( such(
transcripts( were( involved( in( cell( signalling( and( metabolism,( followed( by( gene(
expression,( cell( cycle,(membrane( trafficking( and( ECM/( cytoskeletal.( Out( of( these(
categories,(when(considering(other(analysis(performed(on(the(rest(of(the(data(set(
and( not( just( those( over( a( fold( change( of( two,(metabolism(was( verified( by( KEGG(
pathway( analysis( as( being( highly( regulated( (discussed( later),( cytoskeletal(
transcripts(were( verified( as( being( un6conserved( between( cell( lines( (figure( 5.22)(
and( there( is( some( verification( of( differential(membrane( trafficking( between( cell(
lines( from( the( differences( observed( in( amino( acid( flux( (discussed( later).( The(
distribution( of( direction( of( regulation( (i.e.( up( in( evolved( or( parental)( is(
approximately( equal( for( most( categories.( This( indicates( that( no( particular(
functional(categories(are(being(overexpressed(as(a(whole(in(either(cell( line,(more(
just(a(balanced(exchange(in(what(is(being(expressed.(However,(what(is(not(known(
from( this( data( is( whether( the( transcripts( are( negative( or( positive( regulators( of(
their( functions.( Manually( inspecting( each( transcript( one( by( one( for( this(






is( also( important( to( remember( that( just( because( a( large( number( of( transcripts(
associated(with(a(particular(function(may(have(changed,(doesn’t(necessarily(mean(
the(you’d( see(observable(differences( in( that( function,(or( in( fact( the(proteins( that(
would(be(translated(from(them.(For(example,(in(contrast,(the(up6regulation(of(just(
a( certain( single( transcript( in( a( largely( un6regulated( functional( group( may( have(
profound(biological(effects(on(the(cell.(
SA( Bioscience( transcripts( sets( were( used( to( perform( a( conservation( analysis,( in(
other( words,( these( pre6defined( lists( were( used( to( determine( whether( the(
regulation( of( certain( cellular( systems( were( conserved( along( the( evolutionary(
process.(As(was(summarised(in(figure(5.22,(out(of(the(SA(Bioscience(transcript(sets(
investigated,( housekeeping( (i.e.( typically( constitutive( genes( that( are( required( for(
the( maintenance( of( basic( cellular( function,( often( used( for( normalisation( or(
reference(purposes)( and(glycosylation(were( seen(as( significantly(up6regulated( in(
the( parental( cell( line( (compared( to( the( median( change( of( all( transcripts),( and(
cytoskeletal(and(amino(acid(metabolism(were(seen(as(up6regulated(in(the(evolved(
cell( line.( The( reader( is( reminded( here( again( that( “up6regulated”( is( used( for(
convenience,(and(can(alternatively(imply(down6regulation(in(the(opposing(cell(line.(
One(possible(explanation(for(the(apparent(up6regulation(in(housekeeping(genes(in(
the( parental( cell( line( (or( down6regulation( in( the( evolved( cell( line)( could( be( that(
these(genes(are(regulated(in(proportion(to(ploidy,(rather(than(cell(size/total(RNA(
content:( the( expression( levels( of( housekeeping( genes( might( have( remained( the(
same( through( evolution( despite( the( increase( in( total( RNA,( which( then( as( a(
consequence( of( the( normalisation( processes( by( the( Affymetrix( protocol(
(normalising( to( total( chip( fluorescence( to( account( for( cRNA( load( onto( the( chip),(
would(perceive(the(housekeeping(genes(as(down6regulated( in( the( larger,(evolved(
cell( type,( while( the( majority( of( transcripts( are( regulated( in( proportion( to( total(
cellular(RNA(content.(
Although( glycosylation( is( observed( as( up6regulated( in( the( parental( cell( line,( the(







expression(of(glycosylation( transcripts( is(not(as(relevant(as( the(end(products(are(
satisfactorily(similar.(A(related(study(was(performed(in(house(at(Lonza(that(looked(
at(the(expression(of(glycosylation(genes(in(multiple(clones(and(their(corresponding(
IgG4(mAb(glycosylation(profiles:( gene( expression(was(highly( conserved(between(
clones(but(there(was(considerable(variation(in(mAb(product(quality,(showing(a(lack(
of( correlation( between( glycosylation( gene( expression( and( glycosylation( itself(
(O’Callaghan(et(al.(2015).(
Amino(acid(metabolism(was(seen(as(up6regulated(in(the(evolved(cell(line(compared(
to( the( parental( cell( line,( implying( disparity( in( the( utilisation( of( amino( acids(
between(cell(lines.(Phenotypically,(the(cell(lines(differ(significantly(in(size((volume(
and( total( biomass( content)( so( one(might( expect( amino( acid(metabolism( to( vary,(
just(as(one(might(expect(there(to(be(metabolic(differences(between(large(and(small(
organisms( of( the( same( species.( On( a( cellular( level,( amino( acids( are( exchanged(
through(a(variety(of(types(of(transporters(situated(in(the(cell(membrane,(however,(
as(a(cell( increases( in(size,( the(surface(area(per(unit(volume( is( relatively( reduced.(
This( could( mean( that( the( relative( proportion( of( amino( acid( transporters( in( the(
evolved( cell( line( has( been( reduced;( alternatively( the( cell(may( have( up6regulated(
certain( transcripts( to( result( in( a( more( “transporter6dense”( membrane.( For(
simplicity( for( the( reader,( further( comment( on( amino( acid(metabolism( transcript(
regulation(is(discussed(later,(in(synergy(with(the(findings(from(the(amino(acid(flux(
through(fed(batch(culture(experiment.((
As( previously( mentioned,( cytoskeletal6associated( transcripts( were( observed( as(
significantly( up6regulated( in( the( evolved( cell( line.( The( profound( phenotypic(
difference(between(the(two(cell(lines(in(terms(of(cell(size(was(itself(indicative(that(
modifications(to(the(underlying(structural(elements(of(the(evolved(cell(line(would(
have( occurred.( The( cytoskeleton( creates( and( maintains( the( morphology( and(




facilitating( in( trafficking(and(signal( transduction((Amos(&(Amos(1991).(However,(
cytoskeleton( structural( elements( are( also( known( to( change( in( response( to( low(
temperature,( for(example(mRNA(abundance(of(actin(and(tubulin(has(been(shown(
on(multiple(occasions(to(vary(with(reduction(in(temperature,(as(well(as(the(spatial(
arrangement( of( the( actin( microfilaments( (Denlinger( &( Lee( 2010).( Additionally,(
cytoskeletal( elements( have( been( shown( to( co6operate( closely( with( molecular(
chaperones(such(as(heat6shock(proteins((Mounier(&(Arrigo(2002).(From(a(physical(
viewpoint,( remodelling( of( the( cytoskeleton(may( be( advantageous( to( the( evolved(
cell( line( in( response( to( increased( shear( stress( that( it( would( be( inevitably( more(
prone( to( than( the(parental( cell( line:( in(equivalent(orbital( shake( flask( culture,( the(
increased(cell(mass(will(result( in(a( larger(centrifugal( force(against(the( inner(flask(
surface(and(surrounding(fluid.(It(has(been(shown(on(numerous(occasions(that(the(
cytoskeleton(has(a(role(in(protection(against(shear(induced(stress(and(cell(damage(
(Girard( &( Nerem( 1993;( Malek( &( Izumo( 1996;( Loufrani( &( Henrion( 2008),( so( it(
wouldn’t( be( unreasonable( to( assume( a( similar( scenario( has( developed( in( the(
evolved(cell(line.((




and( to( increase( fatty( acid( chain( length( in( the( membrane,( changes( that( are(
accomplished( by( adjustments( in( lipid( metabolism( (Mansilla( &( Mendoza( 2005).(
Two( transcripts( that( were( observed( as( significantly( differentially( expressed( are(
exemplary( support( for( membrane( fluidity( adjustments( occurring( in( the( evolved(
cell( line.(These(are(phospholipase(A2( (Pla2g2a)(and(desaturase( (des)(which(both(
showed( up6regulation( in( the( evolved( cell( line,( with( respective( fold( changes( of( a(
staggering( 87.98( and( 3.56.( Phospholipase( A2( has( been( shown( to( cold6inducibly(
regulate( membrane( unsaturation( and( fluidity( by( hydrolysing( phospholipids( and(
releasing(free(fatty(acids(and(lysophospholipids(from(the(membrane((Zeiger(et(al.(
2011).( Additionally,( inhibition( of( phospholipase( A2( activity( has( been( shown( to(





by( introducing( double( bonds( into( pre6existing( saturated( fatty( acid( chains,( the(




transcripts( in(particular(were( very( close( to(being( so,( and(had(a( large(bias( in( the(
distribution(of(outliers(towards(being(up6regulated(in(the(evolved(cell( line.(When(
considering(the(results(from(the(Seahorse(XF24(studies(that(show(vast(differences(
between( the( two( cell( lines( across( multiple( mitochondrial( functions,( it( is( not(
surprising( to( observe( interesting( distribution( of( outliers( of( mitochondrial(
transcripts(in(the(evolved(cell(line.(Upon(individual(inspection(of(some(of(the(more(
differentially( expressed( transcripts( (i.e.( those(with( a( higher( fold( change)( several(
were( flagged( due( to( associations( with( the( adaptive( thermogenesis( hypothesis.(
Firstly,( Pla2g2a( (phospholipase( A2),( which( has( previously( been( discussed( in( the(
context( of(membrane( fluidity( and( is( 87.98( fold( higher( in( the( evolved( cell( line,( is(
also(known(to(have(a(role(in(thermogenesis(in(mitochondria:(proton(leak(through(
UCP1( is( activated( by( long6chain( fatty( acids( which( are( released( from( the(
mitochondrial( membrane( by( phospholipase( A2( (Harms( &( Seale( 2013).( Although(
UCPs(were(not(found(to(be(differentially(expressed,(the(activity(of(UCPs(and(their(
role(in(possible(thermogenesis(in(the(evolved(cell(line(may(have(been(enhanced(as(
a( result( of( increased( phospholipase( A2.( Interestingly,( other( mitochondrial(
transcripts( that(are( commonly(associated(with(adaptive( thermogenesis( in(brown(
adipose( tissue( (BAT)(were(observed(as(up6regulated( in( the(evolved( cell( line.(For(
example,(Ca5b(which(is(enriched(20(fold(in(BAT((Forner(et(al.(2009),(was(increased(
3.68(fold( in(the(evolved(cell( line,(and(Fabp4,(Lamb3,(and(Rarres2(were( increased(
9.45,( 3.83( and( 3.67( fold,( respectively,( which( are( all( associated( with( BAT(
differentiation((Kang(et(al.(2005;(Goralski(et(al.(2007;(Lee(et(al.(2013).(
The( following(paragraphs( focus(on(notable( findings( from(KEGG(pathway(analysis(




changes( or( were( simply( of( interest.( The( latter( was( performed( as,( although(
pragmatically( ‘omics( studies( can(only(be(efficiently( analysed(on(a(global( scale( as(
has( mostly( been( represented( so( far,( there( was( enticing( potential( to( identify(
supplementary( gene( targets( that( could( potentially( be( used( to( engineer( an(
improved(CHO(cell(phenotype.((
KEGG( is( a( popular( pathway( analysis( programme( for( analysing( ‘omic( data,(
permitting( ‘group(testing’,(where(a( list(of(genes(can(be(mapped(onto(a(particular(
pathway(to(determine(whether(certain(function(and(pathways(are(being(regulated(
by(groups(of(genes( (Monoli(et(al.( 2006).(To(perform(such(analysis,( gene( lists(are(
entered(using( a( recognised( identifier( (UniProt( IDs),( however,(we( cannot( assume(
that( just( because( certain(pathways( aren’t( highlighted( as( regulated,( doesn’t(mean(
they(aren’t(being(regulated.(This(is(because(the(annotation(of(the(Affymetrix(data(
set,(as(previously(mentioned,(is(not(complete.(This(limits(the(conclusions(that(can(




















(when( considering( its( growth6halting( environment).( Cdc20(was( observed( as( up6
regulated( in( the(evolved(cell( line,(which( is(known( to(be(an(essential( regulator(of(
cell( division,( having( an( important( role( in( activating( the( anaphase( promoting(
complex( (APC/C)( and( appearing( to( interact( with( multiple( other( proteins(
throughout( the( cell( cycle( (Weinstein( et( al.( 1994).( Additionally,( Tfdp2( was( up6
regulated( in( the(evolved(cell( line,(which( is(a( critical( cofactor( required( for(proper(
cell(cycle(and(controls(the(progression(from(G1(to(S(phase((Chen(&(Lodish(2014).(
In( contrast,( the( parental( cell( line( shows( an( up6regulation( of( Cdkn2c,( a( cyclin(
dependent( kinase( inhibitor( that( has( been( shown( to( suppress( tumorigenesis( and(
cell( cycle( progression( (Stein( et(al.( 2013).( Another( transcript( that( is(mitogenic( in(
nature(but( is(not( encompassed( in( the(KEGG(cell( cycle(pathway(map( is(Rps6ka,( a(
transcript(that(was(up6regulated(by(5.28(fold(in(the(evolved(cell(line.(
As( stated( in( the( results( section( of( this( chapter,( protein( processing( in( the(
endoplasmic( reticulum( was( a( KEGG( pathway( that( was( not( particularly( highly(
represented,(but(due(to(the(large(differences(between(the(evolved(and(parental(cell(
line( in( their( recombinant( protein( productivities( it( was( investigated( nonetheless.(
The( most( interesting( outcome( from( this( was( the( finding( that( ATF4( was( up6
regulated(in(the(evolved(cell( line.(ATF4(is(a(central(factor(in(the(unfolded(protein(
response( (UPR)( and( overexpression( of( ATF4( has( been( shown( on( numerous(
occasions(to(increase(the(productivity(of(recombinant(protein(in(CHO(cells((Ohya(et(
al.(2007;(Haredy(et(al.(2011;(Edros(et(al.(2013).( It(has(been(suggested( that(ATF4(




Lastly,( the( KEGG( pathway( map( for( metabolism( was( the( one( that( was( the( most(
represented(in(this(analysis.(The(most(striking(observation(from(figure(5.23(is(the(
number( of( changes( over( multiple( areas( of( metabolism,( which( demonstrates( the(





expression( from( classical( gene( engineering( approaches.( In( particular,( lipid(
metabolism(was( found( to( be( highly( differentially( regulated( between( the( evolved(
and( parental( cell( line.( It( is( hypothesised( that( this( could( be( related( to( the( pre6
discussed( role( that( lipid( modification( has( in( both( membrane( fluidity( and(
thermogenesis( (free( fatty( acids( are( hydrolysed( and( activate( UCP1).( Interesting,(
ATF4,( already( demonstrated( to( have( links( to( high( recombinant( protein(
productivity(and(thermogenesis,(has(also(been(shown(to(regulate(lipid(metabolism(
(Wang( et( al.( 2010).( Areas( of( amino( acid( metabolism,( too,( are( seen( to( be(









When( inspecting( the( actual( amino( acid( flux( data,( it( can( be( seen( that( largely( the(
evolved(and(parental(cell(lines(have(similar(total(cell(specific(amino(acid(transport(
rates( at( early( exponential,( mid( exponential( and( stationary( phases( (figure( 5.30).(
Looking( further( into( the( data( at( the( direction( of( transport,( it( can( be( seen( that(
import( and( export( rates( are( relatively( similar( between( cell( lines( throughout( all(
culture(phases((figure(5.29).(However,(differences(between(cell(lines(were(noticed(
at(early(exponential(phase(of(growth(where(import(rates(of(lysine,(proline,(leucine,(
valine,( isoleucine,( arginine,( phenylalanine( and( histidine( are( much( larger( in( the(
evolved(cell(line(than(the(parental(cell(line.(Out(of(interest((as(RNA(was(extracted(at(
early(exponential(phase),( the( transcript(data(set(was(searched( for( transcripts( for(
amino( acid( transporters( and( it( was( found( that( SLC38A4( (SNAT4)( and( SLC43A2(
(LAT4)(were(up6regulated(in(the(evolved(cell(line(with(increases(of(10.24(and(2.20(





histidine( and( proline( into( the( evolved( cell( line( in( early( exponential( phase(
(Padmanabhan( et( al.(2012).( SLC43A2( is( a( transporter( of( branched( chain( amino(
acids( and( could( explain( the( increased( import( of( leucine,( isoleucine,( valine( and(
phenylalanine(into(the(evolved(cell(line(in(early(exponential(phase((Wang(&(Holst(
2015).( Increased( arginine( import( could( result( from( the( up6regulation( of( Odc1,(





There( are( numerous( methods( in( which( proline( has( been( shown( to( do( this(





proline( uptake( is( a( feature( of( hypothermia6related( hibernation( in(mammals( and(
recovery(during(arousal(from(hibernation((Kirstoffersson(&(Broberg(1986;(Carey(&(
Sills(1992).((
It( is( interesting(to(note(at( this(point( that(certain(biological(anomalies(are(seen( in(
this( dataset,( one( example( being( that( of( tryptophan( and( threonine( which( are(
observed(as(being(produced(by(cells(in(the(early(phase(of(growth.(This(is(unusual(
as(these(amino(acids(are(essential(amino(acids(and(are(not(synthesised(by(cells.(As(
they( error( rate( of( the( analytical( method( was( stated( as( negligible( (direct(




it( is( transporting( the( same( amount( and( a( similar( profile( of( amino( acids( as( the(




content( and( capable( of( producing( significantly( more( recombinant( protein( upon(
transfection.(
In( line( with( the( previous( comment,( and( as( has( been( noted( throughout( this(
discussion,(a(discernible(feature(of(the(evolved(cell(line(is(its(significant(increase(in(
size.(Whether(this(is(a(physical(thermodynamic(response(to(conserve(heat,(or(has(
occurred( for(unidentified(reasons,( it( is(an( impressive(biophysical( feat( that(would(











to(multiple( cellular( functions.(We’ve( seen( that(mitochondrial( bioenergetics( have(
been(significantly(altered,(notably(with(increased(proton(leak(and(increased(basal(
respiratory(levels(which(coupled(with(the(decrease(in(ROS(levels(in(the(evolved(cell(
line,( support( the( hypothesis( that( the( evolved( cell( line( is( using( adaptive( non6
shivering( thermogenesis(mechanisms( to( produce( intracellular( heat.( Additionally,(
when( looking( at( transcriptomic( differences( using( Affymetrix( technology,( certain(
transcripts(were(up6regulated(in(the(evolved(cell(line(that(are(known(to(play(roles(
in(cellular(thermogenesis,(for(example,(Ca5b,(ATF4(and(Pla2g2a,(the(latter(of(which(







KEGG(pathway(analysis( (which(mostly( showed(up6regulation( in( the(parental( cell(
line)(and(conservation(analysis(using(SA(Bioscience(transcript(sets((which(showed(
up6regulation( in( the( evolved( cell( line)( highlights( the( need( for( a( standardised(
transcriptome(analysis(platform(that(facilitates(the(probing(of(particular(functional(
attributes.( In( vitro( analysis( of( amino( acid( flux( actually( showed( very( little(
differences( in( total(cell( specific( transport(rates(between(cell( lines,( indicating( that(
the(evolved(cell(line(has(become(more(‘biomass(efficient’(when(also(considering(its(
significant( increased( production( capabilities.( This( also( demonstrates( that( there(





orthogonal( transcriptomic( technique,( such( as( RNA6seq.( This( would( ensure(
additional(confidence(in(the(findings(presented(here.(However,(for(the(purposes(of(
identifying(gene6engineering(targets(for(overexpression,(this(could(be(superfluous(














Other( suggestions( for( future( work( include( investigating( the( size( and( number( of(
mitochondria( in( the( evolved( cell( line( compared( to( the( parental( to( determine( if(
either( of( these( factors( have( contributed( to( the( improved( mitochondrial(
bioenergetics(observed(in(evolved(cell(line.(Additionally,(assessment(of(membrane(
fluidity(could(be( investigated( to(see( if( this(correlates(with( the( indicative( findings(
from( the( transcriptomic( analysis.( Furthermore,( advances( in( the( recently(
developed,(but(not(widely(available,(so6called(“nanothermometers”(could(allow(for(
the(direct(measurement(of( internal(cellular(temperature,(which(would(enable(the(
adaptive( non6shivering( thermogenesis( hypothesis( to( be( explicitly( confirmed( or(
rejected( depending( on( whether( the( evolved( cells( are( indeed( internally( warmer(

































A( fundamental( conclusion( of( this( chapter(would( be( that( directed( evolution( as( a(

























This% chapter% summarises% the% conclusions% drawn% throughout% this% thesis% and%
comments% on% how% the% research% presented% contributes% to% the% wider% field% of%
biopharmaceutical% production.% Suggested% directions% for% future% work% are% also%
considered%here.%
%
6.1$ A$ summary$ of$ conclusions$ drawn$ from$ the$ research$ chapters$ of$ this$
thesis$
This( thesis( has( been( presented( in( a( chronological( and( sequential( manner,( with(
chapter(3(forming(the(basis(of(the(subsequent(work,(and(chapters(4(and(5(drawing(
on( the( results( of( the( previous,( taking( these( findings( forward( to( be( investigated(
from(a(different(perspective.(In(chapter(3(it(was(shown(that(the(average(change(in(
cell(growth(rate(per(day(could(be(improved(by(the(manipulation(of(simple(in(vitro(
parameters:( seeding( density( and( passage( frequency.( This( information( could( be(
useful(in(directed(evolution(experiments(where(rapid(increases(in(growth(rate(are(
required,( potentially( facilitating( faster( adaptation( to( particular( environments( or(
stressors.(The(remaining(work(presented(in(chapter(3(focussed(on(the(adaptation(
of( CHOK1SV( host( cells( to( hypothermia( via( longKterm( culturing( at( 32°C.( The(
purpose(of(this(study(was(to(generate(a(host(cell(culture(that(could(grow(rapidly(at(
32°C(whilst(retaining(the(high(production(abilities(that(are(observed(during(a(twoK




initial( rapid( proliferation( to( achieve( high( culture( density( and( then( secondly( the(
temperature( is( reduced( to( 32°C( and( proliferation( is( halted.( As( previously(
explained,(this(strategy(has(regularly(been(associated(with(multiKfold(increased(in(
productivity( (Chuppa( et% al.( 1997;( Slikker( et% al.( 2001;( Vergara( et% al.( 2014).(
However,( titre( could(be( improved( further( if( cells( could(continue( to(proliferate(at(





in( chapter( 3,( hypothermiaKadapted( cultures( were( successfully( attained( through(
longKterm(adaptive(evolution.(Not(only(this,(but(other(interesting(phenotypes(were(




As( stated,( the(purpose(of( the(work(described( in(chapter(4(was( to( investigate( the(
functional( attributes( of( the( hypothermiaKadapted( cell( cultures.( The( functional(
attributes( referred( to( here( relate( essentially( to( those( that( would( be( of( direct(
interest(to(the(biopharmaceutical(industry,(fundamentally,(addressing(the(question(
of(whether(the(hypothermiaKadapted(cultures(have(the(potential(to(make(a(suitable(
industrial( host( cell( line( for( producing( recombinant( protein( products.( The(
hypothermiaKadapted( cultures( were( compared( to( their( parental( counterparts(
throughout.(Firstly(it(was(shown(that,(in(terms(of(transient(SEAP(productivity,(the(
hypothermiaKadapted( cell( cultures( (at( 32°C)( exhibited( an( impressive( ~100%(
increase(on(the(parental(cultures((at(37°C),(and(also(importantly(showed(a(marked(
increase(on(the(amount(of(SEAP(produced(by(the(parental(cells(that(had(undergone(
a( ‘coldKshock’( (at( 32°C)( post( transfection.( Because( of( this( exciting( result,( the(
hypothermiaKadapted(cultures(were(investigated(in(terms(of(transfection(efficiency(
using(transient(GFP(transfection(and(here(it(was(again(seen(that(the(hypothermiaK






and( parental( cell( lines( from( here( on,( both( were( tested( for( their( productivity( of(
cB72.3((an(IgG4(mAb)(and(Enbrel((a(difficultKtoKexpress(IgG1(FcKfusion(protein)(in(




line,( the( next( logical( functional( assessment( was( to( establish( stable( cell( lines.(
Separate(stable(pools(producing(cB72.3(or(Enbrel(were(formed(from(both(evolved(
and(parental(cell(lines(and(again,(the(evolved(cell(line(outperformed(the(parental(in(
terms( of( titre( of( both( proteins.( Additionally,( the( evolved( cell( line( unusually(
exhibited(better(titres(of(the(difficultKtoKexpress(Enbrel(than(it(did(cB72.3,(showing(
promise( that( this( cell( line( could( be( used( as( a( candidate( cell( line( for( producing(
higher( titres(of(other(difficultKtoKexpress(protein(products.(A( superficial(productK
quality( analysis( was( also( performed( in( terms( of( glycan( profiling( of( cB72.3( and(
Enbrel( produced( by( the( two( cell( lines,( both( transiently( and( stably.( The( central(








this(work(was( associated(with( the(hypothesis( that( the( evolved( cell( line( could(be(
coping(with(the(stress(of(hypothermia(by(generating(localised(heat(within(the(cell(
by( processes( such( as( adaptive( non:shivering% thermogenesis.( To( investigate( this(
theory,( a( combination( of( specific( hypothesisKtesting( experiments( (for( example(
those( that( investigated( mitochondrial( capacity( and( oxidative( stress)( were(




Affymetrix®( differential( gene( expression( analysis( and( amino( acid( flux( through(
culture).(As(is(discussed(in(more(detail(in(chapter(5,(results(from(this(work(showed(
some(interesting(support(for(certain(adaptation(theories.(For(example,(the(evolved(
cell( line( showed( substantially( lower( levels( of( cellular( reactive( oxygen( species(
(ROS)(compared(to(the(parental(cell(line(and(there(was(evidence(that(the(evolved(
cell( line( exhibits( increased( inner(mitochondrial(membrane( permeability.( Both( of(
these( results,( coupled( with( the( increased( maximal( respiratory( capacity( of( the(
evolved( cell( line,( are( all( key( features( of( adaptive( nonKshivering( thermogenesis,(
suggesting( the( cell( could( indeed( be( using( this( mechanism( to( generate( heat.(
Indications(of(support(for(this(theory(were(also(found(when(comparing(transcript(
regulation( between( the( two( cell( lines:( Pla2g2a( (phospholipase( A2),( which( has( a(
direct(role(in(adaptive(nonKshivering(thermogenesis,(was(found(to(be(upKregulated(
in(the(evolved(cells(by(a(staggering(87.98(fold((Harms(&(Seale(2013).(Interestingly,(
this( transcript( (along( with( several( others( that( were( upKregulated)( is( known( to(
increase( membrane( fluidity( and( stability,( which( is( a( common( coldKadaptation(
strategy((Schaeffer(et%al.(2005).(Likewise,(changes(to(membrane(fluidity(could(also(
be( inferred(by(the( large(differences( in(cytoskeletal( transcripts(between(cell( lines.(
Interesting( differences( were( also( observed( in( the( cell( cycle( pathways( which( to(
some( degree( would( be( expected( given( that( under( normal( circumstances(









exponential,( mid( exponential( and( stationary( phases.( In( addition( to( this,( it( was(
shown( that( import( and( export( rates( are( relatively( similar( between( cell( lines(





interesting( example( given( in( the( large( import( of( proline( in( the( evolved( cell( line(
whilst( the(parental( cell( line( largely( exported( this.( This(was( of( particular( bearing(
due( to( the( numerous( associations( between( proline( uptake( and( its( role( in( coldK
adaptation,(specifically(by:(acting(as(a(cryoprotectant(and(molecular(chaperone(to(
stabilise(the(structure(of(proteins(in(hypothermic(conditions,(playing(a(key(role(in(
antioxidant( systems( by( reducing( ROS( concentrations,( influencing( membrane(
fluidity(and(also(maintaining(osmotic(balance((Kumar(&(Yadav(2009;(Ishmayana(et%
al.%2011;(Hayat(et%al.%2012;(Koštál(et%al.(2012;(Liu(et%al.(2013).((
Overall,( the( compilation( of( the( findings( in( these( research( chapters( show( chiefly(
that(the(adaptation(of(hypothermiaKadapted(host(cell(line(has(been(more(successful(
than(previous(attempts(that(have(endeavoured(to(adapt(already(stably(producing(







end( of( each( research( chapter,( a( brief( summary( of( those( are( given( here.( One(
primary(and(basic(recommendation(for(future(work(includes(attempting(to(evolve(
a(hypothermiaKadapted(cell(line(from(an(alternative(host(CHO(cell(line,(for(example(
CHOKS( or(DG44( cells,( and( if( successful( subsequently( assessing( their( productivity(
and(ability(to(generate(stably(producing(cell(lines.(This(would(confirm(whether(the(
capacity( to( adapt( to( hypothermia( is( common( across( multiple( parental( host( cell(
lines( or( unique( to( CHOK1SV,(which( contains( the( GS( selection( system.( Other( cell(
lines(contain(different(selection(systems(meaning(they(will(have(varying(metabolic(
requirements(and(they(may(require(bespoke(culture(medium((i.e.(not(the(CD(CHO(
media( used( for( this( project).( These( factors( indicate( that( other( cell( lines( may(




hypothermia.( ( From( a( mechanistic( characterisation( point( of( view,( it( could( be(
suggested( that( both( the( parental( and( evolved( cell( lines( undergo( karyotyping( to(
determine(whether(there(are(any(major(chromosomal(changes(that(have(occurred(
either( as( a( result( of,( or( to( facilitate,( the( adaptation( process,( as( it( is( know( that(
aneuploidy( has( been( strongly( associated( with( stress( adaptation( (Derouazi( et% al.(
2006;(Chen(et%al.(2012).(Although(chapter(4(has(demonstrated(that(the(evolved(cell(
line(has(outKperformed(the(parental(cell(line(in(terms(of(industrial(functionality,(a(
full( industrialKgrade( technology( readiness( level( (TRL)( assessment( may( be(
beneficial( before( recommending( this( cell( line( for( use( in( industrial(
biopharmaceutical( production.( Other( studies( that( could( be( conducted( to(
corroborate( the( observed( industrial( advantages( of( the( evolved( cell( line( include(
testing( the( production( of( other( difficultKtoKexpress( proteins( and( those( that( are(
prone( to( aggregation( and( also( testing( the( ability( to( scaleKup( to( bioreactors( or(
equivalent(large(scale(vessels((a(necessity(for(an(industrial(cell( line).(It(could(also(
be( beneficially( to( preform( clonal( selection( on( the( stable( pools( to( isolate( high(
producing(clones.(
In( terms( of( recommended( work( that( could( build( upon( the( findings( of( the(
mechanistic(analysis((chapter(5),(it(could(be(valuable(to(validate(the(findings(from(




number( of( mitochondria( in( the( evolved( cell( line( compared( to( the( parental( to(
determine( if( either( of( these( factors( have( contributed( to( the( improved(
mitochondrial( bioenergetics( observed( in( evolved( cell( line.( Finally,( as( there( are(
many( indications( that( cell(membrane( fluidity(may(have( increased( in( the( evolved(
cell( line( as( a( direct( result( of( adaptation( to( hypothermia,( this( could( be( directly(
measured( using( commercially( available( kits( (e.g.( available( from( Abcam(









any( other( published( attempts( in( this( vein( have( used( cell( lines( that( were( stably(
producing( recombinant( protein( prior( to( hypothermia( adaptation( and( were(
ultimately(unsuccessful(either(in(terms(of(low(final(productivity((Yoon(et%al.(2006),(
or(in(the(inherent(health(of(the(adapted(cells((Sunley(et%al.(2008).((Not(only(has(the(
work( here( resulted( in( a( potential( new( cell( line( platform( that( has( exhibited(
improved(manufacturing(properties(compared(to(the(parental(cell(line,(it(has(also(
offered(insight(into(possible(gene(engineering(targets(that(could(be(used(in(future(
cell( line( development( strategies.( However,( the( vast( and( global( changes( between(
the( evolved( and( parental( cell( lines( that( have( been( observed( as( a( result( of( the(
evolution(process(demonstrate( the(power( of( directed( evolution( as( a( strategy( for(
cell( line( engineering( compared( to( classical( gene( engineering( and( overexpression(
techniques.( Such( classical( techniques( are( highly( unlikely,( at( least( within( the(





Whilst( this( would( inevitably( be( of( commercial( value,( it( also( perhaps( more(
important( to( consider( that( the( most( significant( beneficiary( of( this( work( could(
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Tukey's multiple comparisons test Significant? Summary Adjusted P Value
Every1 days, seeding 1x10^6 vs. Every1 days, seeding 3x10^6 No ns 0.4104
Every1 days, seeding 1x10^6 vs. Every1 days, seeding 5x10^6 No ns 0.9998
Every1 days, seeding 1x10^6 vs. Every2 days, seeding 1x10^6 No ns 0.2839
Every1 days, seeding 1x10^6 vs. Every2 days, seeding 3x10^6 Yes **** < 0.0001
Every1 days, seeding 1x10^6 vs. Every2 days, seeding 5x10^6 Yes **** < 0.0001
Every1 days, seeding 1x10^6 vs. Every3 days, seeding 1x10^6 No ns > 0.9999
Every1 days, seeding 1x10^6 vs. Every3 days, seeding 3x10^6 No ns 0.1738
Every1 days, seeding 1x10^6 vs. Every4 days, seeding 1x10^6 Yes *** 0.0003
Every1 days, seeding 1x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every1 days, seeding 3x10^6 vs. Every1 days, seeding 5x10^6 No ns 0.7618
Every1 days, seeding 3x10^6 vs. Every2 days, seeding 1x10^6 Yes ** 0.0026
Every1 days, seeding 3x10^6 vs. Every2 days, seeding 3x10^6 Yes **** < 0.0001
Every1 days, seeding 3x10^6 vs. Every2 days, seeding 5x10^6 Yes **** < 0.0001
Every1 days, seeding 3x10^6 vs. Every3 days, seeding 1x10^6 No ns 0.303
Every1 days, seeding 3x10^6 vs. Every3 days, seeding 3x10^6 No ns 0.9999
Every1 days, seeding 3x10^6 vs. Every4 days, seeding 1x10^6 Yes **** < 0.0001
Every1 days, seeding 3x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every1 days, seeding 5x10^6 vs. Every2 days, seeding 1x10^6 No ns 0.1011
Every1 days, seeding 5x10^6 vs. Every2 days, seeding 3x10^6 Yes **** < 0.0001
Every1 days, seeding 5x10^6 vs. Every2 days, seeding 5x10^6 Yes **** < 0.0001
Every1 days, seeding 5x10^6 vs. Every3 days, seeding 1x10^6 No ns 0.9976
Every1 days, seeding 5x10^6 vs. Every3 days, seeding 3x10^6 No ns 0.434
Every1 days, seeding 5x10^6 vs. Every4 days, seeding 1x10^6 Yes **** < 0.0001
Every1 days, seeding 5x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every2 days, seeding 1x10^6 vs. Every2 days, seeding 3x10^6 Yes **** < 0.0001
Every2 days, seeding 1x10^6 vs. Every2 days, seeding 5x10^6 Yes **** < 0.0001
Every2 days, seeding 1x10^6 vs. Every3 days, seeding 1x10^6 No ns 0.3874
Every2 days, seeding 1x10^6 vs. Every3 days, seeding 3x10^6 Yes *** 0.0008
Every2 days, seeding 1x10^6 vs. Every4 days, seeding 1x10^6 No ns 0.067
Every2 days, seeding 1x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every2 days, seeding 3x10^6 vs. Every2 days, seeding 5x10^6 Yes **** < 0.0001
Every2 days, seeding 3x10^6 vs. Every3 days, seeding 1x10^6 Yes **** < 0.0001
Every2 days, seeding 3x10^6 vs. Every3 days, seeding 3x10^6 Yes **** < 0.0001
Every2 days, seeding 3x10^6 vs. Every4 days, seeding 1x10^6 Yes ** 0.0041
Every2 days, seeding 3x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) No ns 0.483
Every2 days, seeding 5x10^6 vs. Every3 days, seeding 1x10^6 Yes **** < 0.0001
Every2 days, seeding 5x10^6 vs. Every3 days, seeding 3x10^6 Yes **** < 0.0001
Every2 days, seeding 5x10^6 vs. Every4 days, seeding 1x10^6 Yes **** < 0.0001
Every2 days, seeding 5x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every3 days, seeding 1x10^6 vs. Every3 days, seeding 3x10^6 No ns 0.1185
Every3 days, seeding 1x10^6 vs. Every4 days, seeding 1x10^6 Yes *** 0.0004
Every3 days, seeding 1x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001
Every3 days, seeding 3x10^6 vs. Every4 days, seeding 1x10^6 Yes **** < 0.0001
Every3 days, seeding 3x10^6 vs. CTRL(Every3-4 days, seeding 0.2x10^6) Yes **** < 0.0001













Tukey's multiple comparisons test Significant? Summary Adjusted P Value
A:Evolved vs. A:Parental Yes **** < 0.0001
A:Evolved vs. B:Evolved No ns 0.6377
A:Evolved vs. B:Parental Yes *** 0.0001
A:Evolved vs. C:Evolved No ns 0.9591
A:Evolved vs. C:Parental Yes **** < 0.0001
A:Parental vs. B:Evolved Yes *** 0.0001
A:Parental vs. B:Parental No ns 0.548
A:Parental vs. C:Evolved Yes **** < 0.0001
A:Parental vs. C:Parental No ns 0.8544
B:Evolved vs. B:Parental Yes ** 0.0014
B:Evolved vs. C:Evolved No ns 0.9722
B:Evolved vs. C:Parental Yes *** 0.0006
B:Parental vs. C:Evolved Yes *** 0.0004
B:Parental vs. C:Parental No ns 0.9912
C:Evolved vs. C:Parental Yes *** 0.0002
RNA$concentration$from$5x10^6$cells
Tukey's multiple comparisons test Significant? Summary Adjusted P Value
A:Evolved vs. A:Parental Yes **** < 0.0001
A:Evolved vs. B:Evolved No ns 0.4224
A:Evolved vs. B:Parental Yes **** < 0.0001
A:Evolved vs. C:Evolved No ns 0.5279
A:Evolved vs. C:Parental Yes **** < 0.0001
A:Parental vs. B:Evolved Yes *** 0.0002
A:Parental vs. B:Parental No ns 0.9857
A:Parental vs. C:Evolved Yes *** 0.0001
A:Parental vs. C:Parental No ns 0.9447
B:Evolved vs. B:Parental Yes *** 0.0004
B:Evolved vs. C:Evolved No ns > 0.9999
B:Evolved vs. C:Parental Yes *** 0.0006
B:Parental vs. C:Evolved Yes *** 0.0003
B:Parental vs. C:Parental No ns 0.9999



























Tukey's multiple comparisons test Significant? Summary Adjusted P Value
Culture 32A at 32oC incbuabtion vs. Culture 32B at 32oC incbuabtion No ns 0.0747
Culture 32A at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion No ns 0.3518
Culture 32A at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion No ns 0.999
Culture 32B at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion No ns 0.9935
Culture 37A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns 0.9282
Culture 37A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns > 0.9999
Culture 37B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 37oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns > 0.9999
Culture 32A at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns > 0.9999
Culture 32A at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns > 0.9999
Culture 32A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9282
Culture 32A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.999
Culture 32B at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.974
Culture 32B at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns > 0.9999
Culture 32B at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.999
Culture 32B at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns > 0.9999
Culture 32C at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.9935
Culture 32C at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.6056
Culture 32C at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.9282
Culture 37A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9935
Culture 37A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns > 0.9999






Tukey's multiple comparisons test Significant? Summary Adjusted P Value
Culture 32A at 32oC incbuabtion vs. Culture 32B at 32oC incbuabtion Yes * 0.0245
Culture 32A at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion No ns 0.9892
Culture 32A at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes *** 0.0004
Culture 32A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns 0.6318
Culture 32A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes *** 0.0009
Culture 32A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion No ns 0.2442
Culture 32B at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes * 0.0167
Culture 32B at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion No ns 0.291
Culture 32B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns 0.8456
Culture 32B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns 0.7838
Culture 32B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns 0.9581
Culture 32B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.0542
Culture 32B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes ** 0.0074
Culture 32B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.1842
Culture 32B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes *** 0.0002
Culture 32C at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes *** 0.0006
Culture 32C at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes ** 0.0064
Culture 32C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns 0.9974
Culture 32C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes * 0.0143
Culture 32C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes *** 0.0003
Culture 32C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion No ns 0.9496
Culture 37A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns 0.4512
Culture 37A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes *** 0.0002
Culture 37A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns 0.273
Culture 37A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns > 0.9999
Culture 37A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns > 0.9999
Culture 37A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9887
Culture 37A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.7274
Culture 37B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns 0.997
Culture 37B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes ** 0.0062
Culture 37B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns 0.9693
Culture 37B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.9987
Culture 37B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.8242
Culture 37B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns > 0.9999
Culture 37B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.0858
Culture 37C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns 0.0564
Culture 37C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns > 0.9999
Culture 37C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.7738
Culture 37C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.2705
Culture 37C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9795
Culture 37C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes ** 0.0099
Culture 32A at 37oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns 0.1134
Culture 32A at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes *** 0.0007
Culture 32A at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes ** 0.0033
Culture 32A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.5679
Culture 32B at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.1484
Culture 32B at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9004
Culture 32B at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes ** 0.0044
Culture 32C at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.9988
Culture 32C at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns > 0.9999
Culture 32C at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.404
Culture 37A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.9294
Culture 37A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.8963






Tukey's multiple comparisons test Significant?SummaryAdjusted P Value
Culture 32A at 32oC incbuabtion vs. Culture 32B at 32oC incbuabtion No ns 0.3041
Culture 32A at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion Yes *** 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns > 0.9999
Culture 32A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns > 0.9999
Culture 32A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes ** 0.007
Culture 32A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32C at 32oC incbuabtion No ns 0.0734
Culture 32B at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion Yes * 0.0102
Culture 32B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion No ns 0.2813
Culture 32B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns 0.5845
Culture 32B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.7984
Culture 32B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37A at 32oC incbuabtion Yes ** 0.0091
Culture 32C at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion No ns 0.9987
Culture 32C at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion Yes * 0.0244
Culture 32C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes *** 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes *** 0.0005
Culture 32C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.8869
Culture 32C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.0988
Culture 37A at 32oC incbuabtion vs. Culture 37B at 32oC incbuabtion No ns 0.0666
Culture 37A at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns > 0.9999
Culture 37A at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37A at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes *** 0.0002
Culture 37A at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.1669
Culture 37A at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes *** 0.0004
Culture 37A at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.9929
Culture 37B at 32oC incbuabtion vs. Culture 37C at 32oC incbuabtion No ns 0.1554
Culture 37B at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion No ns 0.384
Culture 37B at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 37B at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns 0.4463
Culture 37C at 32oC incbuabtion vs. Culture 32A at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 32B at 37oC incbuabtion Yes **** < 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes *** 0.0005
Culture 37C at 32oC incbuabtion vs. Culture 37A at 37oC incbuabtion No ns 0.0721
Culture 37C at 32oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes *** 0.0001
Culture 37C at 32oC incbuabtion vs. Culture 37C at 37oC incbuabtion No ns > 0.9999
Culture 32A at 37oC incbuabtion vs. Culture 32B at 37oC incbuabtion No ns > 0.9999
Culture 32A at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes ** 0.0063
Culture 32A at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 37oC incbuabtion vs. Culture 32C at 37oC incbuabtion Yes * 0.0219
Culture 32B at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32B at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 37oC incbuabtion vs. Culture 37A at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion Yes **** < 0.0001
Culture 32C at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes ** 0.0025
Culture 37A at 37oC incbuabtion vs. Culture 37B at 37oC incbuabtion No ns 0.3038
Culture 37A at 37oC incbuabtion vs. Culture 37C at 37oC incbuabtion Yes * 0.0171









































Tukey's multiple comparisons test Significant? Summary Adjusted P Value
32C Evolved cB72.3 vs. 32C Evolved Enbrel No ns 0.9989
32C Evolved cB72.3 vs. 32C Parental cB72.3 Yes * 0.0284
32C Evolved cB72.3 vs. 32C Parental Enbrel No ns 0.2703
32C Evolved cB72.3 vs. 37C Evolved cB72.3 Yes *** 0.0002
32C Evolved cB72.3 vs. 37C Evolved Enbrel Yes *** 0.0003
32C Evolved cB72.3 vs. 37C Parental cB72.3 No ns 0.5106
32C Evolved cB72.3 vs. 37C Parental Enbrel No ns 0.8263
32C Evolved Enbrel vs. 32C Parental cB72.3 Yes ** 0.0096
32C Evolved Enbrel vs. 32C Parental Enbrel No ns 0.1078
32C Evolved Enbrel vs. 37C Evolved cB72.3 Yes **** < 0.0001
32C Evolved Enbrel vs. 37C Evolved Enbrel Yes *** 0.0001
32C Evolved Enbrel vs. 37C Parental cB72.3 No ns 0.2393
32C Evolved Enbrel vs. 37C Parental Enbrel No ns 0.5106
32C Parental cB72.3 vs. 32C Parental Enbrel No ns 0.8936
32C Parental cB72.3 vs. 37C Evolved cB72.3 No ns 0.2703
32C Parental cB72.3 vs. 37C Evolved Enbrel No ns 0.3405
32C Parental cB72.3 vs. 37C Parental cB72.3 No ns 0.6524
32C Parental cB72.3 vs. 37C Parental Enbrel No ns 0.3405
32C Parental Enbrel vs. 37C Evolved cB72.3 Yes * 0.0284
32C Parental Enbrel vs. 37C Evolved Enbrel Yes * 0.0385
32C Parental Enbrel vs. 37C Parental cB72.3 No ns 0.9996
32C Parental Enbrel vs. 37C Parental Enbrel No ns 0.9605
37C Evolved cB72.3 vs. 37C Evolved Enbrel No ns > 0.9999
37C Evolved cB72.3 vs. 37C Parental cB72.3 Yes * 0.0112
37C Evolved cB72.3 vs. 37C Parental Enbrel Yes ** 0.0038
37C Evolved Enbrel vs. 37C Parental cB72.3 Yes * 0.0153
37C Evolved Enbrel vs. 37C Parental Enbrel Yes ** 0.0051






















Tukey's multiple comparisons test Significant? Summary Adjusted P Value
Evolved cB72.3 vs. Parental cB72.3 Yes * 0.0152
Evolved cB72.3 vs. Evolved Enbrel Yes * 0.0152
Evolved cB72.3 vs. Parental Enbrel Yes **** < 0.0001
Parental cB72.3 vs. Evolved Enbrel Yes *** 0.0002
Parental cB72.3 vs. Parental Enbrel Yes *** 0.0003




























12.19& 5.73& 87.98& 0.00226& Pla2g2a& P31482& UP&
11.61& 5.82& 55.23& 0.001023& Fmod& P50608& UP&
10.34& 4.83& 45.37& 0.002687& Selenbp1& D6RHN2& UP&
8.38& 3.63& 26.89& 0.000921& LOC100753012& #N/A& UP&
8.38& 3.86& 22.97& 0.001947& LOC100771217& #N/A& UP&
10.94& 6.49& 21.89& 0.000946& Col6a1& Q04857& UP&
8.18& 3.87& 19.77& 0.001353& Gnat3& Q3V3I2& UP&






10.77& 6.7& 16.87& 0.000921& I79_011941& #N/A& UP&
8.27& 4.24& 16.37& 0.001353& Arhgap42& B2RQE8& UP&
9.52& 5.51& 16.1& 0.001353& Fgfr2& E9PX60& UP&
11.18& 7.43& 13.42& 0.001023& Odz2& #N/A& UP&
12.1& 8.39& 13.1& 0.000921& Cd36& Q08857& UP&
10.03& 6.45& 11.97& 0.005042& LOC100768488& #N/A& UP&
8.26& 4.78& 11.17& 0.001353& Clcn5& Q8C6W8& UP&
8.6& 5.25& 10.26& 0.002392& Cyp4a14& O35728& UP&
9.54& 6.18& 10.24& 0.001055& Slc38a4& Q9CVZ0& UP&
10.92& 7.63& 9.74& 0.002879& Ulbp1& Q3MI26& UP&
10.52& 7.28& 9.45& 0.001361& Fabp4& Q99M00& UP&
8.49& 5.25& 9.43& 0.002388& LOC100768137& #N/A& UP&
9.04& 5.88& 8.93& 0.002155& Angpt2& #N/A& UP&
9.61& 6.49& 8.7& 0.001954& I79_007854& #N/A& UP&
8.92& 5.81& 8.6& 0.003795& Angpt2& #N/A& UP&
9.71& 6.7& 8.07& 0.001353& Vcam1& Q3UPN1& UP&
9.77& 6.78& 7.94& 0.001432& Gjb5& Q91XA4& UP&
8.73& 5.74& 7.92& 0.002975& Spp1& Q3TLP1& UP&
8.15& 5.17& 7.89& 0.001055& I79_022127& #N/A& UP&
11.11& 8.22& 7.46& 0.001353& Cxcl3& #N/A& UP&
9.6& 6.8& 6.96& 0.001361& Sorl1& O88307& UP&
8.7& 5.91& 6.93& 0.004471& LOC100761143& #N/A& UP&
11.54& 8.76& 6.86& 0.001353& Rbm3& O89086& UP&
8.53& 5.79& 6.68& 0.002148& Slc38a4& Q9CVZ0& UP&
8.21& 5.48& 6.66& 0.001926& Spn& P15702& UP&
12.53& 9.83& 6.5& 0.001353& Ccl7& #N/A& UP&
9.11& 6.42& 6.49& 0.001023& Tmem176a& Q99JK9& UP&
9.79& 7.17& 6.13& 0.00235& Tmem176b& #N/A& UP&
6.53& 3.95& 5.98& 0.002841& LOC100756455& #N/A& UP&
9.87& 7.29& 5.97& 0.000921& LOC100767308& #N/A& UP&
8.96& 6.44& 5.75& 0.00405& LOC100773073& #N/A& UP&
8.8& 6.3& 5.65& 0.003051& Vcam1& Q3UPN1& UP&
9.17& 6.72& 5.44& 0.006887& Cd9& P40240& UP&
8.99& 6.57& 5.37& 0.005809& Cyp4b1& Q64462& UP&
8.86& 6.46& 5.28& 0.001055& Rps6ka2& Q7TPD5& UP&
9& 6.64& 5.13& 0.003372& I79_018773& #N/A& UP&
7.92& 5.59& 5.03& 0.001947& Tcra& P01849& UP&
10.48& 8.15& 5& 0.001055& Gpr133& B2RXV6& UP&
11.8& 9.49& 4.94& 0.002985& Ndrg1& Q545R3& UP&
9.48& 7.2& 4.87& 0.001947& Plet1& Q8VEN2& UP&
8.6& 6.32& 4.83& 0.004524& Pdzrn3& Q3UXA7& UP&
8.21& 5.95& 4.78& 0.002687& Krt7& D3Z6N5& UP&
9.15& 6.91& 4.71& 0.004216& Sema4d& Q8BJC1& UP&




7.47& 5.25& 4.66& 0.002104& I79_010791& #N/A& UP&
7.09& 4.89& 4.59& 0.005969& Faim2& #N/A& UP&
8.39& 6.2& 4.57& 0.006085& C10orf112& #N/A& UP&
8.4& 6.21& 4.55& 0.001551& Pla2g5& P97391& UP&
7.95& 5.78& 4.51& 0.002041& Grhl2& F6TZV3& UP&
8.12& 5.96& 4.45& 0.003& Slpi& P97430& UP&
7.72& 5.57& 4.44& 0.005969& Nedd9& #N/A& UP&
6.98& 4.83& 4.43& 0.002818& Themis& Q8BGW0& UP&
8.22& 6.09& 4.37& 0.00209& Tmcc3& Q8R310& UP&
9.21& 7.1& 4.3& 0.003738& I79_005369& #N/A& UP&
9.14& 7.05& 4.26& 0.002841& Sorl1& O88307& UP&
9.73& 7.67& 4.18& 0.001353& Traf1& P39428& UP&
8.29& 6.24& 4.15& 0.00388& Parvg& Q9ERD8& UP&
9.89& 7.85& 4.13& 0.003125& I79_025705& #N/A& UP&
7.51& 5.51& 4.02& 0.002041& I79_005372& #N/A& UP&
9.47& 7.46& 4.02& 0.00209& I79_018466& #N/A& UP&
6.89& 4.89& 4.02& 0.003103& I79_020126& #N/A& UP&
7.93& 5.93& 4.01& 0.003944& Sertad4& A7DTG3& UP&
9.47& 7.47& 4& 0.001421& Casp12& O08736& UP&
8.04& 6.05& 3.98& 0.004923& Ulbp1& Q3MI26& UP&
7.08& 5.1& 3.95& 0.003221& Myom2& Q14BI5& UP&
7.06& 5.09& 3.92& 0.003162& Ncf1& Q09014& UP&
9.91& 7.94& 3.92& 0.002995& Lmo7& Q3UPW3& UP&
7.93& 5.98& 3.86& 0.009598& I79_018190& #N/A& UP&
9.05& 7.11& 3.83& 0.001907& Lamb3& Q61087& UP&
7.66& 5.73& 3.82& 0.001529& Sorl1& O88307& UP&
9.97& 8.04& 3.8& 0.003009& S100a4& D3YUT9& UP&
6.83& 4.91& 3.79& 0.007005& LOC100757275& #N/A& UP&
8.13& 6.22& 3.78& 0.005448& Pde1c& Q64338& UP&
9.6& 7.72& 3.68& 0.001353& Vnn1& Q9Z0K8& UP&
10.28& 8.4& 3.68& 0.001055& Ca5b& #N/A& UP&
11.65& 9.78& 3.67& 0.001353& Rarres2& Q9DD06& UP&
5.33& 3.46& 3.65& 0.002041& I79_005370& #N/A& UP&
9.1& 7.25& 3.61& 0.001926& Cyp7b1& Q60991& UP&
9.4& 7.55& 3.6& 0.001715& Pglyrp2& A2TJ61& UP&
8.53& 6.7& 3.56& 0.009008& Eml1& Q05BC3& UP&
11.18& 9.37& 3.5& 0.001846& Cxcr7& #N/A& UP&
7.65& 5.85& 3.49& 0.004384& Wisp1& D3Z6X6& UP&
7.45& 5.66& 3.45& 0.00878& Susd1& E9Q3H4& UP&
6.51& 4.74& 3.43& 0.004216& Tnfsf13b& Q8BVA3& UP&
8.14& 6.36& 3.42& 0.001926& Cldn15& Q9Z0S5& UP&
8.38& 6.62& 3.4& 0.002995& Ccrl2& #N/A& UP&
7.72& 5.96& 3.38& 0.006892& I79_017897& #N/A& UP&




7.98& 6.25& 3.32& 0.002041& Tnfsf15& Q5UCC2& UP&
7.82& 6.09& 3.3& 0.001947& LOC100765994& #N/A& UP&
8.63& 6.9& 3.3& 0.005006& Slc11a1& #N/A& UP&
7.51& 5.8& 3.29& 0.005373& Gjb4& Q8C677& UP&
9.99& 8.29& 3.25& 0.001713& I79_001143& #N/A& UP&
7.12& 5.42& 3.23& 0.004246& Sdc2& Q99L05& UP&
8.89& 7.21& 3.21& 0.008768& Muc13& #N/A& UP&
8.54& 6.86& 3.19& 0.002995& Cxcl12& H7BX38& UP&
7.2& 5.58& 3.09& 0.009387& Krt14& #N/A& UP&
7.92& 6.31& 3.05& 0.002392& Fam55d& #N/A& UP&
9.15& 7.57& 3& 0.002639& I79_025704& #N/A& UP&
8.35& 6.77& 2.98& 0.004355& I79_012233& #N/A& UP&
8.94& 7.36& 2.97& 0.009874& Star& P51557& UP&
8.06& 6.5& 2.96& 0.006211& Mab21l3& Q8CI17& UP&
7.63& 6.07& 2.94& 0.002736& Ccl11& #N/A& UP&
9.67& 8.11& 2.94& 0.001353& Sars2& #N/A& UP&
7& 5.46& 2.91& 0.003536& Myo1g& Q5SUA5& UP&
6.92& 5.39& 2.9& 0.003314& Enpp6& Q8BGN3& UP&
7.71& 6.21& 2.83& 0.003503& Cryab& #N/A& UP&
10.22& 8.72& 2.83& 0.001353& Sars2& #N/A& UP&
7.88& 6.38& 2.82& 0.002392& Sulf2& Q8CFG0& UP&
8.25& 6.77& 2.8& 0.004077& I79_021562& #N/A& UP&
9.59& 8.13& 2.75& 0.005927& LOC100763064& #N/A& UP&
8.72& 7.27& 2.73& 0.003757& Ccl17& F6R5P4& UP&
9.21& 7.76& 2.73& 0.003795& Gm12824& #N/A& UP&
7.59& 6.15& 2.72& 0.001684& Ndrg1& Q545R3& UP&
8.53& 7.09& 2.72& 0.00453& I79_006740& #N/A& UP&
10.65& 9.21& 2.71& 0.001715& I79_022735& #N/A& UP&
7.14& 5.71& 2.68& 0.009793& LOC100759235& #N/A& UP&
8.84& 7.47& 2.6& 0.005665& I79_021639& #N/A& UP&
9.52& 8.15& 2.6& 0.008107& LOC100761328& #N/A& UP&
7.12& 5.74& 2.59& 0.008335& Sult1a1& D3Z2P8& UP&
8.14& 6.77& 2.59& 0.005056& Tnfsf15& Q5UCC2& UP&
9.98& 8.61& 2.58& 0.001353& Gcom1& E9PZ54& UP&
9.66& 8.29& 2.58& 0.001353& Ebi3& #N/A& UP&
10.08& 8.71& 2.58& 0.003009& Gm12824& #N/A& UP&
10.21& 8.84& 2.57& 0.001023& Il18& Q80SS8& UP&
8.17& 6.81& 2.56& 0.003372& Pstpip1& P97814& UP&
7.52& 6.17& 2.56& 0.004562& I79_010833& #N/A& UP&
7.73& 6.4& 2.53& 0.003718& Matn4& O89029& UP&
6.77& 5.44& 2.51& 0.007362& Gabrb3& F6WUM4& UP&
10.88& 9.58& 2.46& 0.001353& Smad3& A2CG45& UP&
10.16& 8.87& 2.44& 0.001023& Upb1& Q8VC97& UP&




7.5& 6.23& 2.41& 0.002535& Fbn3& #N/A& UP&
10.06& 8.82& 2.37& 0.001947& Atad3& #N/A& UP&
9.06& 7.81& 2.37& 0.004788& I79_004634& #N/A& UP&
7.34& 6.09& 2.37& 0.005107& Plxna4& #N/A& UP&
7.18& 5.94& 2.36& 0.006469& LOC100757355& #N/A& UP&
7.58& 6.34& 2.36& 0.001023& LOC100768668& #N/A& UP&
9.88& 8.65& 2.35& 0.00687& I79_005883& #N/A& UP&
8.22& 6.99& 2.35& 0.001926& LOC100767926& #N/A& UP&
10.09& 8.88& 2.33& 0.003424& Xlr3a& Q60595& UP&
11.26& 10.05& 2.32& 0.002995& fff& #N/A& UP&
8.1& 6.89& 2.32& 0.003478& Plxna4& #N/A& UP&
6.95& 5.74& 2.31& 0.002841& Mfng& O09008& UP&
8.88& 7.67& 2.31& 0.001575& I79_004393& #N/A& UP&
9.01& 7.8& 2.31& 0.001907& Znf667& #N/A& UP&
9.7& 8.51& 2.29& 0.001023& Retsat& F7CW61& UP&
10.01& 8.81& 2.29& 0.004307& Tomm40& G3UY77& UP&
9.6& 8.41& 2.29& 0.004384& I79_005395& #N/A& UP&
7.69& 6.5& 2.28& 0.002995& Bmpr1b& D6RET5& UP&
8.69& 7.49& 2.28& 0.004292& Pramef12& Q9D2F1& UP&
9.91& 8.73& 2.27& 0.002841& I79_005396& #N/A& UP&
9.15& 7.98& 2.25& 0.001353& Tln2& Q71LX4& UP&
5.99& 4.83& 2.24& 0.003309& Pramef18& #N/A& UP&
10.01& 8.84& 2.24& 0.002407& Prpf31& #N/A& UP&
9.36& 8.2& 2.22& 0.001926& Smg9& Q9DB90& UP&
9.06& 7.9& 2.22& 0.00226& I79_021748& #N/A& UP&
9.66& 8.51& 2.21& 0.002429& Retsat& F7CW61& UP&
8.2& 7.06& 2.21& 0.005185& Env& Q811N5& UP&
7.63& 6.49& 2.2& 0.004477& I79_003704& #N/A& UP&
9.39& 8.25& 2.2& 0.004537& I79_011079& #N/A& UP&
8.64& 7.51& 2.19& 0.003843& Slc39a2& E0CY93& UP&
10.4& 9.27& 2.19& 0.001432& Dhx33& Q80VY9& UP&
6.65& 5.51& 2.19& 0.003769& LOC100758982& #N/A& UP&
6.18& 5.06& 2.17& 0.007242& Sycp3& M0QW86& UP&
7.97& 6.85& 2.17& 0.002995& Gem& Q3U4X4& UP&
7.56& 6.45& 2.17& 0.002292& LOC100756916& #N/A& UP&
8.24& 7.13& 2.17& 0.002995& Pde1b1& #N/A& UP&
6.63& 5.52& 2.16& 0.008329& Abcg1& #N/A& UP&
9.96& 8.86& 2.15& 0.001353& Ldlrap1& Q3TEF2& UP&
10.6& 9.49& 2.15& 0.002995& Kctd20& Q8CDD8& UP&
7.07& 5.97& 2.14& 0.005532& Nnmt& O55239& UP&
9.25& 8.16& 2.12& 0.001904& Abhd6& Q8R2Y0& UP&
8.85& 7.76& 2.12& 0.002887& LOC100771057& #N/A& UP&
8.82& 7.75& 2.11& 0.005006& Gramd1b& D3YWR0& UP&




8.41& 7.33& 2.11& 0.005993& Plxna4& #N/A& UP&
9.46& 8.39& 2.1& 0.00415& Hmgcs2& P54869& UP&
9.96& 8.89& 2.1& 0.004302& I79_001308& #N/A& UP&
8.69& 7.63& 2.09& 0.003474& Slc27a3& B2RUG3& UP&
9.36& 8.29& 2.09& 0.001353& Acsl3& E9PUC2& UP&
6.28& 5.21& 2.09& 0.004965& Ndrg1& Q545R3& UP&
10.99& 9.93& 2.09& 0.001353& Odc1& Q8CIC5& UP&
8.24& 7.18& 2.09& 0.005185& LOC100751789& #N/A& UP&
8.76& 7.71& 2.08& 0.00411& I79_026111& #N/A& UP&
9.24& 8.18& 2.07& 0.001754& Nipsnap3a& B1AWZ3& UP&
7.89& 6.84& 2.07& 0.006015& Vill& D3YZN9& UP&
10.08& 9.03& 2.07& 0.009492& I79_003711& #N/A& UP&
7.85& 6.8& 2.07& 0.001676& I79_017685& #N/A& UP&
6.6& 5.56& 2.06& 0.00474& Enpep& P16406& UP&
8& 6.96& 2.05& 0.001353& Fscn1& F7BDR1& UP&
9.68& 8.65& 2.05& 0.009387& Ahcy& P50247& UP&
7.59& 6.56& 2.05& 0.003331& Arl11& Q6P3A9& UP&
8& 6.96& 2.05& 0.00949& Env& Q811N5& UP&
8& 6.96& 2.05& 0.00949& Env& Q811N5& UP&
9.77& 8.74& 2.05& 0.003467& Mtrr& Q8C1A3& UP&
9.43& 8.4& 2.05& 0.005727& Extl1& Q9JKV7& UP&
9.13& 8.1& 2.04& 0.003816& Pol& P10400& UP&
10.53& 9.51& 2.04& 0.001353& Dusp1& Q3UCQ6& UP&
7.13& 6.1& 2.04& 0.004095& I79_008870& #N/A& UP&
10.1& 9.07& 2.04& 0.007025& I79_026190& #N/A& UP&
7.75& 6.73& 2.03& 0.00388& N4bp2& F8VQG7& UP&
7.89& 6.86& 2.03& 0.002895& Rhoj& Q3TZU6& UP&
11.1& 10.08& 2.03& 0.002995& Ftsj1& Q8JZY1& UP&
11.1& 10.08& 2.03& 0.001432& Trmt6& #N/A& UP&
6.37& 5.35& 2.02& 0.007984& Cyp11a1& Q6NV84& UP&
10.51& 9.49& 2.02& 0.002041& Lrrc1& Q80VQ1& UP&
9.89& 8.88& 2.02& 0.003309& Ppap2b& #N/A& UP&
10.79& 9.78& 2.01& 0.003978& Agpat5& F8WGD9& UP&
8.01& 7.01& 2.01& 0.009746& Angptl4& Q3UYS5& UP&
8.24& 7.23& 2.01& 0.008824& I79_008949& #N/A& UP&
8.76& 7.76& 2& 0.006593& Svil& Q8K4L3& UP&
7.03& 6.03& 2& 0.004216& Aldh1a1& #N/A& UP&
8.65& 7.65& 2& 0.008638& LOC100754972& #N/A& UP&
10.43& 9.43& 2& 0.002879& Slc39a8& #N/A& UP&
9.97& 8.98& 1.98& 0.008209& Serpine1& D0ESZ6& UP&
7.41& 6.43& 1.98& 0.006078& Cacng4& Q9JJV4& UP&
8.48& 7.49& 1.98& 0.007345& I79_023483& #N/A& UP&
6.79& 5.8& 1.98& 0.007908& Serpinb9& #N/A& UP&




9.27& 8.29& 1.97& 0.003604& Tmod2& Q9JKK7& UP&
8.36& 7.38& 1.97& 0.006774& I79_000123& #N/A& UP&
9.05& 8.07& 1.97& 0.007475& Znf540& #N/A& UP&
10.12& 9.15& 1.96& 0.007164& Ada& P03958& UP&
9.98& 9.01& 1.96& 0.005817& Ppcs& #N/A& UP&
11.33& 10.36& 1.95& 0.003005& Serpinb1a& Z4YK03& UP&
8.56& 7.6& 1.94& 0.003718& Lztfl1& Q9JHQ5& UP&
9.36& 8.4& 1.94& 0.00597& Sufu& Q9Z0P7& UP&
7.5& 6.55& 1.94& 0.006426& Plekha7& S4R243& UP&
6& 5.04& 1.94& 0.008826& I79_009161& #N/A& UP&
10.77& 9.82& 1.94& 0.004635& I79_020131& #N/A& UP&
7.5& 6.55& 1.93& 0.007164& Rplp2& P99027& UP&
9.94& 9& 1.93& 0.002597& Mitf& Q3U2D2& UP&
7.85& 6.91& 1.93& 0.008793& I79_021323& #N/A& UP&
10.14& 9.19& 1.92& 0.006887& Nupr1& Q9WTK0& UP&
9.91& 8.97& 1.92& 0.004056& I79_025541& #N/A& UP&
9.02& 8.08& 1.92& 0.003696& Rnf19a& #N/A& UP&
7.86& 6.92& 1.92& 0.006915& Znf227& #N/A& UP&
9.68& 8.75& 1.91& 0.00687& LOC100757283& #N/A& UP&
9.74& 8.82& 1.9& 0.005014& Amdhd2& Q8JZV7& UP&
8.72& 7.8& 1.9& 0.005619& I79_024095& #N/A& UP&
9.66& 8.73& 1.9& 0.005212& Nt5c3l& #N/A& UP&
11.42& 10.5& 1.89& 0.001353& Mthfd2l& D3YZG8& UP&
9.26& 8.34& 1.89& 0.007269& Gls& F6U529& UP&
12.43& 11.51& 1.89& 0.001353& Ppp2r1a& Q76MZ3& UP&
9.11& 8.19& 1.89& 0.002593& Itfg2& Q91WI7& UP&
7.27& 6.35& 1.89& 0.007273& Prelp& Q9JK53& UP&
10.31& 9.4& 1.88& 0.009628& Mthfd2l& D3YZG8& UP&
8.93& 8.02& 1.88& 0.006248& Ikbke& Q8CI55& UP&
11.49& 10.59& 1.87& 0.001353& Gag& Q7M6U4& UP&
10.64& 9.74& 1.87& 0.002867& Sufu& Q9Z0P7& UP&
10.53& 9.63& 1.87& 0.003718& Slc39a8& #N/A& UP&
6.33& 5.44& 1.86& 0.005759& I79_013110& #N/A& UP&
9.83& 8.94& 1.85& 0.005969& Rassf5& D3Z6G2& UP&
6.5& 5.61& 1.85& 0.003414& Aox1& Q3UV07& UP&
7.38& 6.5& 1.85& 0.008727& Col7a1& Q63870& UP&
7.27& 6.38& 1.85& 0.007005& I79_010496& #N/A& UP&
6.99& 6.11& 1.85& 0.002895& I79_022914& #N/A& UP&
8.91& 8.03& 1.85& 0.005651& I79_024051& #N/A& UP&
6.39& 5.5& 1.85& 0.009785& Kiaa1257& #N/A& UP&
9.21& 8.33& 1.84& 0.004363& Ttc38& A3KMP2& UP&
11.09& 10.21& 1.84& 0.004691& Hmox1& P14901& UP&
10.15& 9.27& 1.84& 0.009553& Hps1& Q3U309& UP&




6.77& 5.89& 1.84& 0.00944& Gfra2& Q9Z2A3& UP&
8.77& 7.9& 1.83& 0.003949& Tatdn2& B7ZNL9& UP&
9.68& 8.81& 1.83& 0.003949& Nuak1& F6XZX4& UP&
7.3& 6.43& 1.83& 0.002727& Thbs2& Q7TMT3& UP&
11.39& 10.52& 1.83& 0.000921& Ifrd2& Q7TSB3& UP&
8.85& 7.98& 1.83& 0.002967& Abcb8& Q9CXJ4& UP&
9.43& 8.56& 1.83& 0.001023& Cds1& #N/A& UP&
6.65& 5.77& 1.83& 0.003331& Dnajb3& #N/A& UP&
8.57& 7.7& 1.82& 0.003718& Dnajc25& A2ALW5& UP&
8.79& 7.93& 1.82& 0.003722& Pink1& Q99MQ3& UP&
8.52& 7.66& 1.82& 0.006916& I79_006743& #N/A& UP&
9.4& 8.54& 1.82& 0.006774& I79_023238& #N/A& UP&
7.86& 7& 1.82& 0.003253& I79_026033& #N/A& UP&
10.62& 9.76& 1.81& 0.006785& Scfd2& Q3UXF7& UP&
8.94& 8.09& 1.81& 0.003738& Abcc3& Q59DK8& UP&
10.24& 9.39& 1.81& 0.004151& Rab32& Q9CZE3& UP&
10.97& 10.12& 1.81& 0.008374& I79_020132& #N/A& UP&
7.24& 6.39& 1.81& 0.007396& LOC100763344& #N/A& UP&
10& 9.14& 1.81& 0.008264& LOC100767950& #N/A& UP&
10.44& 9.58& 1.81& 0.005619& Mrps22& #N/A& UP&
10.96& 10.1& 1.81& 0.004495& Pop7& #N/A& UP&
10.72& 9.87& 1.8& 0.002104& Tgfbr2& Q62312& UP&
7.9& 7.05& 1.8& 0.005401& LOC100758541& #N/A& UP&
8.68& 7.83& 1.8& 0.006532& S100a6& #N/A& UP&
10.78& 9.94& 1.79& 0.002392& Lgals3bp& F6VRP8& UP&
10.92& 10.08& 1.79& 0.006448& Eif5& P59325& UP&
10.51& 9.67& 1.79& 0.004128& Sod2& Q3U8W4& UP&
8.19& 7.36& 1.79& 0.00388& LOC100753996& #N/A& UP&
8.9& 8.07& 1.78& 0.005619& Klf4& B7ZCH2& UP&
9.71& 8.88& 1.78& 0.002298& Serpine1& D0ESZ6& UP&
9.04& 8.21& 1.78& 0.001353& Slc16a6& H9KUY0& UP&
9.53& 8.69& 1.78& 0.002985& Wbscr16& Q9CYF5& UP&
8.62& 7.79& 1.78& 0.006211& I79_010035& #N/A& UP&
10.01& 9.17& 1.78& 0.00183& I79_018215& #N/A& UP&
11.08& 10.25& 1.78& 0.005771& Mlf1ip& #N/A& UP&
10.17& 9.34& 1.78& 0.005465& Rabl2a& #N/A& UP&
9.27& 8.44& 1.77& 0.004404& Slc29a3& D6RI95& UP&
7.95& 7.13& 1.77& 0.007908& Gng7& Q3UGN1& UP&
8.96& 8.13& 1.77& 0.003565& St14& Q543E3& UP&
10.18& 9.35& 1.77& 0.00235& Tmem51& Q99LG1& UP&
8.81& 7.99& 1.76& 0.006935& Rchy1& Q8R593& UP&
7.61& 6.79& 1.76& 0.005279& Gas8& #N/A& UP&
6.64& 5.82& 1.76& 0.008608& I79_002907& #N/A& UP&




6.44& 5.63& 1.76& 0.005831& LOC100771615& #N/A& UP&
6.98& 6.17& 1.75& 0.004486& Tfap2c& A2APA8& UP&
9.79& 8.97& 1.75& 0.002392& Cirbp& D3YU80& UP&
11.28& 10.47& 1.75& 0.005131& Tmc4& Q7TQ65& UP&
12.17& 11.36& 1.75& 0.009731& Ppp3ca& Q8C649& UP&
9.59& 8.78& 1.75& 0.002995& Dusp15& Q8R4V2& UP&
10.23& 9.43& 1.75& 0.009517& C1qbp& #N/A& UP&
9.86& 9.05& 1.75& 0.004216& Tsta3& #N/A& UP&
9.42& 8.63& 1.74& 0.001551& Fam120c& B7ZW94& UP&
10.26& 9.46& 1.74& 0.002041& Ercc2& Q3UKK7& UP&
9.61& 8.8& 1.74& 0.002041& Tnfaip3& Q7TQD1& UP&
10.43& 9.63& 1.74& 0.00878& Rpl14& Q9CR57& UP&
9.23& 8.43& 1.74& 0.00163& Oasl& #N/A& UP&
8.51& 7.71& 1.74& 0.003471& Slc15a3& #N/A& UP&
10.7& 9.91& 1.73& 0.005812& Pkn1& D6RH37& UP&
6.95& 6.17& 1.73& 0.009008& Lrrn4& P59383& UP&
7.57& 6.78& 1.73& 0.009969& Rnf122& Q8BP31& UP&
9.25& 8.45& 1.73& 0.006426& Xkr8& Q8C0T0& UP&
9.12& 8.33& 1.73& 0.004101& Zbtb20& Q8CAI3& UP&
9.47& 8.68& 1.73& 0.005138& LOC100766458& #N/A& UP&
9.64& 8.85& 1.72& 0.00338& Guf1& Q8C3X4& UP&
11.47& 10.69& 1.72& 0.001926& Zfp64& Q99KE8& UP&
10.49& 9.71& 1.72& 0.002995& Trip13& #N/A& UP&
9.31& 8.53& 1.71& 0.002801& Rnd3& E9Q8D7& UP&
9.33& 8.56& 1.71& 0.004677& Unc5b& Q3TYW6& UP&
13.12& 12.35& 1.71& 0.005052& Sprr1a& Q62266& UP&
11.51& 10.74& 1.71& 0.002392& Tfdp2& Q8BHD2& UP&
9.8& 9.03& 1.71& 0.00944& Ndufb3& Q9CQZ6& UP&
6.59& 5.81& 1.71& 0.009114& I79_009605& #N/A& UP&
9.25& 8.48& 1.7& 0.005532& Nfatc1& Q6P7T9& UP&
11.63& 10.87& 1.7& 0.005213& Ppp3ca& Q8C649& UP&
10.51& 9.75& 1.7& 0.008257& Exosc10& Q8K366& UP&
9.22& 8.45& 1.7& 0.004721& Pdss1& Q9CZQ1& UP&
9.83& 9.06& 1.7& 0.001926& Cdc42se2fA& #N/A& UP&
10.58& 9.82& 1.69& 0.007412& Tspan9& D3YU98& UP&
7.74& 6.98& 1.69& 0.009983& Wisp1& D3Z6X6& UP&
9.33& 8.57& 1.69& 0.007164& Mns1& Q61884& UP&
10.4& 9.64& 1.69& 0.007005& Tpm1& Q8BSH3& UP&
7.6& 6.85& 1.69& 0.007472& Ptprt& Q99M80& UP&
10.64& 9.89& 1.69& 0.005006& Clptm1& #N/A& UP&
9.14& 8.38& 1.69& 0.008121& Fbxo4& #N/A& UP&
9.25& 8.49& 1.69& 0.007039& I79_006856& #N/A& UP&
9.31& 8.56& 1.69& 0.005014& I79_023554& #N/A& UP&




7.03& 6.27& 1.69& 0.004246& LOC100774241& #N/A& UP&
7.7& 6.95& 1.68& 0.009649& Plekha2& D3Z3L8& UP&
8.56& 7.82& 1.68& 0.003331& Limk2& O54785& UP&
8.85& 8.1& 1.68& 0.005552& Tgfbr1& Q64729& UP&
7.78& 7.04& 1.68& 0.008799& Dtx4& Q6PDK8& UP&
12.03& 11.28& 1.68& 0.00338& Hprt1& #N/A& UP&
10.78& 10.04& 1.67& 0.001353& Vtn& P29788& UP&
8.84& 8.1& 1.67& 0.004611& Trub2& Q91WG3& UP&
7.18& 6.45& 1.67& 0.006785& Btbd17& Q9DB72& UP&
8.55& 7.81& 1.67& 0.007462& Xpa& S4R260& UP&
11.14& 10.4& 1.67& 0.005373& I79_007599& #N/A& UP&
8.96& 8.23& 1.66& 0.005185& Polr1e& G8JL51& UP&
9.36& 8.63& 1.66& 0.005868& Slc4a2& Q7TPS4& UP&
10.52& 9.79& 1.66& 0.009755& Tbl3& Q8C4J7& UP&
10.66& 9.93& 1.66& 0.002841& Phf20l1& Q8CCJ9& UP&
7.24& 6.51& 1.66& 0.007861& Morn1& Q9D5M3& UP&
9.12& 8.38& 1.66& 0.001981& Sepf03& #N/A& UP&
10.03& 9.3& 1.66& 0.004371& fff& #N/A& UP&
8.91& 8.18& 1.66& 0.003718& LOC100751805& #N/A& UP&
11.47& 10.74& 1.65& 0.003718& Cxcl1& Q5U5W9& UP&
8.84& 8.12& 1.65& 0.004302& Oscp1& Q8BHW2& UP&
7.59& 6.87& 1.65& 0.008969& Notch1& Q8BY39& UP&
11.02& 10.29& 1.65& 0.007271& Fam113a& #N/A& UP&
8.38& 7.67& 1.64& 0.009438& Prss35& Q8C0F9& UP&
10.81& 10.1& 1.64& 0.009236& Ncln& Q8VCM8& UP&
7.3& 6.59& 1.64& 0.006183& Add2& Q9QYB8& UP&
7.68& 6.97& 1.64& 0.007164& Dnah11& #N/A& UP&
9.13& 8.41& 1.64& 0.004234& Trdmt1& #N/A& UP&
9.02& 8.32& 1.63& 0.002967& Ccdc61& F6XT04& UP&
10.6& 9.89& 1.63& 0.00689& Sh3bp5l& Q3TK15& UP&
9.68& 8.97& 1.63& 0.00599& Slc43a2& Q5ND23& UP&
9.17& 8.46& 1.63& 0.001904& Lrrc1& Q80VQ1& UP&
7.18& 6.47& 1.63& 0.003894& Me3& Q8BMF3& UP&
9.13& 8.43& 1.63& 0.007122& fff& #N/A& UP&
11.54& 10.83& 1.63& 0.005014& Cyr61& #N/A& UP&
10.64& 9.93& 1.63& 0.004577& I79_003401& #N/A& UP&
8.07& 7.36& 1.63& 0.004307& I79_014351& #N/A& UP&
8.66& 7.95& 1.63& 0.007942& LOC100768576& #N/A& UP&
8.72& 8.02& 1.62& 0.005151& Rbmx& A2AFI4& UP&
10.4& 9.7& 1.62& 0.004018& Eci2& E9PUY9& UP&
12.12& 11.42& 1.62& 0.003009& Dcn& P28654& UP&
11.7& 11& 1.62& 0.007382& Ncl& Q3TGR3& UP&
9.16& 8.47& 1.62& 0.001575& Lig1& Q3U4X8& UP&




8.98& 8.29& 1.62& 0.00388& Hsd3b7& Q9EQC1& UP&
8.44& 7.75& 1.62& 0.00439& LOC100752900& #N/A& UP&
8.8& 8.11& 1.62& 0.005619& LOC100765957& #N/A& UP&
8.47& 7.77& 1.62& 0.00878& Map3k6& #N/A& UP&
7.09& 6.4& 1.61& 0.005361& Glb1l2& Q3UPY5& UP&
9.5& 8.81& 1.61& 0.002818& Brd9& Q3UQU0& UP&
7.76& 7.07& 1.61& 0.003816& Klhdc9& Q3USL1& UP&
11.01& 10.32& 1.61& 0.00436& Trim28& Q5EBP9& UP&
7.63& 6.95& 1.61& 0.009175& Col7a1& Q63870& UP&
9.82& 9.14& 1.61& 0.00884& Sympk& Q80X82& UP&
8.13& 7.44& 1.61& 0.00561& Mxd1& Q8K1Z8& UP&
9.3& 8.61& 1.61& 0.004216& Aagab& Q8R2R3& UP&
9.65& 8.97& 1.61& 0.001926& Commd5& Q8R395& UP&
10.79& 10.1& 1.61& 0.001353& Lrrc49& Q91YK0& UP&
6.81& 6.13& 1.61& 0.006731& I79_010008& #N/A& UP&
8.47& 7.78& 1.61& 0.005477& LOC100765978& #N/A& UP&
9.94& 9.26& 1.6& 0.002429& Vegfa& F8WH10& UP&
8.29& 7.61& 1.6& 0.008551& Mitf& Q3U2D2& UP&
10.12& 9.43& 1.6& 0.005783& Vps33a& Q80XK7& UP&
8.33& 7.65& 1.6& 0.00993& Xrcc6bp1& Q9CWQ3& UP&
11.01& 10.34& 1.6& 0.005889& Adh5& #N/A& UP&
7.46& 6.79& 1.6& 0.00899& Hmgn4& #N/A& UP&
10.58& 9.9& 1.6& 0.009956& I79_000422& #N/A& UP&
9.92& 9.24& 1.6& 0.004677& I79_002600& #N/A& UP&
10.5& 9.83& 1.6& 0.001353& I79_010093& #N/A& UP&
9.27& 8.6& 1.6& 0.004124& Mettl19& #N/A& UP&
9.27& 8.59& 1.6& 0.007124& Nom1& #N/A& UP&
10.08& 9.4& 1.59& 0.004542& Atp6v1g2& B0V2H4& UP&
6.82& 6.15& 1.59& 0.006629& Loxl2& P58022& UP&
11.77& 11.1& 1.59& 0.003718& Bcl10& Q3THY9& UP&
9.53& 8.86& 1.59& 0.003962& Znf419& #N/A& UP&
10.23& 9.57& 1.58& 0.002324& Wdr12& D3Z369& UP&
11.19& 10.53& 1.58& 0.003853& Kcnab2& Q3UPV6& UP&
9.92& 9.26& 1.58& 0.007931& Rnf187& Q8BFX1& UP&
10.28& 9.62& 1.58& 0.005552& Osbpl2& Q8BX94& UP&
10.08& 9.43& 1.58& 0.00388& Aco1& Q8VDC3& UP&
8.57& 7.92& 1.58& 0.009028& I79_016913& #N/A& UP&
8.89& 8.23& 1.58& 0.004611& I79_022183& #N/A& UP&
10.67& 10.01& 1.58& 0.001551& Ppp6r1& #N/A& UP&
10.6& 9.95& 1.57& 0.001715& Cpped1& D3Z7F7& UP&
8.98& 8.32& 1.57& 0.00762& Rad54b& Q6PFE3& UP&
9.05& 8.4& 1.57& 0.003584& Fam116a& #N/A& UP&
7.93& 7.28& 1.57& 0.005969& I79_000228& #N/A& UP&




10.81& 10.16& 1.57& 0.006056& Rg9mtd2& #N/A& UP&
10.05& 9.42& 1.56& 0.004077& Dab2ip& D6RDE3& UP&
9.78& 9.13& 1.56& 0.007047& Ptprg& Q05909& UP&
10.92& 10.28& 1.56& 0.003718& Ppp2r1b& Q7TNP2& UP&
10.29& 9.65& 1.56& 0.002879& Samm50& Q8BGH2& UP&
6.07& 5.43& 1.56& 0.007124& Metap1& Q8BP48& UP&
10.77& 10.13& 1.56& 0.002606& Acsl4& Q8BW44& UP&
10.22& 9.58& 1.56& 0.004923& Tmem51& Q99LG1& UP&
7.99& 7.34& 1.56& 0.003949& Fiz1& Q9WTJ4& UP&
7.63& 6.99& 1.56& 0.006312& I79_001976& #N/A& UP&
12.07& 11.42& 1.56& 0.00235& I79_016573& #N/A& UP&
9.37& 8.73& 1.55& 0.008727& Loxl4& E9Q600& UP&
8.14& 7.51& 1.55& 0.004404& Figf& Q6P5N9& UP&
10.94& 10.31& 1.55& 0.004225& Pak1ip1& Q9DCE5& UP&
10.45& 9.82& 1.55& 0.006593& Dnajc15& #N/A& UP&
7.91& 7.27& 1.55& 0.007164& Gpr182& #N/A& UP&
10.72& 10.09& 1.55& 0.00474& I79_003196& #N/A& UP&
9.79& 9.15& 1.55& 0.002789& I79_024530& #N/A& UP&
9.84& 9.21& 1.55& 0.003002& Kiaa0664& #N/A& UP&
7.84& 7.21& 1.55& 0.002041& LOC100756814& #N/A& UP&
8.88& 8.25& 1.55& 0.008295& Rp2& #N/A& UP&
9.51& 8.88& 1.54& 0.008824& Med22& A2ALA4& UP&
9.59& 8.97& 1.54& 0.003795& Arrdc3& E0CZE1& UP&
9.34& 8.72& 1.54& 0.009792& Foxred1& Q3TQB2& UP&
9.77& 9.15& 1.54& 0.005783& Cerk& Q8K4Q7& UP&
10.2& 9.58& 1.54& 0.007222& I79_020563& #N/A& UP&
8.46& 7.83& 1.54& 0.005766& LOC100750991& #N/A& UP&
11.29& 10.67& 1.54& 0.001353& LOC100761050& #N/A& UP&
9.08& 8.46& 1.53& 0.004542& Farp1& F8VPU2& UP&
10.26& 9.65& 1.53& 0.005666& Yars& Q91WQ3& UP&
11.17& 10.55& 1.53& 0.004943& Jub& #N/A& UP&
9.64& 9.03& 1.53& 0.006697& LOC100770476& #N/A& UP&
9.01& 8.39& 1.53& 0.003718& Tbc1d2& #N/A& UP&
13.55& 12.95& 1.52& 0.005918& Hspb1& D3YZ06& UP&
9.81& 9.21& 1.52& 0.007782& Elof1& P60003& UP&
9.58& 8.98& 1.52& 0.009637& Irs2& P81122& UP&
10.48& 9.88& 1.52& 0.004471& Tank& Q05BS9& UP&
9.67& 9.06& 1.52& 0.002392& Wdr36& Q3TAQ9& UP&
9.98& 9.37& 1.52& 0.00388& Slc35c2& Q5GMG8& UP&
11.22& 10.62& 1.52& 0.002995& Ift46& Q9DB07& UP&
8.7& 8.09& 1.52& 0.00543& I79_007182& #N/A& UP&
10.66& 10.05& 1.52& 0.008521& Slc29a2& #N/A& UP&
8.65& 8.05& 1.51& 0.005868& Slc12a9& D3Z362& UP&




10.53& 9.94& 1.51& 0.004302& Nsun2& H3BJF3& UP&
10.22& 9.62& 1.51& 0.003051& Dnajb14& Q149L6& UP&
9.34& 8.75& 1.51& 0.007925& Sptlc1& Q3V3A0& UP&
8.08& 7.48& 1.51& 0.006887& Rdh13& Q8CEE7& UP&
10.39& 9.8& 1.51& 0.008976& Spns1& Q8R0G7& UP&
9.24& 8.64& 1.51& 0.002995& Rrp7a& Q9D1C9& UP&
7.9& 7.31& 1.51& 0.009587& I79_007740& #N/A& UP&
7.7& 7.1& 1.51& 0.009151& I79_012054& #N/A& UP&
11.03& 10.44& 1.51& 0.007345& I79_014221& #N/A& UP&
9.71& 9.11& 1.51& 0.001551& Znf703& #N/A& UP&
6.26& 5.67& 1.5& 0.009094& Lrit3& J3QNQ8& UP&
9.96& 9.37& 1.5& 0.009258& Ets2& P15037& UP&
9.98& 9.39& 1.5& 0.003372& Fig4& Q3TA31& UP&
8.5& 7.92& 1.5& 0.005532& Xpnpep2& Q8BU59& UP&
10.59& 10& 1.5& 0.003331& Ak2& Q9WTP6& UP&
9.52& 8.93& 1.5& 0.0067& I79_011118& #N/A& UP&
9.36& 8.79& 1.49& 0.00837& Nmi& O35309& UP&
7.14& 6.56& 1.49& 0.005532& Mt2& P02798& UP&
8.66& 8.08& 1.49& 0.006968& Rad50& P70388& UP&
10.67& 10.09& 1.49& 0.002463& Mcrs1& Q3TJY1& UP&
9.17& 8.6& 1.49& 0.006211& Rps6ka1& Q505N6& UP&
9.08& 8.5& 1.49& 0.00411& Tia1& Q80ZW7& UP&
7.08& 6.51& 1.49& 0.008852& Gk5& Q8BX05& UP&
7.72& 7.14& 1.49& 0.001216& Slmo2& Q9CYY7& UP&
8.54& 7.97& 1.49& 0.007164& I79_004695& #N/A& UP&
9.87& 9.3& 1.49& 0.007164& Prss27& #N/A& UP&
9.53& 8.97& 1.48& 0.007914& Pih1d1& D3Z026& UP&
10.08& 9.52& 1.48& 0.008209& Acsl1& D3Z457& UP&
6.97& 6.41& 1.48& 0.005014& Ank3& G5E8K5& UP&
11.67& 11.11& 1.48& 0.004914& Rae1& Q6PAS9& UP&
9.53& 8.97& 1.48& 0.008557& Ccdc23& Q99LQ4& UP&
6.3& 5.73& 1.48& 0.009279& Rnase6& Q9D244& UP&
11.71& 11.15& 1.48& 0.001947& Ak2& Q9WTP6& UP&
8.24& 7.67& 1.48& 0.008042& Sfrp4& Q9Z1N6& UP&
9.38& 8.82& 1.48& 0.002343& Kiaa0664& #N/A& UP&
9.07& 8.5& 1.48& 0.009753& LOC100755981& #N/A& UP&
7.95& 7.39& 1.48& 0.009175& LOC100765287& #N/A& UP&
9.9& 9.35& 1.47& 0.002372& Zcchc24& B2RVL6& UP&
7.19& 6.64& 1.47& 0.007164& Ebf4& B7ZNC0& UP&
10.68& 10.12& 1.47& 0.002567& Cyb5r4& G3UY26& UP&
10.03& 9.48& 1.47& 0.006621& Adal& Q80SY6& UP&
9.75& 9.2& 1.47& 0.009682& Pbx1& Q8BFR8& UP&
9.07& 8.51& 1.47& 0.006795& Pole3& Q9JKP7& UP&




9.41& 8.85& 1.47& 0.003467& LOC100763895& #N/A& UP&
10.25& 9.69& 1.47& 0.003503& LOC100765870& #N/A& UP&
10.21& 9.66& 1.47& 0.006887& Mlst8& #N/A& UP&
9.85& 9.3& 1.47& 0.006477& Nop14& #N/A& UP&
8.89& 8.33& 1.47& 0.006584& Selrc1& #N/A& UP&
9.85& 9.3& 1.46& 0.001575& Rhbdd2& D6RCZ4& UP&
10.94& 10.4& 1.46& 0.002392& Ppip5k2& E9Q9J4& UP&
9.15& 8.6& 1.46& 0.009604& Nsd1& O88491& UP&
9.97& 9.42& 1.46& 0.005138& Casp8& O89110& UP&
10.07& 9.52& 1.46& 0.005373& Zhx2& Q3TZR8& UP&
8.62& 8.07& 1.46& 0.008042& Fbxo25& Q3UYF5& UP&
8.47& 7.92& 1.46& 0.009439& Arl9& Q6IMB2& UP&
9.66& 9.11& 1.46& 0.005727& Rufy2& Q8BR30& UP&
10.58& 10.04& 1.46& 0.007833& Gas2l1& Q8JZP9& UP&
9.01& 8.47& 1.46& 0.009638& Nav1& Q8K1B1& UP&
8.57& 8.02& 1.46& 0.007524& Klhl36& Q8R124& UP&
10.17& 9.62& 1.46& 0.002521& Rilpl2& Q99LE1& UP&
10.74& 10.2& 1.46& 0.003718& Drg2& Q9QXB9& UP&
9.86& 9.31& 1.46& 0.008163& fff& #N/A& UP&
9.32& 8.77& 1.46& 0.009992& Actr2& #N/A& UP&
8.73& 8.19& 1.46& 0.005825& Antxr1& #N/A& UP&
9.64& 9.1& 1.46& 0.00643& Eepd1& #N/A& UP&
11.99& 11.45& 1.46& 0.0091& Hnrnpab& #N/A& UP&
6.5& 5.95& 1.46& 0.007336& I79_003590& #N/A& UP&
9.95& 9.4& 1.46& 0.009688& LOC100756440& #N/A& UP&
6.43& 5.89& 1.46& 0.00687& LOC100766020& #N/A& UP&
8.56& 8.01& 1.46& 0.007122& LOC100767137& #N/A& UP&
10.73& 10.18& 1.46& 0.009846& LOC100774657& #N/A& UP&
9.8& 9.26& 1.45& 0.001421& Prkcd& Q1MX42& UP&
11.27& 10.73& 1.45& 0.002856& Dhx9& Q3TEB2& UP&
8.69& 8.15& 1.45& 0.008264& Abcd2& Q3TU16& UP&
10.65& 10.11& 1.45& 0.005727& Bclaf1& Q3UDL9& UP&
9.34& 8.8& 1.45& 0.001676& Ercc2& Q3UKK7& UP&
8.67& 8.13& 1.45& 0.005392& Gad2& Q3URJ3& UP&
11.47& 10.94& 1.45& 0.007396& Bola3& Q8CEI1& UP&
10.78& 10.24& 1.45& 0.005052& Higd2a& Q9CQJ1& UP&
6.56& 6.03& 1.45& 0.002995& C1ql3& #N/A& UP&
8.79& 8.25& 1.45& 0.001954& Dcaf13& #N/A& UP&
8.41& 7.87& 1.45& 0.006915& Dmap1& #N/A& UP&
12.04& 11.51& 1.44& 0.0067& Eif6& D6RJJ3& UP&
12.17& 11.64& 1.44& 0.00523& Eif5& P59325& UP&
10.27& 9.74& 1.44& 0.002635& Gnb5& P62881& UP&
8.15& 7.62& 1.44& 0.0067& Atg16l1& Q3TQX8& UP&




8.63& 8.11& 1.44& 0.00565& Sdcbp2& Q99JZ0& UP&
10.46& 9.93& 1.44& 0.003415& I79_007848& #N/A& UP&
10.7& 10.18& 1.43& 0.006915& Glul& D3YVK1& UP&
8.61& 8.09& 1.43& 0.00481& Fam198b& D3YXF7& UP&
9.5& 8.99& 1.43& 0.007124& Dtx3l& I6L9G8& UP&
10.43& 9.92& 1.43& 0.008969& Pmm1& O35621& UP&
11.85& 11.33& 1.43& 0.00474& F2r& Q3UK34& UP&
9.68& 9.17& 1.43& 0.006597& Kiaa1551& Q5DTW7& UP&
8.03& 7.52& 1.43& 0.00388& Tpp2& Q64514& UP&
8.53& 8.01& 1.43& 0.006887& Commd10& Q8JZY2& UP&
10.77& 10.25& 1.43& 0.005006& C15orf44& #N/A& UP&
10.55& 10.03& 1.43& 0.004324& Gpam& #N/A& UP&
12.04& 11.53& 1.43& 0.006282& I79_018556& #N/A& UP&
8.58& 8.07& 1.43& 0.008542& I79_023830& #N/A& UP&
6.78& 6.26& 1.43& 0.006822& LOC100760249& #N/A& UP&
9.5& 8.99& 1.42& 0.008007& Dock11& A2AF65& UP&
10.35& 9.84& 1.42& 0.005014& Lrrfip1& A6H5U5& UP&
11.21& 10.7& 1.42& 0.006406& Glul& D3YVK1& UP&
5.43& 4.92& 1.42& 0.009397& Rsad2& D6RJ49& UP&
11.02& 10.52& 1.42& 0.004055& Ddx46& Q05C73& UP&
10.38& 9.87& 1.42& 0.008204& Apbb1ip& Q3TS23& UP&
12.16& 11.65& 1.42& 0.00672& Slc6a6& Q8BRX2& UP&
8.35& 7.85& 1.42& 0.009258& Hoxa9& #N/A& UP&
7.63& 7.13& 1.42& 0.002372& I79_002910& #N/A& UP&
12.91& 12.41& 1.42& 0.002392& I79_013057& #N/A& UP&
9.02& 8.51& 1.42& 0.005138& Mmp23& #N/A& UP&
9.45& 8.95& 1.42& 0.008638& Slc12a7& #N/A& UP&
10.13& 9.62& 1.42& 0.002817& Tns3& #N/A& UP&
10.02& 9.53& 1.41& 0.008783& Tspan17& E9PWC3& UP&
9.15& 8.65& 1.41& 0.002428& Hfe& F7CW53& UP&
9.41& 8.91& 1.41& 0.008547& Mfn2& Q3TEX7& UP&
11.33& 10.84& 1.41& 0.006935& Noc2l& Q3UZI6& UP&
11.27& 10.78& 1.41& 0.004065& Eif4ebp1& Q60876& UP&
8.22& 7.72& 1.41& 0.006532& Gmppb& Q8BTZ7& UP&
11.28& 10.79& 1.41& 0.002995& Arrb1& Q8BWG8& UP&
7.61& 7.12& 1.41& 0.008638& Rgs3& Q9DC04& UP&
11.3& 10.81& 1.41& 0.002392& 40797& #N/A& UP&
10.81& 10.32& 1.41& 0.003718& Derp6& #N/A& UP&
10.12& 9.63& 1.41& 0.002967& Eif3e& #N/A& UP&
7.2& 6.7& 1.41& 0.009638& I79_000205& #N/A& UP&
7.25& 6.75& 1.41& 0.004442& I79_010716& #N/A& UP&
7.25& 6.75& 1.41& 0.004442& I79_010717& #N/A& UP&
7.25& 6.75& 1.41& 0.004442& I79_010718& #N/A& UP&




10.76& 10.28& 1.4& 0.006482& Dnajc7& Q3UL32& UP&
9.62& 9.13& 1.4& 0.003738& Mapkapk3& Q3UMW7& UP&
8.22& 7.73& 1.4& 0.009279& Efnb2& Q3V1E0& UP&
10.76& 10.28& 1.4& 0.004302& Cyp20a1& Q8BKE6& UP&
8.74& 8.25& 1.4& 0.006249& Afap1& Q8BV31& UP&
9.83& 9.34& 1.4& 0.007687& Dock8& Q8C147& UP&
8.83& 8.35& 1.4& 0.004713& Phf20l1& Q8CCJ9& UP&
10.16& 9.67& 1.4& 0.005969& Mospd1& Q8VEL0& UP&
9.48& 8.99& 1.4& 0.003936& Wdr6& Q99ME2& UP&
11.35& 10.86& 1.4& 0.006457& Icmt& Q9EQK7& UP&
10.35& 9.86& 1.4& 0.00762& fff& #N/A& UP&
7.58& 7.09& 1.4& 0.003894& Asap3& #N/A& UP&
10.42& 9.93& 1.4& 0.008783& I79_005240& #N/A& UP&
10.19& 9.7& 1.4& 0.007596& I79_005741& #N/A& UP&
7.89& 7.4& 1.4& 0.009731& LOC100758600& #N/A& UP&
9.09& 8.61& 1.4& 0.003191& Samd9& #N/A& UP&
9.53& 9.05& 1.39& 0.005138& Zfand2a& D3YUL0& UP&
10.29& 9.82& 1.39& 0.00982& Dnttip1& F7B2G8& UP&
8.99& 8.51& 1.39& 0.008083& Tor2a& P0C7W3& UP&
9.33& 8.86& 1.39& 0.005532& Parp16& Q7TMM8& UP&
7.62& 7.15& 1.39& 0.007717& Qrfp& Q8CE23& UP&
10.12& 9.65& 1.39& 0.009198& Tmbim4& Q8K191& UP&
7.95& 7.47& 1.39& 0.008783& Nle1& Q8VEJ4& UP&
10.5& 10.02& 1.39& 0.006774& Etfa& Q99LC5& UP&
7.77& 7.3& 1.39& 0.005929& Mageh1& Q9NWG9& UP&
10.93& 10.46& 1.39& 0.004677& Prosc& Q9Z2Y8& UP&
12.12& 11.65& 1.39& 0.005053& Csrp1& #N/A& UP&
7.63& 7.16& 1.39& 0.009874& I79_013164& #N/A& UP&
9.51& 9.04& 1.39& 0.009008& Ift27& #N/A& UP&
10.39& 9.92& 1.39& 0.003098& Mthfd1l& #N/A& UP&
11.39& 10.92& 1.38& 0.005812& Atic& B0LAC5& UP&
11.21& 10.75& 1.38& 0.007005& Aifm1& B1AU25& UP&
8.99& 8.53& 1.38& 0.007164& Rpsa& B2CY77& UP&
8.83& 8.37& 1.38& 0.007596& Blnk& D3YWR2& UP&
9.31& 8.85& 1.38& 0.007285& Gpd1l& D3Z0L6& UP&
9.28& 8.82& 1.38& 0.008465& Spsb3& D6RI75& UP&
9.84& 9.38& 1.38& 0.00313& Por& P37040& UP&
8.1& 7.63& 1.38& 0.00543& Rpl30& P62889& UP&
9.33& 8.87& 1.38& 0.00878& Urod& P70697& UP&
10.03& 9.56& 1.38& 0.009741& Anapc4& Q3TI31& UP&
8.85& 8.39& 1.38& 0.005377& Tnfaip2& Q61333& UP&
6.93& 6.47& 1.38& 0.006527& Nudt13& Q8JZU0& UP&
8.84& 8.38& 1.38& 0.009846& Toe1& Q9D2E2& UP&




10.36& 9.89& 1.38& 0.003497& Epdr1& #N/A& UP&
9.06& 8.6& 1.38& 0.00481& Gtf3c3& #N/A& UP&
6.75& 6.29& 1.38& 0.008952& I79_000241& #N/A& UP&
8.97& 8.51& 1.38& 0.003438& Zfp112& #N/A& UP&
9.78& 9.33& 1.37& 0.005184& Atg9a& A1A4C2& UP&
8.86& 8.41& 1.37& 0.004677& Rnf19b& B2KG08& UP&
9.05& 8.6& 1.37& 0.003718& Sash1& P59808& UP&
10.28& 9.83& 1.37& 0.0067& Nfyc& P70353& UP&
10.45& 9.99& 1.37& 0.007596& Tle3& Q3TY99& UP&
10.39& 9.93& 1.37& 0.009537& Taf5l& Q3U3C7& UP&
10.13& 9.67& 1.37& 0.009074& Cops5& Q3V0K7& UP&
9.95& 9.5& 1.37& 0.002841& Ptprm& Q3V3S2& UP&
9.93& 9.47& 1.37& 0.001715& Tnfrsf1b& Q545P4& UP&
9.38& 8.93& 1.37& 0.008763& Paqr3& Q6TCG8& UP&
9.36& 8.91& 1.37& 0.006697& Strada& Q80VZ9& UP&
9.41& 8.96& 1.37& 0.008257& Napg& Q8C1T5& UP&
12.27& 11.81& 1.37& 0.007242& Asf1b& Q9DAP7& UP&
11.56& 11.11& 1.37& 0.0091& Eif2s3& #N/A& UP&
6.37& 5.92& 1.37& 0.00643& LOC100762746& #N/A& UP&
7.68& 7.22& 1.37& 0.005138& LOC100771985& #N/A& UP&
8.31& 7.85& 1.37& 0.008952& Mtg1& #N/A& UP&
8.95& 8.5& 1.37& 0.006887& Trmt61a& #N/A& UP&
11.02& 10.58& 1.36& 0.001713& Kctd17& F7C1U0& UP&
12.5& 12.05& 1.36& 0.009436& Hdac1& O09106& UP&
9.31& 8.87& 1.36& 0.007412& Alad& O89061& UP&
12.06& 11.62& 1.36& 0.007391& Idh3g& P70404& UP&
11.58& 11.14& 1.36& 0.00715& Pes1& Q5SQ20& UP&
9.48& 9.04& 1.36& 0.008326& Stx16& Q8BVI5& UP&
10.31& 9.86& 1.36& 0.005138& Pdcd6& Q8C5M4& UP&
10.76& 10.32& 1.36& 0.005212& Gnl2& Q99LH1& UP&
10.94& 10.5& 1.36& 0.005783& Abhd5& Q9DBL9& UP&
9.17& 8.72& 1.36& 0.009992& Cyp2d10& #N/A& UP&
10.47& 10.02& 1.36& 0.005927& Ezr& #N/A& UP&
10.34& 9.89& 1.36& 0.007465& Lmf2& #N/A& UP&
8.76& 8.32& 1.36& 0.003821& LOC100755470& #N/A& UP&
9.67& 9.23& 1.36& 0.009983& Snx18& #N/A& UP&
9.35& 8.9& 1.36& 0.005249& Snx33& #N/A& UP&
8.26& 7.83& 1.35& 0.006482& Ino80b& D6RES5& UP&
7.5& 7.06& 1.35& 0.004376& Tmem222& D6RIQ5& UP&
10.02& 9.59& 1.35& 0.009279& Adsl& E9Q0A0& UP&
11.07& 10.64& 1.35& 0.007933& Rpa2& F6V8R7& UP&
10.74& 10.3& 1.35& 0.002305& Fus& P56959& UP&
9.52& 9.09& 1.35& 0.006928& Pqlc2& Q8C4N4& UP&




7.98& 7.54& 1.35& 0.003051& Cenpb& Q923C5& UP&
8.99& 8.56& 1.35& 0.008969& Prpf18& Q9CYU9& UP&
10.98& 10.54& 1.35& 0.003971& fff& #N/A& UP&
8.25& 7.82& 1.35& 0.002041& Agphd1& #N/A& UP&
10.2& 9.77& 1.35& 0.006429& I79_006544& #N/A& UP&
11.63& 11.19& 1.35& 0.009286& I79_026128& #N/A& UP&
10.58& 10.16& 1.34& 0.007672& Tcf25& B2ZAC8& UP&
6.31& 5.88& 1.34& 0.00183& Zan& O88799& UP&
10.37& 9.95& 1.34& 0.004542& Slc19a1& P41438& UP&
8.92& 8.5& 1.34& 0.007251& Sap25& Q1EHW4& UP&
8.98& 8.56& 1.34& 0.009279& Traf3& Q3UHJ1& UP&
10.05& 9.64& 1.34& 0.008209& Tmem164& Q6PHN7& UP&
9.25& 8.83& 1.34& 0.002392& Sdad1& Q80UZ2& UP&
8.59& 8.16& 1.34& 0.00743& Tmem161b& Q8C2L6& UP&
11.17& 10.75& 1.34& 0.009131& Arhgef6& Q8K4I3& UP&
10.41& 9.99& 1.34& 0.004216& Ankrd10& Q99LW0& UP&
9.41& 8.99& 1.34& 0.002995& Tbc1d7& Q9D0K0& UP&
11.21& 10.78& 1.34& 0.005056& Ppih& Q9D868& UP&
8.6& 8.18& 1.34& 0.005731& Arhgef40& S4R1Y4& UP&
10.73& 10.3& 1.34& 0.005588& fff& #N/A& UP&
9.19& 8.77& 1.34& 0.008933& Fam204a& #N/A& UP&
8.68& 8.26& 1.34& 0.005373& LOC100757796& #N/A& UP&
8.34& 7.93& 1.34& 0.009541& Nadkd1& #N/A& UP&
9.21& 8.79& 1.34& 0.008925& Nod1& #N/A& UP&
8.42& 8& 1.34& 0.007412& Pgap3& #N/A& UP&
10.05& 9.63& 1.34& 0.007261& Trpv2& #N/A& UP&
11.64& 11.23& 1.33& 0.006006& Mybl2& A2A5P3& UP&
9.87& 9.46& 1.33& 0.004635& Aspscr1& A2AC01& UP&
9.03& 8.61& 1.33& 0.005817& Tada2b& D3YW26& UP&
8.88& 8.47& 1.33& 0.003967& Cc2d1b& H3BKI0& UP&
12.9& 12.49& 1.33& 0.002041& Ccl2& Q3U5S8& UP&
10.12& 9.71& 1.33& 0.002372& Rapgef1& Q3UGX8& UP&
9.55& 9.14& 1.33& 0.009279& Srpx2& Q8R054& UP&
11.86& 11.44& 1.33& 0.006651& Ywhab& Q9CQV8& UP&
10.26& 9.85& 1.33& 0.008319& Tlr9& Q9EQU3& UP&
10.13& 9.72& 1.33& 0.007448& Mncbf2990& Q9JJ93& UP&
8.66& 8.25& 1.33& 0.009741& Dph2& V9GX25& UP&
9.9& 9.49& 1.33& 0.001383& I79_006203& #N/A& UP&
10.78& 10.37& 1.33& 0.007267& LOC100751988& #N/A& UP&
10.67& 10.26& 1.33& 0.006593& Taf1d& #N/A& UP&
9.88& 9.48& 1.32& 0.00822& Slc1a5& F7CEQ5& UP&
11.74& 11.35& 1.32& 0.006043& Atf4& Q06507& UP&
9.23& 8.83& 1.32& 0.005035& Anapc4& Q3TI31& UP&




10.26& 9.86& 1.32& 0.005139& Lmbrd2& Q8C561& UP&
10.92& 10.51& 1.32& 0.002016& Ddx41& Q91VN6& UP&
10.11& 9.71& 1.32& 0.006035& Tars& Q9D0R2& UP&
9.01& 8.61& 1.32& 0.009236& Hinfp& #N/A& UP&
10.85& 10.45& 1.32& 0.007005& I79_006202& #N/A& UP&
7.11& 6.71& 1.32& 0.007908& I79_016672& #N/A& UP&
9.26& 8.86& 1.32& 0.006887& I79_021809& #N/A& UP&
8.65& 8.25& 1.32& 0.002736& Shcbp1& #N/A& UP&
8.59& 8.2& 1.31& 0.003103& Mecr& A2A845& UP&
10.73& 10.34& 1.31& 0.002041& Srxn1& A2AQU8& UP&
11.47& 11.08& 1.31& 0.0091& Mcm7& D3Z0J6& UP&
8.58& 8.19& 1.31& 0.008422& Trmu& E0CZ49& UP&
11.89& 11.5& 1.31& 0.004943& Rnaseh2b& E9PYC5& UP&
10.7& 10.31& 1.31& 0.007164& Nhp2l1& E9PZS4& UP&
10.45& 10.05& 1.31& 0.006074& Wipf1& F6QWW7& UP&
9.63& 9.24& 1.31& 0.008369& Bag5& Q8CI32& UP&
9.71& 9.33& 1.31& 0.007672& Ptcd2& Q8R3K3& UP&
10.2& 9.81& 1.31& 0.008413& Cstf1& Q99LC2& UP&
9.59& 9.2& 1.31& 0.004376& Rhobtb1& Q9DAK3& UP&
9.63& 9.25& 1.31& 0.007596& Exoc1& #N/A& UP&
10.38& 9.99& 1.31& 0.005279& Golm1& #N/A& UP&
7.45& 7.05& 1.31& 0.008105& LOC100761549& #N/A& UP&
9.35& 8.97& 1.31& 0.007717& Sp110& #N/A& UP&
10.02& 9.64& 1.31& 0.004677& Ube2e1& #N/A& UP&
10.09& 9.71& 1.3& 0.006785& Tfe3& A2AEW0& UP&
9.11& 8.73& 1.3& 0.006915& Pcbp4& P57724& UP&
9.83& 9.46& 1.3& 0.004234& Sh3pxd2b& Q3TDV5& UP&
10.35& 9.97& 1.3& 0.005986& Tbc1d1& Q3U3T9& UP&
8.89& 8.51& 1.3& 0.0091& Marf08& Q3U7P8& UP&
11.45& 11.07& 1.3& 0.003949& Wars& Q4FJZ4& UP&
10.93& 10.55& 1.3& 0.002597& Insig1& Q8BGI3& UP&
8.74& 8.37& 1.3& 0.004923& Gtf2f2& Q8R0A0& UP&
11.33& 10.94& 1.3& 0.006892& Txnip& Q91X82& UP&
10.01& 9.64& 1.3& 0.003821& Btf3l4& Q9CQH7& UP&
9.16& 8.79& 1.3& 0.006774& Gemin7& Q9CWY4& UP&
9.32& 8.94& 1.3& 0.004843& I79_006441& #N/A& UP&
2.28& 1.91& 1.3& 0.003414& I79_019636& #N/A& UP&
5.75& 5.38& 1.3& 0.008339& LOC100770473& #N/A& UP&
9.27& 8.89& 1.3& 0.008319& Mrps31& #N/A& UP&
9.41& 9.02& 1.3& 0.00702& Rnf14& #N/A& UP&
8.17& 7.79& 1.3& 0.00949& Tceanc2& #N/A& UP&
10.37& 10& 1.29& 0.008557& Lpar1& A2AMJ0& UP&
10.9& 10.53& 1.29& 0.005783& Mtdh& F6ZSG0& UP&




10.17& 9.8& 1.29& 0.009279& Cpsf1& Q3U1X8& UP&
8.87& 8.5& 1.29& 0.008654& Tap2& Q3UA79& UP&
12.1& 11.73& 1.29& 0.004537& Gdi2& Q3UUX9& UP&
10.21& 9.85& 1.29& 0.009874& Heatr1& Q3V1X6& UP&
9.37& 9.01& 1.29& 0.003718& Fmr1& Q6AXB7& UP&
9.08& 8.72& 1.29& 0.00932& Gypc& Q78HU7& UP&
9.78& 9.42& 1.29& 0.006916& Dctn4& Q8CBY8& UP&
10.61& 10.24& 1.29& 0.005268& Tcea1& Q9JMB4& UP&
12.28& 11.92& 1.29& 0.002995& Tcp1& W0TYI4& UP&
7.7& 7.34& 1.29& 0.006205& Bend3& #N/A& UP&
8.12& 7.75& 1.29& 0.007994& Ffr& #N/A& UP&
11.33& 10.97& 1.29& 0.007941& I79_001984& #N/A& UP&
9.57& 9.2& 1.29& 0.008295& LOC100763885& #N/A& UP&
10.78& 10.42& 1.29& 0.005665& Sord& #N/A& UP&
8.28& 7.93& 1.28& 0.007122& Per2& O54943& UP&
11.98& 11.63& 1.28& 0.003949& Arhgap1& Q5FWK3& UP&
8.39& 8.04& 1.28& 0.002292& Mfsd3& Q5U419& UP&
10.27& 9.91& 1.28& 0.009095& Grk6& Q792R0& UP&
11.18& 10.82& 1.28& 0.008107& Psmd6& Q99JI4& UP&
9.84& 9.49& 1.28& 0.003912& Lcmt1& Q9D963& UP&
9.51& 9.15& 1.28& 0.004292& Acox3& Q9EPL9& UP&
10.39& 10.03& 1.28& 0.003797& Pigb& Q9JJQ0& UP&
11.88& 11.52& 1.28& 0.005006& fff& #N/A& UP&
9.3& 8.95& 1.28& 0.007047& LOC100769365& #N/A& UP&
9.3& 8.94& 1.28& 0.007462& LOC100770616& #N/A& UP&
11.31& 10.95& 1.28& 0.006578& Rlim& #N/A& UP&
11.92& 11.57& 1.27& 0.005927& Ifrd1& E9PZB9& UP&
8.75& 8.4& 1.27& 0.007596& Slc2a9& Q3T9X0& UP&
10.74& 10.4& 1.27& 0.006426& Psme4& Q5SSW0& UP&
11.29& 10.94& 1.27& 0.00436& Acly& Q91V92& UP&
9.91& 9.56& 1.27& 0.008598& Adrm1& #N/A& UP&
9.87& 9.52& 1.27& 0.00455& Cdc42ep1& #N/A& UP&
10.22& 9.88& 1.27& 0.007462& Ppan& #N/A& UP&
9.56& 9.21& 1.27& 0.008326& Rbfox2& #N/A& UP&
10.63& 10.29& 1.27& 0.004225& Sar1b& #N/A& UP&
8.52& 8.17& 1.27& 0.006345& Slc10a3& #N/A& UP&
9.56& 9.23& 1.26& 0.005969& Fam171a1& A2ATK9& UP&
11.46& 11.12& 1.26& 0.008783& Nop56& F6USW7& UP&
9.54& 9.2& 1.26& 0.008209& Gabpb2& P81069& UP&
10.46& 10.13& 1.26& 0.0098& Ddx10& Q80Y44& UP&
9.52& 9.18& 1.26& 0.007645& Hus1& Q8BQY8& UP&
10.85& 10.52& 1.26& 0.009956& Pabpc4& Q91YZ8& UP&
11.76& 11.43& 1.26& 0.005541& Ndufa10& Q99LC3& UP&




6.03& 5.7& 1.26& 0.008563& Hes3& #N/A& UP&
9.38& 9.05& 1.26& 0.006774& I79_015825& #N/A& UP&
10.81& 10.47& 1.26& 0.004302& LOC100765868& #N/A& UP&
10.53& 10.19& 1.26& 0.008169& LOC100766729& #N/A& UP&
10.02& 9.7& 1.25& 0.008393& Rrn3& B2RS91& UP&
9.52& 9.2& 1.25& 0.006963& Erbb2ip& B7ZNX6& UP&
11.15& 10.83& 1.25& 0.00949& Serinc1& E9Q553& UP&
11.71& 11.39& 1.25& 0.007086& Zmpste24& I7HIP5& UP&
12.53& 12.22& 1.25& 0.009441& Ptma& P26350& UP&
6.9& 6.58& 1.25& 0.003949& Nudt15& Q3TH44& UP&
9.45& 9.13& 1.25& 0.008204& Insig1& Q8BGI3& UP&
9.59& 9.27& 1.25& 0.006687& Acad9& Q8JZN5& UP&
10.55& 10.23& 1.25& 0.007064& Rragc& Q99K70& UP&
10.19& 9.86& 1.25& 0.005014& fff& #N/A& UP&
10.6& 10.28& 1.25& 0.009413& Akr7a2& #N/A& UP&
10.5& 10.18& 1.25& 0.00209& Ecm29& #N/A& UP&
8.72& 8.4& 1.25& 0.007164& I79_013111& #N/A& UP&
12.11& 11.79& 1.25& 0.003005& Serinc3& #N/A& UP&
10.77& 10.44& 1.25& 0.004355& Tmem185a& #N/A& UP&
5.05& 4.74& 1.24& 0.008209& Rpsa& B2CY77& UP&
9.69& 9.38& 1.24& 0.006333& Micall2& E9PZD2& UP&
9.01& 8.7& 1.24& 0.009008& Hdac7& E9PZG4& UP&
9.84& 9.53& 1.24& 0.009876& Ascc2& Q3UG63& UP&
10.6& 10.28& 1.24& 0.004355& Net1& Q3USZ7& UP&
11.18& 10.87& 1.24& 0.004545& Dusp14& Q542U4& UP&
10.77& 10.46& 1.24& 0.00432& Utp15& Q8C7V3& UP&
9.08& 8.77& 1.24& 0.007862& B3galt6& Q91Z92& UP&
9.37& 9.06& 1.24& 0.00671& LOC100754521& #N/A& UP&
8.34& 8.04& 1.23& 0.009114& Igdcc4& E9QAQ0& UP&
8.71& 8.41& 1.23& 0.003718& Znf512b& F6PYY4& UP&
11.77& 11.47& 1.23& 0.008459& Prmt5& F6QQQ6& UP&
10.84& 10.54& 1.23& 0.009973& Mprip& F6S5I0& UP&
9.39& 9.09& 1.23& 0.009114& Rpusd3& Q14AI6& UP&
9.86& 9.56& 1.23& 0.008684& Cnot10& Q8BH15& UP&
7.92& 7.62& 1.23& 0.006248& Cables2& Q8K3M5& UP&
10.84& 10.54& 1.23& 0.008976& Atp6v0b& Q91VS4& UP&
11.96& 11.66& 1.23& 0.003502& Ccni& Q9Z2V9& UP&
11.46& 11.17& 1.22& 0.009874& Mbnl2& D0EX61& UP&
11.46& 11.17& 1.22& 0.008927& Rps2& D3YVC1& UP&
10.84& 10.55& 1.22& 0.008264& Zeb2& H3BLE2& UP&
10.18& 9.88& 1.22& 0.006333& Ppfibp1& Q3UJ84& UP&
10.67& 10.38& 1.22& 0.005041& Fam149a& Q8CFV2& UP&
9.97& 9.69& 1.22& 0.008848& Spg21& Q9CQC8& UP&




7.05& 6.76& 1.22& 0.007844& LOC100754083& #N/A& UP&
8.86& 8.59& 1.21& 0.006272& Txlng& A2AFJ4& UP&
9.29& 9.02& 1.21& 0.009106& Map3k7& A2AP93& UP&
11.51& 11.24& 1.21& 0.004814& Ctnnb1& E9Q6A9& UP&
11.27& 10.99& 1.21& 0.005989& Plaa& F7D1R5& UP&
7.65& 7.37& 1.21& 0.009911& Fzd7& Q61090& UP&
8.67& 8.39& 1.21& 0.009196& Kri1& Q8VDQ9& UP&
9.64& 9.37& 1.21& 0.004355& Tacc3& Q99LH8& UP&
11.66& 11.39& 1.21& 0.003478& Kpna3& Q9CT07& UP&
8.55& 8.27& 1.21& 0.00313& Ctu1& #N/A& UP&
5.6& 5.33& 1.21& 0.008326& LOC100757919& #N/A& UP&
12.28& 12.01& 1.21& 0.007251& Prelid1& #N/A& UP&
8.8& 8.53& 1.21& 0.007242& Slc24a6& #N/A& UP&
10.49& 10.23& 1.2& 0.006887& Chek1& G3UYC5& UP&
10.65& 10.39& 1.2& 0.007122& Tfdp1& Q08639& UP&
11.19& 10.93& 1.2& 0.005361& Hp1bp3& Q3TEA8& UP&
10.13& 9.86& 1.2& 0.002632& Wbp11& Q3U6Q1& UP&
11.3& 11.04& 1.2& 0.008903& Calm1& Q3UKW2& UP&
10.05& 9.79& 1.2& 0.003002& Galnt2& Q6PB93& UP&
7.74& 7.48& 1.2& 0.009874& Pik3c3& Q6PF93& UP&
8.17& 7.9& 1.2& 0.004814& I79_013783& #N/A& UP&
8.66& 8.4& 1.2& 0.008851& I79_016332& #N/A& UP&
10.3& 10.03& 1.2& 0.009755& Nup50& #N/A& UP&
11.28& 11.02& 1.2& 0.008851& Serpinb6& #N/A& UP&
12.98& 12.72& 1.19& 0.007164& Eif5a& P63242& UP&
10& 9.76& 1.19& 0.007171& Sppl2b& Q3TD49& UP&
11.13& 10.88& 1.19& 0.001947& Gnl3& Q3TK27& UP&
9.89& 9.63& 1.19& 0.009731& Ehd1& Q8K1X5& UP&
8.61& 8.36& 1.19& 0.009114& Stap2& Q8R0L1& UP&
11.87& 11.62& 1.19& 0.009637& Cdc20& Q9JJ66& UP&
8.58& 8.34& 1.18& 0.008442& Nbn& A2AMG5& UP&
8.86& 8.63& 1.18& 0.007921& Vcp& Q01853& UP&
10.52& 10.29& 1.18& 0.004511& Ccnc& Q62447& UP&
10.32& 10.08& 1.18& 0.008326& Coq2& Q66JT7& UP&
11.43& 11.19& 1.18& 0.009667& Ubl7& Q91W67& UP&
11.39& 11.14& 1.18& 0.008123& Vta1& Q9CR26& UP&
7.86& 7.62& 1.18& 0.007717& I79_014916& #N/A& UP&
7.86& 7.62& 1.18& 0.007717& I79_023585& #N/A& UP&
12.08& 11.85& 1.18& 0.005783& Nsmce2& #N/A& UP&
7.46& 7.21& 1.18& 0.008209& Ppp6r2& #N/A& UP&
10.17& 9.94& 1.17& 0.005843& Ranbp9& E9Q5D6& UP&
8.4& 8.18& 1.17& 0.002284& Ksr1& Q5SXE1& UP&
10.75& 10.52& 1.17& 0.009983& Gpr176& #N/A& UP&




12.06& 11.84& 1.17& 0.009309& Naa11& #N/A& UP&
11.74& 11.53& 1.16& 0.003757& Med14& A2BDP0& UP&
10.82& 10.6& 1.16& 0.007242& Ap2a1& F6TPX8& UP&
11.47& 11.26& 1.16& 0.008264& Fasn& P19096& UP&
9.13& 8.92& 1.16& 0.008159& Edrf1& Q6GQV7& UP&
12.75& 12.53& 1.16& 0.008673& Gja1& Q6T9D4& UP&
8.55& 8.33& 1.16& 0.006078& Qpctl& Q8BH73& UP&
8.69& 8.47& 1.16& 0.007939& Epc1& Q8C9X6& UP&
11.07& 10.86& 1.16& 0.009962& Pak2& Q8CIN4& UP&
8.95& 8.74& 1.16& 0.009983& Ccdc22& #N/A& UP&
7.12& 6.9& 1.16& 0.009846& Znf304& #N/A& UP&
11.74& 11.53& 1.15& 0.004371& Akt1& D3Z783& UP&
8.25& 8.05& 1.15& 0.005623& Fubp3& Q3TIX6& UP&
12.63& 12.43& 1.15& 0.006785& Eif4g2& Q3U9U9& UP&
9.59& 9.4& 1.15& 0.009943& Usp30& Q3UN04& UP&
10.38& 10.18& 1.15& 0.005138& Thap4& Q6P3Z3& UP&
11.59& 11.39& 1.15& 0.005488& Oxa1l& Q8BGA9& UP&
11.85& 11.64& 1.15& 0.009753& Acat2& Q8CAY6& UP&
8.53& 8.33& 1.15& 0.003718& Emilin1& Q99K41& UP&
9.69& 9.49& 1.15& 0.008161& Dido1& #N/A& UP&
7.4& 7.2& 1.15& 0.009541& Tmsb10& #N/A& UP&
10.43& 10.22& 1.15& 0.007157& Topbp1& #N/A& UP&
9.75& 9.56& 1.14& 0.002995& Slc25a16& D3YVC9& UP&
9.97& 9.78& 1.14& 0.005212& Mtmr14& Q8VEL2& UP&
12.98& 12.8& 1.13& 0.004335& Tsc22d1& H3BLI9& UP&
11.62& 11.44& 1.13& 0.009131& Cd81& Q3UWG5& UP&
11.7& 11.52& 1.13& 0.008209& Ccnb1& Q68EM3& UP&
9.23& 9.04& 1.13& 0.004216& Tmem205& Q91XE8& UP&
11.01& 10.83& 1.13& 0.003103& LOC100758537& #N/A& UP&
13.26& 13.08& 1.13& 0.004124& Tuba& #N/A& UP&
11& 10.84& 1.12& 0.009428& Aaas& P58742& UP&
9.18& 9.03& 1.11& 0.00878& Mst1r& #N/A& UP&
8.1& 7.95& 1.11& 0.009637& Znf180& #N/A& UP&
5.05& 4.92& 1.1& 0.003949& Myo3b& Q1EG27& UP&
9.87& 9.73& 1.1& 0.008727& Stam2& Q3YEC8& UP&
7.95& 7.81& 1.1& 0.009583& Gtf2ird1& Q6PD35& UP&
8.42& 8.29& 1.1& 0.009983& Bcdin3d& Q91YP1& UP&
12& 11.87& 1.09& 0.007861& Surf4& Q3U7E6& UP&
10.66& 10.53& 1.09& 0.007267& Zswim1& Q9CWV7& UP&
9.38& 9.26& 1.09& 0.009839& Znf828& #N/A& UP&
5.79& 5.68& 1.08& 0.009846& I79_021715& #N/A& UP&
12.09& 11.99& 1.07& 0.00481& Atp6v0c& Q8C1D9& UP&
11.22& 11.35& f1.09& 0.006896& Osbpl9& Q5FWX7& DOWN&




5.4& 5.54& f1.1& 0.004216& Tspan8& Q8R3G9& DOWN&
8.91& 9.06& f1.1& 0.005759& I79_008571& #N/A& DOWN&
5.52& 5.67& f1.11& 0.004721& Prr16& A3KMN5& DOWN&
10.57& 10.72& f1.11& 0.008319& Atp6v1b2& B0LAC8& DOWN&
10.47& 10.62& f1.11& 0.009399& Lin54& E9PV28& DOWN&
12.1& 12.26& f1.11& 0.007994& Pigt& Q3U5R2& DOWN&
12.58& 12.73& f1.11& 0.008183& Kiaa0100& Q5SYL3& DOWN&
11.08& 11.23& f1.11& 0.002041& Prc1& Q99K43& DOWN&
6.54& 6.7& f1.12& 0.008159& Papln& Q9EPX2& DOWN&
9.67& 9.83& f1.12& 0.001361& Panx1& Q9JIP4& DOWN&
9.94& 10.11& f1.12& 0.004923& Ppp6r3& #N/A& DOWN&
11.52& 11.7& f1.13& 0.003926& Got1& P05201& DOWN&
8.96& 9.13& f1.13& 0.002364& Uhrf1bp1& Q3UNI3& DOWN&
11.28& 11.45& f1.13& 0.006025& Ogdh& Q6P8I7& DOWN&
11.78& 11.95& f1.13& 0.002392& Pxk& Q8BX57& DOWN&
10.81& 10.99& f1.13& 0.004246& Anxa6& Q8CEX0& DOWN&
6.69& 6.86& f1.13& 0.008329& Acbd6& Q9D061& DOWN&
10& 10.18& f1.13& 0.006248& I79_014469& #N/A& DOWN&
11.45& 11.65& f1.14& 0.004963& Fkbp10& F6W360& DOWN&
10.76& 10.95& f1.14& 0.003705& Dcxr& Q91X52& DOWN&
8.55& 8.74& f1.14& 0.009587& Rev1& #N/A& DOWN&
9.31& 9.51& f1.15& 0.009317& Ncapg& B2RQA7& DOWN&
12.21& 12.41& f1.15& 0.003718& Arf4& P61750& DOWN&
11.12& 11.32& f1.15& 0.007251& Tmem127& Q8BGP5& DOWN&
8.54& 8.74& f1.15& 0.007164& Cecr5& Q91WM2& DOWN&
10.56& 10.76& f1.15& 0.009139& Csnk1g2& Q99JQ5& DOWN&
9.93& 10.13& f1.15& 0.009236& Ap1s2& Q9DB50& DOWN&
8.73& 8.92& f1.15& 0.008799& I79_002830& #N/A& DOWN&
9.01& 9.22& f1.16& 0.003949& Tmem106a& Q8VC04& DOWN&
9.62& 9.84& f1.16& 0.009874& Usp16& Q99LG0& DOWN&
11.65& 11.87& f1.16& 0.0063& Glrx& #N/A& DOWN&
10.11& 10.33& f1.17& 0.009197& Kif2a& F6RLL5& DOWN&
9.69& 9.91& f1.17& 0.00932& Vti1b& F6T4B9& DOWN&
11.14& 11.37& f1.17& 0.00904& Hadha& Q8BMS1& DOWN&
8.25& 8.48& f1.17& 0.008969& Ttc26& Q8BS45& DOWN&
11& 11.24& f1.17& 0.005224& Rbm14& Q8C2Q3& DOWN&
5.4& 5.62& f1.17& 0.007833& I79_011405& #N/A& DOWN&
9.59& 9.82& f1.17& 0.008952& LOC100757451& #N/A& DOWN&
7.99& 8.22& f1.17& 0.007782& Wbp7& #N/A& DOWN&
9.02& 9.26& f1.18& 0.008092& Setdb1& D3YYC3& DOWN&
8.23& 8.46& f1.18& 0.006929& Aplf& Q9D842& DOWN&
10.4& 10.65& f1.18& 0.009549& Kctd13& #N/A& DOWN&
10.68& 10.93& f1.19& 0.007717& Alg3& D6RCW8& DOWN&




10.54& 10.8& f1.19& 0.008118& Ap2a2& Q3U7X9& DOWN&
11.48& 11.73& f1.19& 0.005544& N4bp1& Q99KT2& DOWN&
11.42& 11.66& f1.19& 0.005532& Cuta& Q9CQ89& DOWN&
10.65& 10.91& f1.19& 0.007113& Mrpl14& Q9D1I6& DOWN&
12.06& 12.31& f1.19& 0.00565& Rpn2& Q9DBG6& DOWN&
9.36& 9.61& f1.19& 0.008547& Tm9sf1& Q9DBU0& DOWN&
10.17& 10.43& f1.19& 0.007947& Epb41& #N/A& DOWN&
10.96& 11.2& f1.19& 0.004677& I79_026136& #N/A& DOWN&
10.86& 11.12& f1.19& 0.00949& Rnf2& #N/A& DOWN&
11.49& 11.74& f1.19& 0.004495& Tmed10& #N/A& DOWN&
10.38& 10.64& f1.19& 0.002887& Zfand6& #N/A& DOWN&
11.47& 11.74& f1.2& 0.004302& St3gal1& Q3UU61& DOWN&
5.47& 5.74& f1.2& 0.009094& Tbc1d9& Q6PGG9& DOWN&
10.21& 10.46& f1.2& 0.004511& Cog6& Q8BRB0& DOWN&
8.85& 9.11& f1.2& 0.006114& Daglb& Q91WC9& DOWN&
7.85& 8.12& f1.2& 0.009587& Dcaf12l2& #N/A& DOWN&
9.72& 9.98& f1.2& 0.008547& Mettl21b& #N/A& DOWN&
10.58& 10.86& f1.21& 0.008739& R3hdm1& B9EHE8& DOWN&
11.23& 11.5& f1.21& 0.005373& Ak3& F6RP11& DOWN&
7.03& 7.31& f1.21& 0.00949& Pknox1& O70477& DOWN&
11.76& 12.04& f1.21& 0.00599& Top2a& Q3TTG4& DOWN&
10.4& 10.67& f1.21& 0.008209& Spag5& Q7TME2& DOWN&
9.94& 10.22& f1.21& 0.005552& Snx27& Q8BYM0& DOWN&
9.15& 9.43& f1.21& 0.0091& Arfip2& Q8K221& DOWN&
8.96& 9.25& f1.22& 0.009198& Lepre1& A2A7Q5& DOWN&
7.32& 7.61& f1.22& 0.009787& Usp20& A2AQ35& DOWN&
10.99& 11.28& f1.22& 0.002552& Tjp1& B9EHJ3& DOWN&
8.8& 9.09& f1.22& 0.003672& Sp3& O70494& DOWN&
9.28& 9.57& f1.22& 0.007164& Klc2& O88448& DOWN&
11.51& 11.8& f1.22& 0.008103& Rras2& P62071& DOWN&
11.22& 11.51& f1.22& 0.0067& Ccnd1& Q3TC96& DOWN&
10.16& 10.45& f1.22& 0.008796& Usp15& Q3TQV7& DOWN&
12.56& 12.85& f1.22& 0.005532& Hspa5& Q3TUS2& DOWN&
8.53& 8.81& f1.22& 0.009414& Cbx2& Q3URA3& DOWN&
9.21& 9.49& f1.22& 0.004344& Slc33a1& Q3UXZ5& DOWN&
9.53& 9.82& f1.22& 0.002995& Prepl& Q8BKS6& DOWN&
11.12& 11.4& f1.22& 0.007014& Hnrnpcl1& #N/A& DOWN&
9.92& 10.22& f1.23& 0.008952& Slc45a1& B0QZL3& DOWN&
10.9& 11.2& f1.23& 0.007325& Ccdc6& D3YZP9& DOWN&
10.74& 11.03& f1.23& 0.008257& Fam3c& E9Q6F0& DOWN&
11.19& 11.49& f1.23& 0.005788& Micu1& F6Z1Z9& DOWN&
9.46& 9.76& f1.23& 0.007242& Trak2& G3UZH5& DOWN&
11.18& 11.48& f1.23& 0.004302& Setd8& Q2YDW7& DOWN&




10.25& 10.55& f1.23& 0.009114& Ppa2& Q91VM9& DOWN&
10.74& 11.04& f1.23& 0.008209& Dennd5a& #N/A& DOWN&
7.91& 8.21& f1.23& 0.009151& Fam86a& #N/A& DOWN&
7.29& 7.59& f1.23& 0.006224& I79_007603& #N/A& DOWN&
7.04& 7.33& f1.23& 0.005164& I79_016537& #N/A& DOWN&
8.22& 8.51& f1.23& 0.006312& I79_021646& #N/A& DOWN&
10.95& 11.26& f1.24& 0.007086& Lasp1& A2A6G0& DOWN&
9.13& 9.44& f1.24& 0.006896& Adm& P97297& DOWN&
5.2& 5.51& f1.24& 0.007149& Lhfp& Q8BM86& DOWN&
8.47& 8.79& f1.24& 0.00944& Rassf8& Q8CJ96& DOWN&
12.43& 12.74& f1.24& 0.009907& Plac8& Q9JI48& DOWN&
8.28& 8.59& f1.24& 0.004588& Kcnk5& Q9JK62& DOWN&
12.63& 12.94& f1.24& 0.004923& Arpc1b& Q9WV32& DOWN&
11.6& 11.91& f1.24& 0.002801& Qki& #N/A& DOWN&
10.03& 10.35& f1.25& 0.002967& Smurf2& A2A5Z6& DOWN&
9.8& 10.11& f1.25& 0.008118& Cdc27& A2A6Q5& DOWN&
9.59& 9.9& f1.25& 0.009839& Lrp10& B0LAD7& DOWN&
11.67& 11.99& f1.25& 0.006916& Gnptab& D3YXC6& DOWN&
9.92& 10.24& f1.25& 0.006078& Orc5& D3Z0X3& DOWN&
9.46& 9.78& f1.25& 0.004151& Nsun5& E9QAY1& DOWN&
9.32& 9.64& f1.25& 0.003967& Rptor& F6U5L3& DOWN&
11.13& 11.46& f1.25& 0.003565& Rangrf& Q05D49& DOWN&
10.42& 10.74& f1.25& 0.007921& Jmjd8& Q3TA59& DOWN&
7.66& 7.98& f1.25& 0.009945& Marf09& Q3TZ87& DOWN&
9.2& 9.52& f1.25& 0.008046& Cenpc1& Q3UUX2& DOWN&
9.54& 9.86& f1.25& 0.008654& I79_020151& #N/A& DOWN&
10.19& 10.51& f1.25& 0.004943& Trip10& #N/A& DOWN&
7.52& 7.86& f1.26& 0.00338& Pikfyve& D3Z5N5& DOWN&
8.34& 8.67& f1.26& 0.005636& Arhgap6& O54834& DOWN&
10.44& 10.78& f1.26& 0.008169& Edem3& Q2HXL6& DOWN&
9.37& 9.71& f1.26& 0.006763& Fuz& Q3UYI6& DOWN&
10.46& 10.79& f1.26& 0.009197& Pcyt2& Q922E4& DOWN&
12.08& 12.41& f1.26& 0.006043& Ly6e& Q9CXN2& DOWN&
9.71& 10.05& f1.26& 0.007931& Gdap2& Q9DBL2& DOWN&
11.07& 11.4& f1.26& 0.009846& Dedd& Q9Z1L3& DOWN&
9.11& 9.44& f1.26& 0.003821& Acer3& #N/A& DOWN&
6.77& 7.1& f1.26& 0.00904& LOC100753391& #N/A& DOWN&
9.29& 9.64& f1.27& 0.003718& Fndc3a& F6TLV3& DOWN&
9.25& 9.6& f1.27& 0.009453& Rab33b& O35963& DOWN&
10.27& 10.61& f1.27& 0.002392& Ptpn12& P35831& DOWN&
8.24& 8.58& f1.27& 0.005006& Taf1b& P97358& DOWN&
9.93& 10.28& f1.27& 0.004027& Slc30a4& Q3TM66& DOWN&
8.09& 8.44& f1.27& 0.007412& Ppp2r5b& Q3V3S8& DOWN&




11.28& 11.63& f1.27& 0.001844& Tmed4& Q5SVW9& DOWN&
9.53& 9.87& f1.27& 0.008159& Adrbk1& Q7TS64& DOWN&
10.15& 10.5& f1.27& 0.008927& Tlcd1& Q99JT6& DOWN&
8.59& 8.93& f1.27& 0.007994& Snx7& Q9CY18& DOWN&
9.28& 9.62& f1.27& 0.006599& Tmem135& Q9CYV5& DOWN&
10.76& 11.11& f1.27& 0.004569& Csnk1e& Q9JMK2& DOWN&
8.54& 8.89& f1.27& 0.009229& Disp1& #N/A& DOWN&
8.24& 8.59& f1.27& 0.007005& Fer& #N/A& DOWN&
9.88& 10.22& f1.27& 0.007832& Me1& #N/A& DOWN&
9.71& 10.05& f1.27& 0.004292& Mpzl1& #N/A& DOWN&
9& 9.35& f1.27& 0.008283& Rilpl1& #N/A& DOWN&
7.6& 7.95& f1.28& 0.009797& Kank1& E9Q238& DOWN&
8.32& 8.67& f1.28& 0.002995& Clip1& F6RAY2& DOWN&
8.32& 8.68& f1.28& 0.006837& Fam160a2& J3QP99& DOWN&
10.48& 10.83& f1.28& 0.001353& Clock& O08785& DOWN&
8.85& 9.21& f1.28& 0.00481& Prkar2b& P31324& DOWN&
10.35& 10.7& f1.28& 0.002856& Pcnx& Q3TD89& DOWN&
9.94& 10.29& f1.28& 0.007345& Sgpp1& Q3U4P6& DOWN&
8.31& 8.66& f1.28& 0.002887& Arhgap17& Q3UIA2& DOWN&
9.29& 9.65& f1.28& 0.004383& Mmp9& Q3UQ52& DOWN&
10.29& 10.64& f1.28& 0.005647& Ncapd3& Q80W41& DOWN&
9.86& 10.22& f1.28& 0.006916& Zcchc11& Q8BIZ5& DOWN&
9.41& 9.77& f1.28& 0.006369& Scyl1& Q9EQC5& DOWN&
9.61& 9.97& f1.28& 0.008547& Plod3& Q9R0E1& DOWN&
6.53& 6.88& f1.28& 0.002041& Cttnbp2& R7RU63& DOWN&
7.6& 7.96& f1.28& 0.004686& I79_018240& #N/A& DOWN&
9.19& 9.54& f1.28& 0.009846& I79_025063& #N/A& DOWN&
8.99& 9.34& f1.28& 0.004355& LOC100758211& #N/A& DOWN&
10.19& 10.56& f1.28& 0.00762& LOC100766560& #N/A& DOWN&
8.77& 9.13& f1.28& 0.006345& Mastl& #N/A& DOWN&
8.36& 8.72& f1.28& 0.00529& Pard6b& #N/A& DOWN&
9.11& 9.48& f1.29& 0.006399& Mapk8& A6P3E4& DOWN&
10.28& 10.65& f1.29& 0.003811& Sec11a& D3YWT0& DOWN&
10.11& 10.48& f1.29& 0.003309& Zc3hc1& D3Z0B2& DOWN&
10.28& 10.64& f1.29& 0.004244& Adam17& Q3UEW9& DOWN&
7.6& 7.96& f1.29& 0.008777& Ptbp2& Q3V328& DOWN&
9.18& 9.55& f1.29& 0.009008& Plekhm1& Q7TSI1& DOWN&
9.67& 10.04& f1.29& 0.007305& Tmem209& Q8BRG8& DOWN&
5.53& 5.9& f1.29& 0.005373& Hdgfrp3& Q9JMG7& DOWN&
8.72& 9.08& f1.29& 0.007047& C5orf25& #N/A& DOWN&
7.48& 7.84& f1.29& 0.007164& Cep152& #N/A& DOWN&
7.26& 7.64& f1.3& 0.009279& Otud7b& B2RUR8& DOWN&
9.31& 9.69& f1.3& 0.004355& Fto& D3Z127& DOWN&




10.32& 10.69& f1.3& 0.00397& Atf2& P16951& DOWN&
11.9& 12.28& f1.3& 0.004627& Mfge8& P21956& DOWN&
9.71& 10.09& f1.3& 0.008325& Ctps2& P70303& DOWN&
10.47& 10.85& f1.3& 0.003565& Brd2& Q3TH63& DOWN&
9.63& 10.01& f1.3& 0.005955& Lrrc28& Q3TX51& DOWN&
9.45& 9.84& f1.3& 0.004898& Foxn2& Q8BSS2& DOWN&
11.59& 11.96& f1.3& 0.003718& Bst2& Q8R2Q8& DOWN&
10.2& 10.58& f1.3& 0.009455& Adipor1& Q91VH1& DOWN&
8.44& 8.82& f1.3& 0.005868& Spry2& Q9QXV8& DOWN&
8.94& 9.32& f1.3& 0.002841& Deaf1& Q9Z1T5& DOWN&
6.77& 7.16& f1.3& 0.009114& I79_023912& #N/A& DOWN&
8.6& 8.99& f1.31& 0.006399& Pdpr& D3Z443& DOWN&
7.13& 7.52& f1.31& 0.005041& Rsf1& E9PWW9& DOWN&
9.64& 10.03& f1.31& 0.004955& Uty& P79457& DOWN&
9.23& 9.63& f1.31& 0.008257& Ppp1r12a& Q3TS88& DOWN&
8.17& 8.55& f1.31& 0.00481& Ttc9c& Q810A3& DOWN&
7.04& 7.44& f1.31& 0.003718& Hectd2& Q8CDU6& DOWN&
9.9& 10.3& f1.31& 0.009258& Sertad2& Q91VV6& DOWN&
7.89& 8.28& f1.31& 0.008264& Dlg1& S4R2V5& DOWN&
9.77& 10.16& f1.31& 0.006701& Tlr4& U5LL67& DOWN&
11.03& 11.41& f1.31& 0.00605& G6pc3& #N/A& DOWN&
10.34& 10.72& f1.31& 0.009205& Hist2h2bf& #N/A& DOWN&
9.56& 9.96& f1.31& 0.003002& I79_006325& #N/A& DOWN&
9.57& 9.96& f1.31& 0.007122& LOC100773978& #N/A& DOWN&
9.56& 9.96& f1.32& 0.007005& Gpd2& A2AQR0& DOWN&
10.67& 11.07& f1.32& 0.009495& Asxl2& D3Z112& DOWN&
11.91& 12.32& f1.32& 0.008037& Tinagl1& H3BJ97& DOWN&
10.49& 10.88& f1.32& 0.003478& Asap1& H3BK40& DOWN&
8.53& 8.93& f1.32& 0.004567& Brca2& Q3TN53& DOWN&
10.44& 10.84& f1.32& 0.004495& Alg8& Q3URN2& DOWN&
6.25& 6.65& f1.32& 0.007266& Ltbp3& Q61810& DOWN&
9.74& 10.13& f1.32& 0.006731& Uvrag& Q8C0K8& DOWN&
7.49& 7.89& f1.32& 0.007832& Noxa1& Q8CJ00& DOWN&
10.51& 10.91& f1.32& 0.002597& Gak& Q99KY4& DOWN&
11.13& 11.53& f1.32& 0.004562& Uqcrc2& Q9DB77& DOWN&
11.91& 12.32& f1.32& 0.004322& Pfn2& Q9JJV2& DOWN&
9.65& 10.05& f1.32& 0.008891& Aak1& #N/A& DOWN&
7.36& 7.77& f1.32& 0.006765& I79_014386& #N/A& DOWN&
9.53& 9.94& f1.32& 0.009785& LOC100759120& #N/A& DOWN&
9.5& 9.9& f1.32& 0.007396& Neurl& #N/A& DOWN&
10.08& 10.47& f1.32& 0.008189& Rgnef& #N/A& DOWN&
9.31& 9.71& f1.32& 0.002999& Znf187& #N/A& DOWN&
9.59& 10& f1.33& 0.002995& Yeats2& B9EKJ4& DOWN&




8.34& 8.76& f1.33& 0.003103& Tgif1& E0CYI0& DOWN&
8.2& 8.61& f1.33& 0.008295& Gpr137& E9Q9I0& DOWN&
9.67& 10.08& f1.33& 0.004537& Pds5b& F8WHU5& DOWN&
9.95& 10.36& f1.33& 0.006915& Agpat1& O35083& DOWN&
9.39& 9.8& f1.33& 0.006833& Irf2& P23906& DOWN&
10.28& 10.69& f1.33& 0.009028& Tnfrsf1a& Q3TVS9& DOWN&
8.01& 8.42& f1.33& 0.002041& Athl1& Q8BP56& DOWN&
8.49& 8.89& f1.33& 0.006887& Ccdc165& #N/A& DOWN&
10.5& 10.92& f1.33& 0.006248& Dexi& #N/A& DOWN&
7.8& 8.21& f1.33& 0.005138& Glt25d1& #N/A& DOWN&
10.92& 11.33& f1.33& 0.006856& I79_001770& #N/A& DOWN&
8.91& 9.32& f1.33& 0.006731& Kdm5b& #N/A& DOWN&
10.5& 10.92& f1.33& 0.006928& LOC100762757& #N/A& DOWN&
10.42& 10.83& f1.33& 0.001055& LOC100763741& #N/A& DOWN&
9.36& 9.78& f1.34& 0.002597& Med24& A6PW47& DOWN&
10.26& 10.68& f1.34& 0.005969& Plk4& E9PVH4& DOWN&
10.84& 11.26& f1.34& 0.005969& Ap2b1& H3BKM0& DOWN&
9.84& 10.26& f1.34& 0.003718& Dtnb& O70585& DOWN&
9.91& 10.32& f1.34& 0.005076& Cpd& O89001& DOWN&
10.45& 10.87& f1.34& 0.005783& Ptpn11& P35235& DOWN&
10.86& 11.28& f1.34& 0.007242& Sos2& Q02384& DOWN&
9.27& 9.69& f1.34& 0.006935& Ankrd12& Q3U569& DOWN&
8.77& 9.2& f1.34& 0.0091& Mfhas1& Q3V1N1& DOWN&
9.62& 10.04& f1.34& 0.006875& Map4k5& Q8BPM2& DOWN&
10.3& 10.73& f1.34& 0.008324& Frmd6& Q8C0V9& DOWN&
9.97& 10.38& f1.34& 0.008325& Ing3& Q8VEK6& DOWN&
8.96& 9.38& f1.34& 0.009229& Stard13& Q923Q2& DOWN&
10.13& 10.55& f1.34& 0.009403& Rnf111& Q99ML9& DOWN&
5.2& 5.62& f1.34& 0.009839& Slc44a3& #N/A& DOWN&
10.56& 10.97& f1.34& 0.005138& Ubxn7& #N/A& DOWN&
9.62& 10.05& f1.35& 0.008209& Med24& A6PW47& DOWN&
9.97& 10.41& f1.35& 0.002407& Dgcr2& E9QNU3& DOWN&
9.92& 10.36& f1.35& 0.005008& Terf2& F6VIR4& DOWN&
8.2& 8.64& f1.35& 0.003315& Fam13a& G3UYL7& DOWN&
10.39& 10.82& f1.35& 0.004495& Cep170& H7BX26& DOWN&
11.29& 11.72& f1.35& 0.009982& Nit1& Q8VDK1& DOWN&
10.82& 11.25& f1.35& 0.006025& Gpx8& Q9D7B7& DOWN&
8.93& 9.37& f1.35& 0.004675& Oma1& Q9D8H7& DOWN&
9.36& 9.79& f1.35& 0.002867& Eps15l1& #N/A& DOWN&
9.63& 10.07& f1.35& 0.005138& Fam168a& #N/A& DOWN&
10.86& 11.29& f1.35& 0.009223& Kirrel& #N/A& DOWN&
9.83& 10.26& f1.35& 0.007164& LOC100764634& #N/A& DOWN&
10.25& 10.69& f1.36& 0.002104& Wdr46& A0A068BFS0& DOWN&




8.5& 8.95& f1.36& 0.007514& Fam111a& D3YYD2& DOWN&
8.67& 9.11& f1.36& 0.007086& Angel2& F6SBQ6& DOWN&
8.51& 8.95& f1.36& 0.007267& Tspyl2& J3QP69& DOWN&
10.29& 10.74& f1.36& 0.005014& Gba& P17439& DOWN&
7.55& 8& f1.36& 0.002372& Galc& P54818& DOWN&
8.94& 9.39& f1.36& 0.003313& Rspry1& Q3T9K3& DOWN&
8.09& 8.53& f1.36& 0.005996& Cog8& Q3U5F9& DOWN&
10.87& 11.31& f1.36& 0.001055& Lman1& Q3U944& DOWN&
8.69& 9.13& f1.36& 0.006227& Cand2& Q3UM57& DOWN&
10.51& 10.95& f1.36& 0.003718& Ints3& Q7TPD0& DOWN&
9.31& 9.75& f1.36& 0.006794& Prr14& Q7TPN9& DOWN&
10.2& 10.64& f1.36& 0.005056& Itih5& Q8BJD1& DOWN&
9.95& 10.4& f1.36& 0.009823& Naa25& Q8BKI9& DOWN&
9.41& 9.85& f1.36& 0.004267& Rab3ip& Q8BR32& DOWN&
7.59& 8.04& f1.36& 0.007092& Smyd3& Q8C2Y2& DOWN&
10.1& 10.54& f1.36& 0.005516& Etfdh& Q921G7& DOWN&
9.61& 10.05& f1.36& 0.005989& Dnajc14& Q921R4& DOWN&
10.69& 11.13& f1.36& 0.001414& Tmem39a& Q9CYC3& DOWN&
10.12& 10.56& f1.36& 0.005855& Acaca& Q9ESZ5& DOWN&
4.7& 5.14& f1.36& 0.009066& Dnah12& #N/A& DOWN&
9.05& 9.5& f1.36& 0.004843& I79_003829& #N/A& DOWN&
9.19& 9.63& f1.36& 0.009024& I79_016242& #N/A& DOWN&
8.04& 8.48& f1.36& 0.009279& Ppm1k& #N/A& DOWN&
11.77& 12.23& f1.37& 0.008087& Slc25a39& B0QZI3& DOWN&
9.8& 10.25& f1.37& 0.007242& Prkx& B1AVU1& DOWN&
9.63& 10.08& f1.37& 0.002995& Ikzf5& D3YYG0& DOWN&
11.97& 12.43& f1.37& 0.006935& Sparc& P07214& DOWN&
8.94& 9.39& f1.37& 0.004442& Sass6& Q3UM73& DOWN&
9.12& 9.57& f1.37& 0.00235& Trim6& Q8BGE7& DOWN&
10.79& 11.25& f1.37& 0.00904& Setd5& Q8C2M5& DOWN&
10.5& 10.96& f1.37& 0.003757& Brox& Q8K2Q7& DOWN&
10.49& 10.94& f1.37& 0.005783& Ube3b& Q9ES34& DOWN&
6.66& 7.12& f1.37& 0.00879& Fam164c& #N/A& DOWN&
8.9& 9.35& f1.37& 0.006482& I79_002539& #N/A& DOWN&
9.06& 9.51& f1.37& 0.005138& I79_016335& #N/A& DOWN&
8.87& 9.33& f1.37& 0.005565& LOC100764678& #N/A& DOWN&
9.39& 9.85& f1.37& 0.004843& LOC100774070& #N/A& DOWN&
12.65& 13.1& f1.37& 0.002292& S100a11& #N/A& DOWN&
9.26& 9.72& f1.37& 0.001353& Slc30a7& #N/A& DOWN&
4.72& 5.18& f1.37& 0.008295& Tuba1c& #N/A& DOWN&
10.21& 10.67& f1.37& 0.006248& Wwtr1& #N/A& DOWN&
8.17& 8.63& f1.38& 0.00643& Fbxl8& D6RGN0& DOWN&
8.44& 8.9& f1.38& 0.005565& Btaf1& E9QAE3& DOWN&




9.68& 10.15& f1.38& 0.005465& Uggt1& G3UY73& DOWN&
11.57& 12.04& f1.38& 0.001383& Mfge8& P21956& DOWN&
9.84& 10.31& f1.38& 0.007947& Pros1& Q3V0M0& DOWN&
11.38& 11.84& f1.38& 0.006426& Bre& Q8K3W0& DOWN&
8.57& 9.03& f1.38& 0.004923& Kif18a& Q91WD7& DOWN&
9.53& 9.99& f1.38& 0.00949& Mllt3& Q9D2P1& DOWN&
12.57& 13.04& f1.38& 0.002557& fff& #N/A& DOWN&
10.75& 11.21& f1.38& 0.007852& Dcaf12& #N/A& DOWN&
9.54& 10& f1.38& 0.009036& Gdf11& #N/A& DOWN&
9.26& 9.72& f1.38& 0.003438& Herc2& #N/A& DOWN&
8.01& 8.47& f1.38& 0.005993& I79_025753& #N/A& DOWN&
10.85& 11.31& f1.38& 0.00397& Isyna1& #N/A& DOWN&
10.73& 11.19& f1.38& 0.007242& Map1b& #N/A& DOWN&
8.72& 9.2& f1.39& 0.003221& Ctnnal1& B1AZA7& DOWN&
9.46& 9.94& f1.39& 0.006332& Pgs1& F8WI04& DOWN&
10.22& 10.69& f1.39& 0.005178& Mdm2& P23804& DOWN&
10.13& 10.61& f1.39& 0.009983& Brca1& P48754& DOWN&
9.65& 10.12& f1.39& 0.006599& Vangl1& Q3UXU7& DOWN&
9.14& 9.61& f1.39& 0.00338& Prune& Q8BIW1& DOWN&
9.84& 10.31& f1.39& 0.008877& Tbck& Q8BM85& DOWN&
9.83& 10.31& f1.39& 0.003372& Gtf3c1& Q8K284& DOWN&
8.74& 9.22& f1.39& 0.004814& Uxs1& Q91XL3& DOWN&
9.57& 10.04& f1.39& 0.002291& Gpr108& Q9CU01& DOWN&
10.63& 11.1& f1.39& 0.008105& Skp2& Q9Z0Z3& DOWN&
11.63& 12.11& f1.39& 0.006887& Ddr2& #N/A& DOWN&
7.83& 8.31& f1.39& 0.004611& I79_020071& #N/A& DOWN&
8.64& 9.12& f1.39& 0.004168& I79_021515& #N/A& DOWN&
7.6& 8.07& f1.39& 0.00643& Klhl28& #N/A& DOWN&
10.08& 10.55& f1.39& 0.006929& LOC100762576& #N/A& DOWN&
9.72& 10.19& f1.39& 0.004569& LOC100763193& #N/A& DOWN&
9.13& 9.61& f1.39& 0.003002& Znf770& #N/A& DOWN&
7.55& 8.03& f1.4& 0.008557& Ston1& D3Z0U0& DOWN&
8.64& 9.13& f1.4& 0.00762& Agtpbp1& E9PXA7& DOWN&
8.49& 8.98& f1.4& 0.005008& Clip1& F6RAY2& DOWN&
7.41& 7.89& f1.4& 0.004477& Pol& P10400& DOWN&
9.47& 9.96& f1.4& 0.008727& Tmem231& Q3U284& DOWN&
10.04& 10.52& f1.4& 0.005969& Cln5& Q3UMW8& DOWN&
8.91& 9.39& f1.4& 0.004065& Srgap2& Q3UPB8& DOWN&
10.78& 11.27& f1.4& 0.005212& Acd& Q5EE38& DOWN&
10.73& 11.21& f1.4& 0.003936& Mef2a& Q60929& DOWN&
9.54& 10.03& f1.4& 0.00671& Casc4& Q6P2L7& DOWN&
9.89& 10.37& f1.4& 0.00911& Prdm4& Q80V63& DOWN&
8.13& 8.62& f1.4& 0.001353& Sec62& Q8CIK3& DOWN&




8.49& 8.98& f1.4& 0.006915& Pygl& Q9ET01& DOWN&
9.34& 9.83& f1.4& 0.009141& Foxf1& #N/A& DOWN&
8.64& 9.13& f1.4& 0.007191& I79_014905& #N/A& DOWN&
8.95& 9.43& f1.4& 0.004384& LOC100758878& #N/A& DOWN&
8.25& 8.74& f1.41& 0.002392& Spg20& D3Z3F8& DOWN&
10.06& 10.55& f1.41& 0.008209& Atxn2& E9QM77& DOWN&
8.78& 9.28& f1.41& 0.007672& Tsc1& F2Z3X2& DOWN&
9.53& 10.02& f1.41& 0.002041& Kdm5c& F6WXI0& DOWN&
9.69& 10.19& f1.41& 0.009674& Jmjd1c& G3UZM1& DOWN&
9.44& 9.94& f1.41& 0.003696& Dnmt3a& O88508& DOWN&
8.83& 9.33& f1.41& 0.002535& Cant1& Q8VCF1& DOWN&
11.47& 11.97& f1.41& 0.004692& Gatad2b& Q8VHR5& DOWN&
8.38& 8.88& f1.41& 0.006664& Stat2& Q9WVL2& DOWN&
10.61& 11.11& f1.41& 0.009453& Skp2& Q9Z0Z3& DOWN&
7.59& 8.09& f1.41& 0.003103& Bcar3& #N/A& DOWN&
6.26& 6.75& f1.41& 0.006785& I79_010558& #N/A& DOWN&
9.47& 9.96& f1.41& 0.008264& Synj2bp& #N/A& DOWN&
9.42& 9.92& f1.42& 0.004542& Ptprs& B0V2N1& DOWN&
10.54& 11.04& f1.42& 0.003953& Golim4& F6RUD1& DOWN&
9.15& 9.66& f1.42& 0.008673& Nav3& F6U6A7& DOWN&
9.18& 9.69& f1.42& 0.006774& Fkbp14& P59024& DOWN&
11.06& 11.57& f1.42& 0.001926& Nfe2l2& Q05DU7& DOWN&
10.84& 11.34& f1.42& 0.002041& Cnot4& Q3TMM0& DOWN&
9.38& 9.89& f1.42& 0.007242& Rngtt& Q3TUK6& DOWN&
8.36& 8.86& f1.42& 0.007285& Evi5l& Q3U1G0& DOWN&
11.06& 11.56& f1.42& 0.00226& Neo1& Q7TQG5& DOWN&
8.67& 9.17& f1.42& 0.005532& Slc22a17& Q8C0Y4& DOWN&
8.63& 9.14& f1.42& 0.008532& Flad1& Q8R123& DOWN&
11.36& 11.87& f1.42& 0.004567& Rtn3& Q9ES97& DOWN&
8.11& 8.62& f1.42& 0.00787& Pvrl3& Q9JLB9& DOWN&
9.1& 9.61& f1.42& 0.007687& Gabbr1& Q9WV18& DOWN&
11& 11.51& f1.42& 0.006426& I79_005363& #N/A& DOWN&
10.18& 10.69& f1.42& 0.007388& I79_015026& #N/A& DOWN&
8.39& 8.9& f1.42& 0.002392& Irx3& #N/A& DOWN&
7.14& 7.65& f1.42& 0.006916& Kiaa0232& #N/A& DOWN&
9& 9.52& f1.43& 0.00949& Ssfa2& A2AQD6& DOWN&
9.63& 10.14& f1.43& 0.00701& Mbtps1& A3QWY0& DOWN&
8.41& 8.94& f1.43& 0.006915& Phf3& B2RQG2& DOWN&
10.78& 11.3& f1.43& 0.007833& Coq10a& B2RWC6& DOWN&
9.52& 10.04& f1.43& 0.005887& Ankib1& B2RX15& DOWN&
8.97& 9.48& f1.43& 0.007062& Fnbp1l& E9PUK3& DOWN&
10.38& 10.9& f1.43& 0.009983& Man2a1& F6QMB7& DOWN&
11.44& 11.96& f1.43& 0.005969& Gatad1& F7CAN4& DOWN&




9.61& 10.13& f1.43& 0.005006& Sort1& Q6PHU5& DOWN&
8.43& 8.95& f1.43& 0.006074& Mef2c& Q8CFN5& DOWN&
9.15& 9.67& f1.43& 0.008557& Frmd4b& Q920B0& DOWN&
7.26& 7.77& f1.43& 0.005006& Bbs12& Z4YKQ3& DOWN&
10.71& 11.22& f1.43& 0.003331& Cers6& #N/A& DOWN&
9.15& 9.66& f1.43& 0.007687& Flrt3& #N/A& DOWN&
9.91& 10.42& f1.43& 0.009649& I79_000877& #N/A& DOWN&
7.71& 8.23& f1.43& 0.005955& I79_005651& #N/A& DOWN&
6.84& 7.36& f1.43& 0.008673& I79_019977& #N/A& DOWN&
9.13& 9.65& f1.43& 0.006541& Isca2& #N/A& DOWN&
10.37& 10.88& f1.43& 0.005138& Lpcat4& #N/A& DOWN&
9.72& 10.24& f1.43& 0.003587& Znf800& #N/A& DOWN&
7.91& 8.44& f1.44& 0.009236& Wdr47& A2AGC6& DOWN&
8.89& 9.41& f1.44& 0.00453& Arfip1& A2RSX9& DOWN&
8.24& 8.77& f1.44& 0.004943& Casc5& A3KGI3& DOWN&
9.36& 9.88& f1.44& 0.005918& Tmem132a& D3Z4S6& DOWN&
9.6& 10.12& f1.44& 0.003221& Slc35b2& Q3TJQ2& DOWN&
9.73& 10.26& f1.44& 0.009943& Cdkn2c& Q60772& DOWN&
10.15& 10.67& f1.44& 0.003139& Tbc1d22b& Q6PAT2& DOWN&
8.33& 8.86& f1.44& 0.004787& Akap9& Q8C0C6& DOWN&
11.12& 11.64& f1.44& 0.008209& Cd151& Q921J7& DOWN&
10.02& 10.54& f1.44& 0.003821& Sgsh& Q9JHK6& DOWN&
9.42& 9.95& f1.44& 0.003538& Dst& S4R1Y6& DOWN&
9.22& 9.74& f1.44& 0.004719& Btbd7& #N/A& DOWN&
9.03& 9.56& f1.44& 0.007609& I79_014653& #N/A& DOWN&
7.72& 8.25& f1.44& 0.008608& LOC100763467& #N/A& DOWN&
7.54& 8.07& f1.44& 0.009483& Map6& #N/A& DOWN&
9.46& 9.99& f1.44& 0.007271& Specc1l& #N/A& DOWN&
8.32& 8.85& f1.44& 0.008557& Zcchc2& #N/A& DOWN&
10.43& 10.97& f1.45& 0.009279& Pcyox1& F7CIP8& DOWN&
9.24& 9.78& f1.45& 0.00338& Tob1& Q3UQ91& DOWN&
7.79& 8.33& f1.45& 0.002841& Mybl1& Q3ZB49& DOWN&
10.52& 11.06& f1.45& 0.006491& Sec24d& Q6NXL1& DOWN&
8.82& 9.35& f1.45& 0.008632& Kiaa0195& Q7TSH8& DOWN&
8.28& 8.82& f1.45& 0.004292& Tcp11l1& Q8BTG3& DOWN&
8.44& 8.97& f1.45& 0.007472& Klhl2& Q8JZP3& DOWN&
10.43& 10.97& f1.45& 0.007565& Elk3& Q91W17& DOWN&
7.09& 7.62& f1.45& 0.00804& Rabgap1l& Q9CRQ7& DOWN&
10.81& 11.34& f1.45& 0.003912& Arl2& Q9D0J4& DOWN&
12.22& 12.76& f1.45& 0.00671& fff& #N/A& DOWN&
10.16& 10.7& f1.45& 0.003967& Bcar3& #N/A& DOWN&
7.15& 7.7& f1.45& 0.007921& LOC100761811& #N/A& DOWN&
9.21& 9.75& f1.45& 0.008282& LOC100763232& #N/A& DOWN&




7.51& 8.05& f1.45& 0.007164& LOC100767949& #N/A& DOWN&
11.27& 11.81& f1.45& 0.006915& Spcs2& #N/A& DOWN&
8.02& 8.57& f1.46& 0.007832& Brpf3& B2KF05& DOWN&
12.17& 12.71& f1.46& 0.003114& Capns1& D3YW48& DOWN&
9.91& 10.45& f1.46& 0.007164& Man2a1& F6QMB7& DOWN&
9.17& 9.71& f1.46& 0.007416& Synj1& F6XIX0& DOWN&
8.6& 9.15& f1.46& 0.009638& Slc5a6& Q5U4D8& DOWN&
6.41& 6.96& f1.46& 0.003894& Cp& Q61147& DOWN&
9.38& 9.93& f1.46& 0.004562& Fbxo11& Q7TPD1& DOWN&
11.06& 11.61& f1.46& 0.002016& Rin2& Q9D684& DOWN&
10.73& 11.27& f1.46& 0.001651& Gpc1& Q9QZF2& DOWN&
9.99& 10.53& f1.46& 0.005636& Ccdc56& #N/A& DOWN&
10.6& 11.15& f1.46& 0.003718& LOC100752106& #N/A& DOWN&
10.5& 11.05& f1.46& 0.003672& LOC100755646& #N/A& DOWN&
8.32& 8.87& f1.46& 0.004588& Znf451& #N/A& DOWN&
8.08& 8.63& f1.47& 0.002292& Chd2& E9PZM4& DOWN&
9.9& 10.46& f1.47& 0.005001& Atf6b& G3UXQ6& DOWN&
11.16& 11.72& f1.47& 0.001947& Ubash3b& H3BJB9& DOWN&
8.68& 9.24& f1.47& 0.002597& Ipo13& Q3UDQ3& DOWN&
9.58& 10.14& f1.47& 0.005565& Ezh2& Q6AXH7& DOWN&
9.6& 10.15& f1.47& 0.007396& Atl2& Q8C081& DOWN&
10.01& 10.57& f1.47& 0.009638& Dnajb9& Q9QYI6& DOWN&
10.59& 11.15& f1.47& 0.004355& Gpc1& Q9QZF2& DOWN&
8.88& 9.43& f1.47& 0.008083& Cd320& Q9Z1P5& DOWN&
11.01& 11.57& f1.47& 0.00474& Ccdc80& #N/A& DOWN&
6.17& 6.73& f1.47& 0.005101& I79_005615& #N/A& DOWN&
6.82& 7.38& f1.47& 0.00388& I79_020153& #N/A& DOWN&
9.27& 9.82& f1.47& 0.008799& I79_021371& #N/A& DOWN&
9.54& 10.09& f1.47& 0.003478& LOC100766184& #N/A& DOWN&
8.28& 8.83& f1.47& 0.009272& Wdr85& #N/A& DOWN&
8.82& 9.38& f1.48& 0.003816& Camsap1& A2AHC3& DOWN&
7.73& 8.29& f1.48& 0.004843& Acbd4& E0CXU7& DOWN&
9.28& 9.85& f1.48& 0.008319& Pi4ka& E9Q3L2& DOWN&
8.92& 9.48& f1.48& 0.009552& Xbp1& H3BLF6& DOWN&
10.03& 10.59& f1.48& 0.002041& Clk2& O35491& DOWN&
9.3& 9.87& f1.48& 0.00671& Rad52& P43352& DOWN&
8.1& 8.66& f1.48& 0.008007& Cpeb1& Q059Z2& DOWN&
11.05& 11.62& f1.48& 0.007984& Stip1& Q60864& DOWN&
8.93& 9.49& f1.48& 0.00543& Kiaa1841& Q68FF0& DOWN&
9.43& 10& f1.48& 0.003372& Mamdc2& Q8CG85& DOWN&
9.97& 10.54& f1.48& 0.00397& Txndc11& Q8K2W3& DOWN&
8.02& 8.59& f1.48& 0.00388& Mxra7& Q9D1T2& DOWN&
9.38& 9.94& f1.48& 0.007251& Agrn& Z4YK85& DOWN&




10.73& 11.3& f1.48& 0.00991& LOC100760205& #N/A& DOWN&
10.05& 10.62& f1.48& 0.009008& Rad9a& #N/A& DOWN&
10.86& 11.43& f1.48& 0.004326& Wdr67& #N/A& DOWN&
9.48& 10.06& f1.49& 0.003051& Phf21a& A2AHG3& DOWN&
10.01& 10.58& f1.49& 0.009873& Ptprs& B0V2N1& DOWN&
9.65& 10.23& f1.49& 0.006426& Sbf2& E9Q372& DOWN&
9.03& 9.6& f1.49& 0.009956& Mut& P16332& DOWN&
8.38& 8.96& f1.49& 0.003718& Snx25& Q3ZT31& DOWN&
8.43& 9& f1.49& 0.004923& Heatr6& Q6P1G0& DOWN&
9.21& 9.78& f1.49& 0.005993& Tbc1d22b& Q6PAT2& DOWN&
10.24& 10.82& f1.49& 0.001708& Foxk2& Q811H2& DOWN&
8.24& 8.81& f1.49& 0.004747& Klhl24& Q8BRG6& DOWN&
10& 10.57& f1.49& 0.009873& Tmem175& Q9CXY1& DOWN&
8.99& 9.57& f1.49& 0.006244& Slc25a19& Q9DAM5& DOWN&
9.62& 10.19& f1.49& 0.003718& Cab39l& Q9DB16& DOWN&
9.04& 9.62& f1.49& 0.004322& Cd320& Q9Z1P5& DOWN&
8.64& 9.22& f1.49& 0.008727& Ccdc76& #N/A& DOWN&
7.03& 7.61& f1.49& 0.008833& Dclk2& #N/A& DOWN&
8.22& 8.79& f1.49& 0.00944& I79_011251& #N/A& DOWN&
8.29& 8.86& f1.49& 0.006224& I79_012309& #N/A& DOWN&
8.81& 9.38& f1.49& 0.009094& LOC100753065& #N/A& DOWN&
7.65& 8.23& f1.49& 0.006591& LOC100764227& #N/A& DOWN&
9.25& 9.83& f1.49& 0.008598& Zfc3h1& #N/A& DOWN&
10.45& 11.04& f1.5& 0.005005& Glg1& E9PWD8& DOWN&
7.33& 7.91& f1.5& 0.002887& Map3k13& Q1HKZ5& DOWN&
10.42& 11.01& f1.5& 0.002392& Dpy19l3& Q71B07& DOWN&
10.11& 10.7& f1.5& 0.002567& Tmem184b& Q8BG09& DOWN&
7.51& 8.1& f1.5& 0.005619& Pygl& Q9ET01& DOWN&
8.69& 9.28& f1.5& 0.007164& Pign& Q9R1S3& DOWN&
8.41& 9& f1.5& 0.009541& I79_007541& #N/A& DOWN&
6.06& 6.65& f1.5& 0.003718& I79_023557& #N/A& DOWN&
7.34& 7.94& f1.51& 0.00481& Ppm1e& B2KGP3& DOWN&
8.73& 9.33& f1.51& 0.008527& Map3k12& E9PZU4& DOWN&
7.25& 7.84& f1.51& 0.008739& Socs3& Q3U9J8& DOWN&
9.41& 10.01& f1.51& 0.003587& Ddr1& Q544T2& DOWN&
7.55& 8.14& f1.51& 0.00667& Pcyt1b& Q811Q9& DOWN&
7.25& 7.85& f1.51& 0.002557& Phf21b& Q8C966& DOWN&
8.3& 8.89& f1.51& 0.009602& Nrm& Q8VC65& DOWN&
9.39& 9.98& f1.51& 0.004101& Aig1& Q9D8B1& DOWN&
6.15& 6.75& f1.51& 0.008522& I79_003763& #N/A& DOWN&
9.2& 9.8& f1.51& 0.004216& I79_026264& #N/A& DOWN&
10.24& 10.83& f1.51& 0.005373& LOC100760720& #N/A& DOWN&
8.13& 8.74& f1.52& 0.007267& Larp1b& E9PYM4& DOWN&




8.3& 8.91& f1.52& 0.006085& Exd2& F8WID1& DOWN&
10.68& 11.28& f1.52& 0.005465& Fuca1& Q3TCW3& DOWN&
10.55& 11.15& f1.52& 0.008796& Rad23a& Q3TN85& DOWN&
8.36& 8.96& f1.52& 0.009139& Rint1& Q8BZ36& DOWN&
6.96& 7.57& f1.52& 0.006953& Pmvk& Q9D1G2& DOWN&
7.15& 7.75& f1.52& 0.007149& B3galnt1& #N/A& DOWN&
8.38& 8.98& f1.52& 0.009139& Cntnap1& #N/A& DOWN&
7.41& 8.01& f1.52& 0.001373& Heatr7a& #N/A& DOWN&
8.8& 9.4& f1.52& 0.005373& I79_004782& #N/A& DOWN&
5.2& 5.81& f1.52& 0.005885& I79_005205& #N/A& DOWN&
5.83& 6.43& f1.52& 0.001353& I79_020723& #N/A& DOWN&
3.47& 4.07& f1.52& 0.006249& Or4a15& #N/A& DOWN&
9.23& 9.83& f1.52& 0.002041& Pot1& #N/A& DOWN&
9.04& 9.64& f1.52& 0.00878& Rft2& #N/A& DOWN&
8.79& 9.39& f1.52& 0.007941& Spast& #N/A& DOWN&
9.78& 10.39& f1.53& 0.001947& Pcgf5& B7ZP24& DOWN&
10.43& 11.04& f1.53& 0.004355& Hyou1& E0CYZ2& DOWN&
8.83& 9.44& f1.53& 0.005007& Crtc3& F6UMS9& DOWN&
7.59& 8.2& f1.53& 0.005821& Tmem44& F7D1Q2& DOWN&
7.97& 8.58& f1.53& 0.008532& Trim13& Q3TSD2& DOWN&
8.48& 9.1& f1.53& 0.003414& Lrrc58& Q3UGP9& DOWN&
9.7& 10.32& f1.53& 0.007939& Abr& Q5SSL4& DOWN&
9.44& 10.05& f1.53& 0.001353& Ahcyl2& Q68FL4& DOWN&
7.16& 7.77& f1.53& 0.001713& Loxl1& Q8BP04& DOWN&
10.93& 11.54& f1.53& 0.005588& Mamdc2& Q8CG85& DOWN&
8.61& 9.22& f1.53& 0.0067& Cep57l1& Q9D9M1& DOWN&
8.83& 9.44& f1.53& 0.006822& Ago61& #N/A& DOWN&
10.23& 10.85& f1.53& 0.005623& Pycard& #N/A& DOWN&
7.82& 8.43& f1.53& 0.001353& Tmem237& #N/A& DOWN&
9.93& 10.55& f1.54& 0.000921& Clec16a& D3YVA1& DOWN&
8.09& 8.71& f1.54& 0.007276& Gpt2& D6RFQ8& DOWN&
9.3& 9.92& f1.54& 0.006599& Ubash3b& H3BJB9& DOWN&
11.47& 12.09& f1.54& 0.001055& Rras& P10833& DOWN&
8.76& 9.39& f1.54& 0.006918& Pja2& Q0VDX8& DOWN&
9.73& 10.35& f1.54& 0.005373& Col5a2& Q3U962& DOWN&
8.64& 9.26& f1.54& 0.00338& Fam135a& Q6NS59& DOWN&
9.13& 9.76& f1.54& 0.001541& Eif4a2& Q8BTU6& DOWN&
10.32& 10.95& f1.54& 0.00417& Minpp1& Q8C9C2& DOWN&
7.15& 7.77& f1.54& 0.003718& Stx3& Q8CAN1& DOWN&
9.56& 10.18& f1.54& 0.003876& Rnf183& Q8QZS5& DOWN&
8.84& 9.47& f1.54& 0.006731& Acp5& #N/A& DOWN&
9.84& 10.47& f1.54& 0.002841& I79_005632& #N/A& DOWN&
8.73& 9.36& f1.54& 0.005843& I79_015611& #N/A& DOWN&




8.69& 9.32& f1.54& 0.003221& Nedd1& #N/A& DOWN&
9.41& 10.05& f1.55& 0.003004& Parp4& E9PYK3& DOWN&
10.82& 11.46& f1.55& 0.003587& Rock2& P70336& DOWN&
10.83& 11.46& f1.55& 0.001862& Arid5b& Q3TRJ5& DOWN&
9.27& 9.9& f1.55& 0.003051& Lrrc58& Q3UGP9& DOWN&
9.71& 10.35& f1.55& 0.003604& Baz2a& Q3UXC9& DOWN&
7.13& 7.77& f1.55& 0.005212& Letm2& Q7TNU7& DOWN&
9& 9.63& f1.55& 0.007596& Nagpa& Q8BJ48& DOWN&
9.42& 10.04& f1.55& 0.00209& Gdpd5& #N/A& DOWN&
8.32& 8.96& f1.55& 0.009139& Tada3& #N/A& DOWN&
9.86& 10.49& f1.56& 0.005636& Hipk1& A0S0L5& DOWN&
8.8& 9.45& f1.56& 0.007388& Msl1& F7CR37& DOWN&
9.4& 10.04& f1.56& 0.007273& Pde5a& Q8BJ62& DOWN&
9.83& 10.47& f1.56& 0.003718& Bbx& Q8C9P7& DOWN&
9.24& 9.88& f1.56& 0.003862& Uap1& Q91YN5& DOWN&
8.41& 9.06& f1.56& 0.007672& Phf14& Q9D4H9& DOWN&
7.5& 8.14& f1.56& 0.005279& Slc5a3& Q9JKZ2& DOWN&
9.74& 10.39& f1.56& 0.004495& Fam160b1& #N/A& DOWN&
7.38& 8.03& f1.56& 0.002995& Heatr5a& #N/A& DOWN&
5.7& 6.35& f1.56& 0.004588& I79_007835& #N/A& DOWN&
6.5& 7.14& f1.56& 0.009214& I79_009106& #N/A& DOWN&
6.68& 7.32& f1.56& 0.008638& I79_021705& #N/A& DOWN&
5.52& 6.15& f1.56& 0.008927& LOC100751350& #N/A& DOWN&
8.07& 8.72& f1.56& 0.005809& LOC100767289& #N/A& DOWN&
7.45& 8.11& f1.57& 0.007058& Ankrd34a& B2RW11& DOWN&
11.28& 11.93& f1.57& 0.002879& Itgb5& O70309& DOWN&
10.83& 11.48& f1.57& 0.004562& Dcakd& Q8BHC4& DOWN&
11.47& 12.12& f1.57& 0.001715& Scarb1& Q8BNQ0& DOWN&
7.86& 8.51& f1.57& 0.00751& Arid4a& Q8BY40& DOWN&
10.85& 11.51& f1.57& 0.002995& Smpd1& Q8K011& DOWN&
8.48& 9.13& f1.57& 0.004721& Pycr1& Q922W5& DOWN&
8.48& 9.13& f1.57& 0.003718& Tctn2& Q9D8A8& DOWN&
8.71& 9.36& f1.57& 0.004677& Mapk1ip1& #N/A& DOWN&
9.18& 9.83& f1.57& 0.006593& Tfap2a& #N/A& DOWN&
10.6& 11.27& f1.58& 0.003718& Pxdn& D3Z5M7& DOWN&
8.42& 9.08& f1.58& 0.001926& Chka& D6RG40& DOWN&
7.89& 8.55& f1.58& 0.009222& Uspl1& Q3ULM6& DOWN&
8.39& 9.04& f1.58& 0.002879& Eras& Q7TN89& DOWN&
8.38& 9.04& f1.58& 0.004302& Sccpdh& Q8R127& DOWN&
6.56& 7.22& f1.58& 0.001947& Ccrl1& #N/A& DOWN&
9.3& 9.96& f1.58& 0.006491& Ebf2& #N/A& DOWN&
9.34& 10& f1.58& 0.004302& Hspa2& #N/A& DOWN&
6.22& 6.88& f1.58& 0.008422& Tbc1d8& #N/A& DOWN&




10.2& 10.87& f1.59& 0.009638& Mesdc2& D3YVR4& DOWN&
9.5& 10.17& f1.59& 0.004216& Igsf8& D3Z4Q8& DOWN&
7.62& 8.29& f1.59& 0.007861& Sorbs1& E9PYX6& DOWN&
6.88& 7.55& f1.59& 0.001947& Shox2& F6UTR6& DOWN&
7.81& 8.49& f1.59& 0.004611& Eapp& Q5BU09& DOWN&
8.61& 9.28& f1.59& 0.009604& Boc& Q6AZB0& DOWN&
6.23& 6.9& f1.59& 0.003503& Adck1& Q9D0L4& DOWN&
10.53& 11.2& f1.59& 0.002343& Dcbld2& Q9D9K5& DOWN&
5.67& 6.34& f1.59& 0.009888& Cttnbp2& R7RU63& DOWN&
7.36& 8.03& f1.59& 0.006593& I79_019388& #N/A& DOWN&
10.08& 10.75& f1.6& 0.002041& Cnpy3& B0V2V1& DOWN&
9.13& 9.81& f1.6& 0.004355& Ttc17& E9PVB5& DOWN&
9.37& 10.05& f1.6& 0.005185& Tgfb1i1& E9PYQ1& DOWN&
10.63& 11.31& f1.6& 0.002856& Ermp1& F6TQS9& DOWN&
8.67& 9.35& f1.6& 0.007124& Cnih2& Q3SYI8& DOWN&
8.03& 8.7& f1.6& 0.004898& Prkca& Q3TQ39& DOWN&
7.84& 8.52& f1.6& 0.005616& Mga& Q3ULI0& DOWN&
6.15& 6.83& f1.6& 0.005518& Gm4952& Q5FW57& DOWN&
7.38& 8.06& f1.6& 0.008727& Nhlrc3& Q8CCH2& DOWN&
8.53& 9.21& f1.6& 0.005056& Scamp4& Q9JKV5& DOWN&
8.59& 9.26& f1.6& 0.001502& I79_024494& #N/A& DOWN&
9.1& 9.79& f1.61& 0.00984& Srpk2& O54781& DOWN&
7.31& 8& f1.61& 0.002415& Phtf1& Q80YS3& DOWN&
8.13& 8.82& f1.61& 0.005014& Zbtb11& Q8BXA4& DOWN&
8.52& 9.21& f1.61& 0.003565& Sh3d19& Q91X43& DOWN&
9.11& 9.79& f1.61& 0.004355& Itsn2& Q9CQD9& DOWN&
9.12& 9.81& f1.61& 0.001353& Pigc& Q9CXR4& DOWN&
6.97& 7.66& f1.61& 0.004292& I79_004233& #N/A& DOWN&
9.77& 10.46& f1.61& 0.008209& LOC100764737& #N/A& DOWN&
8.06& 8.75& f1.61& 0.003315& LOC100773413& #N/A& DOWN&
7.47& 8.15& f1.61& 0.008565& Nfkbiz& #N/A& DOWN&
9.21& 9.9& f1.62& 0.009688& Trmt1l& A2RSY6& DOWN&
7.68& 8.37& f1.62& 0.005138& Rpgrip1l& D3Z0V3& DOWN&
8.26& 8.96& f1.62& 0.003565& Chka& D6RG40& DOWN&
8.59& 9.29& f1.62& 0.00411& Ptgr2& D6RGL6& DOWN&
9.39& 10.09& f1.62& 0.002392& Plxna2& F6VSI0& DOWN&
8.03& 8.72& f1.62& 0.008374& Ube3a& O08759& DOWN&
8.58& 9.28& f1.62& 0.00751& Pias3& O54714& DOWN&
6.57& 7.26& f1.62& 0.004963& Col4a1& P02463& DOWN&
6.41& 7.1& f1.62& 0.005861& Ctsk& P55097& DOWN&
6.9& 7.6& f1.62& 0.002817& Sdccag8& Q05DD9& DOWN&
9.18& 9.88& f1.62& 0.006482& Etv1& Q549J8& DOWN&
9.28& 9.98& f1.62& 0.006025& Adam23& Q5SRA0& DOWN&




8.62& 9.32& f1.62& 0.00701& Cacna2d1& Q8C6Y3& DOWN&
8.67& 9.37& f1.62& 0.009552& Creld1& Q91XD7& DOWN&
5.26& 5.96& f1.62& 0.008332& I79_003014& #N/A& DOWN&
8.49& 9.19& f1.62& 0.007939& I79_015167& #N/A& DOWN&
8.14& 8.84& f1.63& 0.003947& Txndc16& D3Z7P6& DOWN&
8.02& 8.73& f1.63& 0.005565& Irf3& P70671& DOWN&
8.3& 9.01& f1.63& 0.00878& Ttc21b& Q3TP46& DOWN&
9.24& 9.94& f1.63& 0.00701& Cdon& Q3TZM7& DOWN&
8.33& 9.03& f1.63& 0.005599& Fam178a& Q6P9P0& DOWN&
6.72& 7.42& f1.63& 0.00481& Aqp11& Q8BHH1& DOWN&
9.74& 10.44& f1.63& 0.007345& Psd3& Q8C0E9& DOWN&
10.17& 10.88& f1.63& 0.007345& Baiap2l1& #N/A& DOWN&
6.4& 7.1& f1.63& 0.008768& I79_010994& #N/A& DOWN&
10.58& 11.29& f1.63& 0.004355& LOC100760682& #N/A& DOWN&
8.14& 8.85& f1.63& 0.005185& LOC100768853& #N/A& DOWN&
8.81& 9.51& f1.63& 0.004355& Mettl2& #N/A& DOWN&
8.23& 8.94& f1.63& 0.001926& Pot1& #N/A& DOWN&
7.43& 8.13& f1.63& 0.004227& Znf654& #N/A& DOWN&
9.23& 9.94& f1.64& 0.004355& Efemp2& E9Q8E0& DOWN&
10.79& 11.51& f1.64& 0.00671& Vgll3& P85442& DOWN&
8.59& 9.31& f1.64& 0.004302& Fchsd2& Q3U0A9& DOWN&
8.86& 9.58& f1.64& 0.006426& Arhgap10& Q6Y5D8& DOWN&
9.04& 9.75& f1.64& 0.005014& Osbpl3& Q80UX3& DOWN&
8.63& 9.35& f1.64& 0.004151& Arsj& Q8BM89& DOWN&
10.27& 10.98& f1.64& 0.004183& Foxo1& Q8BPP2& DOWN&
7.99& 8.71& f1.64& 0.002985& Dnase1l1& Q9D7J6& DOWN&
9.3& 10.01& f1.64& 0.005783& Git2& Q9JLQ2& DOWN&
11.49& 12.21& f1.64& 0.00944& I79_026010& #N/A& DOWN&
10.26& 10.98& f1.64& 0.005224& LOC100757521& #N/A& DOWN&
9.17& 9.88& f1.64& 0.001715& Napepld& #N/A& DOWN&
7.73& 8.44& f1.65& 0.003769& Fblim1& A2ADE8& DOWN&
6.78& 7.51& f1.65& 0.007947& Pcdh7& E9Q2S0& DOWN&
11.51& 12.23& f1.65& 0.00209& Gaa& P70699& DOWN&
10.12& 10.85& f1.65& 0.002292& Wsb2& Q3UC26& DOWN&
9.52& 10.24& f1.65& 0.007164& Sipa1l1& Q4VBF8& DOWN&
9.99& 10.71& f1.65& 0.00508& Sipa1& Q7TMS2& DOWN&
9.5& 10.22& f1.65& 0.006968& Dock4& Q8BMP2& DOWN&
9.03& 9.75& f1.65& 0.002392& Nqo1& Q99KL8& DOWN&
11.61& 12.33& f1.65& 0.00545& fff& #N/A& DOWN&
8.18& 8.9& f1.65& 0.009695& Cnnm2& #N/A& DOWN&
6.3& 7.02& f1.65& 0.005927& I79_010657& #N/A& DOWN&
8.17& 8.89& f1.65& 0.005955& Wasf1& #N/A& DOWN&
7.71& 8.43& f1.65& 0.006482& Znf318& #N/A& DOWN&




9.89& 10.62& f1.66& 0.005518& Tgfbr3& O88393& DOWN&
10.32& 11.05& f1.66& 0.002967& Met& P16056& DOWN&
9.2& 9.93& f1.66& 0.003795& Nek1& P51954& DOWN&
9.54& 10.27& f1.66& 0.001515& Etv4& Q3TYM4& DOWN&
6.76& 7.49& f1.66& 0.008315& Ipp& Q8BY33& DOWN&
8.96& 9.7& f1.66& 0.003471& Ctsf& Q9R013& DOWN&
8.98& 9.71& f1.66& 0.002392& Cflar& #N/A& DOWN&
7.89& 8.62& f1.66& 0.002429& I79_000078& #N/A& DOWN&
6.08& 6.81& f1.66& 0.009279& I79_016894& #N/A& DOWN&
10.1& 10.83& f1.66& 0.003331& Inm02& #N/A& DOWN&
9.08& 9.81& f1.66& 0.008714& Ints6& #N/A& DOWN&
9.03& 9.76& f1.66& 0.003894& LOC100752469& #N/A& DOWN&
7.9& 8.64& f1.66& 0.006588& Ngf& #N/A& DOWN&
7.22& 7.96& f1.67& 0.002041& Ttbk2& A2AW14& DOWN&
10.71& 11.46& f1.67& 0.003458& Lamb1& E9QN70& DOWN&
11.91& 12.65& f1.67& 0.001353& Thbs1& Q80YQ1& DOWN&
7.82& 8.55& f1.67& 0.006327& Pign& Q9R1S3& DOWN&
9.88& 10.61& f1.67& 0.003002& fff& #N/A& DOWN&
7.14& 7.88& f1.67& 0.001625& I79_013426& #N/A& DOWN&
7.43& 8.17& f1.67& 0.002392& I79_020093& #N/A& DOWN&
8.01& 8.75& f1.67& 0.004898& LOC100773770& #N/A& DOWN&
6.5& 7.25& f1.68& 0.005185& Serpinf1& E9PWS2& DOWN&
7.53& 8.28& f1.68& 0.00474& Bahcc1& E9Q7G4& DOWN&
8.15& 8.91& f1.68& 0.008369& Nav3& F6U6A7& DOWN&
9.84& 10.59& f1.68& 0.004355& E2f6& O54917& DOWN&
7.48& 8.24& f1.69& 0.009945& Ctnna2& E0CXB9& DOWN&
8.2& 8.96& f1.69& 0.006286& Atat1& F6RPX5& DOWN&
10.38& 11.13& f1.69& 0.006332& Plod2& Q9R0B9& DOWN&
10.27& 11.03& f1.69& 0.002567& Cachd1& Z4YK18& DOWN&
9.67& 10.42& f1.69& 0.002041& I79_003336& #N/A& DOWN&
8.22& 8.98& f1.69& 0.008319& I79_007417& #N/A& DOWN&
9.52& 10.28& f1.7& 0.002392& Sh2b3& D3Z0T9& DOWN&
9.56& 10.32& f1.7& 0.009874& Acss2& F7CU63& DOWN&
9.3& 10.07& f1.7& 0.002995& Lrp5& H3BIY3& DOWN&
7.27& 8.04& f1.7& 0.006915& Rap1gap2& Q5SUE5& DOWN&
12.06& 12.82& f1.7& 0.001947& Serpinh1& Q8BVU9& DOWN&
6.86& 7.63& f1.7& 0.009541& Cdkl2& #N/A& DOWN&
8.7& 9.46& f1.7& 0.008267& I79_004447& #N/A& DOWN&
8.69& 9.46& f1.71& 0.00313& Exosc9& F6Y747& DOWN&
8.43& 9.21& f1.71& 0.002538& Fam96b& F8WHV1& DOWN&
8.58& 9.36& f1.71& 0.004939& Abca2& Q3TMR1& DOWN&
10.13& 10.91& f1.71& 0.001373& Anln& Q8K298& DOWN&
10.57& 11.34& f1.71& 0.007149& fff& #N/A& DOWN&




6.25& 7.02& f1.71& 0.009552& I79_015691& #N/A& DOWN&
9.13& 9.92& f1.72& 0.004355& Cdk14& D6RHB2& DOWN&
6.35& 7.14& f1.72& 0.003718& Zfhx4& E9Q5A7& DOWN&
9.77& 10.55& f1.72& 0.002392& Flot1& O08917& DOWN&
8.23& 9.02& f1.72& 0.005178& Fchsd2& Q3U0A9& DOWN&
8.37& 9.16& f1.72& 0.009247& Hmga2& Q6NSP9& DOWN&
8.66& 9.44& f1.72& 0.005093& Nav2& V9GXT5& DOWN&
4.92& 5.7& f1.72& 0.006224& Areg& #N/A& DOWN&
6.27& 7.06& f1.72& 0.005544& I79_002403& #N/A& DOWN&
6.87& 7.65& f1.72& 0.006399& I79_003410& #N/A& DOWN&
8.56& 9.35& f1.72& 0.008209& LOC100770196& #N/A& DOWN&
11.11& 11.89& f1.72& 0.001715& Pdia4& #N/A& DOWN&
9.67& 10.46& f1.73& 0.004976& Hcfc1r1& J3QPD4& DOWN&
9.08& 9.87& f1.73& 0.007373& Dnase1l3& O55070& DOWN&
9.44& 10.23& f1.73& 0.003718& Itfg3& Q8C0Z1& DOWN&
9.34& 10.13& f1.73& 0.00687& Tmem50b& Q9D1X9& DOWN&
8.66& 9.46& f1.74& 0.003718& Pdgfc& D6RGS6& DOWN&
9.16& 9.96& f1.74& 0.001361& Usp32& G3UXQ4& DOWN&
8.21& 9.02& f1.74& 0.007149& Brwd1& Q8BPZ1& DOWN&
10& 10.8& f1.74& 0.008796& Akt3& Q9WUA6& DOWN&
7.58& 8.38& f1.74& 0.008432& Epas1& #N/A& DOWN&
6.25& 7.06& f1.74& 0.009874& Heatr4& #N/A& DOWN&
5.96& 6.76& f1.74& 0.002687& I79_004019& #N/A& DOWN&
6.6& 7.4& f1.74& 0.007164& I79_009797& #N/A& DOWN&
9.63& 10.44& f1.75& 0.009236& Fhl2& O70433& DOWN&
9.02& 9.83& f1.75& 0.006927& Mettl4& Q3U034& DOWN&
10.7& 11.5& f1.75& 0.002222& Ganab& Q3UE86& DOWN&
9.46& 10.27& f1.75& 0.002597& Slc38a10& Q5I012& DOWN&
9.82& 10.63& f1.75& 0.00388& I79_022228& #N/A& DOWN&
9.82& 10.63& f1.75& 0.00388& I79_025164& #N/A& DOWN&
8.08& 8.89& f1.75& 0.007672& Trim34& #N/A& DOWN&
10.39& 11.21& f1.76& 0.002841& Itgav& P43406& DOWN&
10.07& 10.88& f1.76& 0.003672& Tiparp& Q8C1B2& DOWN&
9.02& 9.83& f1.76& 0.001715& C7orf58& #N/A& DOWN&
8.96& 9.77& f1.76& 0.007672& I79_024686& #N/A& DOWN&
7.22& 8.05& f1.77& 0.003718& Kif21a& F8WGN6& DOWN&
8.06& 8.89& f1.77& 0.007119& Tanc2& Q3UF55& DOWN&
7.99& 8.81& f1.77& 0.007659& Ddx50& Q99MJ9& DOWN&
6.83& 7.65& f1.77& 0.002597& Dst& S4R1Y6& DOWN&
6.18& 7.01& f1.77& 0.001353& I79_026093& #N/A& DOWN&
8.14& 8.96& f1.77& 0.009141& Kiaa0240& #N/A& DOWN&
7.6& 8.43& f1.77& 0.004122& Kiaa0586& #N/A& DOWN&
8.57& 9.4& f1.77& 0.002995& Lgr4& #N/A& DOWN&




4.19& 5.03& f1.78& 0.009338& Pol& P10400& DOWN&
9.99& 10.82& f1.78& 0.007164& P4ha1& Q60715& DOWN&
7.67& 8.51& f1.78& 0.005868& Lrif1& Q8CDD9& DOWN&
7.19& 8.02& f1.78& 0.005927& Gstk1& Q9DCM2& DOWN&
7.61& 8.44& f1.78& 0.007164& I79_015359& #N/A& DOWN&
7.81& 8.64& f1.78& 0.004691& I79_024054& #N/A& DOWN&
8.35& 9.18& f1.78& 0.009688& LOC100751127& #N/A& DOWN&
8.48& 9.32& f1.79& 0.003103& Abl2& B2RQ57& DOWN&
9.32& 10.15& f1.79& 0.007242& Mov10& D3YVL0& DOWN&
8.31& 9.16& f1.79& 0.0091& Rasal2& Q3TPW3& DOWN&
7.89& 8.72& f1.79& 0.004719& Syne2& Q6ZWQ0& DOWN&
8.95& 9.79& f1.79& 0.00499& Fut8& Q9WTS2& DOWN&
6.62& 7.46& f1.79& 0.007005& I79_012982& #N/A& DOWN&
7.32& 8.16& f1.79& 0.00701& I79_017575& #N/A& DOWN&
6.36& 7.2& f1.79& 0.005812& LOC100766236& #N/A& DOWN&
8.98& 9.82& f1.8& 0.004565& Dock9& B2RY08& DOWN&
8.33& 9.17& f1.8& 0.007978& Agpat9& D3YUY8& DOWN&
8.14& 8.99& f1.8& 0.007672& Plcd3& F7AAE0& DOWN&
6.95& 7.8& f1.8& 0.007122& Cryba1& P02525& DOWN&
7.64& 8.49& f1.8& 0.004384& Gpr19& Q61121& DOWN&
6.62& 7.47& f1.8& 0.007005& Lpxn& Q99N69& DOWN&
7.46& 8.31& f1.8& 0.005658& Mthfs& Q9D110& DOWN&
10.03& 10.88& f1.8& 0.002429& I79_002408& #N/A& DOWN&
9.02& 9.87& f1.8& 0.007276& I79_011822& #N/A& DOWN&
7.74& 8.58& f1.8& 0.008595& I79_024617& #N/A& DOWN&
10.53& 11.39& f1.81& 0.008326& Adam19& Q3UH67& DOWN&
8.94& 9.79& f1.81& 0.004611& Dmtf1& V9GX14& DOWN&
7.41& 8.27& f1.81& 0.003536& C1rl& #N/A& DOWN&
10.3& 11.16& f1.81& 0.001353& LOC100772783& #N/A& DOWN&
9.69& 10.55& f1.82& 0.002881& Ypel3& D3Z3G7& DOWN&
8.59& 9.45& f1.82& 0.001754& Eif4enif1& Q3TS00& DOWN&
9.08& 9.94& f1.82& 0.003051& Emsy& Q8BMB0& DOWN&
8.96& 9.82& f1.82& 0.007692& Pofut2& Q8VHI3& DOWN&
8.86& 9.72& f1.82& 0.004511& Arhgef5& Q922T1& DOWN&
9.4& 10.26& f1.82& 0.006211& fff& #N/A& DOWN&
10.95& 11.83& f1.83& 0.001353& Errfi1& Q3TJN8& DOWN&
6.28& 7.15& f1.83& 0.006448& Dhrs9& Q58NB6& DOWN&
7.25& 8.12& f1.83& 0.006777& Galk2& Q68FH4& DOWN&
7.18& 8.05& f1.83& 0.002298& I79_005029& #N/A& DOWN&
8.3& 9.17& f1.83& 0.001947& LOC100755141& #N/A& DOWN&
7.54& 8.43& f1.84& 0.004814& Vezt& Q3ZK22& DOWN&
8.18& 9.06& f1.84& 0.003926& Snx13& Q6PHS6& DOWN&
6.65& 7.54& f1.85& 0.007396& Swt1& Q9DBQ9& DOWN&




8.21& 9.11& f1.86& 0.00338& Fam46d& B1ATX4& DOWN&
7.71& 8.6& f1.86& 0.00762& Gstp2& K9JA74& DOWN&
4.45& 5.34& f1.86& 0.003853& Arhgap20& Q3V0V2& DOWN&
9.16& 10.06& f1.86& 0.004065& fff& #N/A& DOWN&
8.19& 9.08& f1.86& 0.001353& Dcaf6& #N/A& DOWN&
7.36& 8.25& f1.86& 0.004542& I79_025169& #N/A& DOWN&
8.62& 9.52& f1.86& 0.005812& Ndp& #N/A& DOWN&
8.85& 9.75& f1.86& 0.003478& Poglut1& #N/A& DOWN&
9.24& 10.14& f1.87& 0.002292& Srsf11& D3Z4B0& DOWN&
9.95& 10.85& f1.87& 0.002345& Arhgap29& Q8CGF1& DOWN&
6.85& 7.76& f1.88& 0.008969& Grhl1& E9QMF0& DOWN&
10.52& 11.43& f1.88& 0.003221& Galm& Q8K157& DOWN&
8& 8.91& f1.88& 0.003584& Aer61& #N/A& DOWN&
8.63& 9.54& f1.88& 0.005665& I79_002570& #N/A& DOWN&
8.37& 9.29& f1.89& 0.001353& Kif21a& F8WGN6& DOWN&
8.36& 9.28& f1.89& 0.007562& Nbea& Q6P2L4& DOWN&
5.29& 6.21& f1.89& 0.004442& Rpf1& #N/A& DOWN&
8.19& 9.12& f1.9& 0.008848& Dhx57& Q6P5D3& DOWN&
6.43& 7.36& f1.9& 0.009621& LOC100752390& #N/A& DOWN&
8.7& 9.63& f1.9& 0.006081& Socs1& #N/A& DOWN&
9.19& 10.11& f1.9& 0.008637& Wdr67& #N/A& DOWN&
5.64& 6.57& f1.91& 0.009638& Vwa5a& D3Z671& DOWN&
9.06& 9.99& f1.91& 0.001353& Mtmr10& Q7TPM9& DOWN&
6.04& 6.98& f1.91& 0.003894& I79_001835& #N/A& DOWN&
6.24& 7.17& f1.91& 0.004442& I79_003701& #N/A& DOWN&
9.42& 10.35& f1.91& 0.006913& I79_026123& #N/A& DOWN&
8.5& 9.43& f1.91& 0.005279& LOC100759025& #N/A& DOWN&
8.26& 9.2& f1.92& 0.00543& Tnrc6c& B1ATC3& DOWN&
7.81& 8.75& f1.92& 0.008068& Plcxd3& Q8BLJ3& DOWN&
8.95& 9.9& f1.92& 0.004721& I79_007625& #N/A& DOWN&
9.49& 10.43& f1.92& 0.005005& Sema3e& #N/A& DOWN&
8.66& 9.61& f1.93& 0.003372& Mtf2& M0QWI3& DOWN&
10.02& 10.98& f1.93& 0.002995& Mcl1& P97287& DOWN&
7.63& 8.58& f1.93& 0.005056& Arid3b& Q3V3M5& DOWN&
7.61& 8.56& f1.93& 0.007687& Katnal1& Q8K0T4& DOWN&
8.49& 9.45& f1.94& 0.004404& Plcxd2& B2RXA1& DOWN&
10.04& 11& f1.94& 0.001023& Fgfrl1& #N/A& DOWN&
7.86& 8.82& f1.95& 0.005128& Smarca1& Q8BS67& DOWN&
9.22& 10.18& f1.95& 0.005185& I79_011973& #N/A& DOWN&
10.41& 11.38& f1.96& 0.002386& Fubp1& Q3TUE1& DOWN&
7.81& 8.79& f1.96& 0.004882& Tpk1& Q9R0M5& DOWN&
9.53& 10.5& f1.96& 0.00209& C7orf60& #N/A& DOWN&
9.44& 10.41& f1.96& 0.009131& I79_017434& #N/A& DOWN&




7.68& 8.66& f1.97& 0.00432& Ptx3& #N/A& DOWN&
9.44& 10.42& f1.98& 0.001361& Lman2l& J3QNZ7& DOWN&
6.24& 7.23& f1.98& 0.002356& I79_020724& #N/A& DOWN&
7.35& 8.34& f1.99& 0.002933& Itga3& Q62470& DOWN&
9.32& 10.31& f1.99& 0.005513& Nbea& Q6P2L4& DOWN&
7.66& 8.65& f1.99& 0.005382& Dhx57& Q6P5D3& DOWN&
8.17& 9.16& f1.99& 0.006074& B3gnt9& Q8VI16& DOWN&
8.23& 9.22& f1.99& 0.002041& Epb41l5& #N/A& DOWN&
8.65& 9.64& f1.99& 0.00327& Znf260& #N/A& DOWN&
9.4& 10.41& f2& 0.002995& Gpsm2& A2AEL5& DOWN&
7.93& 8.93& f2& 0.001589& Il15ra& Q60819& DOWN&
8.17& 9.17& f2& 0.003936& Tmem2& Q8BS93& DOWN&
8.51& 9.52& f2& 0.002867& Tmem170a& #N/A& DOWN&
8.14& 9.14& f2.01& 0.002867& Tars2& E9Q7H6& DOWN&
6.23& 7.24& f2.01& 0.007261& I79_003762& #N/A& DOWN&
8.84& 9.85& f2.01& 0.005536& Kiaa2026& #N/A& DOWN&
8.97& 9.98& f2.01& 0.005108& Nr1d1& #N/A& DOWN&
10.39& 11.41& f2.03& 0.004355& fff& #N/A& DOWN&
5.56& 6.59& f2.03& 0.008442& I79_018889& #N/A& DOWN&
5.44& 6.46& f2.03& 0.008326& I79_021559& #N/A& DOWN&
5.13& 6.16& f2.03& 0.009552& LOC100772772& #N/A& DOWN&
7.81& 8.84& f2.04& 0.004355& Gpr3& B1AUM8& DOWN&
7.52& 8.54& f2.04& 0.003& Lama2& Q60675& DOWN&
9.32& 10.35& f2.04& 0.002853& Ehd3& Q8R0V6& DOWN&
8.96& 9.99& f2.04& 0.003718& Klf7& Q99JB0& DOWN&
6.58& 7.6& f2.04& 0.006429& I79_008854& #N/A& DOWN&
7.44& 8.47& f2.04& 0.004539& I79_011972& #N/A& DOWN&
5.47& 6.49& f2.04& 0.00899& I79_012773& #N/A& DOWN&
8.93& 9.96& f2.05& 0.004065& Btg3& D3Z1M9& DOWN&
7.87& 8.9& f2.05& 0.002041& Rabggtb& P53612& DOWN&
7.74& 8.77& f2.05& 0.005532& Slc12a6& Q3V0N8& DOWN&
8.09& 9.13& f2.05& 0.005006& Ddx26b& Q8BND4& DOWN&
8.74& 9.78& f2.06& 0.005565& Cybrd1& B2RVP1& DOWN&
10.83& 11.87& f2.06& 0.002995& I79_000466& #N/A& DOWN&
9.88& 10.92& f2.06& 0.005185& I79_004545& #N/A& DOWN&
10.83& 11.87& f2.06& 0.002995& I79_015048& #N/A& DOWN&
9.14& 10.19& f2.07& 0.005008& Fez2& Q6TYB5& DOWN&
7.37& 8.42& f2.07& 0.009621& Myl9& #N/A& DOWN&
7.2& 8.26& f2.08& 0.003098& Dusp6& Q3U786& DOWN&
6.18& 7.24& f2.08& 0.009846& Kiaa1024& Q8K3V7& DOWN&
9.21& 10.27& f2.08& 0.004355& Fam48a& #N/A& DOWN&
8.82& 9.88& f2.08& 0.002841& I79_015705& #N/A& DOWN&
8.54& 9.61& f2.1& 0.00523& Eri2& D6RE53& DOWN&




7.76& 8.84& f2.11& 0.0037& Filip1l& E0CYM1& DOWN&
8.39& 9.47& f2.11& 0.001353& Man2a2& Q7TPQ0& DOWN&
9.3& 10.38& f2.11& 0.001353& Pgm2l1& Q8CAA7& DOWN&
7.72& 8.79& f2.11& 0.005373& I79_009763& #N/A& DOWN&
4.89& 5.97& f2.11& 0.004416& LOC100759368& #N/A& DOWN&
9.99& 11.06& f2.11& 0.006918& LOC100770147& #N/A& DOWN&
10.68& 11.77& f2.12& 0.001023& Alcam& Q61490& DOWN&
8.41& 9.49& f2.12& 0.004292& Steap2& Q8BWB6& DOWN&
9.76& 10.84& f2.12& 0.008547& fff& #N/A& DOWN&
7& 8.08& f2.12& 0.005411& I79_000606& #N/A& DOWN&
6.95& 8.03& f2.12& 0.007164& I79_004971& #N/A& DOWN&
9.21& 10.3& f2.13& 0.0091& fff& #N/A& DOWN&
9.34& 10.44& f2.14& 0.002995& Socs2& D3Z441& DOWN&
6.89& 7.99& f2.14& 0.001353& Lama2& Q60675& DOWN&
8.19& 9.3& f2.15& 0.002879& I79_003106& #N/A& DOWN&
7.4& 8.51& f2.15& 0.009279& I79_003281& #N/A& DOWN&
9.46& 10.57& f2.15& 0.002841& Neu1& #N/A& DOWN&
9.65& 10.76& f2.16& 0.003797& Pld3& D3YY25& DOWN&
8.73& 9.84& f2.16& 0.006248& Glcci1& E0CXI8& DOWN&
8.13& 9.24& f2.16& 0.006774& Aff2& Q8BQB7& DOWN&
8.48& 9.59& f2.16& 0.006074& Eif2c3& #N/A& DOWN&
7.62& 8.73& f2.16& 0.001353& LOC100750665& #N/A& DOWN&
9.83& 10.95& f2.17& 0.004542& fff& #N/A& DOWN&
4.98& 6.1& f2.17& 0.004569& Fam5c& #N/A& DOWN&
7.38& 8.51& f2.18& 0.003866& Bfar& Q8R079& DOWN&
9.36& 10.49& f2.18& 0.003139& B4galt3& Q91YY2& DOWN&
8.51& 9.63& f2.18& 0.006482& fff& #N/A& DOWN&
7.78& 8.92& f2.19& 0.006508& Mertk& Q8C584& DOWN&
6.25& 7.39& f2.19& 0.007386& I79_013812& #N/A& DOWN&
9.76& 10.89& f2.2& 0.001353& Idua& P48441& DOWN&
8.33& 9.47& f2.21& 0.005415& Six4& H3BL91& DOWN&
8.97& 10.11& f2.21& 0.004542& Sel1l3& #N/A& DOWN&
9.12& 10.27& f2.22& 0.006426& LOC100774774& #N/A& DOWN&
8.88& 10.04& f2.24& 0.002841& Uhrf2& Q3T995& DOWN&
6.13& 7.3& f2.25& 0.003221& Arhgef16& Q3U5C8& DOWN&
6.82& 7.99& f2.25& 0.003707& Pigk& Q9CXY9& DOWN&
8.8& 9.97& f2.25& 0.00573& fff& #N/A& DOWN&
6.05& 7.22& f2.25& 0.003696& I79_005425& #N/A& DOWN&
8.78& 9.96& f2.25& 0.009839& I79_010455& #N/A& DOWN&
6.58& 7.75& f2.25& 0.005008& Sh3rf2& #N/A& DOWN&
7.81& 8.99& f2.27& 0.004594& Cryz& P47199& DOWN&
8.82& 10& f2.27& 0.002818& fff& #N/A& DOWN&
7.47& 8.65& f2.27& 0.004302& I79_017673& #N/A& DOWN&




8.62& 9.81& f2.28& 0.006588& Plac1& Q9JI83& DOWN&
5.37& 6.56& f2.28& 0.00327& I79_007192& #N/A& DOWN&
6.18& 7.37& f2.28& 0.006831& I79_007718& #N/A& DOWN&
7.41& 8.6& f2.28& 0.001926& I79_016813& #N/A& DOWN&
7.46& 8.66& f2.29& 0.003816& Usp33& D6RES0& DOWN&
8.35& 9.55& f2.29& 0.002817& Tmeff1& Q6PFE7& DOWN&
8.62& 9.82& f2.3& 0.005955& Mtf2& M0QWI3& DOWN&
8.42& 9.62& f2.31& 0.003718& Map1a& #N/A& DOWN&
7.81& 9.03& f2.32& 0.001813& Ssx2ip& Q8VC66& DOWN&
9.67& 10.89& f2.33& 0.003584& Gbp2& Q9Z0E6& DOWN&
9.53& 10.75& f2.33& 0.001589& Mllt11& #N/A& DOWN&
8.25& 9.48& f2.34& 0.001575& Grb14& Q9JLM9& DOWN&
8.51& 9.74& f2.35& 0.005532& Adamts6& D3Z1A5& DOWN&
10.27& 11.51& f2.35& 0.002738& Igfbp4& Q8BSM9& DOWN&
9.24& 10.48& f2.35& 0.003795& Ccnjl& #N/A& DOWN&
9.24& 10.47& f2.35& 0.003162& I79_011371& #N/A& DOWN&
8.41& 9.65& f2.36& 0.003009& Depdc5& Q6GQV2& DOWN&
11& 12.25& f2.37& 0.001353& Tnfsf9& Q3TEQ6& DOWN&
7.9& 9.15& f2.37& 0.00666& I79_006727& #N/A& DOWN&
8.7& 9.94& f2.37& 0.002948& Sel1l3& #N/A& DOWN&
7.9& 9.14& f2.38& 0.003949& I79_007724& #N/A& DOWN&
7.7& 8.97& f2.4& 0.003309& Ptgs2& Q3UMR6& DOWN&
7.29& 8.56& f2.4& 0.002995& Tspan2& Q922J6& DOWN&
7.39& 8.65& f2.41& 0.003103& Dsel& Q0VBN2& DOWN&
9.18& 10.45& f2.41& 0.001629& Ccnjl& #N/A& DOWN&
7.68& 8.96& f2.42& 0.003331& Thsd7a& D3YWC4& DOWN&
7.58& 8.86& f2.43& 0.0091& Lphn2& Q3UQ39& DOWN&
8.82& 10.11& f2.44& 0.006863& Vkorc1& Q9CRC0& DOWN&
9.76& 11.04& f2.44& 0.002817& I79_009395& #N/A& DOWN&
6.14& 7.43& f2.45& 0.006327& LOC100754382& #N/A& DOWN&
8.89& 10.19& f2.46& 0.004376& I79_006177& #N/A& DOWN&
10.03& 11.33& f2.46& 0.003414& Wls& #N/A& DOWN&
8.7& 10.01& f2.48& 0.003221& Ttc3& D3Z330& DOWN&
9.63& 10.94& f2.48& 0.003385& I79_024475& #N/A& DOWN&
8.81& 10.12& f2.49& 0.002658& Nox4& S4R1R3& DOWN&
8.99& 10.31& f2.51& 0.002977& Gng5& D3Z7Q3& DOWN&
7.08& 8.41& f2.51& 0.005373& Socs5& Q3UXZ1& DOWN&
10.54& 11.87& f2.52& 0.002789& Egr1& Q544D6& DOWN&
7.83& 9.16& f2.52& 0.001926& Senp7& Q9CQN9& DOWN&
8.35& 9.69& f2.53& 0.003315& Il1rap& Q61730& DOWN&
10.1& 11.44& f2.53& 0.001926& Crim1& Q9JLL0& DOWN&
6.78& 8.12& f2.53& 0.00474& I79_007053& #N/A& DOWN&
5.76& 7.1& f2.53& 0.001947& Rundc3b& #N/A& DOWN&




5.76& 7.11& f2.54& 0.009587& Slc14a1& Q8VHL0& DOWN&
6.75& 8.1& f2.54& 0.00837& I79_002524& #N/A& DOWN&
10.2& 11.55& f2.55& 0.004216& fff& #N/A& DOWN&
8.02& 9.37& f2.55& 0.001353& I79_012737& #N/A& DOWN&
6.73& 8.09& f2.56& 0.008547& I79_017183& #N/A& DOWN&
6.73& 8.09& f2.58& 0.005138& Tspan12& D3YW00& DOWN&
9.3& 10.68& f2.6& 0.002985& Rps4& #N/A& DOWN&
7.19& 8.59& f2.62& 0.004843& Mapk10& Q3TQZ7& DOWN&
5.27& 6.67& f2.65& 0.008083& Serpini1& E0CYW0& DOWN&
9.77& 11.19& f2.67& 0.001926& Crim1& Q9JLL0& DOWN&
7.54& 8.97& f2.68& 0.002879& I79_013538& #N/A& DOWN&
6.32& 7.74& f2.68& 0.003696& I79_025946& #N/A& DOWN&
7.78& 9.21& f2.69& 0.001926& Arhgef4& Q3TDW8& DOWN&
6.58& 8.01& f2.7& 0.009258& Thsd7a& D3YWC4& DOWN&
7.87& 9.31& f2.71& 0.001373& Ccdc92& D6RJ58& DOWN&
6.62& 8.08& f2.74& 0.004151& Gls2& E0CYF7& DOWN&
5.38& 6.83& f2.74& 0.003275& I79_005625& #N/A& DOWN&
7.02& 8.48& f2.75& 0.004495& Env& Q811N5& DOWN&
7.73& 9.19& f2.75& 0.002041& C4orf49& #N/A& DOWN&
8.18& 9.64& f2.76& 0.001353& Zzz3& Q6KAQ7& DOWN&
9.13& 10.6& f2.77& 0.003816& Nab2& Q61127& DOWN&
7.95& 9.43& f2.78& 0.001575& Tlr3& Q99MB1& DOWN&
6.14& 7.62& f2.79& 0.002687& Fst& P47931& DOWN&
4.81& 6.31& f2.82& 0.006223& Chrdl1& Q6NXY0& DOWN&
7.12& 8.62& f2.83& 0.002041& Prkacb& Q8CBP8& DOWN&
6.43& 7.95& f2.86& 0.005927& Pol& P10400& DOWN&
7.99& 9.51& f2.87& 0.002041& Aim2& D3Z341& DOWN&
7.2& 8.72& f2.87& 0.002419& Env& Q811N5& DOWN&
8.84& 10.37& f2.89& 0.002041& Prrx1& Q3TMI4& DOWN&
8.06& 9.6& f2.92& 0.002879& LOC100773320& #N/A& DOWN&
5.19& 6.75& f2.94& 0.004537& Sema3a& E9Q668& DOWN&
8& 9.57& f2.97& 0.001554& Elovl4& Q9EQC4& DOWN&
8.88& 10.46& f3& 0.002879& Ppid& Q9CR16& DOWN&
8.62& 10.21& f3.01& 0.004122& I79_004992& #N/A& DOWN&
5.21& 6.82& f3.06& 0.005472& I79_000888& #N/A& DOWN&
6.46& 8.08& f3.06& 0.001353& I79_020713& #N/A& DOWN&
6.28& 7.91& f3.11& 0.008976& Cnksr2& Q3URG0& DOWN&
5.38& 7.02& f3.12& 0.003198& Calcr& Q60755& DOWN&
7.54& 9.19& f3.13& 0.001353& I79_005383& #N/A& DOWN&
8.1& 9.75& f3.14& 0.002995& Pirt& Q8BFY0& DOWN&
6.27& 7.92& f3.15& 0.002804& Fpgt& Q2TB53& DOWN&
6.81& 8.47& f3.15& 0.004216& I79_015692& #N/A& DOWN&
6.2& 7.88& f3.19& 0.005138& I79_010946& #N/A& DOWN&




7.83& 9.51& f3.23& 0.002298& I79_014723& #N/A& DOWN&
9.87& 11.58& f3.27& 0.002041& Ncam1& Q61946& DOWN&
7.56& 9.27& f3.27& 0.003005& Gas2& Q9D699& DOWN&
5.59& 7.35& f3.39& 0.001353& I79_000889& #N/A& DOWN&
7.05& 8.82& f3.4& 0.002368& Ugt1a7c& D3YZ96& DOWN&
4.33& 6.1& f3.4& 0.003718& I79_007567& #N/A& DOWN&
8.45& 10.22& f3.41& 0.001353& Ltbp1& Q8CG19& DOWN&
8.11& 9.88& f3.42& 0.001185& Lrriq3& #N/A& DOWN&
5.38& 7.16& f3.43& 0.00327& Murc& A2AMM0& DOWN&
6.45& 8.25& f3.46& 0.002597& I79_004541& #N/A& DOWN&
6.83& 8.65& f3.52& 0.005138& Env& Q811N5& DOWN&
5.9& 7.73& f3.56& 0.002284& LOC100752107& #N/A& DOWN&
7.42& 9.28& f3.62& 0.003147& LOC100754872& #N/A& DOWN&
5.02& 6.88& f3.65& 0.00329& Acadm& P45952& DOWN&
7.57& 9.44& f3.65& 0.002392& Cnksr2& Q3URG0& DOWN&
9.01& 10.91& f3.71& 0.003009& Ankrd13c& Q3UX43& DOWN&
7.73& 9.62& f3.71& 0.001353& Depdc1a& Q8CIG0& DOWN&
5.97& 7.88& f3.75& 0.009963& I79_005407& #N/A& DOWN&
7.33& 9.35& f4.06& 0.002041& Ptprz1& B9EKR1& DOWN&
8.99& 11.02& f4.08& 0.001977& Tp53& #N/A& DOWN&
7.96& 9.99& f4.09& 0.002296& St3gal6& A6X952& DOWN&
7.83& 9.87& f4.1& 0.002967& Ccl27& #N/A& DOWN&
4.96& 7& f4.11& 0.006127& Ttll7& A4Q9F0& DOWN&
7.05& 9.09& f4.11& 0.006025& Lrrc40& Q9CRC8& DOWN&
8.23& 10.3& f4.19& 0.003718& I79_001952& #N/A& DOWN&
6.52& 8.59& f4.21& 0.001353& Ctbs& Q8R242& DOWN&
4.37& 6.45& f4.23& 0.001715& Dctd& Q8K2D6& DOWN&
10.02& 12.29& f4.83& 0.001353& Env& Q811N5& DOWN&
4.3& 6.62& f5& 0.004898& Cyp11b1& Q3TG86& DOWN&
6.51& 8.89& f5.19& 0.003718& LOC100759571& #N/A& DOWN&
3.89& 6.42& f5.8& 0.00543& Il33& Q8BVZ5& DOWN&
9.88& 12.42& f5.81& 0.001055& Efemp1& F6ZFS0& DOWN&
1.51& 4.13& f6.13& 0.00901& fff& #N/A& DOWN&
4.89& 7.73& f7.17& 0.003718& Fgf7& #N/A& DOWN&
4.86& 8.03& f9.05& 0.001353& LOC100757172& #N/A& DOWN&
6.33& 9.68& f10.23& 0.001353& Sgce& O70258& DOWN&
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Tukey's multiple comparisons test Mean Diff. Significant? Summary 
Adjusted P 
Value 
     Hydroxyproline 
    Evolved at early vs. Evolved at mid 7.676 No ns 0.9572 
Evolved at early vs. Evolved at late 5.515 No ns 0.9901 
Evolved at early vs. Parental at early -23.8 No ns 0.0913 
Evolved at early vs. Parental at mid -5.097 No ns 0.9931 
Evolved at early vs. Parental at late -4.83 No ns 0.9946 
Evolved at mid vs. Evolved at late -2.161 No ns 0.9999 
Evolved at mid vs. Parental at early -31.47 Yes ** 0.0074 
Evolved at mid vs. Parental at mid -12.77 No ns 0.7163 
Evolved at mid vs. Parental at late -12.51 No ns 0.7342 
Evolved at late vs. Parental at early -29.31 Yes * 0.0162 
Evolved at late vs. Parental at mid -10.61 No ns 0.8471 
Evolved at late vs. Parental at late -10.34 No ns 0.8606 
Parental at early vs. Parental at mid 18.7 No ns 0.3035 
Parental at early vs. Parental at late 18.97 No ns 0.2879 
Parental at mid vs. Parental at late 0.267 No ns > 0.9999 
     Histidine 
    Evolved at early vs. Evolved at mid 3.215 No ns 0.9992 
Evolved at early vs. Evolved at late -2.332 No ns 0.9998 
Evolved at early vs. Parental at early -12.42 No ns 0.7399 
Evolved at early vs. Parental at mid -0.1109 No ns > 0.9999 
Evolved at early vs. Parental at late -7.199 No ns 0.9675 
Evolved at mid vs. Evolved at late -5.546 No ns 0.9898 
Evolved at mid vs. Parental at early -15.64 No ns 0.5097 
Evolved at mid vs. Parental at mid -3.326 No ns 0.9991 
Evolved at mid vs. Parental at late -10.41 No ns 0.8572 
Evolved at late vs. Parental at early -10.09 No ns 0.8728 
Evolved at late vs. Parental at mid 2.221 No ns 0.9999 
Evolved at late vs. Parental at late -4.867 No ns 0.9944 
Parental at early vs. Parental at mid 12.31 No ns 0.7471 
Parental at early vs. Parental at late 5.222 No ns 0.9923 
Parental at mid vs. Parental at late -7.088 No ns 0.9696 
     Tryptophan 
    Evolved at early vs. Evolved at mid 4.831 No ns 0.9946 
Evolved at early vs. Evolved at late 0.1576 No ns > 0.9999 
Evolved at early vs. Parental at early -14.09 No ns 0.6229 
Evolved at early vs. Parental at mid 0.7423 No ns > 0.9999 
Evolved at early vs. Parental at late 0.5673 No ns > 0.9999 
Evolved at mid vs. Evolved at late -4.673 No ns 0.9954 




Evolved at mid vs. Parental at mid -4.088 No ns 0.9976 
Evolved at mid vs. Parental at late -4.263 No ns 0.997 
Evolved at late vs. Parental at early -14.25 No ns 0.6114 
Evolved at late vs. Parental at mid 0.5847 No ns > 0.9999 
Evolved at late vs. Parental at late 0.4096 No ns > 0.9999 
Parental at early vs. Parental at mid 14.84 No ns 0.5685 
Parental at early vs. Parental at late 14.66 No ns 0.5814 
Parental at mid vs. Parental at late -0.1751 No ns > 0.9999 
     Methionine 
    Evolved at early vs. Evolved at mid -3.087 No ns 0.9994 
Evolved at early vs. Evolved at late -12.13 No ns 0.7588 
Evolved at early vs. Parental at early -13.17 No ns 0.6891 
Evolved at early vs. Parental at mid -4.889 No ns 0.9943 
Evolved at early vs. Parental at late -13.64 No ns 0.6559 
Evolved at mid vs. Evolved at late -9.043 No ns 0.9164 
Evolved at mid vs. Parental at early -10.08 No ns 0.8733 
Evolved at mid vs. Parental at mid -1.801 No ns > 0.9999 
Evolved at mid vs. Parental at late -10.55 No ns 0.8503 
Evolved at late vs. Parental at early -1.038 No ns > 0.9999 
Evolved at late vs. Parental at mid 7.241 No ns 0.9667 
Evolved at late vs. Parental at late -1.507 No ns > 0.9999 
Parental at early vs. Parental at mid 8.279 No ns 0.9414 
Parental at early vs. Parental at late -0.4686 No ns > 0.9999 
Parental at mid vs. Parental at late -8.748 No ns 0.9267 
     Tyrosine 
    Evolved at early vs. Evolved at mid -5.334 No ns 0.9915 
Evolved at early vs. Evolved at late -15.41 No ns 0.5263 
Evolved at early vs. Parental at early -13.08 No ns 0.6951 
Evolved at early vs. Parental at mid -3.522 No ns 0.9988 
Evolved at early vs. Parental at late -15.3 No ns 0.5342 
Evolved at mid vs. Evolved at late -10.07 No ns 0.8736 
Evolved at mid vs. Parental at early -7.747 No ns 0.9556 
Evolved at mid vs. Parental at mid 1.812 No ns > 0.9999 
Evolved at mid vs. Parental at late -9.968 No ns 0.8785 
Evolved at late vs. Parental at early 2.327 No ns 0.9998 
Evolved at late vs. Parental at mid 11.89 No ns 0.7742 
Evolved at late vs. Parental at late 0.1065 No ns > 0.9999 
Parental at early vs. Parental at mid 9.559 No ns 0.8963 
Parental at early vs. Parental at late -2.221 No ns 0.9999 
Parental at mid vs. Parental at late -11.78 No ns 0.7808 
     Cystine 
    Evolved at early vs. Evolved at mid -23.38 No ns 0.1021 
Evolved at early vs. Evolved at late -28.73 Yes * 0.0198 




Evolved at early vs. Parental at mid -22.55 No ns 0.1272 
Evolved at early vs. Parental at late -28.18 Yes * 0.0239 
Evolved at mid vs. Evolved at late -5.349 No ns 0.9914 
Evolved at mid vs. Parental at early 19.16 No ns 0.2769 
Evolved at mid vs. Parental at mid 0.8348 No ns > 0.9999 
Evolved at mid vs. Parental at late -4.799 No ns 0.9948 
Evolved at late vs. Parental at early 24.51 No ns 0.0748 
Evolved at late vs. Parental at mid 6.184 No ns 0.9833 
Evolved at late vs. Parental at late 0.5509 No ns > 0.9999 
Parental at early vs. Parental at mid -18.33 No ns 0.326 
Parental at early vs. Parental at late -23.96 No ns 0.0873 
Parental at mid vs. Parental at late -5.633 No ns 0.9891 
     Phenylalanine 
    Evolved at early vs. Evolved at mid -9.223 No ns 0.9097 
Evolved at early vs. Evolved at late -19.54 No ns 0.2564 
Evolved at early vs. Parental at early -26.69 Yes * 0.0388 
Evolved at early vs. Parental at mid -7.698 No ns 0.9567 
Evolved at early vs. Parental at late -20.78 No ns 0.1953 
Evolved at mid vs. Evolved at late -10.31 No ns 0.8622 
Evolved at mid vs. Parental at early -17.46 No ns 0.3813 
Evolved at mid vs. Parental at mid 1.525 No ns > 0.9999 
Evolved at mid vs. Parental at late -11.56 No ns 0.7943 
Evolved at late vs. Parental at early -7.151 No ns 0.9684 
Evolved at late vs. Parental at mid 11.84 No ns 0.7772 
Evolved at late vs. Parental at late -1.244 No ns > 0.9999 
Parental at early vs. Parental at mid 18.99 No ns 0.2867 
Parental at early vs. Parental at late 5.907 No ns 0.9865 
Parental at mid vs. Parental at late -13.08 No ns 0.6951 
     Threonine 
    Evolved at early vs. Evolved at mid 15.29 No ns 0.5353 
Evolved at early vs. Evolved at late -2.278 No ns 0.9999 
Evolved at early vs. Parental at early -34.41 Yes ** 0.0023 
Evolved at early vs. Parental at mid 8.47 No ns 0.9357 
Evolved at early vs. Parental at late -14.71 No ns 0.5779 
Evolved at mid vs. Evolved at late -17.56 No ns 0.3746 
Evolved at mid vs. Parental at early -49.7 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -6.817 No ns 0.9743 
Evolved at mid vs. Parental at late -29.99 Yes * 0.0127 
Evolved at late vs. Parental at early -32.14 Yes ** 0.0057 
Evolved at late vs. Parental at mid 10.75 No ns 0.84 
Evolved at late vs. Parental at late -12.43 No ns 0.7393 
Parental at early vs. Parental at mid 42.88 Yes **** < 0.0001 
Parental at early vs. Parental at late 19.71 No ns 0.2474 
Parental at mid vs. Parental at late -23.18 No ns 0.108 





    Evolved at early vs. Evolved at mid -2.056 No ns > 0.9999 
Evolved at early vs. Evolved at late -17.65 No ns 0.3689 
Evolved at early vs. Parental at early -27.68 Yes * 0.0282 
Evolved at early vs. Parental at mid -4.153 No ns 0.9974 
Evolved at early vs. Parental at late -23.51 No ns 0.0986 
Evolved at mid vs. Evolved at late -15.6 No ns 0.5126 
Evolved at mid vs. Parental at early -25.62 No ns 0.054 
Evolved at mid vs. Parental at mid -2.097 No ns > 0.9999 
Evolved at mid vs. Parental at late -21.46 No ns 0.1667 
Evolved at late vs. Parental at early -10.03 No ns 0.8758 
Evolved at late vs. Parental at mid 13.5 No ns 0.6657 
Evolved at late vs. Parental at late -5.862 No ns 0.9869 
Parental at early vs. Parental at mid 23.52 No ns 0.0983 
Parental at early vs. Parental at late 4.163 No ns 0.9973 
Parental at mid vs. Parental at late -19.36 No ns 0.2658 
     Isoleucine 
    Evolved at early vs. Evolved at mid 9.456 No ns 0.9005 
Evolved at early vs. Evolved at late -3.792 No ns 0.9983 
Evolved at early vs. Parental at early -34.87 Yes ** 0.0019 
Evolved at early vs. Parental at mid -5.592 No ns 0.9894 
Evolved at early vs. Parental at late -11.74 No ns 0.7834 
Evolved at mid vs. Evolved at late -13.25 No ns 0.6835 
Evolved at mid vs. Parental at early -44.32 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -15.05 No ns 0.5528 
Evolved at mid vs. Parental at late -21.19 No ns 0.1775 
Evolved at late vs. Parental at early -31.08 Yes ** 0.0086 
Evolved at late vs. Parental at mid -1.801 No ns > 0.9999 
Evolved at late vs. Parental at late -7.945 No ns 0.9506 
Parental at early vs. Parental at mid 29.28 Yes * 0.0164 
Parental at early vs. Parental at late 23.13 No ns 0.1093 
Parental at mid vs. Parental at late -6.145 No ns 0.9838 
     Valine 
    Evolved at early vs. Evolved at mid 16.59 No ns 0.4414 
Evolved at early vs. Evolved at late -0.07855 No ns > 0.9999 
Evolved at early vs. Parental at early -29.35 Yes * 0.016 
Evolved at early vs. Parental at mid 7.571 No ns 0.9597 
Evolved at early vs. Parental at late -5.971 No ns 0.9858 
Evolved at mid vs. Evolved at late -16.67 No ns 0.4359 
Evolved at mid vs. Parental at early -45.94 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -9.016 No ns 0.9174 
Evolved at mid vs. Parental at late -22.56 No ns 0.1269 
Evolved at late vs. Parental at early -29.27 Yes * 0.0164 
Evolved at late vs. Parental at mid 7.65 No ns 0.9579 




Parental at early vs. Parental at mid 36.92 Yes *** 0.0008 
Parental at early vs. Parental at late 23.38 No ns 0.1023 
Parental at mid vs. Parental at late -13.54 No ns 0.6627 
     Lysine 
    Evolved at early vs. Evolved at mid 13.08 No ns 0.6953 
Evolved at early vs. Evolved at late -6.97 No ns 0.9717 
Evolved at early vs. Parental at early -30.24 Yes * 0.0116 
Evolved at early vs. Parental at mid 9.018 No ns 0.9173 
Evolved at early vs. Parental at late -17.26 No ns 0.3951 
Evolved at mid vs. Evolved at late -20.05 No ns 0.2299 
Evolved at mid vs. Parental at early -43.32 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -4.06 No ns 0.9976 
Evolved at mid vs. Parental at late -30.34 Yes * 0.0112 
Evolved at late vs. Parental at early -23.27 No ns 0.1052 
Evolved at late vs. Parental at mid 15.99 No ns 0.4841 
Evolved at late vs. Parental at late -10.29 No ns 0.8634 
Parental at early vs. Parental at mid 39.26 Yes *** 0.0003 
Parental at early vs. Parental at late 12.99 No ns 0.7016 
Parental at mid vs. Parental at late -26.28 Yes * 0.0442 
     Leucine 
    Evolved at early vs. Evolved at mid 10.9 No ns 0.8321 
Evolved at early vs. Evolved at late -13.27 No ns 0.6819 
Evolved at early vs. Parental at early -58.51 Yes **** < 0.0001 
Evolved at early vs. Parental at mid -9.549 No ns 0.8967 
Evolved at early vs. Parental at late -17.91 No ns 0.3521 
Evolved at mid vs. Evolved at late -24.17 No ns 0.0824 
Evolved at mid vs. Parental at early -69.4 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -20.44 No ns 0.2107 
Evolved at mid vs. Parental at late -28.81 Yes * 0.0193 
Evolved at late vs. Parental at early -45.24 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 3.722 No ns 0.9984 
Evolved at late vs. Parental at late -4.642 No ns 0.9956 
Parental at early vs. Parental at mid 48.96 Yes **** < 0.0001 
Parental at early vs. Parental at late 40.59 Yes *** 0.0001 
Parental at mid vs. Parental at late -8.364 No ns 0.9389 
     Proline 
    Evolved at early vs. Evolved at mid -43.57 Yes **** < 0.0001 
Evolved at early vs. Evolved at late -62.59 Yes **** < 0.0001 
Evolved at early vs. Parental at early -122.5 Yes **** < 0.0001 
Evolved at early vs. Parental at mid -62.25 Yes **** < 0.0001 
Evolved at early vs. Parental at late -85 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late -19.01 No ns 0.2853 
Evolved at mid vs. Parental at early -78.91 Yes **** < 0.0001 




Evolved at mid vs. Parental at late -41.43 Yes **** < 0.0001 
Evolved at late vs. Parental at early -59.9 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 0.3329 No ns > 0.9999 
Evolved at late vs. Parental at late -22.41 No ns 0.1317 
Parental at early vs. Parental at mid 60.23 Yes **** < 0.0001 
Parental at early vs. Parental at late 37.48 Yes *** 0.0006 
Parental at mid vs. Parental at late -22.75 No ns 0.1209 
     Glutamic acid 
    Evolved at early vs. Evolved at mid 64.33 Yes **** < 0.0001 
Evolved at early vs. Evolved at late 47.6 Yes **** < 0.0001 
Evolved at early vs. Parental at early -25.02 No ns 0.0645 
Evolved at early vs. Parental at mid 97.03 Yes **** < 0.0001 
Evolved at early vs. Parental at late 99.41 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late -16.73 No ns 0.4314 
Evolved at mid vs. Parental at early -89.35 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid 32.7 Yes ** 0.0046 
Evolved at mid vs. Parental at late 35.08 Yes ** 0.0017 
Evolved at late vs. Parental at early -72.62 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 49.43 Yes **** < 0.0001 
Evolved at late vs. Parental at late 51.81 Yes **** < 0.0001 
Parental at early vs. Parental at mid 122.1 Yes **** < 0.0001 
Parental at early vs. Parental at late 124.4 Yes **** < 0.0001 
Parental at mid vs. Parental at late 2.382 No ns 0.9998 
     Aspartic acid 
    Evolved at early vs. Evolved at mid 65.58 Yes **** < 0.0001 
Evolved at early vs. Evolved at late 121.4 Yes **** < 0.0001 
Evolved at early vs. Parental at early -48.06 Yes **** < 0.0001 
Evolved at early vs. Parental at mid 112.8 Yes **** < 0.0001 
Evolved at early vs. Parental at late 152 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late 55.82 Yes **** < 0.0001 
Evolved at mid vs. Parental at early -113.6 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid 47.25 Yes **** < 0.0001 
Evolved at mid vs. Parental at late 86.39 Yes **** < 0.0001 
Evolved at late vs. Parental at early -169.5 Yes **** < 0.0001 
Evolved at late vs. Parental at mid -8.562 No ns 0.9328 
Evolved at late vs. Parental at late 30.57 Yes * 0.0103 
Parental at early vs. Parental at mid 160.9 Yes **** < 0.0001 
Parental at early vs. Parental at late 200 Yes **** < 0.0001 
Parental at mid vs. Parental at late 39.13 Yes *** 0.0003 
     Glycine 
    Evolved at early vs. Evolved at mid 70.55 Yes **** < 0.0001 
Evolved at early vs. Evolved at late 80.61 Yes **** < 0.0001 
Evolved at early vs. Parental at early -35.86 Yes ** 0.0013 




Evolved at early vs. Parental at late 37.88 Yes *** 0.0005 
Evolved at mid vs. Evolved at late 10.07 No ns 0.8739 
Evolved at mid vs. Parental at early -106.4 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -7.652 No ns 0.9578 
Evolved at mid vs. Parental at late -32.66 Yes ** 0.0047 
Evolved at late vs. Parental at early -116.5 Yes **** < 0.0001 
Evolved at late vs. Parental at mid -17.72 No ns 0.3645 
Evolved at late vs. Parental at late -42.73 Yes **** < 0.0001 
Parental at early vs. Parental at mid 98.75 Yes **** < 0.0001 
Parental at early vs. Parental at late 73.74 Yes **** < 0.0001 
Parental at mid vs. Parental at late -25.01 No ns 0.0647 
     Alanine 
    Evolved at early vs. Evolved at mid 83.63 Yes **** < 0.0001 
Evolved at early vs. Evolved at late 116.5 Yes **** < 0.0001 
Evolved at early vs. Parental at early 12.86 No ns 0.7105 
Evolved at early vs. Parental at mid 26.69 Yes * 0.0389 
Evolved at early vs. Parental at late 161.5 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late 32.83 Yes ** 0.0044 
Evolved at mid vs. Parental at early -70.77 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid -56.94 Yes **** < 0.0001 
Evolved at mid vs. Parental at late 77.9 Yes **** < 0.0001 
Evolved at late vs. Parental at early -103.6 Yes **** < 0.0001 
Evolved at late vs. Parental at mid -89.77 Yes **** < 0.0001 
Evolved at late vs. Parental at late 45.06 Yes **** < 0.0001 
Parental at early vs. Parental at mid 13.83 No ns 0.642 
Parental at early vs. Parental at late 148.7 Yes **** < 0.0001 
Parental at mid vs. Parental at late 134.8 Yes **** < 0.0001 
     Serine 
    Evolved at early vs. Evolved at mid -71.18 Yes **** < 0.0001 
Evolved at early vs. Evolved at late -153 Yes **** < 0.0001 
Evolved at early vs. Parental at early -54.32 Yes **** < 0.0001 
Evolved at early vs. Parental at mid -82.15 Yes **** < 0.0001 
Evolved at early vs. Parental at late -111.9 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late -81.83 Yes **** < 0.0001 
Evolved at mid vs. Parental at early 16.86 No ns 0.4222 
Evolved at mid vs. Parental at mid -10.97 No ns 0.828 
Evolved at mid vs. Parental at late -40.68 Yes *** 0.0001 
Evolved at late vs. Parental at early 98.7 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 70.86 Yes **** < 0.0001 
Evolved at late vs. Parental at late 41.15 Yes *** 0.0001 
Parental at early vs. Parental at mid -27.83 Yes * 0.0268 
Parental at early vs. Parental at late -57.54 Yes **** < 0.0001 
Parental at mid vs. Parental at late -29.71 Yes * 0.0141 
     Asparagine 




Evolved at early vs. Evolved at mid 79.35 Yes **** < 0.0001 
Evolved at early vs. Evolved at late -31.32 Yes ** 0.0078 
Evolved at early vs. Parental at early 78.99 Yes **** < 0.0001 
Evolved at early vs. Parental at mid 113.9 Yes **** < 0.0001 
Evolved at early vs. Parental at late -86.05 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late -110.7 Yes **** < 0.0001 
Evolved at mid vs. Parental at early -0.3638 No ns > 0.9999 
Evolved at mid vs. Parental at mid 34.54 Yes ** 0.0022 
Evolved at mid vs. Parental at late -165.4 Yes **** < 0.0001 
Evolved at late vs. Parental at early 110.3 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 145.2 Yes **** < 0.0001 
Evolved at late vs. Parental at late -54.73 Yes **** < 0.0001 
Parental at early vs. Parental at mid 34.91 Yes ** 0.0019 
Parental at early vs. Parental at late -165 Yes **** < 0.0001 
Parental at mid vs. Parental at late -199.9 Yes **** < 0.0001 
     Glutamine 
    Evolved at early vs. Evolved at mid -558.1 Yes **** < 0.0001 
Evolved at early vs. Evolved at late -672.4 Yes **** < 0.0001 
Evolved at early vs. Parental at early -45.53 Yes **** < 0.0001 
Evolved at early vs. Parental at mid -528.9 Yes **** < 0.0001 
Evolved at early vs. Parental at late -675.9 Yes **** < 0.0001 
Evolved at mid vs. Evolved at late -114.2 Yes **** < 0.0001 
Evolved at mid vs. Parental at early 512.6 Yes **** < 0.0001 
Evolved at mid vs. Parental at mid 29.29 Yes * 0.0163 
Evolved at mid vs. Parental at late -117.7 Yes **** < 0.0001 
Evolved at late vs. Parental at early 626.8 Yes **** < 0.0001 
Evolved at late vs. Parental at mid 143.5 Yes **** < 0.0001 
Evolved at late vs. Parental at late -3.507 No ns 0.9988 
Parental at early vs. Parental at mid -483.3 Yes **** < 0.0001 
Parental at early vs. Parental at late -630.4 Yes **** < 0.0001 
Parental at mid vs. Parental at late -147 Yes **** < 0.0001 
(
